pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites,P_joint,Q_joint
Biosynthesis of unsaturated fatty acids - Homo sapiens (human),KEGG,4,ELOVL7;ACOT7;HACD4;HACD3,27 (27),0.0398,0.456,13,HMDB02368;HMDB02003;HMDB00220;HMDB05060;HMDB02226;HMDB00944;HMDB01388;HMDB02212;HMDB01043;HMDB00673;HMDB02925;HMDB02068;HMDB01999,32 (55),2.08e-17,8.9e-14,3.53e-17,8.95e-14
phospholipases,HumanCyc,5,PLCG2;PLCD3;PLA2G12A;PLCB4;PLD2,41 (41),0.0471,0.498,9,HMDB02003;HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,31 (55),1.25e-10,8.98e-08,1.58e-10,2.01e-07
Alpha Linolenic Acid and Linoleic Acid Metabolism,SMPDB,0,,6 (6),1,1,8,HMDB06547;HMDB02226;HMDB02925;HMDB01388;HMDB01043;HMDB00673;HMDB08048#HMDB08036#HMDB08038;HMDB01999,17 (18),1.57e-11,3.35e-08,4.06e-10,3.42e-07
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),Reactome,3,NCOA1;NCOR1;TBL1XR1,20 (20),0.0703,0.613,5,HMDB01388;HMDB00673;HMDB01999;HMDB01043;HMDB00220,5 (5),4.37e-10,1.55e-07,7.74e-10,4.9e-07
sphingomyelin metabolism/ceramide salvage,HumanCyc,1,SMPD3,8 (8),0.329,1,9,HMDB02003;HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,31 (55),1.25e-10,8.98e-08,1.03e-09,5.19e-07
triacylglycerol degradation,HumanCyc,1,PNPLA2,15 (15),0.526,1,9,HMDB02003;HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,31 (54),1.25e-10,8.98e-08,1.61e-09,6.8e-07
retinol biosynthesis,HumanCyc,1,RDH12,20 (20),0.631,1,8,HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,22 (37),1.96e-10,1.06e-07,2.95e-09,9.5e-07
fatty acid activation,HumanCyc,0,,8 (8),1,1,8,HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,21 (38),1.26e-10,8.98e-08,3e-09,9.5e-07
BMAL1-CLOCK_NPAS2 activates circadian gene expression,Wikipathways,1,NAMPT,10 (10),0.392,1,5,HMDB00220;HMDB00673;HMDB01043;HMDB01999;HMDB01388,5 (5),4.37e-10,1.55e-07,4.02e-09,1.11e-06
GPCR downstream signalling,Reactome,38,JAK1;ADORA2A;RTP4;GPR132;AKT3;PDE6A;PPP3CC;FGD4;PIK3CA;CXCL10;CXCR4;PIK3CG;GPR65;RPS6KA2;GRK5;GNG2;GPR55;RPS6KA3;ARHGEF12;SDC3;PRKCA;SSTR4;DGKH;PLCB4;PDE1A;ARHGEF11;F2RL1;CXCL3;RDH12;S1PR1;SDC1;IL5RA;SDC4;ARHGEF6;EDNRA;TIAM2;GPC4;ITPR2,1171 (1176),0.998,1,15,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038;HMDB00220;HMDB02226;HMDB01201;HMDB02925;HMDB01388;HMDB00806;HMDB01043;HMDB00295;HMDB00673;HMDB01397;HMDB00658#HMDB10370;HMDB01999,146 (209),1.99e-10,1.06e-07,4.63e-09,1.11e-06
Signal Transduction,Reactome,136,CYLD;APH1B;HGF;ARHGAP32;PDE1A;ATP6V1E1;SQSTM1;ARHGAP24;ATP6V0A1;PDE6A;PDGFA;PDGFRA;ZFYVE16;TNFSF10;KDM4C;CXCL10;PPP1R12A;RPS6KA2;RPS6KA3;MKRN1;INSR;LRRK2;DNER;CD55;PDGFD;GPR55;TAX1BP1;ARHGEF11;NCF2;DGKH;ITGA3;PTCH1;MDM2;SSTR4;F2RL1;CLIP1;RTP4;MEF2C;RYK;STAT1;TIAM2;DDX5;FLT4;NRP2;NRP1;JAK1;CFLAR;ADORA2A;BMPR1A;NDEL1;AGO4;RRAGD;BRAF;FGD4;PIK3CA;RAPGEF3;CXCR4;PIK3CG;SDC3;SRGAP1;RASGRP3;BTK;GRAP2;GPC4;PLCB4;SPOP;FGFR2;ALDH1A1;MMP2;PRKAG2;PEBP1;GPR132;SDC1;ITPR2;SDC4;ARHGEF6;RASAL1;APBB1IP;SEL1L;FOXO1;AKT3;SMPD3;RAP1B;GPR65;NR3C1;CAMK2A;CAMK2D;GRK5;PRR5;ARHGAP6;CASP3;ARHGEF12;BIRC2;RDH12;LAMC1;STAM;BCAR1;TEC;SKIL;GNG2;TBL1XR1;CXCL3;S1PR1;LEPR;EDNRA;MKNK1;ARPC2;TGFBR1;RHOQ;NCOR1;GTF2A1;IGF1R;PPP3CC;SRMS;LRIG1;RHPN2;ABI2;CD28;CD80;TLE4;RHOBTB1;ARHGAP12;F11R;PAK1;WNT10A;NCOA1;PRKCA;ATF1;IRS2;PRKCZ;MAML2;SYVN1;MAPK11;IL5RA;EPAS1;ARHGAP31,2633 (2647),0.218,0.928,16,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038;HMDB00220;HMDB02226;HMDB01201;HMDB01397;HMDB01388;HMDB00806;HMDB01043;HMDB04951;HMDB00295;HMDB00673;HMDB02925;HMDB00658#HMDB10370;HMDB01999,192 (271),9.49e-10,2.7e-07,4.82e-09,1.11e-06
Signaling by GPCR,Reactome,41,JAK1;ADORA2A;RTP4;GPR132;AKT3;PDE6A;PPP3CC;FGD4;PIK3CA;CXCL10;CXCR4;PIK3CG;GPR65;RPS6KA2;GRK5;GNG2;GPR55;RPS6KA3;CD55;ARHGEF12;WNT10A;SDC3;PRKCA;SSTR4;DGKH;PLCB4;PTCH1;PDE1A;ARHGEF11;F2RL1;CXCL3;RDH12;S1PR1;SDC1;IL5RA;SDC4;ARHGEF6;EDNRA;TIAM2;GPC4;ITPR2,1234 (1240),0.998,1,15,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038;HMDB00220;HMDB02226;HMDB01201;HMDB02925;HMDB01388;HMDB00806;HMDB01043;HMDB00295;HMDB00673;HMDB01397;HMDB00658#HMDB10370;HMDB01999,148 (213),2.42e-10,1.15e-07,5.6e-09,1.18e-06
the visual cycle I (vertebrates),HumanCyc,1,RDH12,17 (17),0.571,1,9,HMDB02003;HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,36 (58),5.58e-10,1.7e-07,7.28e-09,1.42e-06
RORA activates gene expression,Wikipathways,0,,2 (2),1,1,5,HMDB01388;HMDB00673;HMDB01043;HMDB01999;HMDB00220,5 (5),4.37e-10,1.55e-07,9.85e-09,1.78e-06
Immune System,Reactome,133,IL10;CYLD;LGMN;HGF;SP100;ATP6V1E1;IL18;ATP6V0A1;TRIM25;GBP7;CD55;RPS6KA2;RPS6KA3;B2M;MKRN1;BLNK;RAP1GAP2;GBP2;IRF1;IRF2;IRF4;IRF5;IRF6;PGLYRP2;LY96;TNFRSF17;ITGAL;CREG1;ADAM8;ITGB7;MEF2C;STAT1;YPEL5;DDX3X;MAP3K3;ITPR2;CISH;JAK1;ZBP1;PAK1;MAPK12;TXNDC5;ATP11B;GBP4;GBP5;SERPING1;PIK3CA;RAPGEF3;SQSTM1;RASGRP3;TAX1BP1;GRAP2;NLRC5;AP1S2;PYGL;IRAK3;EIF4E3;ATP11A;UNC93B1;PLCG2;PLD2;TAP1;MNDA;RAB5B;SDC1;CD200;ARMC8;MRC1;MGAM;AKT3;RAP1B;RAP1GAP;ATG7;PILRA;RCHY1;CAMK2A;CAMK2D;PRDX4;GMFG;CASP1;CASP3;FBXL20;RAB3D;PELI1;OAS3;TRIM39;SAMHD1;IL18BP;TEC;NLRP3;PRR5;ARPC2;TXNIP;ASB13;BTK;ORMDL3;RNASEL;KLHL25;IL5RA;ABI2;CD28;CD80;GSDMD;TNFSF13B;EIF4A2;BIRC2;TLR5;XDH;SLPI;TNFRSF13C;CD274;TNFRSF13B;RNF34;CD74;CD79A;CD79B;CARD11;ATF1;XAF1;IRS2;CTLA4;PTPN22;SLAMF7;MAPK11;NCF2;MAPK13;HERC4;CTSO;CTSS;CD96;PRLR;IL27;PDCD1LG2,1827 (1840),5.46e-07,0.000501,5,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB04951;HMDB00658#HMDB10370;HMDB01201;HMDB08048#HMDB08036#HMDB08038,56 (136),0.000992,0.0481,1.21e-08,1.97e-06
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,0,,9 (9),1,1,9,HMDB02003;HMDB00220;HMDB00944;HMDB01388;HMDB00806;HMDB02212;HMDB01043;HMDB00673;HMDB01999,36 (59),5.58e-10,1.7e-07,1.24e-08,1.97e-06
VEGF,INOH,29,JAK1;TGFBR1;AKT3;BMPR1A;FLT4;IGF1R;MAPK12;BRAF;PDGFRA;PIK3CA;CAMK2A;CAMK2D;RPS6KA2;GRK5;BTK;INSR;RPS6KA3;PAK1;PRKCA;PRKCZ;FGFR2;PLCG2;PRKAG2;MAPK11;MAPK13;TEC;RYK;MAP3K3;MKNK1,187 (188),2.63e-08,4.03e-05,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (4),0.0423,0.338,2.41e-08,3.59e-06
Rap1 signaling pathway - Homo sapiens (human),KEGG,28,RAPGEF5;ADORA2A;RASSF5;HGF;AKT3;RAP1B;RAP1GAP;IGF1R;MAPK12;BRAF;PDGFA;PDGFRA;PIK3CA;RAPGEF3;RASGRP3;PDGFD;INSR;PRKCA;MAPK13;PLCB4;PRKCZ;FGFR2;BCAR1;MAPK11;ITGAL;APBB1IP;FLT4;FARP2,206 (206),7.61e-07,0.000582,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,5 (5),0.00193,0.073,3.13e-08,4.41e-06
Circadian Clock,Wikipathways,2,NR1D1;CLOCK,10 (10),0.0818,0.668,5,HMDB00220;HMDB00673;HMDB01043;HMDB01999;HMDB01388,8 (9),2.37e-08,5.33e-06,4.09e-08,5.45e-06
Activation of gene expression by SREBF (SREBP),Wikipathways,0,,20 (20),1,1,5,HMDB00220;HMDB00673;HMDB01999;HMDB01043;HMDB01388,6 (6),2.59e-09,6.92e-07,5.39e-08,6.82e-06
Incretin synthesis_ secretion_ and inactivation,Wikipathways,0,,2 (2),1,1,7,HMDB10384;HMDB00220;HMDB02226;HMDB02925;HMDB01388;HMDB00806;HMDB01999,19 (22),2.79e-09,7e-07,5.76e-08,6.95e-06
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human),KEGG,18,PRKCA;COL3A1;PLCD3;MAPK13;FOXO1;TGFBR1;PIK3CA;AKT3;COL1A2;STAT1;MAPK11;PRKCZ;MMP2;PLCG2;PLCB4;MAPK12;COL1A1;CASP3,99 (99),1.11e-06,0.00064,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (10),0.00287,0.0845,6.58e-08,7.57e-06
G alpha (q) signalling events,Reactome,13,F2RL1;PRKCA;GPR132;GPR65;DGKH;PLCB4;GRK5;EDNRA;RPS6KA2;GNG2;ITPR2;PIK3CA;RPS6KA3,213 (213),0.236,0.973,9,HMDB00295;HMDB00220;HMDB02226;HMDB01201;HMDB02925;HMDB01388;HMDB00806;HMDB01043;HMDB01999,52 (63),1.87e-08,4.44e-06,8.95e-08,9.85e-06
G alpha (q) signalling events,Wikipathways,0,,0 (0),1,1,8,HMDB00295;HMDB00220;HMDB02226;HMDB01201;HMDB02925;HMDB01388;HMDB00806;HMDB01999,42 (52),5.96e-08,1.11e-05,5.96e-08,1.11e-05
Transport of small molecules,Reactome,32,SEL1L;SLC9A9;ATP6V1E1;SLC44A1;ATP6V0A1;ATP2C1;SLC12A2;SLC12A4;ABCA6;ABCA5;EMB;SGK1;CAMK2A;CAMK2D;DERL3;GNG2;ATP11B;SLC26A11;CP;SLC39A4;SLC13A5;ADD3;ATP11A;SLC46A1;ANO10;ATP9A;ABCD2;ATP1B3;SLC40A1;ATP8B2;SLC3A2;MCOLN2,664 (666),0.545,1,14,HMDB10384;HMDB00288;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB02003;HMDB00220;HMDB01201;HMDB01397;HMDB00806;HMDB02212;HMDB00158;HMDB00159;HMDB00673;HMDB08048#HMDB08036#HMDB08038;HMDB00658#HMDB10370,177 (226),3.32e-08,7.09e-06,3.41e-07,3.59e-05
EPO signaling,INOH,29,JAK1;TGFBR1;AKT3;BMPR1A;FLT4;IGF1R;MAPK12;BRAF;PDGFRA;PIK3CA;CAMK2A;CAMK2D;RPS6KA2;GRK5;BTK;INSR;RPS6KA3;PAK1;PRKCA;PRKCZ;FGFR2;PRKAG2;MAPK11;MAPK13;TEC;RYK;STAT1;MAP3K3;MKNK1,185 (186),2.06e-08,4.03e-05,0,,0 (2),1,1,2.06e-08,4.03e-05
Cytokine Signaling in Immune system,Reactome,51,CISH;JAK1;HGF;CASP1;SP100;IL5RA;IL18;RNASEL;TRIM25;GBP4;GBP5;GBP7;CAMK2D;PIK3CA;SQSTM1;CAMK2A;TNFSF13B;IL10;RPS6KA2;RPS6KA3;EIF4A2;B2M;GBP2;BLNK;MAPK11;TNFRSF13C;CASP3;TNFRSF13B;BIRC2;PELI1;IRF1;OAS3;IRAK3;IRF4;IRF5;IRF6;EIF4E3;ATF1;SAMHD1;IRS2;TEC;TNFRSF17;IRF2;SDC1;MEF2C;PRLR;XAF1;STAT1;MAP3K3;IL18BP;IL27,458 (458),2.33e-08,4.03e-05,0,,7 (27),1,1,4.32e-07,4.38e-05
JAK STAT pathway and regulation,INOH,36,IL10;JAK1;TGFBR1;PAK1;AKT3;BMPR1A;FLT4;IL18;IGF1R;MAPK12;BRAF;PDGFRA;TNFSF10;CAMK2A;CAMK2D;PSMA3;GRK5;BTK;RPS6KA2;INSR;RPS6KA3;PSMB9;PRKCA;PRKCZ;FGFR2;PRKAG2;MAPK11;MAPK13;TEC;IL5RA;LEPR;PRLR;RYK;STAT1;MAP3K3;MKNK1,309 (310),9.79e-07,0.00064,1,HMDB01201,2 (2),0.0284,0.317,5.11e-07,4.98e-05
IL-7 signaling,INOH,28,JAK1;TGFBR1;AKT3;BMPR1A;FLT4;IGF1R;MAPK12;BRAF;PDGFRA;PIK3CA;CAMK2A;CAMK2D;RPS6KA2;GRK5;BTK;INSR;RPS6KA3;PAK1;PRKCA;PRKCZ;FGFR2;PRKAG2;MAPK11;MAPK13;TEC;RYK;MAP3K3;MKNK1,184 (185),6.94e-08,7.96e-05,0,,0 (0),1,1,6.94e-08,7.96e-05
Transport of fatty acids,Reactome,0,,8 (8),1,1,5,HMDB00220;HMDB00673;HMDB02212;HMDB00806;HMDB02003,9 (10),5.28e-08,1.03e-05,9.38e-07,8.48e-05
Transcriptional regulation of white adipocyte differentiation,Wikipathways,0,,15 (15),1,1,5,HMDB01388;HMDB00673;HMDB01999;HMDB01043;HMDB00220,9 (9),5.28e-08,1.03e-05,9.38e-07,8.48e-05
Integrin,INOH,20,COL2A1;BRAF;ITGAL;DOCK5;COL3A1;SDC3;COL5A2;TNXB;SDC1;ITGB7;SDC4;ARHGEF6;RAP1B;COL11A1;NCAN;ITGA3;BCAR1;COL1A1;COL1A2;GPC4,124 (124),2.05e-06,0.00105,1,HMDB01201,2 (2),0.0284,0.317,1.03e-06,8.99e-05
Platelet activation - Homo sapiens (human),KEGG,19,MAPK11;COL3A1;MAPK13;TBXAS1;ARHGEF12;PRKCZ;PIK3CA;PIK3CG;COL1A1;AKT3;PPP1R12A;PLCB4;APBB1IP;BTK;PLCG2;RAP1B;MAPK12;ITPR2;COL1A2,123 (123),7.08e-06,0.00232,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,14 (15),0.0162,0.245,1.95e-06,0.000164
Free fatty acid receptors,Reactome,0,,5 (5),1,1,6,HMDB00220;HMDB02226;HMDB02925;HMDB01388;HMDB00806;HMDB01999,20 (24),1.79e-07,3.18e-05,2.95e-06,0.00024
Mitochondrial biogenesis,Wikipathways,1,PERM1,17 (17),0.571,1,5,HMDB00220;HMDB00673;HMDB01043;HMDB01999;HMDB01388,12 (14),3.22e-07,5.5e-05,3.04e-06,0.00024
Fcgamma receptor (FCGR) dependent phagocytosis,Wikipathways,0,,0 (0),1,1,5,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043;HMDB01201;HMDB08048#HMDB08036#HMDB08038,16 (18),1.71e-06,0.00027,1.71e-06,0.00027
Signaling by Receptor Tyrosine Kinases,Reactome,41,ADORA2A;APH1B;HGF;NCOR1;AKT3;ATP6V1E1;FLT4;RAP1B;ATP6V0A1;IGF1R;BRAF;PDGFA;ITGA3;PDGFRA;ABI2;PIK3CA;RPS6KA2;RPS6KA3;PDGFD;GRAP2;INSR;PRR5;PAK1;PRKCA;LAMC1;LRIG1;NCF2;ATF1;IRS2;PRKCZ;FGFR2;STAM;BCAR1;TEC;MAPK11;ITPR2;MEF2C;STAT1;MKNK1;NRP2;NRP1,423 (423),1.87e-05,0.00374,3,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00295;HMDB01201,34 (44),0.0118,0.202,3.6e-06,0.000277
PLC beta mediated events,Reactome,4,PDE1A;PRKCA;PLCB4;ITPR2,44 (44),0.164,0.867,5,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201;HMDB01043;HMDB08048#HMDB08036#HMDB08038,17 (19),2.39e-06,0.000352,6.17e-06,0.000453
Metabolism of lipids,Reactome,50,PIKFYVE;HEXA;B3GALNT1;TBXAS1;LPIN1;GDPD5;PHYH;NCOR1;PNPLA2;SMPD3;BMX;SLC44A1;PTPN13;LPCAT2;HACD3;FIG4;EHHADH;PLA2G12A;PIK3CG;LIPH;GDPD3;ORMDL3;PPM1L;AGPAT4;ACOT7;GPCPD1;PON3;NCOA1;PLEKHA1;PLEKHA2;ETNK1;INPP4B;HACD4;TNFAIP8;PLD2;FAR1;PRKAG2;PNPLA7;ALDH3A2;ESYT2;HSD17B11;TBL1XR1;PIK3C2B;PTGIS;ALOX12;PLEKHA8;FAAH;ELOVL7;PCYT1B;PIK3CA,659 (664),0.00111,0.0718,13,HMDB11592#HMDB06750;HMDB10384;HMDB00295;HMDB00220;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB08048#HMDB08036#HMDB08038;HMDB01388;HMDB01043;HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00673;HMDB00658#HMDB10370;HMDB01999,334 (620),0.000358,0.0204,6.26e-06,0.000453
G-protein mediated events,Reactome,4,PDE1A;PRKCA;PLCB4;ITPR2,45 (45),0.173,0.867,5,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201;HMDB01043;HMDB08048#HMDB08036#HMDB08038,17 (19),2.39e-06,0.000352,6.51e-06,0.000458
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),Wikipathways,1,TIAM2,41 (41),0.871,1,5,HMDB00220;HMDB00673;HMDB01999;HMDB01043;HMDB01388,13 (15),5.18e-07,8.51e-05,7.04e-06,0.000482
Phospholipid metabolism,Reactome,26,PIKFYVE;LPIN1;GDPD5;PNPLA2;PLEKHA8;BMX;SLC44A1;PTPN13;LPCAT2;PIK3C2B;FIG4;PIK3CA;PLA2G12A;PIK3CG;LIPH;GDPD3;AGPAT4;GPCPD1;PLEKHA1;PLEKHA2;ETNK1;TNFAIP8;PLD2;PNPLA7;INPP4B;PCYT1B,216 (216),1.77e-05,0.00374,3,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,50 (103),0.0331,0.336,8.98e-06,0.000598
Sphingolipid metabolism,Wikipathways,0,,0 (0),1,1,7,HMDB11592#HMDB06750;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB08048#HMDB08036#HMDB08038;HMDB00220;HMDB00295,51 (67),4.65e-06,0.000662,4.65e-06,0.000662
Sphingolipid metabolism,Reactome,7,ALDH3A2;HEXA;B3GALNT1;ESYT2;ORMDL3;SMPD3;PPM1L,91 (92),0.153,0.859,7,HMDB11592#HMDB06750;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB08048#HMDB08036#HMDB08038;HMDB00220;HMDB00295,52 (68),5.32e-06,0.000732,1.22e-05,0.000794
C-type lectin receptor signaling pathway - Homo sapiens (human),KEGG,17,PAK1;MDM2;IL10;MAPK13;CYLD;ARHGEF12;PIK3CA;IRF1;CASP1;PPP3CC;AKT3;STAT1;MAPK11;PLCG2;NLRP3;MAPK12;ITPR2,104 (104),9.89e-06,0.00267,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (11),0.096,0.441,1.41e-05,0.000894
Opioid Signalling,Wikipathways,0,,0 (0),1,1,5,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043;HMDB01201;HMDB08048#HMDB08036#HMDB08038,21 (22),7.55e-06,0.000921,7.55e-06,0.000921
Transport of vitamins_ nucleosides_ and related molecules,Wikipathways,0,,0 (0),1,1,7,HMDB00288;HMDB02003;HMDB00220;HMDB01397;HMDB00806;HMDB02212;HMDB00673,56 (60),8.85e-06,0.00104,8.85e-06,0.00104
Oxylipin metabolism,Wikipathways,0,,0 (0),1,1,6,HMDB05060;HMDB01388;HMDB01043;HMDB00673;HMDB02925;HMDB01999,37 (64),9.02e-06,0.00104,9.02e-06,0.00104
Neurotrophin signaling pathway - Homo sapiens (human),KEGG,15,MAPK11;BRAF;MAPK13;PIK3CA;ATF4;IRAK3;CAMK2A;AKT3;CAMK2D;RPS6KA2;RPS6KA3;MAP3K3;PLCG2;RAP1B;MAPK12,119 (119),0.000635,0.0502,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.00193,0.073,1.79e-05,0.00111
Opioid Signalling,Reactome,6,PRKCA;PPP3CC;PDE1A;PLCB4;GNG2;ITPR2,81 (82),0.2,0.918,5,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201;HMDB01043;HMDB08048#HMDB08036#HMDB08038,21 (24),7.55e-06,0.000921,2.17e-05,0.0013
GnRH signaling pathway - Homo sapiens (human),KEGG,13,MAPK11;MAPK13;PRKCA;CACNA1S;ATF4;CAMK2A;CAMK2D;PLCB4;MAP3K3;MMP2;PLD2;MAPK12;ITPR2,93 (93),0.000533,0.0476,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,6 (6),0.00287,0.0845,2.2e-05,0.0013
Senescence and Autophagy in Cancer,Wikipathways,18,IGFBP5;MDM2;CREG1;ATG7;BRAF;KMT2A;IRF1;COL3A1;SQSTM1;IRF5;COL1A1;SLC39A4;SPARC;IGF1R;RNASEL;SH3GLB1;RB1CC1;MAP1LC3B,106 (106),3.11e-06,0.0013,0,,0 (0),1,1,3.11e-06,0.0013
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,34,COL2A1;COL3A1;JAK1;COL5A2;AKT3;RELN;FLT4;COL11A1;IGF1R;FOXO1;PDGFA;PDGFRA;PIK3C2B;PIK3CA;EPAS1;PIK3CG;PDGFD;GNG2;HGF;LAMC1;FGF11;ITGAL;IRS2;FGFR2;ITGA3;MDM2;INSR;TNXB;ITGB7;PRLR;ATF4;CREB3L2;COL1A1;COL1A2,302 (302),4.22e-06,0.00149,0,,0 (2),1,1,4.22e-06,0.00149
Interconversion of nucleotide di- and triphosphates,Wikipathways,0,,0 (0),1,1,6,HMDB01044;HMDB00288;HMDB00295;HMDB01546;HMDB01201;HMDB01397,41 (51),1.67e-05,0.00174,1.67e-05,0.00174
PI Metabolism,Reactome,15,PIKFYVE;PIK3C2B;GDPD5;PLEKHA1;PLEKHA2;GDPD3;PIK3CG;FIG4;BMX;PLEKHA8;PTPN13;TNFAIP8;PNPLA7;PIK3CA;INPP4B,84 (84),1.09e-05,0.00279,1,HMDB08048#HMDB08036#HMDB08038,17 (29),0.218,0.788,3.32e-05,0.00187
Interferon gamma signaling,Reactome,17,IRF6;GBP5;JAK1;GBP7;GBP4;IRF2;GBP2;IRF1;OAS3;IRF4;IRF5;SP100;CAMK2D;STAT1;B2M;TRIM25;CAMK2A,94 (94),2.39e-06,0.00109,0,,4 (5),1,1,3.33e-05,0.00187
Ras Signaling,Wikipathways,20,EXOC2;PAK1;GNG2;PDGFRA;PLA2G12A;RASSF5;RASGRP3;PRKCA;RAPGEF5;RAB5B;AKT3;PLCG2;FLT4;RASAL1;FGFR2;IGF1R;RAP1B;PLD2;INSR;PIK3CA,184 (184),0.000623,0.0502,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,7 (7),0.00398,0.0983,3.45e-05,0.00189
Choline metabolism in cancer - Homo sapiens (human),KEGG,11,PDGFA;PDGFRA;PDGFD;PRKCA;AKT3;DGKH;SLC44A1;PLD2;PCYT1B;PIK3CA;GPCPD1,99 (99),0.00846,0.226,3,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,10 (11),0.000299,0.0174,3.51e-05,0.00189
Phosphate bond hydrolysis by NTPDase proteins,Reactome,1,ENTPD4,8 (8),0.329,1,5,HMDB00288;HMDB00295;HMDB01546;HMDB01201;HMDB01397,22 (25),9.67e-06,0.00109,4.34e-05,0.00229
Focal Adhesion,Wikipathways,26,BLK;COL2A1;HGF;AKT3;RELN;RAP1B;IGF1R;BRAF;PDGFA;PDGFRA;PIK3CA;PPP1R12A;PDGFD;COL5A2;PAK1;SRMS;BIRC2;PRKCA;LAMC1;ITGA3;BCAR1;TNXB;ITGB7;CCND2;COL1A1;COL1A2,198 (198),3.62e-06,0.00138,0,,1 (2),1,1,4.89e-05,0.00252
Ras signaling pathway - Homo sapiens (human),KEGG,23,RAPGEF5;RASSF5;HGF;AKT3;FLT4;IGF1R;EXOC2;PDGFA;PDGFRA;PIK3CA;PLA2G12A;RASGRP3;PDGFD;INSR;PAK1;PRKCA;FGFR2;PLCG2;PLD2;GNG2;RAB5B;RASAL1;RAP1B,232 (232),0.000924,0.0633,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,7 (7),0.00398,0.0983,4.97e-05,0.00252
acyl-CoA hydrolysis,HumanCyc,1,ACOT7,3 (3),0.139,0.811,5,HMDB00220;HMDB00806;HMDB02212;HMDB00944;HMDB02003,27 (39),2.82e-05,0.00256,5.26e-05,0.00261
Integrins in angiogenesis,PID,11,COL2A1;F11R;COL3A1;COL5A2;SDC1;COL11A1;PIK3CA;IGF1R;BCAR1;COL1A1;COL1A2,63 (63),0.000199,0.0234,1,HMDB01201,2 (2),0.0284,0.317,7.4e-05,0.0036
B Cell Receptor Signaling Pathway,Wikipathways,16,BLK;BRAF;FOXO1;BLNK;CD79B;CD79A;IRF4;CAMK2A;MEF2C;CARD11;RASGRP3;MAX;PIK3CG;BTK;PLCG2;TEC,98 (98),1.83e-05,0.00374,0,,0 (0),1,1,1.83e-05,0.00374
Visual phototransduction,Reactome,7,SDC3;PRKCA;SDC1;SDC4;PDE6A;RDH12;GPC4,102 (102),0.227,0.945,6,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220;HMDB01201;HMDB01397;HMDB00673;HMDB00658#HMDB10370,45 (65),2.91e-05,0.00259,8.53e-05,0.00407
Plasma lipoprotein remodeling,Reactome,0,,30 (30),1,1,4,HMDB00658#HMDB10370;HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,10 (20),6.86e-06,0.000888,8.84e-05,0.00407
HDL remodeling,Reactome,0,,10 (10),1,1,4,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB10384;HMDB00658#HMDB10370;HMDB08048#HMDB08036#HMDB08038,10 (17),6.86e-06,0.000888,8.84e-05,0.00407
MAPK signaling pathway - Homo sapiens (human),KEGG,30,TGFBR1;CACNA1E;HGF;CACNA1S;AKT3;RAP1B;IGF1R;MAPK12;PPP3CC;BRAF;PDGFA;PDGFRA;RASGRP3;RPS6KA3;PDGFD;RPS6KA2;INSR;MAX;PAK1;CASP3;PRKCA;CACNA1H;ATF4;MKNK1;FGFR2;MAPK11;MAPK13;MEF2C;MAP3K3;FLT4,295 (295),0.000105,0.0137,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,9.33e-05,0.00422
Long-term potentiation - Homo sapiens (human),KEGG,12,BRAF;PRKCA;RAPGEF3;ATF4;CAMK2A;CAMK2D;RAP1B;RPS6KA3;PLCB4;ITPR2;PPP3CC;RPS6KA2,67 (67),7.98e-05,0.0118,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (7),0.096,0.441,9.79e-05,0.00435
Interferon Signaling,Reactome,22,JAK1;SP100;RNASEL;TRIM25;GBP4;GBP5;GBP7;CAMK2A;CAMK2D;EIF4A2;B2M;OAS3;GBP2;IRF1;IRF2;IRF4;IRF5;IRF6;EIF4E3;SAMHD1;XAF1;STAT1,158 (158),7.8e-06,0.00239,0,,6 (15),1,1,9.96e-05,0.00435
Signaling Pathways in Glioblastoma,Wikipathways,15,MDM2;MDM4;FOXO1;PIK3C2B;PIK3CA;PIK3CG;AKT3;IGF1R;BRAF;PRKCZ;FGFR2;PLCG2;PDGFRA;PRKCA;CCND2,83 (83),9.39e-06,0.00267,0,,1 (3),1,1,0.000118,0.00507
Transport of vitamins_ nucleosides_ and related molecules,Reactome,0,,39 (39),1,1,7,HMDB00288;HMDB02003;HMDB00220;HMDB01397;HMDB00806;HMDB02212;HMDB00673,57 (64),9.99e-06,0.00109,0.000125,0.00528
dolichyl-diphosphooligosaccharide biosynthesis,HumanCyc,1,DPM3,10 (10),0.392,1,3,HMDB00288;HMDB00295;HMDB01201,5 (7),2.61e-05,0.00248,0.000128,0.00528
G alpha (i) signalling events,Reactome,18,SSTR4;PLCB4;SDC3;CXCL3;PRKCA;CXCL10;CXCR4;S1PR1;SDC1;ITPR2;PDE1A;SDC4;GPR55;PPP3CC;PDE6A;GNG2;RDH12;GPC4,399 (400),0.662,1,9,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220;HMDB01201;HMDB01397;HMDB01043;HMDB00673;HMDB08048#HMDB08036#HMDB08038;HMDB00658#HMDB10370,112 (159),1.57e-05,0.00167,0.000129,0.00528
Extracellular matrix organization,Reactome,31,COL2A1;COL3A1;COL5A2;COL24A1;COL11A1;SPARC;FBLN2;FBN2;CASK;F11R;PDGFA;LOX;NCAN;CASP3;SDC3;PRKCA;LAMC1;COL22A1;CAPN5;ADAMTS5;MMP2;ITGA3;ITGAL;ADAM8;TNXB;SDC1;ITGB7;CTSS;SDC4;COL1A1;COL1A2,294 (294),4.06e-05,0.00666,1,HMDB00295,21 (30),0.262,0.923,0.000132,0.00532
Syndecan-1-mediated signaling events,PID,10,COL2A1;COL3A1;COL5A2;SDC1;COL1A1;HGF;COL11A1;FGFR2;CASK;COL1A2,43 (43),3.04e-05,0.00558,0,,0 (0),1,1,3.04e-05,0.00558
Metabolism,Reactome,104,HEXA;B3GALNT1;RAPGEF3;NAT8L;SMPD3;INPP1;ENPP1;ABHD10;ACSS1;ACP5;CACNA1E;GNG2;AGPAT4;ACOT7;GBE1;PGM2L1;SLC46A1;HACD4;CMPK1;HNMT;PTGIS;INPP4B;FAAH;ELOVL7;TNFAIP8;ITPR2;LPIN1;GDPD5;LYVE1;PHYH;BMX;PTPN13;CTPS2;LPCAT2;PIK3C2B;FIG4;PIK3CA;PLA2G12A;ALDH1L2;PTS;PIK3CG;LIPH;SDC3;CSAD;GLS;PRKCA;PPM1L;GPC4;GLUL;NADK;SECISBP2;ETNK1;PDP2;PYGL;PLCB4;PLCG2;PLD2;FAR1;PRKAG2;ALDH3A2;CHPF;DHTKD1;SLC23A1;SDC1;ALOX12;SDC4;NAMPT;PLEKHA8;PCYT1B;CHST3;TBXAS1;SLC25A27;NDST1;PNPLA2;ALDH1A1;SLC25A21;NDUFAF2;HACD3;GDPD3;PON3;XDH;SAMHD1;CHST1;ESYT2;TBL1XR1;ENTPD4;SLC3A2;PIKFYVE;PLCD3;NCOR1;LIPT1;SLC44A1;ORMDL3;GCAT;EHHADH;NCAN;GPCPD1;NCOA1;PLEKHA1;PLEKHA2;PNPLA7;HSD17B11;ALDH7A1;IPMK,1960 (1972),0.171,0.867,23,HMDB01044;HMDB00618#HMDB01548;HMDB00295;HMDB01546;HMDB00220;HMDB00159;HMDB08048#HMDB08036#HMDB08038;HMDB00536;HMDB01388;HMDB00158;HMDB01043;HMDB00658#HMDB10370;HMDB01999;HMDB10384;HMDB00288;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB01397;HMDB01201;HMDB00673;HMDB11592#HMDB06750;HMDB04951;HMDB00925,829 (1384),7.36e-05,0.00622,0.000155,0.00606
Interconversion of nucleotide di- and triphosphates,Reactome,2,CTPS2;CMPK1,34 (34),0.497,1,6,HMDB01044;HMDB00288;HMDB00295;HMDB01546;HMDB01201;HMDB01397,44 (52),2.55e-05,0.00248,0.000156,0.00606
Nucleobase catabolism,Wikipathways,0,,0 (0),1,1,7,HMDB01044;HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01546;HMDB01201;HMDB01397,77 (100),7.43e-05,0.00622,7.43e-05,0.00622
EGF-EGFR Signaling Pathway,Wikipathways,21,BRAF;PAK1;JAK1;REPS2;GJA1;STXBP1;PRKCA;PIK3C2B;PEBP1;CAMK2A;MEF2C;ATF1;STAT1;RPS6KA3;PRKCZ;MAP3K3;FOXO1;PLD2;STAM;BCAR1;RPS6KA2,162 (162),3.75e-05,0.00637,0,,0 (0),1,1,3.75e-05,0.00637
Proteoglycans in cancer - Homo sapiens (human),KEGG,25,HGF;AKT3;IGF1R;MAPK12;BRAF;PIK3CA;CAMK2A;CAMK2D;PPP1R12A;PAK1;CASP3;ARHGEF12;WNT10A;PRKCA;PLCG2;MMP2;PTCH1;MAPK11;MDM2;MAPK13;SDC1;SDC4;PDCD4;DDX5;ITPR2,201 (201),1.45e-05,0.00351,0,,5 (7),1,1,0.000176,0.00676
Membrane Trafficking,Reactome,35,DENND5B;GJA1;MIA3;GAPVD1;CTAGE5;AKT3;TXNDC5;SYT8;USO1;ARFGAP3;RAB30;RIN2;CHMP5;KIF1B;PAFAH1B3;RAB11A;STON2;CD55;AP1S2;VPS36;SCFD1;DENND2D;STAM;FCHO2;PRKAG2;MAP1LC3B;REPS2;VAMP4;STX16;STX17;RAB6B;RAB5B;ARF4;ARPC2;DENND1B,582 (582),0.111,0.747,4,HMDB10384;HMDB00658#HMDB10370;HMDB01201;HMDB08048#HMDB08036#HMDB08038,20 (30),0.000143,0.0102,0.000192,0.00726
Signaling by VEGF,Reactome,14,MAPK11;AKT3;PAK1;ABI2;BCAR1;PRKCA;ITPR2;NCF2;FLT4;PRKCZ;PIK3CA;NRP2;NRP1;PRR5,100 (100),0.000325,0.0341,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,26 (28),0.052,0.374,0.000203,0.00754
Developmental Biology,Reactome,36,FOXO1;NCOR1;KRT7;AKT3;RELN;RAP1GAP;MAPK12;ST14;PLXNC1;CXCR4;SRGAP1;UNC5B;RPS6KA2;RPS6KA3;NCAN;PAK1;CACNA1S;ARHGEF12;NCOA1;PRKCA;LAMC1;FOXP1;CACNA1H;IRS2;ALCAM;POU6F1;HHEX;DCC;MAPK11;ARHGEF11;NRP1;MEF2C;PLXNA1;NRP2;ARPC2;FARP2,619 (620),0.149,0.848,4,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201;HMDB04951,19 (26),0.000116,0.00851,0.000206,0.00756
FoxO signaling pathway - Homo sapiens (human),KEGG,19,MAPK11;MDM2;IL10;MAPK13;FOXO1;TGFBR1;BRAF;PIK3CA;TNFSF10;S1PR1;SGK1;AKT3;IRS2;CCND2;SETD7;IGF1R;INSR;MAPK12;PRKAG2,131 (132),1.79e-05,0.00374,0,,5 (5),1,1,0.000213,0.00772
Class I PI3K signaling events,PID,9,BLK;BLNK;PLEKHA1;PLEKHA2;SGK1;PIK3CG;BTK;PLCG2;PIK3CA,45 (45),0.000261,0.0292,1,HMDB01201,5 (5),0.0695,0.374,0.000216,0.00772
Class A-1 (Rhodopsin-like receptors),Wikipathways,0,,0 (0),1,1,7,HMDB00295;HMDB00220;HMDB02226;HMDB02925;HMDB01388;HMDB00806;HMDB01999,81 (104),0.000103,0.00787,0.000103,0.00787
BCR,NetPath,18,BLK;BLNK;NEDD9;FOXO1;PLEKHA1;PLEKHA2;CD79A;PIK3CG;STAP1;CARD11;STAT1;CD79B;BTK;PLCG2;RASGRP3;BCAR1;ITPR2;TEC,129 (129),5.01e-05,0.00793,0,,0 (0),1,1,5.01e-05,0.00793
IGF-Core,Signalink,7,FOXO1;TGFBR1;PIK3CG;AKT3;IRS2;IGF1R;INSR,22 (22),5.54e-05,0.00848,0,,0 (0),1,1,5.54e-05,0.00848
Dopaminergic synapse - Homo sapiens (human),KEGG,15,MAPK11;MAPK13;CLOCK;MAPK12;PRKCA;CAMK2A;AKT3;CAMK2D;PLCB4;KIF5C;ATF4;GNG2;CREB3L2;ITPR2;PPP3CC,131 (131),0.00171,0.0995,2,HMDB00158;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,12 (12),0.012,0.202,0.000242,0.00851
NOD-like receptor signaling pathway - Homo sapiens (human),KEGG,22,JAK1;CASP1;IL18;NAMPT;RNASEL;MAPK12;GBP4;GBP5;GBP7;GSDMD;STAT1;CARD6;BIRC2;GBP2;OAS3;PLCB4;MAPK11;MAPK13;CXCL3;ITPR2;NLRP3;TXNIP,168 (168),2.1e-05,0.00401,0,,5 (15),1,1,0.000247,0.00857
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,0,,69 (69),1,1,4,HMDB00658#HMDB10370;HMDB08048#HMDB08036#HMDB08038;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB10384,13 (25),2.27e-05,0.00225,0.000265,0.00894
Plasma lipoprotein assembly_ remodeling_ and clearance,Wikipathways,0,,5 (5),1,1,4,HMDB10384;HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,13 (21),2.27e-05,0.00225,0.000265,0.00894
Nucleobase catabolism,Reactome,3,XDH;SAMHD1;ENTPD4,37 (37),0.267,1,7,HMDB01044;HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01546;HMDB01201;HMDB01397,79 (100),8.78e-05,0.0071,0.000273,0.00911
Class A/1 (Rhodopsin-like receptors),Reactome,11,SSTR4;F2RL1;ADORA2A;CXCL3;GPR55;CXCL10;CXCR4;GPR132;S1PR1;EDNRA;GPR65,330 (330),0.931,1,7,HMDB00295;HMDB00220;HMDB02226;HMDB02925;HMDB01388;HMDB00806;HMDB01999,66 (82),2.69e-05,0.0025,0.00029,0.00954
Axon guidance,Reactome,24,CACNA1S;RELN;RAP1GAP;PLXNC1;CXCR4;SRGAP1;UNC5B;RPS6KA2;RPS6KA3;NCAN;PAK1;ARHGEF12;PRKCA;LAMC1;CACNA1H;IRS2;ALCAM;DCC;ARHGEF11;NRP1;PLXNA1;NRP2;ARPC2;FARP2,357 (358),0.067,0.599,3,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,11 (15),0.000407,0.022,0.000314,0.0102
Glioma - Homo sapiens (human),KEGG,11,BRAF;PDGFA;PDGFRA;MDM2;PRKCA;CAMK2A;AKT3;CAMK2D;IGF1R;PLCG2;PIK3CA,71 (71),0.000583,0.0487,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.00037,0.0118
TNF alpha Signaling Pathway,Wikipathways,7,GLUL;CASP3;CFLAR;BIRC2;PYGL;PRKCZ;MAP3K3,93 (93),0.166,0.867,2,HMDB04951;HMDB01043,2 (3),0.000198,0.0126,0.000372,0.0118
IFN-gamma pathway,PID,8,CASP1;JAK1;PIK3CA;IRF1;CAMK2A;CAMK2D;STAT1;RAP1B,42 (42),0.000806,0.0607,1,HMDB01201,3 (4),0.0423,0.338,0.000385,0.012
Focal adhesion - Homo sapiens (human),KEGG,24,COL2A1;HGF;AKT3;RELN;RAP1B;IGF1R;BRAF;PDGFA;PDGFRA;PIK3CA;PPP1R12A;PDGFD;PAK1;BIRC2;PRKCA;LAMC1;ITGA3;BCAR1;TNXB;ITGB7;COL1A2;FLT4;COL1A1;CCND2,199 (199),3.58e-05,0.00631,0,,1 (2),1,1,0.000402,0.0124
Insulin resistance - Homo sapiens (human),KEGG,13,FOXO1;IRS2;PIK3CA;PYGL;AKT3;GFPT1;RPS6KA2;RPS6KA3;PRKCZ;OGT;INSR;CREB3L2;PRKAG2,107 (107),0.002,0.107,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,15 (21),0.0185,0.273,0.000416,0.0127
Retinoid metabolism and transport,Wikipathways,0,,0 (0),1,1,4,HMDB00220;HMDB00673;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00658#HMDB10370,22 (37),0.000212,0.0129,0.000212,0.0129
Insulin Signaling,Wikipathways,20,MAPK11;STXBP1;MAPK13;FOXO1;RHOQ;PRKCA;SGK1;ENPP1;RRAD;IRS2;PIK3CG;PRKCZ;MAP3K3;IGF1R;RPS6KA2;INSR;MAPK12;PIK3CA;STXBP3;RPS6KA3,160 (160),9.55e-05,0.0133,0,,0 (0),1,1,9.55e-05,0.0133
EGFR1,NetPath,41,NEDD9;CYLD;GJA1;LAPTM4A;KRT7;EPPK1;FOXO1;CRIM1;BRAF;ITGA3;STAM;ZFYVE16;PIK3C2B;BCAR1;PIK3CA;PEBP1;PIK3CG;RPS6KA2;RPS6KA3;LPP;INSR;PAK1;SDC3;PRKCA;TNIP1;ATF1;IRS2;PRKCZ;PLCG2;PLD2;ARHGAP32;BCAR3;REPS2;PLEKHN1;SDC1;SDC4;JAK1;STAT1;DDX3X;MAP3K3;ARF4,455 (457),9.87e-05,0.0133,0,,0 (4),1,1,9.87e-05,0.0133
PDGF,INOH,6,PAK1;PDGFRA;PIK3CA;PDGFA;AKT3;ARHGEF6,45 (45),0.0208,0.35,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,5 (7),0.00193,0.073,0.000447,0.0135
N-Glycan biosynthesis,EHMN,4,MGAT4A;ST6GAL1;FUT8;MAN1B1,42 (42),0.145,0.833,4,HMDB00288;HMDB00295;HMDB01546;HMDB01201,24 (51),0.000301,0.0174,0.000483,0.0143
Retinoid metabolism and transport,Reactome,4,SDC3;SDC4;SDC1;GPC4,45 (45),0.173,0.867,4,HMDB00658#HMDB10370;HMDB00673;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220,23 (35),0.000254,0.0153,0.000485,0.0143
COPI-independent Golgi-to-ER retrograde traffic,Reactome,2,RAB6B;PAFAH1B3,34 (34),0.497,1,3,HMDB10384;HMDB01201;HMDB08048#HMDB08036#HMDB08038,7 (8),8.97e-05,0.0071,0.000491,0.0143
Relaxin signaling pathway - Homo sapiens (human),KEGG,16,PRKCA;COL3A1;MAPK13;TGFBR1;CREB3L2;PIK3CA;ATF4;AKT3;PLCB4;MAPK11;PRKCZ;MMP2;GNG2;MAPK12;COL1A1;COL1A2,130 (130),0.000554,0.048,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (6),0.0829,0.406,0.000505,0.0145
Vesicle-mediated transport,Reactome,39,COL3A1;SPARC;DENND5B;GJA1;MIA3;GAPVD1;DENND1B;CTAGE5;AKT3;TXNDC5;SYT8;USO1;ARFGAP3;RAB30;RIN2;CHMP5;KIF1B;PAFAH1B3;RAB11A;STON2;CD55;AP1S2;VPS36;SCFD1;DENND2D;STAM;FCHO2;PRKAG2;MAP1LC3B;REPS2;VAMP4;STX16;STX17;RAB6B;RAB5B;ARPC2;ARF4;COL1A1;COL1A2,620 (620),0.0581,0.551,4,HMDB10384;HMDB00658#HMDB10370;HMDB01201;HMDB08048#HMDB08036#HMDB08038,31 (66),0.000831,0.0418,0.000528,0.015
GPCR ligand binding,Reactome,15,SSTR4;CD55;WNT10A;F2RL1;ADORA2A;CXCL3;GPR55;CXCL10;CXCR4;S1PR1;GPR132;EDNRA;GNG2;GPR65;PTCH1,465 (466),0.968,1,8,HMDB00295;HMDB00220;HMDB02226;HMDB01201;HMDB02925;HMDB01388;HMDB00806;HMDB01999,101 (141),5.7e-05,0.00497,0.000597,0.0168
Death Receptor Signalling,Reactome,14,ARHGEF11;CYLD;CFLAR;TNFSF10;FGD4;BIRC2;SQSTM1;APH1B;ARHGEF6;TIAM2;TAX1BP1;SMPD3;CASP3;ARHGEF12,138 (141),0.00717,0.21,2,HMDB04951;HMDB01201,10 (11),0.00831,0.159,0.000639,0.0178
CD28 co-stimulation,Reactome,7,PAK1;PIK3CA;CD28;CD80;AKT3;GRAP2;PRR5,33 (33),0.000871,0.0625,1,HMDB01201,5 (6),0.0695,0.374,0.000649,0.0178
SLC-mediated transmembrane transport,Reactome,11,SLC12A4;SLC26A11;EMB;SLC9A9;CP;SLC40A1;SLC39A4;SLC13A5;SLC44A1;SLC3A2;SLC12A2,244 (245),0.644,1,9,HMDB00288;HMDB02003;HMDB00220;HMDB00159;HMDB01397;HMDB00806;HMDB02212;HMDB00158;HMDB00673,140 (166),9.5e-05,0.00737,0.000654,0.0178
MAPK Signaling Pathway,Wikipathways,24,TGFBR1;CACNA1E;CACNA1S;AKT3;RAP1B;MAPK12;PPP3CC;BRAF;PDGFA;RASGRP3;MAX;LRRK2;RPS6KA3;PAK1;CASP3;PRKCA;FGF11;ATF4;FGFR2;MAPK11;CACNA1H;MAPK13;MEF2C;MKNK1,246 (246),0.000905,0.0633,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,0.000672,0.0181
Necroptosis - Homo sapiens (human),KEGG,15,GLUL;CASP1;JAK1;CFLAR;ZBP1;TNFSF10;BIRC2;PYGL;NLRP3;SQSTM1;CAMK2A;CAMK2D;STAT1;CHMP5;CYLD,162 (162),0.0124,0.272,2,HMDB04951;HMDB01043,8 (10),0.00526,0.118,0.000692,0.0185
T cell receptor signaling pathway - Homo sapiens (human),KEGG,13,MAPK11;IL10;MAPK13;PIK3CA;CD28;PAK1;AKT3;CARD11;CTLA4;GRAP2;MAPK12;PPP3CC;TEC,101 (101),0.00118,0.075,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0007,0.0185
pdgf signaling pathway,BioCarta,6,PDGFA;JAK1;PRKCA;STAT1;PDGFRA;PIK3CA,27 (27),0.00158,0.0942,1,HMDB01201,3 (3),0.0423,0.338,0.000709,0.0185
Intra-Golgi and retrograde Golgi-to-ER traffic,Wikipathways,0,,0 (0),1,1,3,HMDB10384;HMDB01201;HMDB08048#HMDB08036#HMDB08038,11 (12),0.000407,0.022,0.000407,0.022
Diseases of signal transduction,Reactome,25,SEL1L;FOXO1;TGFBR1;APH1B;HGF;NCOR1;CD80;AKT3;RAP1B;BRAF;PDGFA;PDGFRA;ATG7;PIK3CA;CD28;PEBP1;PRR5;IRS2;FGFR2;MAML2;SYVN1;MDM2;TBL1XR1;STAT1;APBB1IP,248 (248),0.00044,0.0412,1,HMDB01201,15 (52),0.195,0.719,0.000889,0.0229
GPCR GroupI metabotropic glutamate receptor,INOH,4,BRAF;PRKCA;PLCB4;PRKCZ,28 (28),0.0447,0.492,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,5 (6),0.00193,0.073,0.000894,0.0229
Linoleic acid metabolism - Homo sapiens (human),KEGG,1,PLA2G12A,29 (29),0.764,1,4,HMDB00673;HMDB02925;HMDB01043;HMDB08048#HMDB08036#HMDB08038,19 (28),0.000116,0.00851,0.000913,0.023
Metabolism of fat-soluble vitamins,Reactome,4,SDC3;SDC4;SDC1;GPC4,49 (49),0.213,0.928,4,HMDB00658#HMDB10370;HMDB00673;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220,26 (41),0.000415,0.0222,0.000916,0.023
phospho-PLA2 pathway,Reactome,0,,2 (2),1,1,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,7 (7),8.97e-05,0.0071,0.000926,0.023
Regulation of toll-like receptor signaling pathway,Wikipathways,18,MAPK11;CISH;MAPK13;CYLD;CD80;TLR5;PIK3CA;CXCL10;IRAK3;SQSTM1;IRF5;AKT3;STAT1;PIK3CG;BTK;LY96;MAPK12;PELI1,143 (143),0.000193,0.0233,0,,0 (2),1,1,0.000193,0.0233
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,25,FOXO1;GJA1;RAP1B;TXNIP;MAPK12;NDRG1;ERN1;PIK3CA;RAB11A;PAK1;PRKCA;NCF2;ATF4;PRKCZ;MMP2;STAM;BCAR1;EIF2AK3;TNXB;HERPUD1;MEF2C;STAT1;INPP4B;MKNK1;NRP2,236 (236),0.000206,0.0237,0,,0 (0),1,1,0.000206,0.0237
Adaptive Immune System,Reactome,49,MRC1;LGMN;ASB13;AKT3;RAP1B;RAP1GAP;PIK3CA;RNF34;KLHL25;CTSO;ATG7;PILRA;RCHY1;RAPGEF3;CD28;CD80;RASGRP3;B2M;MKRN1;GRAP2;PRR5;BLNK;PAK1;RAP1GAP2;CD274;AP1S2;XDH;BTK;CD74;CD79A;CD79B;PTPN22;NCF2;CARD11;TRIM39;CTLA4;PLCG2;LY96;SLAMF7;FBXL20;ITGAL;TAP1;HERC4;ITGB7;CTSS;CD96;CD200;PDCD1LG2;ITPR2,728 (732),0.0124,0.272,3,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,29 (54),0.00756,0.154,0.000966,0.0238
Leukocyte transendothelial migration - Homo sapiens (human),KEGG,16,F11R;MAPK11;BCAR1;ITGAL;RASSF5;PIK3CA;RAPGEF3;CXCR4;NCF2;MAPK13;RAP1B;CLDN7;PLCG2;MMP2;MAPK12;PRKCA,112 (112),9.75e-05,0.0133,0,,3 (4),1,1,0.000998,0.0243
Human cytomegalovirus infection - Homo sapiens (human),KEGG,22,JAK1;AKT3;MAPK12;PPP3CC;PDGFRA;PIK3CA;CXCR4;B2M;GNG2;CASP3;ARHGEF12;PRKCA;ATF4;BCAR1;MAPK11;MDM2;ARHGEF11;MAPK13;TAP1;PLCB4;CREB3L2;ITPR2,225 (225),0.00142,0.0855,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (6),0.0695,0.374,0.00101,0.0243
HS-GAG biosynthesis,Reactome,5,SDC3;SDC4;NDST1;SDC1;GPC4,31 (31),0.0158,0.297,2,HMDB00288;HMDB00295,9 (9),0.0067,0.14,0.00108,0.0257
B cell receptor signaling pathway - Homo sapiens (human),KEGG,10,BLNK;PIK3CA;CD79A;CD79B;AKT3;CARD11;RASGRP3;BTK;PLCG2;PPP3CC,70 (71),0.00193,0.106,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0011,0.026
UTP and CTP dephosphorylation I,HumanCyc,1,CTPS2,3 (3),0.139,0.811,3,HMDB00288;HMDB00295;HMDB01546,14 (15),0.000871,0.0428,0.00121,0.0282
IL2-mediated signaling events,PID,8,MAPK11;CISH;JAK1;PIK3CA;IRS2;IKZF3;STAT1;STAM,54 (54),0.00426,0.158,1,HMDB01201,2 (3),0.0284,0.317,0.00121,0.0282
Interferon alpha/beta signaling,Reactome,12,JAK1;IRF2;GBP2;IRF1;OAS3;IRF4;IRF5;IRF6;XAF1;STAT1;RNASEL;SAMHD1,70 (70),0.000124,0.0158,0,,4 (11),1,1,0.00124,0.0284
Linoleate metabolism,EHMN,2,SLC23A1;PLA2G12A,72 (74),0.871,1,4,HMDB10384;HMDB00673;HMDB00295;HMDB08048#HMDB08036#HMDB08038,20 (24),0.000143,0.0102,0.00124,0.0284
Prolactin Signaling Pathway,Wikipathways,12,PAK1;JAK1;PIK3CA;IRF1;CISH;PIK3CG;STAT1;PRLR;IRS2;CASP3;TEC;RPS6KA2,76 (76),0.000277,0.0303,0,,0 (0),1,1,0.000277,0.0303
Osteoclast differentiation - Homo sapiens (human),KEGG,17,BLNK;AKT3;MAPK13;JAK1;TGFBR1;PIK3CA;SQSTM1;NCF2;STAT1;MAPK11;ACP5;BTK;PLCG2;CYLD;MAPK12;PPP3CC;TEC,127 (128),0.000136,0.0168,0,,3 (3),1,1,0.00134,0.0304
Golgi-to-ER retrograde transport,Reactome,5,RAB6B;ARF4;PAFAH1B3;ARFGAP3;KIF1B,116 (116),0.67,1,3,HMDB10384;HMDB01201;HMDB08048#HMDB08036#HMDB08038,9 (10),0.000211,0.0129,0.0014,0.0313
Glycosphingolipid biosynthesis - globoseries,EHMN,2,HEXA;FUT1,18 (18),0.217,0.928,3,HMDB11592#HMDB06750;HMDB00295;HMDB01201,13 (23),0.000691,0.0356,0.00147,0.0323
Metabolism of proteins,Reactome,85,SEL1L;USP16;CISH;RAB23;CYLD;LY6D;CREBRF;ADORA2A;PHYH;SRPRB;PNPLA2;SCFD1;EIF2AK3;ST8SIA6;SP100;DDX17;OGT;TRIM25;CTAGE5;BIRC2;SATB1;ERN1;RNF103;TGFBR1;ATXN3;USO1;GOLM1;WFS1;USP3;SPON1;ARFGAP3;EHHADH;CD55;RAB30;PSMA3;RNF144A;EIF4A2;RAB3D;MGAT4A;GNG2;ASB13;RAB11A;EIF5;IGFBP5;PSMB9;RAB2B;VNN3;FBXL20;DPM3;CUL9;LAMC1;CP;FUT8;TNIP1;ST6GAL1;CPE;MIA3;NEGR1;ADAMTS5;MMP2;STAM;SERP1;SYVN1;MDM2;MDM4;RNF128;STX17;RAB6B;VCPIP1;FEM1C;RAB5B;KLHL25;GFPT1;EPAS1;NUB1;NLRP3;MAN1B1;BGLAP;VCPKMT;ARF4;TTLL7;CREB3L2;ATXN7;NGLY1;TUBB2B,1999 (2008),0.925,1,8,HMDB00288;HMDB00295;HMDB01546;HMDB01201;HMDB08048#HMDB08036#HMDB08038;HMDB00158;HMDB00159;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,117 (269),0.000164,0.0115,0.00149,0.0323
Metabolism of nucleotides,Reactome,5,CMPK1;CTPS2;SAMHD1;XDH;ENTPD4,105 (105),0.582,1,8,HMDB01044;HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01546;HMDB01201;HMDB01397;HMDB00536,125 (152),0.000261,0.0155,0.00149,0.0323
Glycosphingolipid metabolism,Reactome,4,SMPD3;ESYT2;B3GALNT1;HEXA,46 (47),0.183,0.874,4,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295,31 (41),0.000831,0.0418,0.00149,0.0323
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,8,MAPK11;MAPK13;PIK3CA;AKT3;BTK;PLCG2;MAPK12;PRKCA,67 (68),0.0154,0.297,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,11 (11),0.0101,0.18,0.00152,0.0324
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,12,PRKCA;MAPK11;MAPK13;F2RL1;PIK3CA;ALOX12;CAMK2D;PLCB4;PLCG2;CAMK2A;MAPK12;ITPR2,99 (99),0.003,0.135,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,26 (36),0.052,0.374,0.00152,0.0324
Ca-dependent events,Reactome,2,PDE1A;PRKCA,28 (28),0.397,1,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,11 (12),0.000407,0.022,0.00157,0.0332
bcr signaling pathway,BioCarta,6,BLNK;PRKCA;CD79A;CD79B;BTK;PPP3CC,32 (32),0.00394,0.15,1,HMDB01201,3 (3),0.0423,0.338,0.00162,0.0338
Amoebiasis - Homo sapiens (human),KEGG,10,PRKCA;COL3A1;IL10;CASP3;PIK3CA;LAMC1;RAB5B;PLCB4;COL1A1;COL1A2,95 (96),0.0168,0.311,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,11 (13),0.0101,0.18,0.00163,0.0339
Protein digestion and absorption - Homo sapiens (human),KEGG,12,COL2A1;COL3A1;ATP1B3;KCNK5;KCNN4;COL5A2;COL24A1;COL22A1;COL11A1;SLC3A2;COL1A1;COL1A2,90 (90),0.00132,0.0818,2,HMDB00158;HMDB00159,44 (47),0.129,0.543,0.00165,0.034
Type II interferon signaling (IFNG),Wikipathways,8,PSMB9;CXCL10;JAK1;TAP1;IRF1;IRF2;IRF4;STAT1,37 (37),0.000327,0.0341,0,,0 (0),1,1,0.000327,0.0341
CXCR4-mediated signaling events,PID,11,BLK;PAK1;FOXO1;PIK3CA;CXCR4;PIK3CG;STAT1;PRKCZ;RAP1B;GNG2;BCAR1,87 (87),0.00316,0.139,1,HMDB01201,4 (4),0.056,0.374,0.00171,0.0349
Leishmaniasis - Homo sapiens (human),KEGG,7,MAPK11;IL10;MAPK13;JAK1;NCF2;STAT1;MAPK12,73 (74),0.0634,0.582,2,HMDB04951;HMDB01043,6 (6),0.00287,0.0845,0.00175,0.0354
UTP and CTP <i>de novo</i> biosynthesis,HumanCyc,3,CTPS2;CMPK1;CMPK2,13 (13),0.0226,0.359,2,HMDB00288;HMDB00295,10 (11),0.00831,0.159,0.0018,0.0362
Globoid Cell Leukodystrophy,SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
Sphingolipid Metabolism,SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
Metachromatic Leukodystrophy (MLD),SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
Fabry disease,SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
Krabbe disease,SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
Gaucher Disease,SMPDB,0,,22 (22),1,1,5,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295;HMDB08048#HMDB08036#HMDB08038,40 (40),0.000201,0.0126,0.00191,0.0367
fas signaling pathway (cd95),BioCarta,4,PAK1;CASP3;CFLAR;PTPN13,20 (20),0.0143,0.281,1,HMDB04951,1 (1),0.0143,0.22,0.00195,0.037
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human),KEGG,4,HEXA;B3GALNT1;FUT1;B3GALT5,15 (15),0.0049,0.167,1,HMDB11592#HMDB06750,3 (23),0.0423,0.338,0.00196,0.0371
the information processing pathway at the ifn beta enhancer,BioCarta,7,IRF1;IRF2;GTF2A1;IRF4;IRF5;IRF6;NR3C1,29 (29),0.000377,0.0376,0,,0 (1),1,1,0.000377,0.0376
Proteoglycan syndecan-mediated signaling events,PID,3,SDC3;SDC4;SDC1,4 (4),0.00044,0.0412,0,,0 (0),1,1,0.00044,0.0412
Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,11,ATP1B3;PRKCA;CACNA1S;CAMK2A;CACNA1H;CAMK2D;ATF1;PLCB4;ATF4;CREB3L2;ITPR2,96 (96),0.00674,0.205,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,21 (24),0.0351,0.338,0.00221,0.0415
Sphingolipid de novo biosynthesis,Reactome,3,ALDH3A2;PPM1L;ORMDL3,45 (45),0.375,1,4,HMDB00220;HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,29 (35),0.00064,0.0338,0.00224,0.0417
mTOR signaling pathway,PID,9,RRAGD;BRAF;CLIP1;PRKCA;SGK1;PDCD4;PLD2;RB1CC1;PRR5,64 (65),0.00358,0.143,1,HMDB01201,5 (5),0.0695,0.374,0.00231,0.0427
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,7,MAPK11;BRAF;PAK1;ADORA2A;PIK3CA;RAPGEF3;PRKCZ,38 (38),0.00209,0.108,1,HMDB01201,9 (9),0.122,0.512,0.00236,0.043
VEGFA-VEGFR2 Pathway,Reactome,11,MAPK11;AKT3;PAK1;ABI2;PRKCA;NCF2;PRKCZ;PIK3CA;BCAR1;ITPR2;PRR5,92 (92),0.00489,0.167,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,26 (28),0.052,0.374,0.00236,0.043
FGF,INOH,5,PLCG2;BRAF;PIK3CA;FGF11;FGFR2,67 (67),0.225,0.941,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,4 (5),0.00117,0.0493,0.00243,0.044
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,8,VAMP4;STX16;RAB6B;ARFGAP3;RAB30;KIF1B;PAFAH1B3;ARF4,186 (186),0.688,1,3,HMDB10384;HMDB01201;HMDB08048#HMDB08036#HMDB08038,11 (12),0.000407,0.022,0.00257,0.0461
Prolactin signaling pathway - Homo sapiens (human),KEGG,10,MAPK11;CISH;MAPK13;PIK3CA;IRF1;AKT3;PRLR;STAT1;MAPK12;CCND2,70 (70),0.00193,0.106,1,HMDB00158,11 (11),0.147,0.579,0.0026,0.0464
CD4 T cell receptor signaling,INOH,10,BRAF;PSMB9;PIK3CA;CD28;CD80;AKT3;CARD11;PSMA3;PLCG2;PPP3CC,130 (130),0.101,0.704,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,6 (7),0.00287,0.0845,0.00265,0.0468
EGF-Core,Signalink,14,MAPK11;BRAF;PAK1;MAPK13;JAK1;TGFBR1;PIK3CG;MEF2C;ATF1;MAX;MAP3K3;IGF1R;MKNK1;MAPK12,105 (105),0.000539,0.0476,0,,0 (0),1,1,0.000539,0.0476
BCR signaling pathway,PID,9,BLNK;PIK3CA;CD79A;CD79B;CARD11;IBTK;BTK;PLCG2;PPP3CC,68 (68),0.00539,0.178,1,HMDB01201,4 (4),0.056,0.374,0.00275,0.0484
VEGF Signaling Pathway,PharmGKB,10,MAPK11;MAPK13;PIK3C2B;PRKCA;AKT3;PRKCZ;FGFR2;PLCG2;MAPK12;NRP1,61 (61),0.00065,0.0506,0,,0 (3),1,1,0.00065,0.0506
Netrin-mediated signaling events,PID,6,PAK1;PIK3CA;CAMK2A;UNC5B;BCAR1;DCC,33 (33),0.00462,0.166,1,HMDB01201,5 (5),0.0695,0.374,0.0029,0.0507
Innate Immune System,Reactome,62,CYLD;ZBP1;LGMN;ORMDL3;MGAM;PAK1;SERPING1;RAP1B;ATP6V0A1;TXNIP;TRIM25;MAPK12;BIRC2;TXNDC5;ATP11B;CTSS;PGLYRP2;ATG7;ABI2;PIK3CA;GSDMD;RPS6KA2;PRDX4;TAX1BP1;GRAP2;TLR5;SLPI;GMFG;CASP1;CD55;NLRC5;RAB3D;PELI1;B2M;PYGL;IRAK3;NCF2;CARD11;ATP11A;ITGAL;UNC93B1;PLCG2;BTK;PLD2;LY96;TEC;MAPK11;MAPK13;CREG1;ADAM8;ATP6V1E1;MNDA;RAB5B;ITPR2;MEF2C;ATF1;NLRP3;YPEL5;DDX3X;RPS6KA3;ARMC8;ARPC2,1065 (1077),0.0755,0.643,4,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00658#HMDB10370;HMDB01201;HMDB08048#HMDB08036#HMDB08038,48 (99),0.00433,0.104,0.00295,0.0511
N-glycan antennae elongation in the medial/trans-Golgi,Reactome,4,MGAT4A;ST6GAL1;FUT8;ST8SIA6,26 (26),0.0352,0.427,2,HMDB00295;HMDB01201,11 (22),0.0101,0.18,0.00317,0.0546
Visual phototransduction,Wikipathways,0,,0 (0),1,1,4,HMDB00220;HMDB00673;HMDB01201;HMDB01397,35 (57),0.00133,0.0551,0.00133,0.0551
Intestinal immune network for IgA production - Homo sapiens (human),KEGG,9,TNFRSF17;TNFRSF13C;TNFRSF13B;CXCR4;CD28;IL10;CD80;TNFSF13B;ITGB7,47 (49),0.000368,0.0376,0,,2 (2),1,1,0.00328,0.0558
Post-translational protein modification,Reactome,71,SEL1L;RAB6B;CISH;RAB23;CYLD;LY6D;TGFBR1;ASB13;PNPLA2;SCFD1;SP100;DDX17;OGT;TRIM25;CTAGE5;BIRC2;SATB1;RNF103;USO1;GOLM1;WFS1;SPON1;ARFGAP3;RAB30;PSMA3;RNF144A;VNN3;RAB3D;MGAT4A;RAB11A;ATXN3;IGFBP5;PSMB9;CD55;FBXL20;DPM3;CUL9;LAMC1;CP;FUT8;TNIP1;ST6GAL1;USP16;NUB1;MIA3;NEGR1;ADAMTS5;ST8SIA6;STAM;RAB2B;SYVN1;MDM2;MDM4;RNF128;STX17;USP3;FEM1C;RAB5B;KLHL25;GFPT1;EPAS1;NLRP3;MAN1B1;BGLAP;VCPKMT;ARF4;TTLL7;VCPIP1;ATXN7;NGLY1;TUBB2B,1378 (1383),0.313,1,6,HMDB00288;HMDB00295;HMDB01546;HMDB01201;HMDB00158;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,87 (176),0.00118,0.0493,0.00328,0.0558
Hemostasis,Reactome,39,CD84;MAFG;DOCK5;PDPN;HGF;PDE1A;ITGAL;RAP1B;SPARC;PIK3CA;STXBP3;F11R;PDGFA;SDC4;DOCK11;RAPGEF3;PIK3CG;KIF1B;JCHAIN;GNG2;SERPING1;SDC3;IRF2;PRKCA;IRF1;CD74;DGKH;PRKCZ;PLCG2;ITGA3;BCAR1;ATP1B3;EPCAM;JMJD1C;SDC1;CTSW;APBB1IP;SLC3A2;ITPR2,667 (668),0.13,0.8,4,HMDB00658#HMDB10370;HMDB01043;HMDB01201;HMDB01397,43 (67),0.00289,0.0845,0.00335,0.0565
IGF1 pathway,PID,5,IGF1R;BCAR1;PIK3CA;IRS2;PRKCZ,30 (30),0.0138,0.281,1,HMDB01201,2 (2),0.0284,0.317,0.00347,0.0582
Non-genomic actions of 1_25 dihydroxyvitamin D3,Wikipathways,11,MAPK11;MAPK13;JAK1;PRKCA;CAMK2A;CAMK2D;PLCB4;PRKCZ;PLCG2;STAT1;MAPK12,68 (68),0.000398,0.0389,0,,3 (4),1,1,0.00351,0.0585
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,8,HEXA;CHPF;SDC3;SDC1;SDC4;NCAN;CHST3;GPC4,50 (50),0.00261,0.123,1,HMDB00295,12 (25),0.159,0.616,0.00364,0.0603
Costimulation by the CD28 family,Reactome,10,PAK1;CD274;PIK3CA;CD28;CD80;AKT3;CTLA4;GRAP2;PDCD1LG2;PRR5,77 (77),0.00395,0.15,1,HMDB01201,8 (9),0.109,0.479,0.00376,0.0619
ErbB1 downstream signaling,PID,12,BRAF;PRKCA;PEBP1;MEF2C;ATF1;STAT1;RPS6KA3;PRKCZ;PIK3CA;PLD2;ARF4;ARPC2,106 (107),0.00525,0.177,1,HMDB01201,6 (6),0.0829,0.406,0.0038,0.0621
Inflammatory Response Pathway,Wikipathways,7,COL3A1;LAMC1;CD28;CD80;IL5RA;COL1A1;COL1A2,33 (33),0.000871,0.0625,0,,0 (0),1,1,0.000871,0.0625
Relationship between inflammation_ COX-2 and EGFR,Wikipathways,4,AKT3;BRAF;PIK3CA;PIK3CG,25 (25),0.0309,0.399,1,HMDB01043,1 (2),0.0143,0.22,0.00386,0.0626
Fcgamma receptor (FCGR) dependent phagocytosis,Reactome,8,PAK1;ABI2;PIK3CA;ITPR2;BTK;PLCG2;PLD2;ARPC2,159 (159),0.511,1,3,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201;HMDB08048#HMDB08036#HMDB08038,14 (20),0.000871,0.0428,0.00388,0.0626
Chemokine signaling pathway,Wikipathways,16,BRAF;PAK1;PLCB4;TIAM2;CXCL3;PIK3CA;CXCL10;CXCR4;PIK3CG;AKT3;RAP1B;GRK5;PRKCZ;STAT1;GNG2;BCAR1,165 (165),0.00651,0.2,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,0.00394,0.0631
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,9,MAPK11;MAPK13;PRKCA;CACNA1S;PLCB4;FAAH;GNG2;MAPK12;ITPR2,148 (148),0.292,1,3,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043;HMDB08048#HMDB08036#HMDB08038,17 (19),0.00158,0.0637,0.00401,0.0639
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,4,DPM3;NEGR1;LY6D;VNN3,94 (95),0.676,1,3,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00295;HMDB01201,13 (21),0.000691,0.0356,0.00405,0.0641
Apoptosis,Wikipathways,12,MDM2;CASP1;CASP3;CFLAR;TNFSF10;BIRC2;IRF1;IRF2;IRF4;IRF5;IRF6;IGF1R,87 (87),0.000974,0.0658,0,,0 (0),1,1,0.000974,0.0658
L1CAM interactions,Reactome,8,PAK1;LAMC1;RPS6KA2;RPS6KA3;ALCAM;NCAN;NRP2;NRP1,102 (103),0.122,0.792,2,HMDB00220;HMDB01201,7 (9),0.00398,0.0983,0.00421,0.066
Inositol Metabolism,SMPDB,6,PIKFYVE;PLCD3;FIG4;PIK3CA;INPP1;IPMK,22 (22),0.00049,0.045,0,,29 (31),1,1,0.00422,0.066
role of pi3k subunit p85 in regulation of actin organization and cell migration,BioCarta,5,PAK1;PDGFA;PDGFRA;ARPC2;PIK3CA,17 (17),0.00101,0.0672,0,,0 (0),1,1,0.00101,0.0672
Adipocytokine signaling pathway - Homo sapiens (human),KEGG,4,AKT3;LEPR;IRS2;PRKAG2,69 (69),0.433,1,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (7),0.00117,0.0493,0.00435,0.0675
A tetrasaccharide linker sequence is required for GAG synthesis,Reactome,5,SDC3;SDC4;NCAN;SDC1;GPC4,26 (26),0.00748,0.211,1,HMDB00295,5 (6),0.0695,0.374,0.00445,0.0686
Fc-epsilon receptor I signaling in mast cells,PID,5,PIK3CA;PLD2;BTK;S1PR1;PTPN13,62 (62),0.182,0.871,2,HMDB01201;HMDB08048#HMDB08036#HMDB08038,6 (8),0.00287,0.0845,0.00447,0.0686
CD4 T cell receptor signaling-JNK cascade,INOH,4,PLCG2;CD28;CD80;PPP3CC,55 (55),0.277,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,5 (6),0.00193,0.073,0.00457,0.0697
Collagen chain trimerization,Reactome,8,COL2A1;COL3A1;COL5A2;COL24A1;COL22A1;COL11A1;COL1A1;COL1A2,44 (44),0.00111,0.0718,0,,0 (0),1,1,0.00111,0.0718
Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human),KEGG,4,B3GALNT1;FUT1;B3GALT5;FUT4,27 (27),0.0398,0.456,1,HMDB11592#HMDB06750,1 (54),0.0143,0.22,0.00482,0.0728
aspirin blocks signaling pathway involved in platelet activation,BioCarta,2,PRKCA;TBXAS1,17 (17),0.199,0.916,2,HMDB01201;HMDB01043,6 (6),0.00287,0.0845,0.00483,0.0728
B cell receptor signaling,INOH,9,BLNK;BRAF;PSMB9;PIK3CA;CD79A;CD79B;CARD11;PSMA3;PLCG2,134 (134),0.204,0.922,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,6 (7),0.00287,0.0845,0.00494,0.0736
Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,7,PRKCA;PAK1;PIK3CA;AKT3;PLCG2;PLD2;ARPC2,90 (91),0.147,0.838,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,7 (8),0.00398,0.0983,0.00494,0.0736
JAK-STAT,Wikipathways,14,MDM2;PAK1;FOXO1;NCOA1;PIK3CA;IRF1;IRS2;CISH;PIK3CG;LEPR;STAT1;IGF1R;JAK1;TEC,106 (106),0.000594,0.0487,0,,1 (2),1,1,0.00501,0.0738
Protein alkylation leading to liver fibrosis,Wikipathways,9,MAPK11;COL3A1;MAPK13;PDGFRA;TNFSF10;MMP2;MAPK12;COL1A1;COL1A2,50 (50),0.000595,0.0487,0,,6 (11),1,1,0.00501,0.0738
Rap1 signalling,Reactome,4,RAP1GAP2;RAPGEF3;RAP1B;RAP1GAP,16 (16),0.00628,0.196,1,HMDB01201,7 (8),0.096,0.441,0.00507,0.0743
VEGF signaling pathway - Homo sapiens (human),KEGG,8,PRKCA;MAPK11;MAPK13;PIK3CA;AKT3;PLCG2;MAPK12;PPP3CC,59 (59),0.00735,0.211,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (6),0.0829,0.406,0.00512,0.0745
MTHFR deficiency,Wikipathways,1,CASP3,10 (10),0.392,1,3,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,17 (20),0.00158,0.0637,0.0052,0.0752
p75 NTR receptor-mediated signalling,Reactome,8,ARHGEF11;CASP3;ARHGEF12;FGD4;SQSTM1;APH1B;ARHGEF6;TIAM2,96 (99),0.0945,0.698,2,HMDB04951;HMDB01201,9 (9),0.0067,0.14,0.0053,0.0763
Glycogen synthesis,Reactome,2,GBE1;PGM2L1,11 (11),0.0969,0.698,2,HMDB00288;HMDB00295,9 (10),0.0067,0.14,0.00542,0.0775
fatty acid &beta;-oxidation,HumanCyc,1,EHHADH,19 (19),0.612,1,5,HMDB00220;HMDB00806;HMDB02212;HMDB00944;HMDB02003,57 (84),0.00108,0.0493,0.00548,0.078
NF-kappa B signaling pathway - Homo sapiens (human),KEGG,10,BLNK;TNFRSF13C;CFLAR;CARD11;BIRC2;TNFSF13B;BTK;PLCG2;TRIM25;LY96,94 (95),0.0157,0.297,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (3),0.0423,0.338,0.00551,0.078
Inositol phosphate metabolism,INOH,8,PLCD3;PIK3CA;INPP1;PIK3CG;PLCB4;INPP4B;IPMK;PLCG2,41 (41),0.000681,0.0521,0,,21 (25),1,1,0.00565,0.0794
Nucleobase biosynthesis,Wikipathways,0,,0 (0),1,1,4,HMDB00288;HMDB00536;HMDB01201;HMDB01397,40 (47),0.0022,0.0812,0.0022,0.0812
fatty acid &beta;-oxidation (peroxisome),HumanCyc,1,EHHADH,19 (19),0.612,1,5,HMDB00220;HMDB00806;HMDB02212;HMDB00944;HMDB02003,58 (85),0.00117,0.0493,0.00588,0.0819
CD4 T cell receptor signaling-ERK cascade,INOH,2,PLCG2;BRAF,42 (42),0.612,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,4 (5),0.00117,0.0493,0.0059,0.0819
IL6-mediated signaling events,PID,6,MAPK11;JAK1;PIK3CA;IRF1;STAT1;FOXO1,47 (47),0.0253,0.377,1,HMDB01201,2 (2),0.0284,0.317,0.00592,0.0819
PDGFR-beta signaling pathway,PID,13,BLK;BRAF;PAK1;SLA;PRKCA;S1PR1;PIK3CG;STAT1;RPS6KA3;PIK3CA;RAP1B;BCAR1;ARPC2,127 (127),0.00872,0.227,1,HMDB01201,6 (7),0.0829,0.406,0.00595,0.0819
miR-509-3p alteration of YAP1-ECM axis,Wikipathways,5,COL3A1;BCAR1;COL1A1;SPARC;EDNRA,18 (18),0.00134,0.0822,0,,0 (0),1,1,0.00134,0.0822
mRNA Capping,Wikipathways,0,,0 (0),1,1,2,HMDB01201;HMDB01397,6 (6),0.00287,0.0845,0.00287,0.0845
Keratinization,Wikipathways,0,,0 (0),1,1,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (9),0.00287,0.0845,0.00287,0.0845
NGF,INOH,1,BRAF,21 (21),0.649,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,4 (5),0.00117,0.0493,0.00621,0.0848
ErbB Signaling Pathway,Wikipathways,10,MDM2;PAK1;FOXO1;BRAF;PRKCA;CAMK2A;AKT3;CAMK2D;PLCG2;PIK3CA,92 (92),0.0136,0.281,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (5),0.056,0.374,0.00623,0.0848
IL2 signaling events mediated by PI3K,PID,3,PIK3CA;JAK1;PRKCZ,37 (37),0.267,1,2,HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB01201,6 (6),0.00287,0.0845,0.00626,0.0848
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,11,BRAF;ARHGEF11;CACNA1S;ARHGEF12;ADORA2A;PRKCA;PLA2G12A;PPP1R12A;PLCB4;EDNRA;ITPR2,121 (121),0.0332,0.411,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,17 (26),0.0236,0.317,0.00638,0.086
Rho GTPase cycle,Reactome,13,ARHGEF11;ARHGEF12;FGD4;RHOQ;ARHGAP31;ARHGAP6;TIAM2;ARHGAP32;SRGAP1;ARHGEF6;ARHGAP24;ARHGAP12;RHOBTB1,140 (144),0.0186,0.329,1,HMDB01201,3 (3),0.0423,0.338,0.00642,0.0861
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,10,LPCAT2;GPCPD1;LPIN1;PLA2G12A;ETNK1;DGKH;PLD2;PNPLA7;PCYT1B;AGPAT4,97 (97),0.0192,0.336,2,HMDB10384;HMDB08048#HMDB08036#HMDB08038,23 (52),0.0416,0.338,0.00648,0.0864
Inositol phosphate metabolism - Homo sapiens (human),KEGG,11,PIKFYVE;PLCD3;PIK3C2B;FIG4;PIK3CA;INPP1;PIK3CG;PLCB4;INPP4B;IPMK;PLCG2,74 (74),0.000834,0.0617,0,,25 (47),1,1,0.00675,0.0894
CREB phosphorylation through the activation of Ras,Reactome,5,BRAF;CAMK2A;RPS6KA2;RPS6KA3;CAMK2D,27 (27),0.00882,0.227,1,HMDB01201,7 (7),0.096,0.441,0.00684,0.0902
EPO signaling pathway,PID,5,PLCG2;STAT1;IRS2;TEC;BTK,33 (33),0.0204,0.346,1,HMDB01201,3 (5),0.0423,0.338,0.00696,0.0905
bioactive peptide induced signaling pathway,BioCarta,5,CAMK2D;PRKCA;STAT1;PIK3CA;CAMK2A,33 (33),0.0204,0.346,1,HMDB01201,3 (3),0.0423,0.338,0.00696,0.0905
Lipid Metabolism Pathway,Wikipathways,3,AKT3;PNPLA2;PRKAG2,29 (29),0.165,0.867,2,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (14),0.00526,0.118,0.00698,0.0905
Long-term depression - Homo sapiens (human),KEGG,5,IGF1R;BRAF;PRKCA;PLCB4;ITPR2,60 (60),0.166,0.867,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,8 (9),0.00526,0.118,0.00701,0.0905
GPCR signaling-G alpha q,INOH,14,BRAF;PDGFA;IL18;WNT10A;TNFSF10;PRKCA;ADORA2A;CD80;BMP6;FGF11;IL10;PLCB4;PRKCZ;HGF,274 (274),0.462,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,5 (6),0.00193,0.073,0.00715,0.0919
Platelet homeostasis,Wikipathways,0,,0 (0),1,1,3,HMDB00658#HMDB10370;HMDB01201;HMDB01397,22 (28),0.00341,0.0928,0.00341,0.0928
Synthesis of PIPs at the plasma membrane,Reactome,9,PIK3C2B;PLEKHA1;PLEKHA2;PIK3CG;BMX;PLEKHA8;PTPN13;PIK3CA;INPP4B,53 (53),0.000924,0.0633,0,,11 (17),1,1,0.00738,0.0944
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,3,CTPS2;CMPK2;CMPK1,22 (22),0.0885,0.697,3,HMDB00288;HMDB00295;HMDB01546,33 (34),0.0109,0.191,0.00763,0.0962
DAP12 signaling,Reactome,5,PLCG2;GRAP2;B2M;PIK3CA;BTK,30 (30),0.0138,0.281,1,HMDB01201,5 (6),0.0695,0.374,0.00764,0.0962
Downstream signal transduction,Reactome,5,STAT1;PDGFA;BCAR1;PIK3CA;PDGFRA,30 (30),0.0138,0.281,1,HMDB01201,5 (7),0.0695,0.374,0.00764,0.0962
L1CAM interactions,Wikipathways,0,,0 (0),1,1,2,HMDB00220;HMDB01201,7 (9),0.00398,0.0983,0.00398,0.0983
Deadenylation-dependent mRNA decay,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB01397,7 (9),0.00398,0.0983,0.00398,0.0983
TCR signaling in na&#xef;ve CD8+ T cells,PID,7,RASSF5;PRKCA;CD28;CD80;CARD11;B2M;GRAP2,56 (56),0.0181,0.323,1,HMDB01201,4 (4),0.056,0.374,0.00801,0.1
Glycosphingolipid biosynthesis - ganglioseries,EHMN,1,HEXA,21 (21),0.649,1,3,HMDB11592#HMDB06750;HMDB00295;HMDB01201,17 (38),0.00158,0.0637,0.00808,0.101
Melanogenesis - Homo sapiens (human),KEGG,6,WNT10A;PRKCA;CAMK2A;CAMK2D;PLCB4;CREB3L2,101 (101),0.367,1,2,HMDB00158;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (6),0.00287,0.0845,0.00827,0.103
Digestion of dietary lipid,Reactome,0,,7 (7),1,1,3,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00658#HMDB10370,15 (17),0.00108,0.0493,0.00845,0.104
Sphingolipid pathway,Wikipathways,0,,26 (26),1,1,3,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975,15 (16),0.00108,0.0493,0.00845,0.104
Asparagine N-linked glycosylation,Reactome,19,SEL1L;MIA3;FUT8;CD55;STX17;USO1;DPM3;NGLY1;ARFGAP3;ST6GAL1;GFPT1;RNF103;MAN1B1;MGAT4A;SCFD1;ST8SIA6;ARF4;CTAGE5;SYVN1,285 (286),0.101,0.704,4,HMDB00288;HMDB00295;HMDB01201;HMDB01546,62 (119),0.0108,0.191,0.0085,0.104
Signaling events mediated by Stem cell factor receptor (c-Kit),PID,6,PIK3C2B;PIK3CA;STAP1;STAT1;GRAP2;TEC,52 (52),0.0392,0.456,1,HMDB01201,2 (4),0.0284,0.317,0.00869,0.105
Acyl chain remodelling of PC,Reactome,2,LPCAT2;PLA2G12A,28 (28),0.397,1,2,HMDB10384;HMDB08048#HMDB08036#HMDB08038,6 (13),0.00287,0.0845,0.00887,0.105
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,6,MAPK11;BRAF;PAK1;PIK3CA;RAPGEF3;PRKCZ,38 (38),0.00938,0.239,1,HMDB01201,9 (9),0.122,0.512,0.00888,0.105
Intracellular signaling by second messengers,Reactome,19,AKT3;MDM2;PDGFA;FOXO1;PIK3CA;PRKCA;RRAGD;CD28;CD80;ITPR2;PDE1A;IRS2;FGFR2;MKRN1;PDGFRA;INSR;HGF;AGO4;PRR5,245 (245),0.03,0.399,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,22 (30),0.0383,0.338,0.00892,0.105
Toll-Like Receptors Cascades,Reactome,15,MAPK11;CTSS;LGMN;PELI1;BTK;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;UNC93B1;BIRC2;PLCG2;LY96;TLR5,154 (154),0.00795,0.217,1,HMDB00658#HMDB10370,11 (29),0.147,0.579,0.00904,0.105
Chylomicron remodeling,Reactome,0,,10 (10),1,1,2,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (7),0.00117,0.0493,0.00906,0.105
Pre-NOTCH Processing in the Endoplasmic Reticulum,Reactome,0,,6 (6),1,1,2,HMDB00295;HMDB01201,4 (4),0.00117,0.0493,0.00906,0.105
Removal of the Flap Intermediate from the C-strand,Reactome,0,,10 (10),1,1,2,HMDB00288;HMDB01397,4 (5),0.00117,0.0493,0.00906,0.105
Removal of the Flap Intermediate,Reactome,0,,14 (14),1,1,2,HMDB00288;HMDB01397,4 (4),0.00117,0.0493,0.00906,0.105
Processive synthesis on the lagging strand,Reactome,0,,15 (15),1,1,2,HMDB00288;HMDB01397,4 (4),0.00117,0.0493,0.00906,0.105
Glycosphingolipid biosynthesis - lactoseries,EHMN,1,FUT1,7 (7),0.294,1,2,HMDB00295;HMDB01201,7 (19),0.00398,0.0983,0.00908,0.105
Cholinergic synapse - Homo sapiens (human),KEGG,12,PRKCA;PIK3CA;CACNA1S;PIK3CG;CAMK2A;AKT3;CAMK2D;PLCB4;ATF4;GNG2;CREB3L2;ITPR2,112 (112),0.00811,0.218,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (12),0.147,0.579,0.00921,0.106
antigen processing and presentation,BioCarta,4,TAP1;CD74;PSMB9;B2M,12 (12),0.00199,0.107,0,,0 (0),1,1,0.00199,0.107
Transmission across Chemical Synapses,Reactome,15,SYN3;MDM2;UNC13B;STXBP1;PRKCA;CAMK2A;CAMK2D;RPS6KA2;RPS6KA3;CACNA1E;GLS;BRAF;GNG2;GLUL;CASK,223 (224),0.126,0.798,4,HMDB00220;HMDB00806;HMDB01201;HMDB01043,60 (65),0.00961,0.18,0.00938,0.107
Oxytocin signaling pathway - Homo sapiens (human),KEGG,11,PRKCA;CACNA1S;PIK3CG;CAMK2A;MEF2C;CAMK2D;PPP1R12A;PLCB4;PPP3CC;ITPR2;PRKAG2,152 (152),0.121,0.785,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,11 (13),0.0101,0.18,0.0094,0.107
IGF signaling,INOH,5,IGFBP5;BRAF;IGF1R;PIK3CA;AKT3,36 (36),0.0288,0.399,1,HMDB01201,3 (4),0.0423,0.338,0.0094,0.107
CD28 dependent Vav1 pathway,Reactome,3,PAK1;CD28;CD80,12 (12),0.0181,0.323,1,HMDB01201,5 (5),0.0695,0.374,0.00964,0.108
Signaling mediated by p38-alpha and p38-beta,PID,4,MEF2C;MKNK1;ATF1;MAPK11,35 (35),0.088,0.697,1,HMDB01201,1 (1),0.0143,0.22,0.00966,0.108
Signaling events mediated by focal adhesion kinase,PID,7,BRAF;ARHGEF11;PIK3CA;PAK1;BMX;RAP1B;BCAR1,62 (62),0.03,0.399,1,HMDB01201,3 (3),0.0423,0.338,0.00973,0.108
Netrin-1 signaling,Reactome,3,PAK1;UNC5B;DCC,41 (41),0.321,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,7 (8),0.00398,0.0983,0.00979,0.108
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,10,MAPK11;MAPK13;PIK3CA;S1PR1;AKT3;PLCB4;PRKCZ;PLD2;MAPK12;PRKCA,118 (118),0.0609,0.569,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,16 (16),0.021,0.302,0.0098,0.108
Caspase activation via extrinsic apoptotic signalling pathway,Reactome,6,CASP3;CFLAR;TNFSF10;UNC5B;LY96;DCC,26 (26),0.00128,0.0805,0,,3 (3),1,1,0.00981,0.108
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,3,CTPS2;CMPK2;CMPK1,15 (15),0.0335,0.411,2,HMDB00288;HMDB00295,22 (23),0.0383,0.338,0.00983,0.108
IL8- and CXCR2-mediated signaling events,PID,5,PLD2;PRKCA;GNG2;RAB11A;PIK3CG,34 (34),0.023,0.359,1,HMDB01201,4 (4),0.056,0.374,0.00987,0.108
terminal <i>O</i>-glycans residues modification,HumanCyc,1,ST6GAL1,12 (12),0.45,1,2,HMDB00295;HMDB01201,6 (9),0.00287,0.0845,0.00988,0.108
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,12,MDM2;PLCD3;ATP1B3;FOXO1;NCOA1;PIK3CA;NCOR1;AKT3;PLCB4;PLCG2;STAT1;PRKCA,116 (116),0.0106,0.247,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,9 (11),0.122,0.512,0.00988,0.108
Syndecan interactions,Reactome,5,SDC3;SDC4;PRKCA;CASK;SDC1,20 (20),0.00224,0.112,0,,0 (2),1,1,0.00224,0.112
visual signal transduction,BioCarta,1,PDE6A,13 (13),0.477,1,2,HMDB01201;HMDB01397,6 (6),0.00287,0.0845,0.0104,0.113
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,14,MAPK11;CACNA1S;CREB3L2;PRKCA;RAPGEF3;ATP1B3;PIK3CG;CAMK2A;AKT3;CAMK2D;MAPK13;ATF4;PLCB4;MAPK12,144 (144),0.0103,0.247,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,10 (11),0.134,0.545,0.0105,0.113
Regulation of lipolysis in adipocytes - Homo sapiens (human),KEGG,5,PNPLA2;AKT3;PIK3CA;INSR;IRS2,54 (54),0.12,0.781,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,12 (15),0.012,0.202,0.0109,0.117
Signaling by Erythropoietin,Wikipathways,0,,0 (0),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,8 (9),0.00526,0.118,0.00526,0.118
Netrin-1 signaling,Wikipathways,0,,0 (0),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,8 (9),0.00526,0.118,0.00526,0.118
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,14,PDGFA;PDGFRA;PIK3CA;RAPGEF3;PIK3CG;AKT3;DGKH;PLCB4;PDGFD;PLCG2;PLD2;INSR;PRKCA;AGPAT4,145 (146),0.0109,0.25,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,10 (13),0.134,0.545,0.011,0.118
Signaling by NTRK1 (TRKA),Reactome,9,MAPK11;BRAF;ADORA2A;PIK3CA;MEF2C;ATF1;IRS2;RPS6KA3;RPS6KA2,76 (76),0.0111,0.252,1,HMDB01201,10 (11),0.134,0.545,0.0112,0.119
Asparagine N-linked glycosylation,Wikipathways,0,,0 (0),1,1,4,HMDB00288;HMDB00295;HMDB01201;HMDB01546,51 (101),0.00539,0.12,0.00539,0.12
Ferroptosis - Homo sapiens (human),KEGG,5,SLC3A2;SLC40A1;CP;ATG7;MAP1LC3B,40 (40),0.043,0.477,2,HMDB02226;HMDB01043,21 (31),0.0351,0.338,0.0113,0.121
TNF signaling pathway - Homo sapiens (human),KEGG,13,MAPK11;CXCL10;CASP3;CFLAR;CREB3L2;PIK3CA;IRF1;AKT3;MAPK13;ATF4;CXCL3;MAPK12;BIRC2,110 (110),0.00257,0.123,0,,0 (0),1,1,0.00257,0.123
Glycerophospholipid biosynthesis,Reactome,11,LPCAT2;GPCPD1;LPIN1;PLA2G12A;ETNK1;LIPH;PNPLA2;SLC44A1;PLD2;PCYT1B;AGPAT4,133 (133),0.0588,0.557,3,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,46 (93),0.0266,0.317,0.0117,0.124
RAB geranylgeranylation,Reactome,7,RAB23;RAB2B;RAB6B;RAB3D;RAB5B;RAB30;RAB11A,65 (65),0.0375,0.449,1,HMDB01201,3 (3),0.0423,0.338,0.0118,0.125
Insulin Pathway,PID,6,RHOQ;PIK3CA;SGK1;PRKCZ;EXOC2;INSR,46 (46),0.023,0.359,1,HMDB01201,5 (5),0.0695,0.374,0.0119,0.125
Fatty acid metabolism,Reactome,13,ALDH3A2;TBXAS1;FAAH;PON3;HACD3;EHHADH;PTGIS;ALOX12;PHYH;HACD4;ELOVL7;ACOT7;PRKAG2,185 (189),0.116,0.767,7,HMDB10384;HMDB00220;HMDB08048#HMDB08036#HMDB08038;HMDB01388;HMDB01043;HMDB00673;HMDB01999,186 (367),0.0139,0.22,0.012,0.125
Endocytosis - Homo sapiens (human),KEGG,19,MDM2;PDGFRA;ZFYVE16;TGFBR1;PRKCZ;CXCR4;RAB5B;ARFGAP3;KIF5C;VPS36;GRK5;CHMP5;FGFR2;IGF1R;PLD2;STAM;SH3GLB1;ARPC2;RAB11A,244 (244),0.0289,0.399,1,HMDB01201,4 (6),0.056,0.374,0.012,0.125
Glycogen metabolism,Reactome,3,GBE1;PGM2L1;PYGL,22 (22),0.0885,0.697,2,HMDB00288;HMDB00295,15 (17),0.0185,0.273,0.0122,0.125
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,17,PRKCA;MAPK11;PAK1;MAPK13;CASP3;AP1S2;PIK3CA;CXCR4;PPP3CC;AKT3;SAMHD1;TAP1;B2M;PLCG2;GNG2;MAPK12;ITPR2,212 (212),0.0294,0.399,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (5),0.056,0.374,0.0122,0.125
Influenza A - Homo sapiens (human),KEGG,18,MAPK11;IVNS1ABP;CASP1;EIF2AK3;JAK1;TNFSF10;PIK3CA;CXCL10;OAS3;AKT3;MAPK13;NLRP3;IL18;RNASEL;STAT1;TRIM25;MAPK12;PRKCA,171 (171),0.00165,0.0971,0,,2 (3),1,1,0.0122,0.125
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,2,CMPK2;CMPK1,17 (17),0.199,0.916,3,HMDB00295;HMDB01546;HMDB01201,30 (31),0.00832,0.159,0.0122,0.125
GPVI-mediated activation cascade,Reactome,5,PLCG2;PDPN;PIK3CA;PRKCZ;PIK3CG,33 (33),0.0204,0.346,1,HMDB01201,6 (8),0.0829,0.406,0.0125,0.127
phospholipids as signalling intermediaries,BioCarta,5,PIK3CA;PRKCA;PDGFRA;PDGFA;S1PR1,33 (33),0.0204,0.346,1,HMDB01201,6 (7),0.0829,0.406,0.0125,0.127
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,8,ARHGEF11;CASP3;ARHGEF12;APH1B;SQSTM1;FGD4;ARHGEF6;TIAM2,76 (78),0.0307,0.399,1,HMDB01201,4 (4),0.056,0.374,0.0127,0.128
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,8,MAPK11;CASP1;MAPK13;TXNIP;BIRC2;NLRP3;CYLD;MAPK12,47 (47),0.00173,0.0995,0,,3 (6),1,1,0.0128,0.129
Nectin adhesion pathway,PID,4,F11R;PIK3CA;RAP1B;FARP2,31 (31),0.0614,0.569,1,HMDB01201,2 (3),0.0284,0.317,0.0128,0.129
Platelet activation_ signaling and aggregation,Reactome,19,APBB1IP;PDGFA;SPARC;SERPING1;PDPN;PRKCA;RAPGEF3;PIK3CG;ITPR2;CTSW;DGKH;RAP1B;PRKCZ;PIK3CA;PLCG2;GNG2;BCAR1;HGF;STXBP3,260 (260),0.0498,0.511,2,HMDB01201;HMDB01043,21 (33),0.0351,0.338,0.0129,0.129
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,6,SDC3;NDST1;SDC1;SDC4;NCAN;GPC4,54 (54),0.0459,0.495,2,HMDB00288;HMDB00295,22 (35),0.0383,0.338,0.0129,0.129
Regulation of TP53 Expression and Degradation,Reactome,7,MDM2;MDM4;RNF34;SGK1;AKT3;PRDM1;PRR5,37 (37),0.00177,0.101,0,,5 (5),1,1,0.013,0.129
Control of immune tolerance by vasoactive intestinalpeptide,Wikipathways,4,IL10;CD28;CTLA4;CD80,13 (13),0.00277,0.13,0,,0 (0),1,1,0.00277,0.13
Leptin,NetPath,9,JAK1;FOXO1;LEPR;NCOA1;IGF1R;IRS2;PLCG2;STAT1;RPS6KA2,62 (62),0.00287,0.132,0,,0 (1),1,1,0.00287,0.132
alpha-Linolenic acid metabolism - Homo sapiens (human),KEGG,1,PLA2G12A,25 (25),0.712,1,3,HMDB01388;HMDB06547;HMDB08048#HMDB08036#HMDB08038,20 (42),0.00257,0.0845,0.0134,0.132
Ca2+ pathway,Reactome,5,PDE6A;PRKCA;GNG2;ITPR2;CAMK2A,53 (53),0.113,0.751,2,HMDB01201;HMDB01397,14 (16),0.0162,0.245,0.0134,0.132
Plasma membrane estrogen receptor signaling,PID,6,MAPK11;PIK3CA;IGF1R;MMP2;GNG2;BCAR1,42 (42),0.0151,0.294,1,HMDB01201,9 (9),0.122,0.512,0.0134,0.132
Pathways in cancer - Homo sapiens (human),KEGG,39,FOXO1;TGFBR1;RASSF5;HGF;AKT3;FLT4;IGF1R;JAK1;BRAF;PDGFA;PDGFRA;PIK3CA;CXCR4;CAMK2A;CAMK2D;RASGRP3;MAX;GNG2;CASP3;ARHGEF12;WNT10A;NCOA1;BIRC2;PRKCA;LAMC1;PLCB4;FGFR2;PLCG2;MMP2;ITGA3;DCC;PTCH1;MDM2;ARHGEF11;IL5RA;EPAS1;STAT1;EDNRA;CCND2,526 (526),0.00558,0.183,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,28 (35),0.333,1,0.0135,0.132
Glycosphingolipid metabolism,EHMN,2,SMPD3;KMT2E,69 (69),0.855,1,4,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975;HMDB00295,40 (55),0.0022,0.0812,0.0137,0.133
Syndecan-4-mediated signaling events,PID,4,SDC4;PRKCA;CXCR4;TNFRSF13B,32 (32),0.0676,0.599,1,HMDB01201,2 (2),0.0284,0.317,0.0139,0.134
MET activates RAP1 and RAC1,Reactome,2,HGF;RAP1B,9 (9),0.0676,0.599,1,HMDB01201,2 (2),0.0284,0.317,0.0139,0.134
PI3K/AKT Signaling in Cancer,Reactome,12,MDM2;PDGFA;FOXO1;HGF;CD28;CD80;AKT3;IRS2;FGFR2;PDGFRA;PIK3CA;PRR5,94 (94),0.00193,0.106,0,,4 (17),1,1,0.014,0.134
Nanoparticle triggered regulated necrosis,Wikipathways,0,,10 (10),1,1,2,HMDB04951;HMDB01043,5 (7),0.00193,0.073,0.014,0.134
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Reactome,3,PLXNA1;NRP1;FARP2,14 (14),0.0278,0.396,1,HMDB01201,5 (5),0.0695,0.374,0.014,0.134
Calcium signaling pathway - Homo sapiens (human),KEGG,16,CACNA1H;PLCD3;PDGFRA;ADORA2A;CACNA1E;PRKCA;CACNA1S;CXCR4;CAMK2A;PDE1A;CAMK2D;PLCB4;EDNRA;PPP3CC;PLCG2;ITPR2,185 (186),0.0182,0.323,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (10),0.109,0.479,0.0143,0.136
Glycosaminoglycan metabolism,Reactome,11,HEXA;CHPF;SDC3;NDST1;SDC1;SDC4;LYVE1;CHST1;NCAN;CHST3;GPC4,119 (119),0.0299,0.399,2,HMDB00288;HMDB00295,30 (60),0.0672,0.374,0.0145,0.137
Refsum Disease,SMPDB,3,PHYH;ALDH3A2;ABCD2,6 (6),0.00204,0.107,0,,24 (24),1,1,0.0147,0.138
Phytanic Acid Peroxisomal Oxidation,SMPDB,3,PHYH;ALDH3A2;ABCD2,6 (6),0.00204,0.107,0,,24 (24),1,1,0.0147,0.138
Collagen biosynthesis and modifying enzymes,Reactome,8,COL2A1;COL3A1;COL5A2;COL24A1;COL22A1;COL11A1;COL1A1;COL1A2,68 (68),0.0168,0.311,1,HMDB00295,9 (9),0.122,0.512,0.0147,0.138
Signaling by FGFR3,Reactome,3,BRAF;PIK3CA;MKNK1,40 (40),0.307,1,2,HMDB00295;HMDB01201,9 (10),0.0067,0.14,0.0148,0.138
IL4,NetPath,9,MAPK11;JAK1;PIK3CA;CXCR4;IRS2;PRKCZ;PLCG2;STAT1;STAM,63 (63),0.00321,0.139,0,,0 (0),1,1,0.00321,0.139
Integration of energy metabolism,Reactome,6,CACNA1E;PRKCA;RAPGEF3;GNG2;ITPR2;PRKAG2,94 (94),0.306,1,3,HMDB00220;HMDB00618#HMDB01548;HMDB01201,28 (34),0.00684,0.142,0.015,0.14
Neurotransmitter release cycle,Reactome,5,SYN3;UNC13B;GLS;STXBP1;CASK,51 (51),0.1,0.703,3,HMDB00220;HMDB00806;HMDB01043,42 (45),0.0209,0.302,0.015,0.14
p75 NTR receptor-mediated signalling,Wikipathways,0,,0 (0),1,1,2,HMDB04951;HMDB01201,9 (9),0.0067,0.14,0.0067,0.14
Signaling by FGFR3,Wikipathways,0,,0 (0),1,1,2,HMDB00295;HMDB01201,9 (12),0.0067,0.14,0.0067,0.14
Synthesis of substrates in N-glycan biosythesis,Reactome,4,DPM3;ST6GAL1;ST8SIA6;GFPT1,63 (63),0.366,1,4,HMDB00288;HMDB00295;HMDB01201;HMDB01546,52 (68),0.00579,0.128,0.0152,0.14
Axon guidance - Homo sapiens (human),KEGG,18,PRKCA;PAK1;RYK;ARHGEF12;CAMK2D;PIK3CA;CXCR4;CAMK2A;PLXNA1;SRGAP1;UNC5B;PLXNC1;PRKCZ;PPP3CC;PLCG2;NRP1;DCC;PTCH1,175 (175),0.00214,0.109,0,,1 (1),1,1,0.0153,0.141
Pyrimidine metabolism,EHMN,5,CMPK1;ENPP2;ENPP1;POLR1A;ENTPD4,135 (136),0.791,1,5,HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01201;HMDB01546,70 (77),0.00272,0.0845,0.0154,0.141
Cell surface interactions at the vascular wall,Reactome,13,CD84;F11R;ATP1B3;JCHAIN;SDC4;EPCAM;PIK3CA;CD74;SDC1;SDC3;ITGAL;SLC3A2;ITGA3,218 (219),0.262,1,2,HMDB00658#HMDB10370;HMDB01201,10 (13),0.00831,0.159,0.0155,0.142
Purine metabolism,Wikipathways,0,,7 (7),1,1,4,HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,40 (42),0.0022,0.0812,0.0157,0.142
Carboxyterminal post-translational modifications of tubulin,Reactome,2,TTLL7;TUBB2B,38 (38),0.557,1,2,HMDB00158;HMDB01201,7 (9),0.00398,0.0983,0.0158,0.142
PI3K-Akt Signaling Pathway,Wikipathways,29,COL2A1;JAK1;HGF;AKT3;RELN;FLT4;SGK1;IGF1R;PDGFA;PDGFRA;PIK3CA;PIK3CG;PDGFD;GNG2;PRKCA;LAMC1;FGF11;ATF4;FGFR2;ITGA3;MDM2;INSR;TNXB;ITGB7;PRLR;CCND2;CREB3L2;COL1A1;COL1A2,339 (340),0.00222,0.112,0,,3 (4),1,1,0.0158,0.142
Activation of the phototransduction cascade,Reactome,1,PDE6A,11 (11),0.422,1,2,HMDB01201;HMDB01397,8 (8),0.00526,0.118,0.0158,0.142
Signaling by NOTCH,Reactome,8,DNER;TBL1XR1;APH1B;NCOR1;TLE4;STAT1;MAML2;AGO4,119 (120),0.221,0.929,2,HMDB00295;HMDB01201,11 (11),0.0101,0.18,0.0158,0.142
MET promotes cell motility,Reactome,4,HGF;ITGA3;RAP1B;LAMC1,27 (27),0.0398,0.456,1,HMDB01201,4 (4),0.056,0.374,0.0158,0.142
PDGF receptor signaling network,PID,3,PDGFA;PDGFRA;PDGFD,7 (7),0.00344,0.143,0,,0 (1),1,1,0.00344,0.143
ras-independent pathway in nk cell-mediated cytotoxicity,BioCarta,5,PIK3CA;CD28;PAK1;IL18;B2M,22 (22),0.00351,0.143,0,,0 (0),1,1,0.00351,0.143
Transcription factor regulation in adipogenesis,Wikipathways,5,FOXO1;INSR;NR3C1;IRS2;LPIN1,22 (22),0.00351,0.143,0,,0 (1),1,1,0.00351,0.143
IL2,NetPath,10,JAK1;PIK3CA;PIK3CG;STAT1;SGK1;PRKCZ;NMI;IRS2;NR3C1;MKNK1,76 (76),0.00359,0.143,0,,0 (0),1,1,0.00359,0.143
EPHA2 forward signaling,PID,3,PAK1;BCAR1;PIK3CA,18 (18),0.054,0.531,1,HMDB01201,3 (3),0.0423,0.338,0.0162,0.144
Rapid glucocorticoid signaling,PID,2,MAPK11;GNG2,8 (8),0.0543,0.531,1,HMDB01201,3 (3),0.0423,0.338,0.0162,0.144
Sphingolipid metabolism - Homo sapiens (human),KEGG,1,SMPD3,47 (47),0.904,1,3,HMDB11592#HMDB06750;HMDB04951;HMDB04971#HMDB04972#HMDB04974#HMDB04975,20 (25),0.00257,0.0845,0.0164,0.145
il-2 receptor beta chain in t cell activation,BioCarta,5,PIK3CA;JAK1;IKZF3;CCND2;NMI,48 (48),0.082,0.668,1,HMDB01201,2 (2),0.0284,0.317,0.0165,0.145
Regulation of CDC42 activity,PID,4,DOCK11;ARHGEF6;BCAR3;FARP2,30 (30),0.0555,0.535,1,HMDB01201,3 (3),0.0423,0.338,0.0166,0.146
Thyroid hormone synthesis - Homo sapiens (human),KEGG,7,PDIA4;ATP1B3;PRKCA;PLCB4;ATF4;CREB3L2;ITPR2,74 (74),0.0673,0.599,2,HMDB00618#HMDB01548;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,21 (21),0.0351,0.338,0.0167,0.146
Transport to the Golgi and subsequent modification,Reactome,12,MIA3;FUT8;CD55;STX17;USO1;ARFGAP3;ST6GAL1;MGAT4A;SCFD1;ST8SIA6;ARF4;CTAGE5,168 (168),0.117,0.771,2,HMDB00295;HMDB01201,16 (36),0.021,0.302,0.0172,0.147
Collagen formation,Reactome,10,COL2A1;COL3A1;COL5A2;COL24A1;CTSS;COL22A1;COL11A1;LOX;COL1A1;COL1A2,92 (92),0.0136,0.281,1,HMDB00295,14 (14),0.183,0.686,0.0174,0.147
Fat digestion and absorption - Homo sapiens (human),KEGG,1,PLA2G12A,41 (41),0.871,1,2,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (13),0.00287,0.0845,0.0175,0.147
HGF,INOH,4,PLCG2;HGF;RAP1B;PIK3CA,35 (35),0.088,0.697,1,HMDB01201,2 (2),0.0284,0.317,0.0175,0.147
Prostate cancer - Homo sapiens (human),KEGG,12,MDM2;PDGFA;PDGFRA;BRAF;PIK3CA;AKT3;ATF4;PDGFD;FGFR2;IGF1R;FOXO1;CREB3L2,97 (97),0.00252,0.123,0,,11 (11),1,1,0.0176,0.147
mTOR signaling pathway - Homo sapiens (human),KEGG,16,RRAGD;BRAF;IGF1R;WNT10A;LPIN1;CLIP1;PIK3CA;SGK1;AKT3;ATP6V1E1;RPS6KA2;RPS6KA3;SLC3A2;INSR;PRKCA;PRR5,150 (151),0.00256,0.123,0,,3 (3),1,1,0.0178,0.147
Tuberculosis - Homo sapiens (human),KEGG,18,MAPK11;CTSS;IL10;MAPK13;JAK1;ARHGEF12;MRC1;CD74;RAB5B;CAMK2A;AKT3;CAMK2D;STAT1;IL18;ATP6V0A1;CASP3;MAPK12;PPP3CC,178 (179),0.00258,0.123,0,,7 (9),1,1,0.0179,0.147
TCR signaling in na&#xef;ve CD4+ T cells,PID,7,RASSF5;PRKCA;CD28;CD80;CARD11;STK39;GRAP2,68 (68),0.0463,0.497,1,HMDB01201,4 (4),0.056,0.374,0.018,0.147
Purine Metabolism,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Xanthinuria type I,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Xanthinuria type II,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Purine Nucleoside Phosphorylase Deficiency,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Adenylosuccinate Lyase Deficiency,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Adenine phosphoribosyltransferase deficiency (APRT),SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Mitochondrial DNA depletion syndrome,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Myoadenylate deaminase deficiency,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Molybdenum Cofactor Deficiency,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Adenosine Deaminase Deficiency,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Gout or Kelley-Seegmiller Syndrome,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
Lesch-Nyhan Syndrome (LNS),SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
AICA-Ribosiduria,SMPDB,1,XDH,37 (37),0.842,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,72 (73),0.00308,0.0845,0.0181,0.147
SHC1 events in ERBB2 signaling,Reactome,1,PRKCA,22 (22),0.666,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,7 (8),0.00398,0.0983,0.0184,0.149
Signaling by MET,Reactome,7,LRIG1;ITGA3;HGF;LAMC1;RAP1B;STAM;PIK3CA,61 (61),0.0277,0.396,1,HMDB01201,7 (8),0.096,0.441,0.0184,0.149
Non-integrin membrane-ECM interactions,Reactome,7,PDGFA;SDC3;PRKCA;LAMC1;SDC1;SDC4;CASK,42 (42),0.00377,0.149,0,,0 (3),1,1,0.00377,0.149
Toll-like Receptor Signaling Pathway,Wikipathways,12,MAPK11;MAPK13;TLR5;PIK3CA;CXCL10;CD80;PIK3CG;IRF5;AKT3;STAT1;LY96;MAPK12,102 (102),0.00384,0.15,0,,0 (0),1,1,0.00384,0.15
Transcriptional misregulation in cancer - Homo sapiens (human),KEGG,18,MDM2;PDGFA;NCOR1;FOXO1;JMJD1C;KMT2A;HMGA2;KDM6A;MLLT3;FUT8;ITGB7;MEF2C;ATF1;MAX;DDX5;IGF1R;HHEX;CCND2,185 (186),0.0039,0.15,0,,0 (0),1,1,0.0039,0.15
Regulation of nuclear SMAD2/3 signaling,PID,10,SKIL;LAMC1;FOXO1;NCOA1;NCOR1;IL10;MEF2C;MAX;NR3C1;COL1A2,77 (78),0.00395,0.15,0,,0 (1),1,1,0.00395,0.15
Cell adhesion molecules (CAMs) - Homo sapiens (human),KEGG,15,F11R;ITGAL;CLDN7;CD274;SDC3;NEGR1;CD28;CD80;SDC1;ITGB7;SDC4;CTLA4;ALCAM;PDCD1LG2;CD276,143 (144),0.00402,0.15,0,,0 (0),1,1,0.00402,0.15
Clathrin-mediated endocytosis,Reactome,9,REPS2;VAMP4;SYT8;RAB5B;GAPVD1;STAM;FCHO2;ARPC2;STON2,138 (138),0.228,0.948,2,HMDB00658#HMDB10370;HMDB01201,12 (16),0.012,0.202,0.0188,0.152
transcription factor creb and its extracellular signals,BioCarta,4,CAMK2D;PRKCA;PIK3CA;CAMK2A,27 (27),0.0398,0.456,1,HMDB01201,5 (5),0.0695,0.374,0.0191,0.152
t cell receptor signaling pathway,BioCarta,6,PRKCA;ARHGAP6;ARFGAP3;NCF2;PIK3CA;PPP3CC,55 (55),0.0495,0.51,1,HMDB01201,4 (5),0.056,0.374,0.0191,0.152
Formation of the cornified envelope,Reactome,1,ST14,75 (75),0.976,1,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (9),0.00287,0.0845,0.0193,0.152
African trypanosomiasis - Homo sapiens (human),KEGG,5,PLCB4;IL10;F2RL1;PRKCA;IL18,34 (35),0.023,0.359,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,9 (10),0.122,0.512,0.0193,0.152
Unfolded Protein Response (UPR),Reactome,5,ERN1;EIF2AK3;CREB3L2;SERP1;CREBRF,21 (21),0.00283,0.131,0,,4 (4),1,1,0.0194,0.152
Keratinization,Reactome,2,ST14;KRT7,129 (129),0.988,1,2,HMDB04951;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (9),0.00287,0.0845,0.0195,0.152
DNA strand elongation,Reactome,0,,32 (32),1,1,2,HMDB00288;HMDB01397,6 (6),0.00287,0.0845,0.0197,0.152
Acyl chain remodeling of CL,Reactome,0,,6 (6),1,1,2,HMDB10384;HMDB08048#HMDB08036#HMDB08038,6 (12),0.00287,0.0845,0.0197,0.152
Lagging Strand Synthesis,Reactome,0,,20 (20),1,1,2,HMDB00288;HMDB01397,6 (6),0.00287,0.0845,0.0197,0.152
mRNA Capping,Reactome,0,,29 (29),1,1,2,HMDB01201;HMDB01397,6 (7),0.00287,0.0845,0.0197,0.152
mRNA decay by 5_ to 3_ exoribonuclease,Reactome,0,,15 (15),1,1,2,HMDB00288;HMDB01397,6 (7),0.00287,0.0845,0.0197,0.152
Thromboxane A2 receptor signaling,PID,7,BLK;MAPK11;PRKCA;PIK3CG;PRKCZ;GNG2;RAB11A,56 (57),0.0181,0.323,1,HMDB01201,12 (12),0.159,0.616,0.0197,0.152
Glycosphingolipid biosynthesis - neolactoseries,EHMN,1,FUT1,16 (16),0.549,1,2,HMDB00295;HMDB01201,8 (48),0.00526,0.118,0.0198,0.152
Semaphorin interactions,Reactome,7,ARHGEF11;ARHGEF12;PLXNC1;PAK1;PLXNA1;NRP1;FARP2,64 (64),0.0349,0.426,1,HMDB01201,6 (6),0.0829,0.406,0.0198,0.152
Proteoglycan biosynthesis,EHMN,2,CHPF;CHST3,30 (30),0.432,1,2,HMDB00288;HMDB00295,9 (19),0.0067,0.14,0.0198,0.152
Phospholipid Biosynthesis,SMPDB,1,PLD2,28 (28),0.752,1,3,HMDB10384;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,23 (24),0.00388,0.0983,0.02,0.153
metabolism of anandamide an endogenous cannabinoid,BioCarta,2,PLD2;FAAH,7 (7),0.042,0.472,1,HMDB01043,5 (6),0.0695,0.374,0.02,0.153
Chemokine signaling pathway - Homo sapiens (human),KEGG,15,BRAF;PAK1;PLCB4;CXCL3;PIK3CA;CXCL10;CXCR4;PIK3CG;AKT3;STAT1;GRK5;PRKCZ;RAP1B;GNG2;BCAR1,189 (189),0.0421,0.472,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,0.02,0.153
Globo Sphingolipid Metabolism,Wikipathways,3,ST6GAL1;FUT1;B3GALT5,20 (20),0.0703,0.613,1,HMDB11592#HMDB06750,3 (3),0.0423,0.338,0.0203,0.154
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,12,PIKFYVE;PLCD3;PIK3C2B;PRKCA;INPP1;ITPR2;DGKH;PLCB4;INPP4B;IPMK;PLCG2;PIK3CA,99 (99),0.003,0.135,0,,21 (29),1,1,0.0204,0.155
Pyrimidine nucleotides nucleosides metabolism,INOH,3,CTPS2;ENTPD4;CMPK1,51 (51),0.453,1,4,HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01546,54 (56),0.00662,0.14,0.0204,0.155
ErbB signaling pathway - Homo sapiens (human),KEGG,8,BRAF;PAK1;PIK3CA;CAMK2A;AKT3;CAMK2D;PLCG2;PRKCA,85 (85),0.0539,0.531,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0205,0.155
Signaling by Interleukins,Reactome,23,IL10;JAK1;HGF;IL18;MEF2C;PIK3CA;SQSTM1;RPS6KA2;RPS6KA3;BLNK;CASP1;CASP3;PELI1;IRAK3;ATF1;IL18BP;TEC;MAPK11;SDC1;IL5RA;STAT1;MAP3K3;IL27,254 (254),0.00303,0.135,0,,4 (14),1,1,0.0206,0.155
Deadenylation-dependent mRNA decay,Reactome,2,EIF4A2;CNOT6L,56 (56),0.763,1,2,HMDB00288;HMDB01397,7 (11),0.00398,0.0983,0.0207,0.155
Ephrin B reverse signaling,PID,3,BLK;PIK3CA;PTPN13,24 (24),0.108,0.739,1,HMDB01201,2 (2),0.0284,0.317,0.0209,0.156
Post NMDA receptor activation events,Reactome,5,BRAF;CAMK2A;RPS6KA2;RPS6KA3;CAMK2D,35 (35),0.0258,0.382,1,HMDB01201,9 (9),0.122,0.512,0.0213,0.158
Platelet homeostasis,Reactome,3,PDE1A;GNG2;ITPR2,89 (89),0.814,1,3,HMDB00658#HMDB10370;HMDB01201;HMDB01397,23 (28),0.00388,0.0983,0.0213,0.158
Synthesis of very long-chain fatty acyl-CoAs,Reactome,3,ELOVL7;HACD4;HACD3,24 (24),0.108,0.739,2,HMDB00220;HMDB01043,19 (27),0.0291,0.317,0.0213,0.158
ctcf: first multivalent nuclear factor,BioCarta,5,MDM2;PIK3CA;TGFBR1;CD79B;CD79A,23 (23),0.00431,0.158,0,,0 (0),1,1,0.00431,0.158
Cell surface interactions at the vascular wall,Wikipathways,0,,0 (0),1,1,2,HMDB00658#HMDB10370;HMDB01201,10 (11),0.00831,0.159,0.00831,0.159
Signaling by ERBB2,Wikipathways,0,,0 (0),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,10 (12),0.00831,0.159,0.00831,0.159
Digestion,Wikipathways,0,,0 (0),1,1,3,HMDB00220;HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,30 (43),0.00832,0.159,0.00832,0.159
Endochondral Ossification,Wikipathways,9,COL2A1;IGF1R;BMP6;ENPP1;MEF2C;BMPR1A;STAT1;ADAMTS5;PTCH1,63 (63),0.00321,0.139,0,,2 (4),1,1,0.0216,0.159
Insulin secretion - Homo sapiens (human),KEGG,9,ATP1B3;KCNN4;PRKCA;CACNA1S;CAMK2A;CAMK2D;ATF4;PLCB4;CREB3L2,85 (85),0.0219,0.353,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (13),0.147,0.579,0.0216,0.159
Metabolism of vitamins and cofactors,Reactome,13,NADK;SDC3;PTGIS;SLC23A1;ALDH1L2;PTS;SDC1;ENPP1;SDC4;SLC46A1;ACP5;NAMPT;GPC4,178 (181),0.0931,0.698,5,HMDB00220;HMDB00673;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00658#HMDB10370;HMDB00159,130 (180),0.0349,0.338,0.0219,0.16
Reactions specific to the complex N-glycan synthesis pathway,Reactome,1,FUT8,10 (10),0.392,1,2,HMDB00295;HMDB01201,10 (19),0.00831,0.159,0.0219,0.16
Visual signal transduction: Rods,PID,2,PDE6A;RDH12,24 (24),0.326,1,2,HMDB01201;HMDB08048#HMDB08036#HMDB08038,11 (13),0.0101,0.18,0.0221,0.161
Th1 and Th2 cell differentiation - Homo sapiens (human),KEGG,8,MAPK11;MAPK13;JAK1;STAT1;TBX21;MAML2;MAPK12;PPP3CC,92 (92),0.0781,0.662,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (3),0.0423,0.338,0.0222,0.161
Purine nucleotides nucleosides metabolism,INOH,4,PDE1A;PDE6A;XDH;ENTPD4,107 (108),0.77,1,5,HMDB00618#HMDB01548;HMDB01044;HMDB00536;HMDB01201;HMDB01397,78 (80),0.00438,0.104,0.0226,0.162
Signaling events regulated by Ret tyrosine kinase,PID,4,BCAR1;PRKCA;IRS2;PIK3CA,39 (39),0.119,0.779,1,HMDB01201,2 (2),0.0284,0.317,0.0226,0.162
CREB phosphorylation,Reactome,3,ATF1;RPS6KA2;RPS6KA3,7 (7),0.00344,0.143,0,,2 (2),1,1,0.023,0.162
Glycerophospholipid catabolism,Reactome,3,GDPD5;GDPD3;PNPLA7,7 (7),0.00344,0.143,0,,6 (11),1,1,0.023,0.162
Glycogen synthetase deficiency,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Sucrase-isomaltase deficiency,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Glycogenosis_ Type VI. Hers disease,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Starch and Sucrose Metabolism,SMPDB,4,GBE1;PGM2L1;PYGL;MGAM,18 (18),0.00978,0.24,1,HMDB00295,30 (30),0.353,1,0.023,0.162
Gastrin-CREB signalling pathway via PKC and MAPK,Reactome,3,PRKCA;RPS6KA2;RPS6KA3,19 (19),0.0619,0.569,1,HMDB01201,4 (5),0.056,0.374,0.0231,0.162
Glycerophospholipid metabolism,EHMN,8,ALDH3A2;PLA2G12A;ATP8B2;DGKH;ALDH7A1;SLC3A2;PLD2;PCYT1B,136 (136),0.341,1,4,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038;HMDB00658#HMDB10370;HMDB10384,61 (96),0.0102,0.181,0.0231,0.162
p75(NTR)-mediated signaling,PID,6,CASP3;APH1B;BIRC2;PIK3CA;SQSTM1;PRKCZ,70 (71),0.124,0.798,1,HMDB01201,2 (2),0.0284,0.317,0.0234,0.163
CD28 dependent PI3K/Akt signaling,Reactome,5,AKT3;PIK3CA;CD28;CD80;PRR5,22 (22),0.00351,0.143,0,,3 (4),1,1,0.0234,0.163
Purine metabolism - Homo sapiens (human),KEGG,6,XDH;ENTPD4;PDE1A;PDE6A;ENPP1;POLR1A,173 (174),0.851,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,77 (95),0.00414,0.1,0.0234,0.163
Pertussis - Homo sapiens (human),KEGG,10,MAPK11;IL10;MAPK13;CASP3;SERPING1;IRF1;CASP1;NLRP3;LY96;MAPK12,76 (76),0.00359,0.143,0,,7 (10),1,1,0.0238,0.165
Resistin as a regulator of inflammation,Wikipathways,6,PLCD3;PIK3CA;PIK3CG;AKT3;PLCB4;PLCG2,33 (33),0.00462,0.166,0,,0 (0),1,1,0.00462,0.166
Vibrio cholerae infection - Homo sapiens (human),KEGG,6,PDIA4;PRKCA;ATP6V1E1;ATP6V0A1;PLCG2;SLC12A2,50 (50),0.0332,0.411,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (9),0.109,0.479,0.0239,0.166
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,BioCarta,4,GJA1;PIK3CA;LY96;EHHADH,40 (40),0.128,0.798,1,HMDB04951,2 (3),0.0284,0.317,0.024,0.166
Ibuprofen Action Pathway,SMPDB,4,PDIA4;PTGIS;TBXAS1;ALOX12,50 (50),0.224,0.937,4,HMDB10384;HMDB00295;HMDB01043;HMDB08048#HMDB08036#HMDB08038,70 (77),0.0163,0.246,0.0242,0.166
Signaling by ERBB2,Reactome,3,AKT3;PRKCA;PIK3CA,50 (50),0.441,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,10 (12),0.00831,0.159,0.0242,0.166
MET in type 1 papillary renal cell carcinoma,Wikipathways,6,BRAF;PAK1;PIK3CA;AKT3;RAP1B;HGF,59 (59),0.0656,0.598,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0243,0.166
angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling,BioCarta,4,MEF2C;PRKCA;BCAR1;PAK1,35 (35),0.088,0.697,1,HMDB01201,3 (3),0.0423,0.338,0.0245,0.167
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,4,DPM3;ST6GAL1;ST8SIA6;GFPT1,78 (78),0.529,1,4,HMDB00288;HMDB00295;HMDB01546;HMDB01201,55 (81),0.00707,0.146,0.0246,0.167
Mercaptopurine Action Pathway,SMPDB,1,XDH,47 (47),0.904,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,77 (84),0.00414,0.1,0.0247,0.167
EGFR Inhibitor Pathway_ Pharmacodynamics,PharmGKB,9,JAK1;PIK3CA;PIK3CG;CAMK2A;AKT3;CAMK2D;STAT1;PLCG2;PRKCA,67 (67),0.00488,0.167,0,,0 (4),1,1,0.00488,0.167
Corticotropin-releasing hormone signaling pathway,Wikipathways,11,BRAF;CASP3;ERN1;GJA1;PRKCA;RAPGEF3;CAMK2A;CACNA1H;RAP1B;IL18;PLCG2,92 (92),0.00489,0.167,0,,0 (0),1,1,0.00489,0.167
BMP2 signaling TAK1,INOH,4,MAPK11;BMPR1A;MAPK13;MAPK12,15 (15),0.0049,0.167,0,,0 (0),1,1,0.0049,0.167
miRNA targets in ECM and membrane receptors,Wikipathways,7,COL3A1;MIR7-1;MIR15B;COL5A2;LAMC1;TNXB;COL1A2,44 (44),0.00493,0.167,0,,0 (0),1,1,0.00493,0.167
Insulin Signalling,SMPDB,3,INSR;IRS2;PIK3CG,17 (17),0.0466,0.497,1,HMDB01201,6 (6),0.0829,0.406,0.0253,0.171
Signaling by SCF-KIT,Reactome,5,PRKCA;STAT1;GRAP2;TEC;PIK3CA,43 (43),0.056,0.537,1,HMDB01201,5 (6),0.0695,0.374,0.0255,0.171
CDC42 signaling events,PID,7,BRAF;PAK1;PIK3CA;ARHGEF6;PRKCZ;BCAR1;ARPC2,71 (71),0.0562,0.537,1,HMDB01201,5 (5),0.0695,0.374,0.0256,0.171
Celecoxib Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,36 (36),0.254,1,4,HMDB10384;HMDB00295;HMDB01043;HMDB08048#HMDB08036#HMDB08038,69 (76),0.0156,0.239,0.0258,0.171
Azathioprine Action Pathway,SMPDB,1,XDH,47 (47),0.904,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,78 (86),0.00438,0.104,0.0259,0.171
Thioguanine Action Pathway,SMPDB,1,XDH,47 (47),0.904,1,5,HMDB00536;HMDB01044;HMDB00618#HMDB01548;HMDB01201;HMDB01397,78 (85),0.00438,0.104,0.0259,0.171
mRNA decay by 3_ to 5_ exoribonuclease,Reactome,0,,16 (16),1,1,2,HMDB00288;HMDB01397,7 (10),0.00398,0.0983,0.026,0.171
Synthesis of dolichyl-phosphate-glucose,Reactome,0,,2 (2),1,1,2,HMDB00288;HMDB00295,7 (7),0.00398,0.0983,0.026,0.171
O-Glycan biosynthesis,EHMN,0,,37 (37),1,1,2,HMDB00288;HMDB00295,7 (17),0.00398,0.0983,0.026,0.171
Epstein-Barr virus infection - Homo sapiens (human),KEGG,19,BLNK;MDM2;ITGAL;JAK1;CIR1;PIK3CA;CXCL10;OAS3;BTK;AKT3;MAPK13;STAT1;MAPK11;B2M;PLCG2;CASP3;MAPK12;TAP1;CCND2,200 (201),0.004,0.15,0,,3 (3),1,1,0.0261,0.171
Nucleobase biosynthesis,Reactome,0,,15 (15),1,1,4,HMDB00288;HMDB00536;HMDB01201;HMDB01397,47 (48),0.00401,0.0984,0.0261,0.171
protein <i>O</i>-[<i>N</i>-acetyl]-glucosylation,HumanCyc,1,OGT,2 (2),0.0948,0.698,1,HMDB00295,3 (5),0.0423,0.338,0.0261,0.171
Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,10,BRAF;ARHGEF11;PRKCA;MEF2C;PLCB4;BGLAP;ATF4;PLD2;CREB3L2;ITPR2,106 (106),0.0331,0.411,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,9 (10),0.122,0.512,0.0262,0.171
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,14,AKT3;ATP1B3;CACNA1S;IRS2;PIK3CG;PPP3CC;MEF2C;PPP1R12A;PLCB4;EDNRA;ATF4;INSR;CREB3L2;ITPR2,163 (163),0.0275,0.396,1,HMDB01397,11 (14),0.147,0.579,0.0262,0.171
Angiopoietin receptor Tie2-mediated signaling,PID,6,PAK1;FOXO1;PIK3CA;BMX;MMP2;PLD2,50 (50),0.0332,0.411,1,HMDB01201,9 (10),0.122,0.512,0.0263,0.171
Neuronal System,Reactome,19,SYN3;MDM2;UNC13B;CACNA1E;PRKCA;KCNN4;DLG2;CAMK2A;PPFIBP1;CAMK2D;GLUL;RPS6KA2;RPS6KA3;GLS;BRAF;GNG2;STXBP1;CASK;PPFIBP2,367 (368),0.42,1,4,HMDB00220;HMDB00806;HMDB01201;HMDB01043,60 (65),0.00961,0.18,0.0263,0.171
Chromosomal and microsatellite instability in colorectal cancer,Wikipathways,6,BRAF;CASP3;TGFBR1;AKT3;EXOC2;DCC,73 (73),0.143,0.826,1,HMDB01043,2 (2),0.0284,0.317,0.0264,0.171
Neurotransmitter release cycle,Wikipathways,0,,0 (0),1,1,3,HMDB00220;HMDB00806;HMDB01043,31 (37),0.00912,0.172,0.00912,0.172
Signaling by FGFR,Reactome,4,MKNK1;PIK3CA;FGFR2;BRAF,87 (87),0.616,1,2,HMDB00295;HMDB01201,9 (11),0.0067,0.14,0.0268,0.173
Statin Pathway,Wikipathways,1,ACSS1,31 (31),0.787,1,2,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (17),0.00526,0.118,0.0269,0.173
RAB GEFs exchange GTP for GDP on RABs,Reactome,8,DENND5B;RAB6B;RAB5B;AKT3;GAPVD1;RIN2;DENND2D;DENND1B,91 (91),0.0743,0.64,1,HMDB01201,4 (4),0.056,0.374,0.027,0.174
CD4 T cell receptor signaling-NFkB cascade,INOH,8,PSMB9;PIK3CA;CD28;CD80;AKT3;CARD11;PSMA3;PLCG2,97 (97),0.0989,0.701,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (4),0.0423,0.338,0.0271,0.174
Signaling by NTRKs,Reactome,9,MAPK11;BRAF;ADORA2A;PIK3CA;MEF2C;ATF1;IRS2;RPS6KA3;RPS6KA2,89 (89),0.0285,0.399,1,HMDB01201,11 (12),0.147,0.579,0.0271,0.174
Th17 cell differentiation - Homo sapiens (human),KEGG,9,MAPK11;MAPK13;JAK1;TGFBR1;IRF4;STAT1;TBX21;MAPK12;PPP3CC,107 (107),0.0757,0.644,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0274,0.175
yaci and bcma stimulation of b cell immune responses,BioCarta,3,TNFRSF17;TNFSF13B;TNFRSF13B,8 (8),0.00531,0.178,0,,0 (0),1,1,0.00531,0.178
adp-ribosylation factor,BioCarta,3,NCF2;ARHGAP6;ARFGAP3,28 (28),0.153,0.859,1,HMDB01201,2 (2),0.0284,0.317,0.0279,0.178
De novo fatty acid biosynthesis,EHMN,1,ACOT7,43 (43),0.883,1,3,HMDB00220;HMDB00806;HMDB00944,25 (59),0.00495,0.117,0.0281,0.179
Signaling by PDGF,Reactome,6,PDGFA;PDGFRA;PIK3CA;STAT1;PDGFD;BCAR1,54 (54),0.0459,0.495,1,HMDB01201,7 (13),0.096,0.441,0.0283,0.18
Clathrin-mediated endocytosis,Wikipathways,0,,0 (0),1,1,2,HMDB00658#HMDB10370;HMDB01201,11 (15),0.0101,0.18,0.0101,0.18
VxPx cargo-targeting to cilium,Reactome,3,EXOC2;ARF4;RAB11A,21 (21),0.0792,0.666,1,HMDB01201,4 (4),0.056,0.374,0.0285,0.18
DAP12 interactions,Reactome,5,PLCG2;GRAP2;BTK;PIK3CA;B2M,45 (45),0.0657,0.598,1,HMDB01201,5 (6),0.0695,0.374,0.0292,0.184
vegf hypoxia and angiogenesis,BioCarta,4,FLT4;PRKCA;BCAR1;PIK3CA,30 (30),0.0555,0.535,1,HMDB01201,6 (6),0.0829,0.406,0.0294,0.185
NOD1/2 Signaling Pathway,Reactome,6,MAPK11;CASP1;MAPK13;CYLD;BIRC2;MAPK12,33 (33),0.00462,0.166,0,,2 (4),1,1,0.0294,0.185
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,4,HGF;ITGA3;BCAR1;PDGFD,44 (44),0.164,0.867,1,HMDB01201,2 (4),0.0284,0.317,0.0296,0.186
Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Reactome,1,ALOX12,1 (1),0.0486,0.503,1,HMDB01043,7 (8),0.096,0.441,0.0297,0.186
MAPK Cascade,Wikipathways,3,BRAF;MAPK12;MAP3K3,29 (29),0.165,0.867,1,HMDB01201,2 (2),0.0284,0.317,0.0298,0.186
CXCR3-mediated signaling events,PID,4,MAPK11;CXCL10;PIK3CA;GNG2,38 (38),0.111,0.747,1,HMDB01201,3 (3),0.0423,0.338,0.0299,0.186
insulin,INOH,7,FOXO1;PIK3CA;AKT3;IRS2;EIF4A2;INSR;PRKAG2,78 (78),0.084,0.681,1,HMDB01201,4 (5),0.056,0.374,0.0299,0.186
Ion transport by P-type ATPases,Reactome,8,ATP11B;ATP1B3;ATP8B2;CAMK2A;CAMK2D;ATP11A;ATP2C1;ATP9A,55 (55),0.00478,0.167,0,,12 (17),1,1,0.0303,0.188
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,14,MAPK11;MAPK13;JAK1;CXCL3;PIK3CA;PIK3CG;PPP3CC;AKT3;STAT1;PLCG2;CASP3;GNG2;MAPK12;ITPR2,186 (186),0.0691,0.611,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,0.0304,0.188
Integrin alphaIIb beta3 signaling,Reactome,4,RAP1B;RAPGEF3;BCAR1;APBB1IP,27 (27),0.0398,0.456,1,HMDB01201,9 (12),0.122,0.512,0.0307,0.188
Integrin signaling,Reactome,4,RAP1B;RAPGEF3;BCAR1;APBB1IP,27 (27),0.0398,0.456,1,HMDB01201,9 (12),0.122,0.512,0.0307,0.188
Chondroitin sulfate biosynthesis,Reactome,3,CHPF;CHST3;NCAN,20 (20),0.0703,0.613,1,HMDB00295,5 (5),0.0695,0.374,0.0309,0.189
mRNA_ protein_ and metabolite inducation pathway by cyclosporin A,Wikipathways,2,SLC3A2;ATF4,6 (6),0.031,0.399,1,HMDB00158,12 (13),0.159,0.616,0.0311,0.19
Pyrimidine metabolism,Wikipathways,5,CMPK1;CTPS2;CMPK2;POLR1A;ENPP1,84 (84),0.387,1,3,HMDB00288;HMDB00295;HMDB01546,35 (40),0.0128,0.214,0.0312,0.19
skeletal muscle hypertrophy is regulated via akt-mtor pathway,BioCarta,3,IGF1R;MKNK1;PIK3CA,25 (25),0.119,0.779,1,HMDB01201,3 (3),0.0423,0.338,0.0317,0.192
tpo signaling pathway,BioCarta,3,PRKCA;STAT1;PIK3CA,25 (25),0.119,0.779,1,HMDB01201,3 (3),0.0423,0.338,0.0317,0.192
Keratan sulfate biosynthesis,Reactome,1,CHST1,28 (28),0.752,1,2,HMDB00288;HMDB00295,9 (9),0.0067,0.14,0.0317,0.192
Pre-NOTCH Expression and Processing,Reactome,2,MAML2;AGO4,42 (42),0.612,1,2,HMDB00295;HMDB01201,10 (10),0.00831,0.159,0.0319,0.193
RAC1 signaling pathway,PID,5,ABI2;NCF2;PAK1;BCAR1;ARPC2,54 (54),0.12,0.781,1,HMDB01201,3 (3),0.0423,0.338,0.032,0.193
mapkinase signaling pathway,BioCarta,8,MAPK11;PAK1;MAPK13;MEF2C;STAT1;MAX;MAP3K3;MAPK12,57 (57),0.00596,0.194,0,,0 (0),1,1,0.00596,0.194
Regulation of Ras family activation,PID,4,PRKCA;RASGRP3;RASAL1;PRKCZ,33 (34),0.0741,0.64,1,HMDB01201,5 (5),0.0695,0.374,0.0323,0.194
ABC transporters in lipid homeostasis,Reactome,3,ABCD2;ABCA6;ABCA5,18 (18),0.054,0.531,1,HMDB08048#HMDB08036#HMDB08038,7 (11),0.096,0.441,0.0325,0.195
FAS (CD95) signaling pathway,PID,6,MAPK11;CASP3;CFLAR;BIRC2;PIK3CA;BTK,35 (35),0.00623,0.196,0,,0 (1),1,1,0.00623,0.196
VEGFR3 signaling in lymphatic endothelium,PID,5,MAPK11;PIK3CA;FLT4;COL1A1;COL1A2,25 (25),0.00629,0.196,0,,0 (0),1,1,0.00629,0.196
Proton Pump Inhibitor Pathway_ Pharmacodynamics,PharmGKB,7,PLCD3;PIK3C2B;PRKCA;AKT3;PLCB4;PRKCZ;PLCG2,46 (46),0.00633,0.196,0,,0 (0),1,1,0.00633,0.196
phenylalanine degradation/tyrosine biosynthesis,HumanCyc,0,,4 (4),1,1,2,HMDB00158;HMDB00159,8 (11),0.00526,0.118,0.0329,0.196
Processive synthesis on the C-strand of the telomere,Reactome,0,,11 (11),1,1,2,HMDB00288;HMDB01397,8 (9),0.00526,0.118,0.0329,0.196
anandamide degradation,HumanCyc,1,FAAH,2 (2),0.0948,0.698,1,HMDB01043,4 (4),0.056,0.374,0.0331,0.197
Beta-catenin independent WNT signaling,Reactome,6,PRKCA;CAMK2A;RYK;PDE6A;GNG2;ITPR2,92 (92),0.289,1,2,HMDB01201;HMDB01397,15 (17),0.0185,0.273,0.0334,0.198
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,9,F11R;MAPK11;PAK1;MAPK13;CASP3;ATP6V1E1;ATP6V0A1;PLCG2;MAPK12,68 (68),0.00539,0.178,0,,4 (7),1,1,0.0336,0.199
Neurotrophic factor-mediated Trk receptor signaling,PID,5,PIK3CA;RAP1B;PRKCZ;SQSTM1;ARHGAP32,63 (63),0.19,0.899,1,HMDB01201,2 (2),0.0284,0.317,0.0336,0.199
chondroitin sulfate biosynthesis (late stages),HumanCyc,2,CHPF;CHST3,13 (13),0.129,0.798,1,HMDB00295,3 (5),0.0423,0.338,0.0339,0.2
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,7,PAK1;HGF;RAP1B;RIN2;PRKCZ;BCAR1;PIK3CA,81 (82),0.098,0.698,1,HMDB01201,4 (4),0.056,0.374,0.0341,0.201
Post-translational modification- synthesis of GPI-anchored proteins,Wikipathways,0,,0 (0),1,1,2,HMDB00295;HMDB01201,12 (21),0.012,0.202,0.012,0.202
adenosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,2,ATP6V1E1;ATP6V0A1,38 (38),0.557,1,2,HMDB00536;HMDB01201,11 (12),0.0101,0.18,0.0347,0.204
Cargo trafficking to the periciliary membrane,Reactome,5,BBS9;EXOC2;ARF4;RAB11A;BBS10,51 (51),0.1,0.703,1,HMDB01201,4 (4),0.056,0.374,0.0347,0.204
the igf-1 receptor and longevity,BioCarta,2,IGF1R;PIK3CA,17 (17),0.199,0.916,1,HMDB01201,2 (2),0.0284,0.317,0.0349,0.204
Activation of NMDA receptor and postsynaptic events,Reactome,5,BRAF;CAMK2A;RPS6KA2;RPS6KA3;CAMK2D,39 (39),0.0391,0.456,1,HMDB01201,11 (11),0.147,0.579,0.0354,0.206
Keratan sulfate/keratin metabolism,Reactome,2,HEXA;CHST1,33 (33),0.481,1,2,HMDB00288;HMDB00295,12 (18),0.012,0.202,0.0354,0.206
IL1-mediated signaling events,PID,6,CASP1;PIK3CA;IRAK3;SQSTM1;PRKCZ;MAP3K3,36 (36),0.00718,0.21,0,,0 (1),1,1,0.00718,0.21
Primary immunodeficiency - Homo sapiens (human),KEGG,6,BLNK;TNFRSF13C;TNFRSF13B;TAP1;CD79A;BTK,36 (37),0.00718,0.21,0,,0 (0),1,1,0.00718,0.21
rac1 cell motility signaling pathway,BioCarta,6,PAK1;PDGFRA;PIK3CA;ARHGAP6;ARFGAP3;NCF2,36 (38),0.00718,0.21,0,,0 (0),1,1,0.00718,0.21
Syndecan-3-mediated signaling events,PID,5,APH1B;SDC3;NCAN;CASK;FGFR2,26 (26),0.00748,0.211,0,,0 (0),1,1,0.00748,0.211
IL27-mediated signaling events,PID,5,STAT1;IL27;JAK1;IL18;TBX21,26 (26),0.00748,0.211,0,,0 (1),1,1,0.00748,0.211
superpathway of purine nucleotide salvage,HumanCyc,2,ATP6V1E1;ATP6V0A1,59 (59),0.788,1,3,HMDB00536;HMDB01201;HMDB01397,29 (30),0.00756,0.154,0.0365,0.212
TCR,NetPath,21,CD84;MAPK11;PAK1;NEDD9;SLA;STK39;PIK3C2B;CD28;CD80;PTPN22;CARD11;ARHGEF6;STAT1;CTLA4;DDX3X;CD2AP;PLCG2;LAX1;GRAP2;TRIM25;TEC,244 (245),0.00795,0.217,0,,0 (0),1,1,0.00795,0.217
Rett syndrome causing genes,Wikipathways,7,BRAF;TBL1XR1;HAP1;NCOR1;KDM5B;MEF2C;STXBP1,48 (48),0.00801,0.218,0,,0 (0),1,1,0.00801,0.218
ECM-receptor interaction - Homo sapiens (human),KEGG,10,COL2A1;SDC4;LAMC1;TNXB;SDC1;ITGB7;RELN;ITGA3;COL1A1;COL1A2,82 (82),0.0062,0.196,0,,1 (1),1,1,0.0377,0.218
MAPK family signaling cascades,Reactome,18,BRAF;PAK1;PDGFA;FOXO1;HGF;IRS2;PEBP1;CAMK2A;IL5RA;CAMK2D;JAK1;RAP1B;RASAL1;APBB1IP;FGFR2;RASGRP3;MMP2;PDGFRA,236 (237),0.0391,0.456,1,HMDB01201,12 (18),0.159,0.616,0.0378,0.218
Fc epsilon receptor (FCERI) signaling,Reactome,8,PAK1;PIK3CA;CARD11;BTK;PLCG2;GRAP2;ITPR2;TEC,150 (150),0.445,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,13 (15),0.014,0.22,0.0379,0.218
Macroautophagy,Reactome,6,RRAGD;ATG7;WDR45;RB1CC1;PRKAG2;MAP1LC3B,57 (57),0.0572,0.545,1,HMDB01201,8 (10),0.109,0.479,0.0379,0.218
Selenium Micronutrient Network,Wikipathways,3,XDH;INSR;PRDX4,83 (83),0.775,1,5,HMDB01388;HMDB00673;HMDB01043;HMDB01999;HMDB02925,90 (103),0.00806,0.159,0.0379,0.218
Activation of RAS in B cells,Reactome,1,RASGRP3,5 (5),0.22,0.928,1,HMDB01201,2 (3),0.0284,0.317,0.038,0.218
Nuclear Events (kinase and transcription factor activation),Reactome,5,MEF2C;MAPK11;ATF1;RPS6KA2;RPS6KA3,25 (25),0.00629,0.196,0,,4 (4),1,1,0.0382,0.218
Synthesis of PC,Reactome,3,PCYT1B;SLC44A1;LPIN1,29 (29),0.165,0.867,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,22 (28),0.0383,0.338,0.0383,0.218
Apoptosis - Homo sapiens (human),KEGG,14,ERN1;CASP3;CFLAR;TNFSF10;BIRC2;PIK3CA;EIF2AK3;CTSO;AKT3;CTSW;ATF4;CTSS;PTPN13;ITPR2,136 (136),0.00632,0.196,0,,4 (4),1,1,0.0383,0.218
RIG-I-like Receptor Signaling,Wikipathways,8,MAPK11;MAPK13;CYLD;CXCL10;DDX3X;DDX17;TRIM25;MAPK12,60 (60),0.00813,0.218,0,,0 (0),1,1,0.00813,0.218
Telomere Maintenance,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB01397,13 (14),0.014,0.22,0.014,0.22
Synthesis of DNA,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB01397,13 (13),0.014,0.22,0.014,0.22
E3 ubiquitin ligases ubiquitinate target proteins,Wikipathways,0,,0 (0),1,1,1,HMDB01201,1 (1),0.0143,0.22,0.0143,0.22
superpathway of inositol phosphate compounds,HumanCyc,9,PIKFYVE;PLCD3;PIK3C2B;FIG4;PIK3CA;PIK3CG;PLCB4;IPMK;PLCG2,70 (70),0.00653,0.2,0,,17 (26),1,1,0.0394,0.224
MHC class II antigen presentation,Reactome,5,CTSS;AP1S2;LGMN;CD74;CTSO,59 (59),0.158,0.867,1,HMDB01201,3 (3),0.0423,0.338,0.0401,0.227
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,Reactome,0,,8 (8),1,1,2,HMDB00220;HMDB01201,9 (11),0.0067,0.14,0.0403,0.227
Free fatty acids regulate insulin secretion,Reactome,0,,8 (8),1,1,2,HMDB00220;HMDB01201,9 (11),0.0067,0.14,0.0403,0.227
IL-7,NetPath,5,JAK1;STAM;IRS2;STAT1;FOXO1,27 (27),0.00882,0.227,0,,0 (0),1,1,0.00882,0.227
Sorafenib Pharmacodynamics,PharmGKB,5,BRAF;PIK3CA;FLT4;PIK3CG;PIK3C2B,27 (27),0.00882,0.227,0,,0 (1),1,1,0.00882,0.227
CMP phosphorylation,HumanCyc,2,CMPK2;CMPK1,11 (11),0.0969,0.698,1,HMDB01546,5 (5),0.0695,0.374,0.0404,0.227
Pancreatic secretion - Homo sapiens (human),KEGG,9,ATP1B3;RAB3D;PRKCA;PLA2G12A;RAP1B;SLC12A2;PLCB4;ITPR2;RAB11A,96 (96),0.0433,0.479,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,12 (17),0.159,0.616,0.0412,0.231
GPR40 Pathway,Wikipathways,2,PLCG2;PLCD3,15 (15),0.163,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (3),0.0423,0.338,0.0413,0.231
Non-small cell lung cancer,Wikipathways,6,BRAF;RASSF5;PIK3CA;AKT3;PLCG2;PRKCA,66 (66),0.1,0.703,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (5),0.0695,0.374,0.0416,0.233
XBP1(S) activates chaperone genes,Wikipathways,7,WFS1;SRPRB;GFPT1;FKBP14;TSPYL2;SERP1;SYVN1,47 (47),0.00713,0.21,0,,4 (4),1,1,0.0424,0.236
Rab regulation of trafficking,Reactome,10,DENND5B;RAB6B;RAB5B;AKT3;GAPVD1;RIN2;DENND1B;DENND2D;RAB11A;MAP1LC3B,126 (126),0.0861,0.693,1,HMDB01201,6 (6),0.0829,0.406,0.0424,0.236
Regulation of TP53 Degradation,Reactome,6,MDM2;MDM4;RNF34;SGK1;AKT3;PRR5,36 (36),0.00718,0.21,0,,5 (5),1,1,0.0426,0.237
Digestion,Reactome,1,MGAM,22 (22),0.666,1,3,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220,33 (43),0.0109,0.191,0.0429,0.237
chondroitin and dermatan biosynthesis,HumanCyc,1,CHPF,6 (6),0.258,1,1,HMDB00295,2 (4),0.0284,0.317,0.0434,0.24
Lysine degradation - Homo sapiens (human),KEGG,8,ALDH3A2;EZH1;KMT2A;EHHADH;KMT2C;ALDH7A1;SETD7;KMT2E,59 (59),0.00735,0.211,0,,39 (55),1,1,0.0435,0.24
C20 prostanoid biosynthesis,HumanCyc,2,TBXAS1;PTGIS,9 (9),0.0676,0.599,1,HMDB01043,8 (8),0.109,0.479,0.0435,0.24
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,28,COL2A1;JAK1;HGF;AKT3;RELN;FLT4;PIK3CG;IGF1R;PDGFA;PDGFRA;PIK3CA;SGK1;PDGFD;GNG2;PRKCA;LAMC1;ATF4;FGFR2;ITGA3;MDM2;INSR;TNXB;ITGB7;PRLR;CCND2;CREB3L2;COL1A1;COL1A2,353 (354),0.00739,0.211,0,,3 (4),1,1,0.0436,0.24
T-Cell Receptor and Co-stimulatory Signaling,Wikipathways,3,PRKCA;CD28;CTLA4,30 (30),0.177,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (3),0.0423,0.338,0.0441,0.242
leukotriene biosynthesis,HumanCyc,0,,6 (6),1,1,3,HMDB00158;HMDB00159;HMDB01043,29 (30),0.00756,0.154,0.0445,0.243
Interferon type I signaling pathways,Wikipathways,4,STAT1;PDCD4;JAK1;IRS2,54 (54),0.267,1,1,HMDB01201,2 (2),0.0284,0.317,0.0445,0.243
GMCSF-mediated signaling events,PID,3,CISH;STAT1;PIK3CA,37 (37),0.267,1,1,HMDB01201,2 (3),0.0284,0.317,0.0446,0.243
Fluid shear stress and atherosclerosis - Homo sapiens (human),KEGG,14,MAPK11;MEF2C;PDGFA;MAPK13;SDC4;PIK3CA;SQSTM1;NCF2;BMPR1A;SDC1;PRKCZ;MMP2;MAPK12;AKT3,139 (139),0.00763,0.214,0,,8 (8),1,1,0.0448,0.243
Role of second messengers in netrin-1 signaling,Reactome,1,DCC,4 (4),0.181,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (4),0.0423,0.338,0.0449,0.243
Photodynamic therapy-induced AP-1 survival signaling.,Wikipathways,7,MAPK11;MAPK13;PDGFRA;CFLAR;TNFSF10;MMP2;MAPK12,50 (50),0.01,0.244,0,,0 (0),1,1,0.01,0.244
Regulation of RhoA activity,PID,4,ARHGEF11;ARHGAP6;ARHGEF12;SRGAP1,46 (48),0.183,0.874,1,HMDB01201,3 (3),0.0423,0.338,0.0454,0.246
Synthesis of dolichyl-phosphate mannose,Reactome,1,DPM3,3 (3),0.139,0.811,1,HMDB01201,4 (4),0.056,0.374,0.0455,0.246
VEGF and VEGFR signaling network,PID,3,NRP2;FLT4;NRP1,10 (10),0.0106,0.247,0,,0 (0),1,1,0.0106,0.247
Nef mediated downregulation of MHC class I complex cell surface expression,Reactome,3,AP1S2;PACS1;B2M,10 (10),0.0106,0.247,0,,0 (0),1,1,0.0106,0.247
Interleukin-27 signaling,Reactome,3,JAK1;IL27;STAT1,10 (10),0.0106,0.247,0,,0 (0),1,1,0.0106,0.247
Melanoma - Homo sapiens (human),KEGG,9,BRAF;PDGFA;PDGFRA;MDM2;HGF;AKT3;PDGFD;IGF1R;PIK3CA,72 (72),0.00785,0.217,0,,1 (1),1,1,0.0459,0.247
Leptin Insulin Overlap,Wikipathways,4,LEPR;INSR;IRS2;PIK3CG,17 (17),0.0079,0.217,0,,1 (2),1,1,0.0462,0.248
Pathways Affected in Adenoid Cystic Carcinoma,Wikipathways,8,FOXP2;KDM6A;PIK3CA;NCOR1;KMT2C;JMJD1C;NFIB;MAX,63 (63),0.0109,0.25,0,,0 (0),1,1,0.0109,0.25
Visual signal transduction: Cones,PID,1,RDH12,23 (23),0.682,1,2,HMDB01201;HMDB08048#HMDB08036#HMDB08038,12 (14),0.012,0.202,0.0474,0.254
Cell Cycle_ Mitotic,Reactome,12,PTTG1;USO1;CLIP1;PRKCA;LPIN1;NIPBL;AKT3;PPP1R12A;MAX;SDCCAG8;NDEL1;CCND2,480 (481),0.997,1,3,HMDB00288;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01397,30 (30),0.00832,0.159,0.048,0.254
Non-small cell lung cancer - Homo sapiens (human),KEGG,6,BRAF;RASSF5;PIK3CA;AKT3;PLCG2;PRKCA,66 (66),0.1,0.703,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (6),0.0829,0.406,0.0481,0.254
Signaling by ROBO receptors,Reactome,6,PAK1;PRKCA;CXCR4;SRGAP1;NRP1;DCC,66 (66),0.1,0.703,1,HMDB01201,6 (8),0.0829,0.406,0.0481,0.254
Translation,Reactome,3,SRPRB;EIF4A2;EIF5,307 (310),1,1,3,HMDB00158;HMDB00159;HMDB01201,30 (78),0.00832,0.159,0.0481,0.254
pyrimidine deoxyribonucleosides salvage,HumanCyc,0,,5 (5),1,1,3,HMDB00295;HMDB01546;HMDB01201,30 (31),0.00832,0.159,0.0481,0.254
VEGFR2 mediated cell proliferation,Reactome,3,PRKCA;ITPR2;PRKCZ,19 (19),0.0619,0.569,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,10 (11),0.134,0.545,0.0482,0.254
Internalization of ErbB1,PID,3,LRIG1;ZFYVE28;PIK3CA,39 (39),0.294,1,1,HMDB01201,2 (2),0.0284,0.317,0.0483,0.254
EPHB forward signaling,PID,3,PIK3CA;RAP1B;PAK1,39 (39),0.294,1,1,HMDB01201,2 (2),0.0284,0.317,0.0483,0.254
SOS-mediated signalling,Reactome,1,IRS2,7 (7),0.294,1,1,HMDB01201,2 (2),0.0284,0.317,0.0483,0.254
insulin Mam,INOH,7,FOXO1;PIK3CA;AKT3;IRS2;EIF4A2;INSR;PRKAG2,82 (82),0.103,0.714,1,HMDB01201,6 (7),0.0829,0.406,0.0492,0.258
Gap junction - Homo sapiens (human),KEGG,8,PDGFA;PDGFRA;GJA1;PRKCA;PLCB4;TUBB2B;PDGFD;ITPR2,88 (88),0.0636,0.583,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,10 (11),0.134,0.545,0.0492,0.258
IL8- and CXCR1-mediated signaling events,PID,3,PRKCA;GNG2;PIK3CG,28 (28),0.153,0.859,1,HMDB01201,4 (4),0.056,0.374,0.0493,0.258
Hedgehog signaling events mediated by Gli proteins,PID,4,RAB23;GNG2;SPOP;PTCH1,48 (48),0.203,0.92,1,HMDB01201,3 (3),0.0423,0.338,0.0495,0.258
Toxoplasmosis - Homo sapiens (human),KEGG,12,MAPK11;IL10;MAPK13;JAK1;BIRC2;LAMC1;PIK3CG;AKT3;STAT1;CASP3;LY96;MAPK12,113 (113),0.00868,0.227,0,,3 (3),1,1,0.0499,0.26
RAF/MAP kinase cascade,Reactome,15,BRAF;PDGFA;JAK1;HGF;IRS2;PEBP1;CAMK2A;IL5RA;CAMK2D;RAP1B;RASAL1;APBB1IP;FGFR2;RASGRP3;PDGFRA,196 (197),0.0547,0.534,1,HMDB01201,12 (18),0.159,0.616,0.05,0.26
Digestion and absorption,Reactome,1,MGAM,27 (27),0.74,1,3,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00220,34 (46),0.0118,0.202,0.0501,0.26
Glutamate Glutamine metabolism,INOH,5,ALDH1A1;GLUL;ALDH3A2;GLS;ALDH7A1,27 (27),0.00882,0.227,0,,29 (34),1,1,0.0505,0.261
NRAGE signals death through JNK,Reactome,5,FGD4;ARHGEF11;ARHGEF6;ARHGEF12;TIAM2,59 (61),0.158,0.867,1,HMDB01201,4 (4),0.056,0.374,0.0506,0.261
Regulation of insulin secretion,Reactome,5,CACNA1E;PRKCA;GNG2;RAPGEF3;ITPR2,70 (70),0.253,1,2,HMDB00220;HMDB01201,21 (25),0.0351,0.338,0.0508,0.262
Prostaglandin Synthesis and Regulation,Wikipathways,5,TBXAS1;PTGFRN;PTGIS;EDNRA;ANXA6,44 (44),0.0608,0.569,1,HMDB01043,11 (13),0.147,0.579,0.051,0.263
Antigen processing-Cross presentation,Reactome,7,CTSS;MRC1;TAP1;BTK;NCF2;B2M;LY96,49 (49),0.00896,0.23,0,,9 (18),1,1,0.0512,0.263
G alpha (12/13) signalling events,Reactome,7,ARHGEF11;ARHGEF12;FGD4;PIK3CA;ARHGEF6;TIAM2;GNG2,87 (89),0.13,0.798,1,HMDB01201,5 (5),0.0695,0.374,0.0514,0.264
Scavenging by Class A Receptors,Reactome,3,COL3A1;COL1A1;COL1A2,19 (19),0.0619,0.569,1,HMDB00658#HMDB10370,11 (29),0.147,0.579,0.0518,0.264
Cell Cycle,Reactome,14,PTTG1;MDM4;USO1;MDM2;CLIP1;PRKCA;LPIN1;NIPBL;AKT3;PPP1R12A;MAX;SDCCAG8;NDEL1;CCND2,563 (564),0.999,1,3,HMDB00288;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01397,31 (33),0.00912,0.172,0.0519,0.264
Aurora B signaling,PID,3,PSMA3;PEBP1;EVI5,41 (41),0.321,1,1,HMDB01201,2 (2),0.0284,0.317,0.0519,0.264
Toll-like receptor signaling pathway - Homo sapiens (human),KEGG,11,MAPK11;MAPK13;TLR5;PIK3CA;CXCL10;CD80;IRF5;AKT3;STAT1;LY96;MAPK12,104 (104),0.0121,0.267,0,,0 (0),1,1,0.0121,0.267
miR-targeted genes in muscle cell - TarBase,Wikipathways,30,COL3A1;DOCK5;GJA1;GEMIN7;IFRD1;SPARC;ATP6V0A1;MAPK12;SLC12A2;SLC12A4;MIR15B;HACD3;DHX40;RAB30;ABHD10;BACH1;LAMC1;FNDC3A;FAR1;SERP1;STX7;CLOCK;SRPRB;NRP1;GFPT1;PDCD4;AMIGO2;ARF4;COL1A1;COL1A2,400 (400),0.0121,0.267,0,,0 (0),1,1,0.0121,0.267
Plexin-D1 Signaling,PID,2,ITGA3;NRP1,24 (24),0.326,1,1,HMDB01201,2 (2),0.0284,0.317,0.0527,0.267
Role of phospholipids in phagocytosis,Reactome,4,PLCG2;PLD2;ITPR2;PIK3CA,108 (108),0.776,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB08048#HMDB08036#HMDB08038,12 (17),0.012,0.202,0.0527,0.267
Depolymerisation of the Nuclear Lamina,Reactome,2,PRKCA;LPIN1,11 (11),0.0969,0.698,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (7),0.096,0.441,0.0528,0.267
Signalling to p38 via RIT and RIN,Reactome,1,BRAF,5 (5),0.22,0.928,1,HMDB01201,3 (3),0.0423,0.338,0.0529,0.267
cAMP signaling pathway - Homo sapiens (human),KEGG,16,BRAF;PAK1;CACNA1S;ADORA2A;PIK3CA;RAPGEF3;ATP1B3;CAMK2A;AKT3;CAMK2D;PPP1R12A;RAP1B;EDNRA;PLD2;CREB3L2;PTCH1,199 (199),0.0331,0.411,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,23 (40),0.283,0.989,0.0532,0.268
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,6,IL10;PKNOX1;GJA1;MEF2C;CASP3;NR3C1,159 (159),0.79,1,2,HMDB00158;HMDB00159,12 (14),0.012,0.202,0.0535,0.27
Fc epsilon receptor (FCERI) signaling,Wikipathways,0,,0 (0),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,15 (17),0.0185,0.273,0.0185,0.273
Glycogen metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB00295,15 (16),0.0185,0.273,0.0185,0.273
IL4-mediated signaling events,PID,8,PARP14;IL10;JAK1;PIK3CA;IRF4;IRS2;COL1A1;COL1A2,65 (65),0.013,0.277,0,,0 (4),1,1,0.013,0.277
NR1D1 (REV-ERBA) represses gene expression,Reactome,2,NCOR1;NR1D1,4 (4),0.0132,0.277,0,,0 (1),1,1,0.0132,0.277
Neurophilin interactions with VEGF and VEGFR,Reactome,2,NRP2;NRP1,4 (4),0.0132,0.277,0,,0 (0),1,1,0.0132,0.277
Ferroptosis,Wikipathways,5,SLC3A2;MAP1LC3B;CP;ATG7;SLC40A1,40 (40),0.043,0.477,1,HMDB01043,18 (29),0.229,0.82,0.0554,0.278
Synthesis of glycosylphosphatidylinositol (GPI),Reactome,0,,18 (18),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00295,11 (18),0.0101,0.18,0.0563,0.28
Fatty acid biosynthesis - Homo sapiens (human),KEGG,0,,13 (13),1,1,2,HMDB00220;HMDB00806,11 (50),0.0101,0.18,0.0563,0.28
Pre-NOTCH Expression and Processing,Wikipathways,0,,5 (5),1,1,2,HMDB00295;HMDB01201,11 (12),0.0101,0.18,0.0563,0.28
Natural killer cell mediated cytotoxicity - Homo sapiens (human),KEGG,9,PRKCA;BRAF;PAK1;ITGAL;CASP3;TNFSF10;PIK3CA;PLCG2;PPP3CC,130 (131),0.181,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.0567,0.28
3-phosphoinositide biosynthesis,HumanCyc,5,PIKFYVE;FIG4;PIK3CA;PIK3CG;PIK3C2B,28 (28),0.0103,0.247,0,,6 (11),1,1,0.0575,0.28
Serotonergic synapse - Homo sapiens (human),KEGG,9,BRAF;CACNA1S;CASP3;PRKCA;RAPGEF3;ALOX12;PLCB4;GNG2;ITPR2,113 (115),0.0984,0.698,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01043,39 (42),0.106,0.479,0.058,0.28
HIF-1 signaling pathway - Homo sapiens (human),KEGG,9,IGF1R;PIK3CA;CAMK2A;AKT3;CAMK2D;PLCG2;MKNK1;INSR;PRKCA,100 (100),0.0538,0.531,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,15 (15),0.195,0.719,0.0582,0.28
The NLRP3 inflammasome,Reactome,3,TXNIP;CASP1;NLRP3,10 (10),0.0106,0.247,0,,2 (2),1,1,0.0587,0.28
Ligand-independent caspase activation via DCC,Reactome,3,UNC5B;CASP3;DCC,10 (10),0.0106,0.247,0,,2 (2),1,1,0.0587,0.28
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Reactome,3,MAPK11;MAPK12;PRKAG2,10 (10),0.0106,0.247,0,,3 (3),1,1,0.0587,0.28
MAPK1/MAPK3 signaling,Reactome,15,BRAF;PDGFA;JAK1;HGF;IRS2;PEBP1;CAMK2A;IL5RA;CAMK2D;RAP1B;RASAL1;APBB1IP;FGFR2;RASGRP3;PDGFRA,202 (203),0.0674,0.599,1,HMDB01201,12 (18),0.159,0.616,0.0593,0.28
E-cadherin signaling in the nascent adherens junction,PID,3,PIK3CA;RAP1B;ITGB7,36 (36),0.254,1,1,HMDB01201,3 (3),0.0423,0.338,0.0594,0.28
role of erk5 in neuronal survival pathway,BioCarta,2,MEF2C;PIK3CA,27 (27),0.38,1,1,HMDB01201,2 (2),0.0284,0.317,0.0597,0.28
TBC/RABGAPs,Reactome,4,RAB6B;RAB5B;RAB11A;MAP1LC3B,47 (47),0.193,0.907,1,HMDB01201,4 (4),0.056,0.374,0.0598,0.28
purine nucleotides <i>de novo</i> biosynthesis,HumanCyc,2,ATP6V1E1;ATP6V0A1,59 (59),0.788,1,3,HMDB00536;HMDB01201;HMDB01397,36 (37),0.0138,0.22,0.06,0.28
Longevity regulating pathway - Homo sapiens (human),KEGG,10,FOXO1;PIK3CA;AKT3;ATF4;IGF1R;IRS2;INSR;CREB3L2;RB1CC1;PRKAG2,89 (89),0.0109,0.25,0,,8 (8),1,1,0.0602,0.28
Pyrimidine metabolism - Homo sapiens (human),KEGG,6,CMPK2;ENTPD4;CMPK1;CTPS2;ENPP1;POLR1A,101 (101),0.367,1,3,HMDB00288;HMDB00295;HMDB01546,48 (66),0.0298,0.323,0.0602,0.28
Lipid storage and perilipins in skeletal muscle,Wikipathways,1,PNPLA2,6 (6),0.258,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (6),0.0423,0.338,0.0603,0.28
Parkinsons Disease Pathway,Wikipathways,5,MAPK11;CASP3;MAPK12;MAPK13;LRRK2,71 (71),0.262,1,1,HMDB00158,3 (4),0.0423,0.338,0.0609,0.28
Viral Acute Myocarditis,Wikipathways,9,IL10;ITGAL;CASP3;CXCR4;CD80;CD55;STAT1;JAK1;TLR5,76 (76),0.0111,0.252,0,,3 (6),1,1,0.061,0.28
EGFR Transactivation by Gastrin,Reactome,1,PRKCA,10 (10),0.392,1,1,HMDB01201,2 (3),0.0284,0.317,0.0612,0.28
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,13,MAPK11;MAPK13;FOXO1;RHOQ;PIK3CA;PIK3CG;IRS2;RPS6KA3;MAP3K3;RPS6KA2;INSR;MAPK12;PRKAG2,131 (131),0.0112,0.253,0,,6 (8),1,1,0.0614,0.28
PIP3 activates AKT signaling,Reactome,16,RRAGD;MDM2;PDGFA;FOXO1;HGF;CD28;CD80;AKT3;IRS2;FGFR2;MKRN1;PDGFRA;INSR;PIK3CA;AGO4;PRR5,214 (214),0.0575,0.546,1,HMDB01201,15 (22),0.195,0.719,0.0615,0.28
Purine catabolism,Reactome,1,XDH,19 (19),0.612,1,3,HMDB01044;HMDB00618#HMDB01548;HMDB01397,40 (53),0.0184,0.273,0.0617,0.28
Glucagon signaling pathway - Homo sapiens (human),KEGG,11,FOXO1;PYGL;CAMK2A;AKT3;CAMK2D;PLCB4;PPP3CC;ATF4;CREB3L2;ITPR2;PRKAG2,103 (103),0.0113,0.253,0,,23 (26),1,1,0.0617,0.28
Rofecoxib Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Leukotriene C4 Synthesis Deficiency,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
Flurbiprofen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Antrafenine Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
Lumiracoxib Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Trisalicylate-choline Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
Nepafenac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Lornoxicam Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
Salsalate Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Tenoxicam Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
Tiaprofenic Acid Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Valdecoxib Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Nabumetone Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Bromfenac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (72),0.0638,0.374,0.0619,0.28
Arachidonic Acid Metabolism,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (71),0.0638,0.374,0.0619,0.28
role of erbb2 in signal transduction and oncology,BioCarta,2,PIK3CA;JAK1,28 (28),0.397,1,1,HMDB01201,2 (2),0.0284,0.317,0.0619,0.28
Osteopontin-mediated events,PID,3,MMP2;PIK3CA;BCAR1,32 (32),0.202,0.918,1,HMDB01201,4 (6),0.056,0.374,0.062,0.28
Arf6 downstream pathway,PID,2,PLD2;RAB11A,15 (15),0.163,0.867,1,HMDB01201,5 (5),0.0695,0.374,0.0622,0.28
Nephrin/Neph1 signaling in the kidney podocyte,PID,3,PIK3CA;PRKCZ;CD2AP,29 (29),0.165,0.867,1,HMDB01201,5 (5),0.0695,0.374,0.0626,0.28
Metabolism of carbohydrates,Reactome,15,HEXA;CHPF;PGM2L1;SDC4;GBE1;NDST1;PYGL;SDC1;SDC3;LYVE1;CHST1;NCAN;ALDH1A1;CHST3;GPC4,263 (264),0.297,1,4,HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01201,91 (137),0.0386,0.338,0.0628,0.28
Glucagon-type ligand receptors,Reactome,1,GNG2,33 (33),0.807,1,1,HMDB01201,1 (4),0.0143,0.22,0.063,0.28
Signaling by PTK6,Reactome,5,NR3C1;EPAS1;BCAR1;SRMS;LRRK2,54 (54),0.12,0.781,1,HMDB01201,7 (7),0.096,0.441,0.0631,0.28
Signaling by Non-Receptor Tyrosine Kinases,Reactome,5,NR3C1;EPAS1;BCAR1;SRMS;LRRK2,54 (54),0.12,0.781,1,HMDB01201,7 (7),0.096,0.441,0.0631,0.28
Inositol phosphate metabolism,Reactome,6,PLCD3;INPP1;PLCB4;INPP4B;IPMK;PLCG2,50 (50),0.0332,0.411,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,30 (43),0.353,1,0.0637,0.28
Salicylate-sodium Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Piroxicam Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Etodolac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Ketoprofen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Acetylsalicylic Acid Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Diflunisal Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Acetaminophen  Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Sulindac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Diclofenac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Ketorolac Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Naproxen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Etoricoxib Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Carprofen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Fenoprofen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Antipyrine Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Magnesium salicylate Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Phenylbutazone Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Tolmetin Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Salicylic Acid Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Oxaprozin Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Meloxicam Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Suprofen Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Mefenamic Acid Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,30 (30),0.177,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0638,0.28
Disease,Reactome,35,SEL1L;FOXO1;TGFBR1;APH1B;CD28;HGF;NCOR1;GTF2A1;PEBP1;AKT3;RAP1B;BRAF;PDGFA;PDGFRA;ATG7;PIK3CA;CXCR4;CD80;CHMP5;DERL3;TAF7;PACS1;PRR5;AP1S2;B2M;IRS2;FGFR2;MAML2;STAM;SYVN1;MDM2;TBL1XR1;PDZD3;STAT1;APBB1IP,508 (510),0.0233,0.359,1,HMDB01201,48 (104),0.503,1,0.0639,0.28
agrin in postsynaptic differentiation,BioCarta,3,LAMC1;ARHGEF6;PAK1,48 (48),0.414,1,1,HMDB01201,2 (2),0.0284,0.317,0.0641,0.281
IL-5 signaling,INOH,3,IL5RA;JAK1;STAT1,11 (11),0.014,0.281,0,,0 (0),1,1,0.014,0.281
Beta1 integrin cell surface interactions,PID,8,COL2A1;COL3A1;COL5A2;LAMC1;COL11A1;ITGA3;COL1A1;COL1A2,66 (66),0.0142,0.281,0,,0 (2),1,1,0.0142,0.281
Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,8,BRAF;JAK1;PIK3CA;RAP1B;RAP1GAP;IGF1R;STAT1;GNG2,66 (66),0.0142,0.281,0,,0 (0),1,1,0.0142,0.281
TGF-beta signaling TAK1,INOH,4,MAPK11;MAPK13;MAPK12;TGFBR1,20 (20),0.0143,0.281,0,,0 (0),1,1,0.0143,0.281
the co-stimulatory signal during t-cell activation,BioCarta,4,PIK3CA;CD28;CTLA4;CD80,20 (20),0.0143,0.281,0,,0 (0),1,1,0.0143,0.281
lissencephaly gene (lis1) in neuronal migration and development,BioCarta,4,DNAH6;CLIP1;NDEL1;RELN,20 (20),0.0143,0.281,0,,0 (0),1,1,0.0143,0.281
ER Quality Control Compartment (ERQC),Reactome,4,SEL1L;RNF103;MAN1B1;SYVN1,19 (20),0.0119,0.267,0,,4 (12),1,1,0.0647,0.283
VEGFR1 specific signals,PID,5,PRKCA;CD2AP;NRP2;NRP1;PIK3CA,29 (29),0.012,0.267,0,,6 (6),1,1,0.065,0.284
GLUT-1 deficiency syndrome,SMPDB,1,CMPK1,11 (11),0.422,1,2,HMDB00288;HMDB00295,19 (19),0.0291,0.317,0.0663,0.288
Congenital disorder of glycosylation CDG-IId,SMPDB,1,CMPK1,11 (11),0.422,1,2,HMDB00288;HMDB00295,19 (19),0.0291,0.317,0.0663,0.288
Lactose Synthesis,SMPDB,1,CMPK1,11 (11),0.422,1,2,HMDB00288;HMDB00295,19 (19),0.0291,0.317,0.0663,0.288
Mitochondrial Uncoupling Proteins,Reactome,1,SLC25A27,5 (5),0.22,0.928,1,HMDB01201,4 (8),0.056,0.374,0.0666,0.288
The proton buffering model,Reactome,1,SLC25A27,5 (5),0.22,0.928,1,HMDB01201,4 (6),0.056,0.374,0.0666,0.288
Indomethacin Action Pathway,SMPDB,3,TBXAS1;PTGIS;ALOX12,31 (31),0.189,0.896,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,66 (72),0.0662,0.374,0.0674,0.291
Allograft Rejection,Wikipathways,10,IL10;CASP3;CD28;CD80;CD55;STAT1;CTLA4;PRKCZ;PDGFRA;LRRK2,91 (91),0.0127,0.275,0,,5 (10),1,1,0.068,0.293
amb2 Integrin signaling,PID,2,MMP2;RAP1B,31 (31),0.448,1,1,HMDB01201,2 (6),0.0284,0.317,0.0683,0.294
Metabolism of RNA,Reactome,14,MAPK11;PPIL4;PRKCA;WDR77;SMNDC1;GEMIN7;RBM22;METTL1;EIF4A2;DDX5;ADAT3;SYF2;SRSF5;CNOT6L,584 (586),0.999,1,3,HMDB00288;HMDB01201;HMDB01397,35 (72),0.0128,0.214,0.0684,0.294
how does salmonella hijack a cell,BioCarta,1,ARPC2,12 (12),0.45,1,1,HMDB01201,2 (2),0.0284,0.317,0.0685,0.294
ErbB4 signaling events,PID,5,MDM2;PRLR;NCOR1;LRIG1;PIK3CA,31 (31),0.0158,0.297,0,,0 (0),1,1,0.0158,0.297
p38 mapk signaling pathway,BioCarta,5,MEF2C;MKNK1;STAT1;MAX;HMGN1,31 (31),0.0158,0.297,0,,0 (0),1,1,0.0158,0.297
regulation of bad phosphorylation,BioCarta,2,IGF1R;PIK3CA,23 (23),0.308,1,1,HMDB04951,3 (4),0.0423,0.338,0.0696,0.298
lysine degradation I (saccharopine pathway),HumanCyc,2,ALDH7A1;DHTKD1,4 (4),0.0132,0.277,0,,14 (16),1,1,0.0705,0.299
Regulation of gene expression in beta cells,Reactome,2,AKT3;FOXO1,4 (4),0.0132,0.277,0,,2 (2),1,1,0.0705,0.299
Regulation of TP53 Expression and Degradation,Wikipathways,2,MDM2;PRDM1,4 (4),0.0132,0.277,0,,5 (5),1,1,0.0705,0.299
AKT-mediated inactivation of FOXO1A,Reactome,2,AKT3;FOXO1,4 (4),0.0132,0.277,0,,2 (2),1,1,0.0705,0.299
Regulation of beta-cell development,Reactome,2,AKT3;FOXO1,4 (4),0.0132,0.277,0,,2 (2),1,1,0.0705,0.299
LPA receptor mediated events,PID,5,CASP3;PLD2;GNG2;BCAR1;MMP2,63 (64),0.19,0.899,1,HMDB01201,5 (5),0.0695,0.374,0.0705,0.299
lipoxin biosynthesis,HumanCyc,1,ALOX12,3 (3),0.139,0.811,1,HMDB01043,7 (7),0.096,0.441,0.0708,0.3
Arf6 trafficking events,PID,4,EXOC2;CPE;PLD2;ITGA3,47 (47),0.193,0.907,1,HMDB01201,5 (5),0.0695,0.374,0.0713,0.301
Nucleotide salvage,Wikipathways,0,,0 (0),1,1,3,HMDB01044;HMDB00288;HMDB01397,42 (45),0.0209,0.302,0.0209,0.302
E3 ubiquitin ligases ubiquitinate target proteins,Reactome,1,RNF144A,59 (59),0.947,1,1,HMDB01201,1 (1),0.0143,0.22,0.0718,0.303
EPHA forward signaling,PID,2,BLK;PIK3CG,33 (33),0.481,1,1,HMDB01201,2 (2),0.0284,0.317,0.0723,0.305
Purine ribonucleoside monophosphate biosynthesis,Reactome,0,,12 (12),1,1,3,HMDB00536;HMDB01201;HMDB01397,36 (37),0.0138,0.22,0.0729,0.305
ISG15 antiviral mechanism,Reactome,5,STAT1;TRIM25;JAK1;EIF4A2;EIF4E3,30 (30),0.0138,0.281,0,,3 (4),1,1,0.073,0.305
Antiviral mechanism by IFN-stimulated genes,Reactome,5,STAT1;TRIM25;JAK1;EIF4A2;EIF4E3,30 (30),0.0138,0.281,0,,3 (4),1,1,0.073,0.305
Ras activation upon Ca2+ influx through NMDA receptor,Reactome,2,CAMK2D;CAMK2A,17 (17),0.199,0.916,1,HMDB01201,5 (5),0.0695,0.374,0.073,0.305
Endothelins,PID,5,COL3A1;PRKCA;BCAR1;EDNRA;COL1A2,64 (64),0.199,0.916,1,HMDB01201,5 (5),0.0695,0.374,0.073,0.305
eicosapentaenoate biosynthesis,HumanCyc,0,,13 (13),1,1,2,HMDB01388;HMDB01999,13 (17),0.014,0.22,0.0738,0.305
Synthesis of DNA,Reactome,0,,75 (75),1,1,2,HMDB00288;HMDB01397,13 (13),0.014,0.22,0.0738,0.305
Telomere C-strand (Lagging Strand) Synthesis,Reactome,0,,24 (24),1,1,2,HMDB00288;HMDB01397,13 (14),0.014,0.22,0.0738,0.305
Telomere Maintenance,Reactome,0,,83 (84),1,1,2,HMDB00288;HMDB01397,13 (14),0.014,0.22,0.0738,0.305
Chromosome Maintenance,Reactome,0,,111 (112),1,1,2,HMDB00288;HMDB01397,13 (15),0.014,0.22,0.0738,0.305
Transport of nucleotide sugars,Reactome,0,,9 (9),1,1,2,HMDB00288;HMDB01397,13 (13),0.014,0.22,0.0738,0.305
Extension of Telomeres,Reactome,0,,30 (30),1,1,2,HMDB00288;HMDB01397,13 (14),0.014,0.22,0.0738,0.305
Stabilization and expansion of the E-cadherin adherens junction,PID,3,IGF1R;LPP;HGF,42 (42),0.334,1,1,HMDB01201,3 (3),0.0423,0.338,0.0744,0.307
Sema4D induced cell migration and growth-cone collapse,Reactome,2,ARHGEF11;ARHGEF12,20 (20),0.253,1,1,HMDB01201,4 (4),0.056,0.374,0.0746,0.307
GPCR Adenosine A2A receptor,INOH,3,BRAF;RAP1B;ADORA2A,36 (36),0.254,1,1,HMDB01201,4 (4),0.056,0.374,0.0747,0.307
Activation of RAC1,Reactome,1,PAK1,14 (14),0.502,1,1,HMDB01201,2 (2),0.0284,0.317,0.0749,0.307
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Reactome,0,,105 (106),1,1,1,HMDB01201,1 (2),0.0143,0.22,0.075,0.307
Axonal growth stimulation,Reactome,0,,4 (4),1,1,1,HMDB01201,1 (1),0.0143,0.22,0.075,0.307
egf signaling pathway,BioCarta,4,JAK1;PRKCA;STAT1;PIK3CA,20 (20),0.0143,0.281,0,,1 (1),1,1,0.0752,0.307
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,15,SEL1L;ERN1;PDIA4;SYVN1;WFS1;EIF2AK3;HERPUD1;ATF4;MAN1B1;SIL1;DERL3;NGLY1;TXNDC5;RRBP1;ATXN3,165 (165),0.0144,0.282,0,,1 (6),1,1,0.0757,0.308
mtor signaling pathway,BioCarta,2,MKNK1;PIK3CA,25 (25),0.344,1,1,HMDB01201,3 (3),0.0423,0.338,0.0762,0.31
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation,Wikipathways,3,PAK1;CASP3;CFLAR,43 (43),0.348,1,1,HMDB04951,3 (3),0.0423,0.338,0.0768,0.312
The phototransduction cascade,Reactome,2,PDE6A;PRKCA,35 (35),0.512,1,2,HMDB01201;HMDB01397,19 (21),0.0291,0.317,0.0777,0.315
Scavenging by Class H Receptors,Reactome,1,SPARC,4 (4),0.181,0.867,1,HMDB00658#HMDB10370,6 (11),0.0829,0.406,0.0778,0.315
Amphetamine addiction - Homo sapiens (human),KEGG,6,PRKCA;CAMK2A;CAMK2D;ATF4;CREB3L2;PPP3CC,68 (68),0.112,0.747,1,HMDB00158,10 (10),0.134,0.545,0.078,0.316
Platelet Aggregation (Plug Formation),Reactome,4,RAP1B;RAPGEF3;BCAR1;APBB1IP,37 (37),0.103,0.714,1,HMDB01201,11 (14),0.147,0.579,0.0785,0.317
Class B-2 (Secretin family receptors),Wikipathways,0,,0 (0),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.0284,0.317
Lipid particle organization,Wikipathways,0,,0 (0),1,1,1,HMDB00658#HMDB10370,2 (3),0.0284,0.317,0.0284,0.317
RAB geranylgeranylation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,2 (3),0.0284,0.317,0.0284,0.317
Arbekacin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,19 (20),0.0291,0.317,0.0291,0.317
Lymecycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,19 (20),0.0291,0.317,0.0291,0.317
Rolitetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,19 (20),0.0291,0.317,0.0291,0.317
Demeclocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,19 (21),0.0291,0.317,0.0291,0.317
Clomocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,19 (20),0.0291,0.317,0.0291,0.317
Glucocorticoid receptor regulatory network,PID,9,MAPK11;MDM2;NCOA1;IRF1;SGK1;STAT1;BGLAP;TBX21;NR3C1,80 (80),0.0152,0.295,0,,1 (3),1,1,0.0789,0.318
EGFR-dependent Endothelin signaling events,PID,1,EDNRA,9 (9),0.361,1,1,HMDB01201,3 (3),0.0423,0.338,0.0792,0.319
trefoil factors initiate mucosal healing,BioCarta,2,PIK3CA;CASP3,37 (37),0.542,1,1,HMDB01201,2 (2),0.0284,0.317,0.0797,0.32
IL12 signaling mediated by STAT4,PID,5,TBX21;IRF1;CD28;CD80;IL18,32 (32),0.018,0.323,0,,0 (1),1,1,0.018,0.323
Nongenotropic Androgen signaling,PID,3,PLCG2;PIK3CA;GNG2,31 (31),0.189,0.896,1,HMDB01201,6 (6),0.0829,0.406,0.0808,0.324
Regulation of p38-alpha and p38-beta,PID,5,BLK;MAPK11;PAK1;CCM2;MAP3K3,31 (31),0.0158,0.297,0,,2 (2),1,1,0.0815,0.325
MAPK targets/ Nuclear events mediated by MAP kinases,Reactome,5,MEF2C;MAPK11;ATF1;RPS6KA2;RPS6KA3,31 (31),0.0158,0.297,0,,4 (4),1,1,0.0815,0.325
Integrin-linked kinase signaling,PID,3,PPP1R12A;ARHGEF6;LIMS1,45 (45),0.375,1,1,HMDB01201,3 (3),0.0423,0.338,0.0815,0.325
a6b1 and a6b4 Integrin signaling,PID,3,PRKCA;LAMC1;PIK3CA,45 (45),0.375,1,1,HMDB01201,3 (3),0.0423,0.338,0.0815,0.325
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,18,PIKFYVE;BRAF;PDGFA;ITGAL;PDGFRA;ARHGEF12;ARHGEF6;ABI2;PIK3CA;CXCR4;PAK1;ITGB7;PPP1R12A;PDGFD;FGFR2;ITGA3;BCAR1;ARPC2,213 (213),0.0159,0.297,0,,3 (6),1,1,0.0816,0.325
Tigecycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Tobramycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Troleandomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Clarithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Clindamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Azithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Methacycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Erythromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Streptomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Spectinomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Josamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Kanamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Gentamicin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Netilmicin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Neomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Roxithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Amikacin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Telithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Doxycycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Oxytetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Minocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Lincomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Chloramphenicol Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Paromomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
Tetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB00288;HMDB01397,20 (20),0.0321,0.326,0.0321,0.326
thrombin signaling and protease-activated receptors,BioCarta,2,PRKCA;PIK3CA,27 (27),0.38,1,1,HMDB01201,3 (3),0.0423,0.338,0.0825,0.328
guanosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,13 (13),1,1,2,HMDB01201;HMDB01397,14 (15),0.0162,0.245,0.083,0.328
DNA Replication,Reactome,0,,80 (80),1,1,2,HMDB00288;HMDB01397,14 (14),0.0162,0.245,0.083,0.328
Beta-catenin independent WNT signaling,Wikipathways,0,,2 (2),1,1,2,HMDB01201;HMDB01397,14 (16),0.0162,0.245,0.083,0.328
O-glycosylation of TSR domain-containing proteins,Reactome,2,ADAMTS5;SPON1,39 (39),0.571,1,1,HMDB00295,2 (2),0.0284,0.317,0.0831,0.328
Signal transduction by L1,Reactome,2,PAK1;NRP1,22 (22),0.29,1,1,HMDB01201,4 (4),0.056,0.374,0.0832,0.328
Beta3 integrin cell surface interactions,PID,6,F11R;LAMC1;SDC1;SDC4;COL1A1;COL1A2,44 (44),0.0188,0.33,0,,0 (3),1,1,0.0188,0.33
RAC1-PAK1-p38-MMP2 Pathway,Wikipathways,8,MAPK11;PAK1;MAPK13;FOXO1;PIK3CA;TNIP1;MMP2;MAPK12,68 (68),0.0168,0.311,0,,1 (1),1,1,0.0854,0.336
nerve growth factor pathway (ngf),BioCarta,1,PIK3CA,18 (18),0.592,1,1,HMDB01201,2 (2),0.0284,0.317,0.0855,0.336
cGMP effects,Reactome,1,PDE1A,18 (18),0.592,1,1,HMDB01397,2 (2),0.0284,0.317,0.0855,0.336
HS-GAG degradation,Reactome,4,SDC3;SDC4;SDC1;GPC4,21 (21),0.017,0.312,0,,11 (23),1,1,0.0865,0.338
regulation of pgc-1a,BioCarta,4,MEF2C;CAMK2D;PPP3CC;CAMK2A,21 (21),0.017,0.312,0,,1 (1),1,1,0.0865,0.338
Interferon alpha-beta signaling,Wikipathways,4,RNASEL;GBP2;SAMHD1;XAF1,21 (21),0.017,0.312,0,,4 (4),1,1,0.0865,0.338
Thrombin signalling through proteinase activated receptors (PARs),Wikipathways,0,,0 (0),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.0423,0.338
Signaling by Rho GTPases,Wikipathways,0,,0 (0),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.0423,0.338
Eukaryotic Translation Elongation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.0423,0.338
Nonsense-Mediated Decay (NMD),Wikipathways,0,,0 (0),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.0423,0.338
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Reactome,4,AP1S2;PACS1;CD28;B2M,22 (22),0.0201,0.346,0,,0 (0),1,1,0.0201,0.346
The human immune response to tuberculosis,Wikipathways,4,STAT1;TAP1;IRF1;JAK1,22 (22),0.0201,0.346,0,,0 (0),1,1,0.0201,0.346
Arf1 pathway,PID,2,PLD2;USO1,20 (20),0.253,1,1,HMDB01201,5 (6),0.0695,0.374,0.0888,0.346
Fatty acyl-CoA biosynthesis,Reactome,3,ELOVL7;HACD4;HACD3,38 (38),0.28,1,2,HMDB00220;HMDB01043,29 (42),0.0633,0.374,0.0893,0.348
Ovarian steroidogenesis - Homo sapiens (human),KEGG,3,IGF1R;INSR;BMP6,49 (49),0.428,1,2,HMDB00658#HMDB10370;HMDB01043,23 (24),0.0416,0.338,0.0895,0.348
ras signaling pathway,BioCarta,1,PIK3CA,20 (20),0.631,1,1,HMDB08048#HMDB08036#HMDB08038,2 (2),0.0284,0.317,0.09,0.349
Ectoderm Differentiation,Wikipathways,13,SKIL;STX16;MIR15B;LHX1;PTPN13;RRBP1;PPFIBP2;BMPR1A;JAKMIP1;FGFR2;WDR44;OGT;PRKAG2,142 (142),0.0207,0.35,0,,0 (0),1,1,0.0207,0.35
Glucocorticoid Receptor Pathway,Wikipathways,8,DNER;NAV3;FGD4;BIRC2;MGAM;ABHD2;NR3C1;AMIGO2,71 (71),0.0213,0.35,0,,0 (1),1,1,0.0213,0.35
Interleukin-18 signaling,Reactome,2,IL18BP;IL18,5 (5),0.0214,0.35,0,,0 (0),1,1,0.0214,0.35
carm1 and regulation of the estrogen receptor,BioCarta,3,MEF2C;NR3C1;GTF2A1,12 (12),0.0181,0.323,0,,1 (1),1,1,0.0905,0.351
FGF signaling pathway,PID,7,HGF;CAMK2A;SDC4;STAT1;FGFR2;BGLAP;PIK3CA,56 (56),0.0181,0.323,0,,3 (5),1,1,0.0907,0.351
Constitutive Signaling by Aberrant PI3K in Cancer,Reactome,8,PDGFA;PDGFRA;HGF;CD28;CD80;IRS2;FGFR2;PIK3CA,69 (69),0.0182,0.323,0,,4 (17),1,1,0.0912,0.352
-arrestins in gpcr desensitization,BioCarta,2,CXCR4;EDNRA,30 (30),0.432,1,1,HMDB01201,3 (4),0.0423,0.338,0.0914,0.353
glycogen biosynthesis,HumanCyc,1,GBE1,8 (8),0.329,1,1,HMDB00295,4 (7),0.056,0.374,0.0919,0.354
Inactivation of CDC42 and RAC1,Reactome,1,SRGAP1,8 (8),0.329,1,1,HMDB01201,4 (4),0.056,0.374,0.0919,0.354
Fatty acid elongation - Homo sapiens (human),KEGG,4,ELOVL7;ACOT7;HACD4;HACD3,30 (30),0.0555,0.535,1,HMDB00220,28 (40),0.333,1,0.0923,0.355
TNF receptor signaling pathway ,PID,6,CYLD;BIRC2;SQSTM1;STAT1;PRKCZ;MAP3K3,46 (46),0.023,0.359,0,,0 (1),1,1,0.023,0.359
p38 MAPK Signaling Pathway,Wikipathways,5,MKNK1;TGFBR1;STAT1;MAX;HMGN1,34 (34),0.023,0.359,0,,0 (0),1,1,0.023,0.359
Pyrimidine metabolism and related diseases,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB00295,24 (31),0.045,0.359,0.045,0.359
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,5,GLS;AKT3;PIK3CA;PDGFRA;FGFR2,65 (65),0.208,0.928,2,HMDB00158;HMDB00159,36 (37),0.0924,0.441,0.095,0.364
TGF-beta super family signaling pathway canonical,INOH,11,MAPK11;PSMB9;MAPK13;TGFBR1;SKIL;BMP6;BMPR1A;TLE4;PSMA3;MAML2;MAPK12,115 (115),0.0239,0.366,0,,0 (0),1,1,0.0239,0.366
Regulation of RAS by GAPs,Reactome,1,RASAL1,23 (24),0.682,1,1,HMDB01201,2 (2),0.0284,0.317,0.0958,0.367
Class B/2 (Secretin family receptors),Reactome,4,GNG2;CD55;WNT10A;PTCH1,95 (96),0.684,1,1,HMDB01201,2 (6),0.0284,0.317,0.096,0.367
PAR1-mediated thrombin signaling events,PID,3,PRKCA;GNG2;PIK3CA,43 (44),0.348,1,1,HMDB01201,4 (4),0.056,0.374,0.0962,0.367
Arachidonic acid metabolism,Reactome,5,TBXAS1;PTGIS;FAAH;PON3;ALOX12,61 (62),0.174,0.867,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,83 (104),0.113,0.495,0.0968,0.368
Noncanonical Wnt signaling pathway,PID,2,PRKCZ;CAMK2A,32 (32),0.465,1,1,HMDB01201,3 (3),0.0423,0.338,0.0969,0.368
role of -arrestins in the activation and targeting of map kinases,BioCarta,2,CXCR4;EDNRA,32 (32),0.465,1,1,HMDB01201,3 (4),0.0423,0.338,0.0969,0.368
Anchoring of the basal body to the plasma membrane,Reactome,4,IQCB1;SDCCAG8;CEP97;RAB11A,97 (97),0.7,1,1,HMDB01201,2 (2),0.0284,0.317,0.0977,0.371
Purine metabolism,EHMN,10,ATP11B;ATP1B3;XDH;ENTPD4;ATP6V1E1;IL18BP;ATP6V0A1;ATP2C1;PDE6A;POLR1A,222 (223),0.642,1,4,HMDB01044;HMDB00536;HMDB01201;HMDB01397,85 (94),0.0311,0.326,0.098,0.371
FoxO family signaling,PID,2,FOXO1;SGK1,50 (50),0.706,1,1,HMDB01201,2 (2),0.0284,0.317,0.0984,0.372
Lysine degradation,INOH,4,ALDH1A1;ALDH3A2;EHHADH;ALDH7A1,22 (22),0.0201,0.346,0,,31 (36),1,1,0.0985,0.372
ERK/MAPK targets,Reactome,4,MEF2C;MAPK11;RPS6KA2;RPS6KA3,22 (22),0.0201,0.346,0,,4 (4),1,1,0.0985,0.372
SHC-related events triggered by IGF1R,Reactome,1,IGF1R,9 (9),0.361,1,1,HMDB01201,4 (4),0.056,0.374,0.0992,0.372
nfat and hypertrophy of the heart ,BioCarta,3,MEF2C;PIK3CA;PPP3CC,44 (44),0.361,1,1,HMDB01201,4 (5),0.056,0.374,0.0992,0.372
Posttranslational regulation of adherens junction stability and dissassembly,PID,3,IGF1R;CASP3;RIN2,53 (53),0.479,1,1,HMDB01201,3 (3),0.0423,0.338,0.0992,0.372
keratinocyte differentiation,BioCarta,3,BIRC2;PRKCA;MAPK13,53 (53),0.479,1,1,HMDB01201,3 (5),0.0423,0.338,0.0992,0.372
S1P2 pathway,PID,2,PIK3CA;PAK1,26 (26),0.362,1,1,HMDB01201,4 (4),0.056,0.374,0.0994,0.372
S1P3 pathway,PID,2,AKT3;CXCR4,26 (26),0.362,1,1,HMDB01201,4 (5),0.056,0.374,0.0994,0.372
role of egf receptor transactivation by gpcrs in cardiac hypertrophy,BioCarta,2,PRKCA;EDNRA,33 (33),0.481,1,1,HMDB01201,3 (3),0.0423,0.338,0.0996,0.372
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,5,SEL1L;NGLY1;RNF103;MAN1B1;SYVN1,33 (34),0.0204,0.346,0,,5 (22),1,1,0.0999,0.373
ARMS-mediated activation,Reactome,1,BRAF,7 (7),0.294,1,1,HMDB01201,5 (5),0.0695,0.374,0.1,0.373
Integrin-mediated Cell Adhesion,Wikipathways,10,BRAF;PAK1;ITGAL;BCAR1;ITGB7;AKT3;RAP1B;CAPN5;ITGA3;MAPK12,101 (101),0.0247,0.374,0,,0 (0),1,1,0.0247,0.374
Endogenous TLR signaling,PID,1,LY96,26 (26),0.726,1,1,HMDB01201,2 (2),0.0284,0.317,0.101,0.374
Glutamatergic synapse - Homo sapiens (human),KEGG,8,GLUL;PRKCA;PPP3CC;PLCB4;GLS;PLD2;GNG2;ITPR2,114 (114),0.19,0.897,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (8),0.109,0.479,0.101,0.374
Signaling by VEGF,Wikipathways,0,,0 (0),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,25 (28),0.0485,0.374,0.0485,0.374
Integration of energy metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00220;HMDB01201,26 (33),0.052,0.374,0.052,0.374
Glycosaminoglycan metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00288;HMDB00295,27 (58),0.0557,0.374,0.0557,0.374
RAB GEFs exchange GTP for GDP on RABs,Wikipathways,0,,0 (0),1,1,1,HMDB01201,4 (4),0.056,0.374,0.056,0.374
Gastrin-CREB signalling pathway via PKC and MAPK,Wikipathways,0,,0 (0),1,1,1,HMDB01201,4 (5),0.056,0.374,0.056,0.374
Carboxyterminal post-translational modifications of tubulin,Wikipathways,0,,0 (0),1,1,1,HMDB01201,4 (9),0.056,0.374,0.056,0.374
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Wikipathways,0,,0 (0),1,1,1,HMDB01201,4 (4),0.056,0.374,0.056,0.374
TBC-RABGAPs,Wikipathways,0,,0 (0),1,1,1,HMDB01201,4 (4),0.056,0.374,0.056,0.374
Fatty acyl-CoA biosynthesis,Wikipathways,0,,0 (0),1,1,2,HMDB00220;HMDB01043,29 (42),0.0633,0.374,0.0633,0.374
Signaling by NTRK2 (TRKB),Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
COPI-mediated anterograde transport,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
DAP12 interactions,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
G alpha (12-13) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
Eukaryotic Translation Initiation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
Mitochondrial translation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
Signal amplification,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
Signaling by Insulin receptor,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
NCAM signaling for neurite out-growth,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
Signaling by SCF-KIT,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
Host Interactions of HIV factors,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
mTOR signalling,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
Gene Silencing by RNA,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.0695,0.374
trans-Golgi Network Vesicle Budding,Wikipathways,0,,0 (0),1,1,1,HMDB01201,5 (6),0.0695,0.374,0.0695,0.374
Lactose synthesis,Wikipathways,0,,0 (0),1,1,1,HMDB00295,5 (5),0.0695,0.374,0.0695,0.374
Synthesis of IP3 and IP4 in the cytosol,Reactome,3,PLCG2;PLCD3;PLCB4,27 (27),0.141,0.818,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (14),0.147,0.579,0.101,0.375
Biogenic Amine Synthesis,Wikipathways,0,,15 (15),1,1,2,HMDB00158;HMDB00159,16 (17),0.021,0.302,0.102,0.377
guanosine nucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,16 (16),1,1,2,HMDB01201;HMDB01397,16 (17),0.021,0.302,0.102,0.377
Triglyceride catabolism,Reactome,0,,24 (24),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB00658#HMDB10370,16 (19),0.021,0.302,0.102,0.377
Signaling by Insulin receptor,Reactome,6,PIK3CA;FGFR2;ATP6V1E1;IRS2;ATP6V0A1;INSR,75 (75),0.156,0.867,1,HMDB01201,10 (13),0.134,0.545,0.102,0.377
Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human),KEGG,4,PRKCA;ATP1B3;PLCB4;RAB11A,47 (47),0.193,0.907,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (9),0.109,0.479,0.102,0.377
IRS activation,Reactome,2,INSR;IRS2,5 (5),0.0214,0.35,0,,2 (2),1,1,0.103,0.377
PTK6 Expression,Reactome,2,EPAS1;NR3C1,5 (5),0.0214,0.35,0,,1 (1),1,1,0.103,0.377
Disinhibition of SNARE formation,Reactome,2,PRKCA;STXBP3,5 (5),0.0214,0.35,0,,4 (5),1,1,0.103,0.377
fatty acid &alpha;-oxidation,HumanCyc,2,PHYH;ALDH3A2,5 (5),0.0214,0.35,0,,17 (20),1,1,0.103,0.377
Vitamin B2 (riboflavin) metabolism,EHMN,2,ENPP2;ENPP1,5 (5),0.0214,0.35,0,,13 (14),1,1,0.103,0.377
The canonical retinoid cycle in rods (twilight vision),Reactome,1,RDH12,22 (22),0.666,1,2,HMDB00220;HMDB00673,20 (33),0.0321,0.326,0.104,0.377
G-protein activation,Reactome,1,GNG2,28 (28),0.752,1,1,HMDB01201,2 (2),0.0284,0.317,0.104,0.377
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway,Wikipathways,6,CISH;JAK1;PIK3CA;STAT1;BTK;TEC,47 (47),0.0253,0.377,0,,0 (0),1,1,0.0253,0.377
Adipogenesis,Wikipathways,12,FOXO1;LPIN1;NCOA1;NCOR1;PTGIS;EPAS1;MEF2C;PRLR;STAT1;NAMPT;IRS2;NR3C1,131 (131),0.0255,0.379,0,,0 (0),1,1,0.0255,0.379
Celecoxib Pathway_ Pharmacodynamics,PharmGKB,7,CASP3;CACNA1E;CACNA1S;PTGIS;CACNA1H;TBXAS1;BCAR1,58 (58),0.0216,0.353,0,,1 (1),1,1,0.104,0.38
Autophagy - animal - Homo sapiens (human),KEGG,12,RRAGD;ERN1;CFLAR;STX17;PIK3CA;EIF2AK3;AKT3;IRS2;IGF1R;SH3GLB1;RB1CC1;ATG7,128 (128),0.0217,0.353,0,,4 (4),1,1,0.105,0.381
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB01388;HMDB00673,31 (42),0.0713,0.381,0.0713,0.381
Progesterone-mediated oocyte maturation - Homo sapiens (human),KEGG,10,MAPK11;BRAF;MAPK13;CPEB3;PIK3CA;AKT3;RPS6KA2;RPS6KA3;IGF1R;MAPK12,99 (99),0.0218,0.353,0,,3 (4),1,1,0.105,0.382
Biopterin metabolism,EHMN,1,PTS,15 (15),0.526,1,2,HMDB00158;HMDB00159,23 (24),0.0416,0.338,0.106,0.382
Nucleotide salvage,Reactome,0,,23 (23),1,1,3,HMDB01044;HMDB00288;HMDB01397,43 (45),0.0223,0.317,0.107,0.387
roles of  arrestin dependent recruitment of src kinases in gpcr signaling,BioCarta,2,CXCR4;EDNRA,36 (36),0.528,1,1,HMDB01201,3 (4),0.0423,0.338,0.107,0.387
Galactose metabolism,EHMN,1,MGAM,44 (44),0.889,1,3,HMDB00288;HMDB00295;HMDB01546,45 (48),0.0251,0.317,0.107,0.387
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Reactome,4,SLC3A2;HNMT;SLC25A21;ALDH7A1,48 (49),0.203,0.92,3,HMDB00158;HMDB01201;HMDB00159,82 (91),0.11,0.483,0.107,0.387
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway,Wikipathways,8,MEF2C;CASP3;SQSTM1;CAMK2A;NCF2;IRS2;RPS6KA3;STAT1,144 (144),0.4,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.108,0.387
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,14,FHL1;IL10;PDGFRA;CISH;PIK3CA;PDGFA;AKT3;LEPR;PRLR;STAT1;IL5RA;JAK1;STAM;CCND2,162 (162),0.0262,0.387,0,,0 (0),1,1,0.0262,0.387
chondroitin sulfate biosynthesis,HumanCyc,2,CHPF;CHST3,21 (21),0.272,1,1,HMDB00295,6 (8),0.0829,0.406,0.108,0.387
Eicosanoid Synthesis,Wikipathways,3,TBXAS1;PTGIS;ALOX12,23 (23),0.0983,0.698,1,HMDB01043,18 (21),0.229,0.82,0.108,0.387
Trafficking and processing of endosomal TLR,Reactome,3,CTSS;LGMN;UNC93B1,13 (13),0.0226,0.359,0,,2 (3),1,1,0.108,0.388
Acyl chain remodeling of DAG and TAG,Reactome,1,PNPLA2,8 (8),0.329,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (10),0.0695,0.374,0.109,0.39
IL6,NetPath,8,JAK1;FOXO1;NCOA1;SGK1;STAT1;BTK;BMX;TEC,74 (74),0.0266,0.392,0,,0 (0),1,1,0.0266,0.392
TLR ECSIT MEKK1 p38,INOH,4,MAPK11;LY96;MAPK13;MAPK12,23 (23),0.0234,0.359,0,,1 (1),1,1,0.111,0.393
growth hormone signaling pathway,BioCarta,4,PRKCA;INSR;CISH;PIK3CA,23 (23),0.0234,0.359,0,,1 (1),1,1,0.111,0.393
Histidine degradation,INOH,4,ALDH1A1;ALDH3A2;ALDH7A1;HNMT,23 (23),0.0234,0.359,0,,26 (28),1,1,0.111,0.393
Dopamine Neurotransmitter Release Cycle,Reactome,4,SYN3;UNC13B;STXBP1;CASK,23 (23),0.0234,0.359,0,,1 (1),1,1,0.111,0.393
Nicotinate Nicotinamide metabolism,INOH,4,ENPP2;ENPP1;NADK;NAMPT,23 (24),0.0234,0.359,0,,26 (26),1,1,0.111,0.393
Phosphatidylinositol Phosphate Metabolism,SMPDB,4,PIKFYVE;FIG4;PIK3CA;INPP4B,23 (23),0.0234,0.359,0,,11 (11),1,1,0.111,0.393
Joubert syndrome,SMPDB,4,PIKFYVE;FIG4;PIK3CA;INPP4B,23 (23),0.0234,0.359,0,,11 (11),1,1,0.111,0.393
GPCR signaling-G alpha i,INOH,10,PDGFA;WNT10A;ADORA2A;HGF;TNFSF10;CD80;BMP6;FGF11;IL10;IL18,262 (262),0.824,1,1,HMDB01201,2 (2),0.0284,0.317,0.111,0.393
GPCR signaling-pertussis toxin,INOH,10,PDGFA;WNT10A;ADORA2A;HGF;TNFSF10;CD80;BMP6;FGF11;IL10;IL18,262 (262),0.824,1,1,HMDB01201,2 (2),0.0284,0.317,0.111,0.393
S Phase,Reactome,1,AKT3,103 (103),0.994,1,2,HMDB00288;HMDB01397,17 (17),0.0236,0.317,0.111,0.393
Regulation of RAC1 activity,PID,2,ARHGEF6;TIAM2,38 (39),0.557,1,1,HMDB01201,3 (3),0.0423,0.338,0.112,0.394
Nucleotide Metabolism,Wikipathways,0,,19 (19),1,1,2,HMDB00536;HMDB01397,17 (18),0.0236,0.317,0.112,0.394
MET activates RAS signaling,Reactome,1,HGF,11 (11),0.422,1,1,HMDB01201,4 (4),0.056,0.374,0.112,0.394
Spinal Cord Injury,Wikipathways,7,COL2A1;CASP3;GJA1;PRKCA;CXCL10;TNFSF13B;NCAN,117 (117),0.341,1,1,HMDB01043,5 (8),0.0695,0.374,0.112,0.394
IL5-mediated signaling events,PID,3,IL5RA;PIK3CA;CISH,14 (14),0.0278,0.396,0,,0 (0),1,1,0.0278,0.396
Vemurafenib Pathway_ Pharmacodynamics,PharmGKB,4,BRAF;FGFR2;FLT4;PDGFRA,25 (25),0.0309,0.399,0,,0 (1),1,1,0.0309,0.399
update your name in edit mode,PharmGKB,4,BRAF;FGFR2;FLT4;PDGFRA,25 (25),0.0309,0.399,0,,0 (1),1,1,0.0309,0.399
Signal Transduction of S1P Receptor,Wikipathways,4,AKT3;MAPK12;S1PR1;PIK3C2B,25 (25),0.0309,0.399,0,,0 (0),1,1,0.0309,0.399
ifn gamma signaling pathway,BioCarta,2,JAK1;STAT1,6 (6),0.031,0.399,0,,0 (1),1,1,0.031,0.399
d4gdi signaling pathway,BioCarta,2,CASP1;CASP3,6 (6),0.031,0.399,0,,0 (0),1,1,0.031,0.399
IFN gamma signaling,INOH,2,JAK1;STAT1,6 (6),0.031,0.399,0,,0 (1),1,1,0.031,0.399
IL-10 signaling,INOH,2,IL10;JAK1,6 (6),0.031,0.399,0,,0 (0),1,1,0.031,0.399
Somatroph axis (GH) and its relationship to dietary restriction and aging,Wikipathways,2,IGF1R;FOXO1,6 (6),0.031,0.399,0,,0 (1),1,1,0.031,0.399
UTP and CTP dephosphorylation II,HumanCyc,1,CTPS2,4 (4),0.181,0.867,1,HMDB00288,10 (11),0.134,0.545,0.114,0.401
Chromatin modifying enzymes,Reactome,21,KMT2E;NCOR1;KMT2A;ARID4A;TBL1XR1;CLOCK;NCOA1;KDM4C;JMJD6;KDM6A;KMT2C;KDM5B;KDM2A;PADI4;KDM5C;WDR77;SETD7;MSL1;OGT;EPC1;ATXN7,272 (272),0.0244,0.371,0,,15 (16),1,1,0.115,0.401
Chromatin organization,Reactome,21,KMT2E;NCOR1;KMT2A;ARID4A;TBL1XR1;CLOCK;NCOA1;KDM4C;JMJD6;KDM6A;KMT2C;KDM5B;KDM2A;PADI4;KDM5C;WDR77;SETD7;MSL1;OGT;EPC1;ATXN7,272 (272),0.0244,0.371,0,,15 (16),1,1,0.115,0.401
mRNA Processing,Wikipathways,4,CLK1;CELF2;SPOP;SRSF5,127 (127),0.871,1,1,HMDB01397,2 (2),0.0284,0.317,0.116,0.405
Cilium Assembly,Reactome,11,BBS9;CEP97;ARF4;TTC26;SDCCAG8;IFT22;IQCB1;EXOC2;BBS10;RAB11A;IFT81,187 (187),0.3,1,1,HMDB01201,6 (6),0.0829,0.406,0.117,0.405
Human papillomavirus infection - Homo sapiens (human),KEGG,25,COL2A1;FOXO1;MPP5;AKT3;ATP6V1E1;ATP6V0A1;JAK1;PIK3CA;IRF1;CASP3;WNT10A;LAMC1;DLG2;PRKCZ;MAML2;ITGA3;MDM2;RELN;TNXB;ITGB7;STAT1;COL1A2;CREB3L2;COL1A1;CCND2,339 (339),0.0249,0.375,0,,3 (3),1,1,0.117,0.405
Synthesis of PA,Reactome,4,PLD2;PLA2G12A;LIPH;AGPAT4,40 (40),0.128,0.798,1,HMDB08048#HMDB08036#HMDB08038,15 (26),0.195,0.719,0.117,0.405
COPII-mediated vesicle transport,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.0829,0.406
GABA receptor activation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (7),0.0829,0.406,0.0829,0.406
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Wikipathways,0,,0 (0),1,1,1,HMDB04951,6 (19),0.0829,0.406,0.0829,0.406
EPH-Ephrin signaling,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (9),0.0829,0.406,0.0829,0.406
Semaphorin interactions,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.0829,0.406
Eukaryotic Translation Termination,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (8),0.0829,0.406,0.0829,0.406
Influenza Life Cycle,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (9),0.0829,0.406,0.0829,0.406
Assembly of the primary cilium,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.0829,0.406
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,EHMN,0,,0 (0),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (15),0.0829,0.406,0.0829,0.406
GPVI-mediated activation cascade,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (8),0.0829,0.406,0.0829,0.406
MHC class II antigen presentation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.0829,0.406
Regulation of TLR by endogenous ligand,Wikipathways,0,,0 (0),1,1,1,HMDB00658#HMDB10370,6 (12),0.0829,0.406,0.0829,0.406
Cilium Assembly,Wikipathways,0,,0 (0),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.0829,0.406
Frs2-mediated activation,Reactome,1,BRAF,9 (9),0.361,1,1,HMDB01201,5 (5),0.0695,0.374,0.118,0.408
Ether lipid metabolism - Homo sapiens (human),KEGG,6,LPCAT2;PLA2G12A;ENPP2;GDPD3;PAFAH1B3;PLD2,47 (47),0.0253,0.377,0,,9 (25),1,1,0.118,0.41
ESC Pluripotency Pathways,Wikipathways,11,BRAF;PDGFA;JAK1;WNT10A;MDM2;FGF11;BMPR1A;FGFR2;PDGFRA;MAPK12;AKT3,116 (116),0.0253,0.377,0,,4 (5),1,1,0.118,0.41
Validated transcriptional targets of AP1 family members Fra1 and Fra2,PID,5,BGLAP;MMP2;ATF4;COL1A2;GJA1,37 (37),0.0321,0.41,0,,0 (2),1,1,0.0321,0.41
il-7 signal transduction,BioCarta,3,PIK3CA;JAK1;NMI,15 (15),0.0335,0.411,0,,0 (0),1,1,0.0335,0.411
ABC-family proteins mediated transport,Reactome,5,SEL1L;ABCD2;ABCA6;ABCA5;DERL3,58 (59),0.15,0.848,1,HMDB08048#HMDB08036#HMDB08038,13 (21),0.171,0.653,0.12,0.413
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,4,GLUL;GLS;GFPT1;NAT8L,35 (35),0.088,0.697,1,HMDB00536,24 (28),0.293,1,0.12,0.415
Prostacyclin signalling through prostacyclin receptor,Reactome,1,GNG2,19 (19),0.612,1,1,HMDB01201,3 (3),0.0423,0.338,0.12,0.415
IRS-related events triggered by IGF1R,Reactome,4,IGF1R;PIK3CA;IRS2;FGFR2,49 (49),0.213,0.928,1,HMDB01201,9 (11),0.122,0.512,0.121,0.415
G Protein Signaling Pathways,Wikipathways,5,PDE1A;AKAP7;PRKCA;PPP3CC;PRKCZ,92 (92),0.464,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.121,0.415
TCR signaling,Reactome,5,CARD11;GRAP2;PAK1;PIK3CA;PTPN22,72 (72),0.271,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (9),0.096,0.441,0.121,0.415
RNA transport - Homo sapiens (human),KEGG,5,ELAC1;GEMIN7;EIF1;EIF4A2;EIF5,171 (171),0.923,1,1,HMDB01201,2 (3),0.0284,0.317,0.122,0.417
pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,16 (16),1,1,2,HMDB00295;HMDB01546,18 (19),0.0263,0.317,0.122,0.417
C-type lectin receptors (CLRs),Wikipathways,0,,3 (3),1,1,2,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218;HMDB01201,18 (23),0.0263,0.317,0.122,0.417
guanosine nucleotides degradation,HumanCyc,1,XDH,4 (4),0.181,0.867,1,HMDB01397,11 (12),0.147,0.579,0.123,0.419
Binding and Uptake of Ligands by Scavenger Receptors,Reactome,4,COL3A1;SPARC;COL1A1;COL1A2,41 (41),0.136,0.811,1,HMDB00658#HMDB10370,15 (41),0.195,0.719,0.123,0.419
Kennedy pathway from Sphingolipids,Wikipathways,2,PCYT1B;ETNK1,13 (13),0.129,0.798,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,16 (18),0.206,0.755,0.123,0.419
SHP2 signaling,PID,4,IGF1R;STAT1;PIK3CA;JAK1,59 (59),0.322,1,1,HMDB01201,6 (8),0.0829,0.406,0.123,0.419
Gastric acid secretion - Homo sapiens (human),KEGG,6,ATP1B3;PRKCA;CAMK2A;CAMK2D;PLCB4;ITPR2,75 (75),0.156,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,13 (14),0.171,0.653,0.124,0.42
Calnexin/calreticulin cycle,Reactome,4,SEL1L;RNF103;MAN1B1;SYVN1,24 (25),0.027,0.396,0,,5 (15),1,1,0.125,0.42
fatty acid &alpha;-oxidation III,HumanCyc,1,ALDH3A2,3 (3),0.139,0.811,1,HMDB00220,15 (22),0.195,0.719,0.125,0.42
Antigen Presentation: Folding_ assembly and peptide loading of class I MHC,Reactome,2,TAP1;B2M,24 (24),0.326,1,1,HMDB01201,6 (8),0.0829,0.406,0.125,0.42
Sema4D in semaphorin signaling,Reactome,2,ARHGEF11;ARHGEF12,24 (24),0.326,1,1,HMDB01201,6 (6),0.0829,0.406,0.125,0.42
Triacylglyceride Synthesis,Wikipathways,2,PNPLA2;AGPAT4,24 (24),0.326,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (10),0.0829,0.406,0.125,0.42
IGF1R signaling cascade,Reactome,4,IGF1R;PIK3CA;IRS2;FGFR2,50 (50),0.224,0.937,1,HMDB01201,9 (11),0.122,0.512,0.125,0.42
Signaling by FGFR3 fusions in cancer,Reactome,1,PIK3CA,10 (10),0.392,1,1,HMDB01201,5 (6),0.0695,0.374,0.126,0.42
Recycling pathway of L1,Reactome,2,RPS6KA2;RPS6KA3,28 (29),0.397,1,1,HMDB01201,5 (6),0.0695,0.374,0.127,0.42
G beta:gamma signalling through PI3Kgamma,Reactome,6,AKT3;JAK1;PIK3CA;PIK3CG;IL5RA;GNG2,48 (48),0.0278,0.396,0,,3 (5),1,1,0.127,0.42
Nicotinate and Nicotinamide Metabolism,SMPDB,3,ENPP1;NADK;NAMPT,14 (14),0.0278,0.396,0,,34 (35),1,1,0.127,0.42
Inositol Phosphate Metabolism,SMPDB,3,INPP1;INPP4B;IPMK,14 (14),0.0278,0.396,0,,23 (23),1,1,0.127,0.42
AKT phosphorylates targets in the cytosol,Reactome,3,MKRN1;MDM2;AKT3,14 (14),0.0278,0.396,0,,2 (2),1,1,0.127,0.42
Osteoblast Signaling,Wikipathways,3,BGLAP;PDGFRA;COL1A1,14 (14),0.0278,0.396,0,,3 (4),1,1,0.127,0.42
ADP signalling through P2Y purinoceptor 12,Reactome,1,GNG2,22 (22),0.666,1,1,HMDB01201,3 (3),0.0423,0.338,0.129,0.42
Apoptosis,Reactome,11,SATB1;CASP3;CFLAR;TNFSF10;BIRC2;AKT3;UNC5B;BMX;LY96;PPP3CC;DCC,118 (118),0.0283,0.399,0,,5 (6),1,1,0.129,0.42
Amino Acid metabolism,Wikipathways,8,GLUL;HNMT;EHHADH;GLS;ACSS1;ALDH7A1;ALDH1A1;PPM1L,91 (91),0.0743,0.64,2,HMDB00158;HMDB00159,92 (108),0.382,1,0.129,0.42
EGF,INOH,0,,28 (28),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
Nuclear import of Rev protein,Reactome,0,,34 (34),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
Recycling of eIF2:GDP,Reactome,0,,8 (8),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
p75NTR regulates axonogenesis,Reactome,0,,9 (10),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
melanocyte development and pigmentation pathway,BioCarta,0,,13 (13),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
mechanism of acetaminophen activity and toxicity,BioCarta,0,,6 (6),1,1,1,HMDB01043,2 (3),0.0284,0.317,0.13,0.42
mechanism of protein import into the nucleus,BioCarta,0,,12 (12),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
cycling of ran in nucleocytoplasmic transport,BioCarta,0,,9 (9),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
mets affect on macrophage differentiation,BioCarta,0,,18 (18),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
multi-drug resistance factors,BioCarta,0,,6 (6),1,1,1,HMDB08048#HMDB08036#HMDB08038,2 (2),0.0284,0.317,0.13,0.42
ceramide signaling pathway,BioCarta,0,,33 (33),1,1,1,HMDB04951,2 (2),0.0284,0.317,0.13,0.42
Lipid particle organization,Reactome,0,,6 (6),1,1,1,HMDB00658#HMDB10370,2 (3),0.0284,0.317,0.13,0.42
map kinase inactivation of smrt corepressor,BioCarta,0,,12 (12),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
GRB2 events in ERBB2 signaling,Reactome,0,,16 (16),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
Axonal growth inhibition (RHOA activation),Reactome,0,,8 (9),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
PI and PC transport between ER and Golgi membranes,Reactome,0,,1 (1),1,1,1,HMDB08048#HMDB08036#HMDB08038,2 (2),0.0284,0.317,0.13,0.42
GRB2 events in EGFR signaling,Reactome,0,,7 (7),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
role of ran in mitotic spindle regulation,BioCarta,0,,11 (11),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
Trafficking of myristoylated proteins to the cilium,Reactome,0,,5 (5),1,1,1,HMDB01201,2 (2),0.0284,0.317,0.13,0.42
Pancreatic adenocarcinoma pathway,Wikipathways,9,BRAF;PAK1;JAK1;TGFBR1;PIK3CA;PEBP1;AKT3;ARHGEF6;STAT1,89 (89),0.0285,0.399,0,,1 (2),1,1,0.13,0.42
Rheumatoid arthritis - Homo sapiens (human),KEGG,9,ITGAL;IL18;TNFSF13B;CD28;CD80;ATP6V1E1;CTLA4;ACP5;ATP6V0A1,89 (90),0.0285,0.399,0,,2 (4),1,1,0.13,0.42
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Reactome,4,IGF1R;PIK3CA;IRS2;FGFR2,51 (51),0.234,0.967,1,HMDB01201,9 (11),0.122,0.512,0.13,0.42
Arf6 signaling events,PID,2,IPCEF1;HGF,35 (35),0.512,1,1,HMDB01201,4 (4),0.056,0.374,0.131,0.421
Starch and sucrose metabolism - Homo sapiens (human),KEGG,5,GBE1;PYGL;ENPP1;MGAM;PGM2L1,36 (36),0.0288,0.399,0,,20 (37),1,1,0.131,0.421
ER to Golgi Anterograde Transport,Reactome,8,CD55;STX17;USO1;ARFGAP3;MIA3;SCFD1;ARF4;CTAGE5,137 (137),0.348,1,1,HMDB01201,6 (10),0.0829,0.406,0.131,0.421
Thromboxane signalling through TP receptor,Reactome,1,GNG2,23 (23),0.682,1,1,HMDB01201,3 (3),0.0423,0.338,0.131,0.421
Phenylalanine_ tyrosine and tryptophan biosynthesis - Homo sapiens (human),KEGG,0,,5 (5),1,1,2,HMDB00158;HMDB00159,19 (35),0.0291,0.317,0.132,0.424
Prolonged ERK activation events,Reactome,1,BRAF,11 (11),0.422,1,1,HMDB01201,5 (5),0.0695,0.374,0.133,0.425
p38MAPK events,Reactome,1,MAPK11,11 (11),0.422,1,1,HMDB01201,5 (5),0.0695,0.374,0.133,0.425
Signaling by FGFR4 in disease,Reactome,1,PIK3CA,11 (11),0.422,1,1,HMDB01201,5 (7),0.0695,0.374,0.133,0.425
Calcium Regulation in the Cardiac Cell,Wikipathways,13,ATP1B3;GJA1;PRKCA;CACNA1S;GJA5;CAMK2A;CAMK2D;ANXA6;PRKCZ;CACNA1E;GNG2;ITPR2;GRK5,149 (149),0.0294,0.399,0,,10 (10),1,1,0.133,0.425
PAR4-mediated thrombin signaling events,PID,1,GNG2,15 (15),0.526,1,1,HMDB01201,4 (4),0.056,0.374,0.133,0.425
DCC mediated attractive signaling,Reactome,1,DCC,15 (15),0.526,1,1,HMDB01201,4 (5),0.056,0.374,0.133,0.425
Negative regulation of the PI3K/AKT network,Reactome,10,PDGFA;PDGFRA;HGF;CD28;CD80;AKT3;IRS2;FGFR2;INSR;PIK3CA,104 (104),0.0295,0.399,0,,7 (14),1,1,0.133,0.425
Degradation pathway of sphingolipids_ including diseases,Wikipathways,1,HEXA,5 (5),0.22,0.928,1,HMDB04951,10 (13),0.134,0.545,0.134,0.425
DAG and IP3 signaling,Reactome,3,PDE1A;PRKCA;ITPR2,32 (32),0.202,0.918,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (13),0.147,0.579,0.134,0.425
miR-targeted genes in epithelium - TarBase,Wikipathways,24,COL3A1;DOCK5;GJA1;GEMIN7;IFRD1;SLC12A2;SLC12A4;MIR15B;HACD3;DHX40;BACH1;LAMC1;FNDC3A;UNC93B1;FAR1;SERP1;STX7;CLOCK;NRP1;GFPT1;DDX5;ARF4;COL1A1;AMIGO2,333 (333),0.0347,0.425,0,,0 (0),1,1,0.0347,0.425
Triglyceride metabolism,Reactome,1,LPIN1,38 (38),0.85,1,2,HMDB00658#HMDB10370;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,21 (28),0.0351,0.338,0.135,0.427
Signaling by ERBB4,Reactome,3,APH1B;PIK3CA;NCOR1,44 (44),0.361,1,1,HMDB01201,6 (8),0.0829,0.406,0.135,0.427
Longevity regulating pathway - multiple species - Homo sapiens (human),KEGG,7,FOXO1;PIK3CA;AKT3;IRS2;IGF1R;INSR;PRKAG2,62 (62),0.03,0.399,0,,2 (2),1,1,0.135,0.427
EPO Receptor Signaling,Wikipathways,4,IRS2;CISH;STAT1;PIK3CG,26 (26),0.0352,0.427,0,,0 (0),1,1,0.0352,0.427
Calcineurin-regulated NFAT-dependent transcription in lymphocytes,PID,6,CASP3;RNF128;IRF4;CTLA4;SLC3A2;TBX21,49 (49),0.0304,0.399,0,,1 (3),1,1,0.137,0.431
Prostaglandin Leukotriene metabolism,INOH,3,TBXAS1;PTGIS;ALOX12,24 (25),0.108,0.739,1,HMDB01043,23 (25),0.283,0.989,0.138,0.431
Signaling by FGFR4,Reactome,3,BRAF;PIK3CA;MKNK1,41 (41),0.321,1,1,HMDB01201,7 (8),0.096,0.441,0.138,0.431
Cannabinoid receptor signaling,Wikipathways,2,FAAH;ADORA2A,20 (20),0.253,1,1,HMDB01043,9 (20),0.122,0.512,0.138,0.431
Propanoate metabolism,INOH,4,ALDH1A1;ALDH3A2;EHHADH;ALDH7A1,25 (25),0.0309,0.399,0,,24 (26),1,1,0.138,0.431
Constitutive Signaling by AKT1 E17K in Cancer,Reactome,4,AKT3;MDM2;FOXO1;PRR5,25 (25),0.0309,0.399,0,,2 (3),1,1,0.138,0.431
Alpha-oxidation of phytanate,Reactome,2,ALDH3A2;PHYH,6 (6),0.031,0.399,0,,23 (25),1,1,0.139,0.431
Choline catabolism,Reactome,2,ALDH7A1;SLC44A1,6 (6),0.031,0.399,0,,14 (15),1,1,0.139,0.431
Interleukin-10 signaling,Reactome,2,IL10;JAK1,6 (6),0.031,0.399,0,,2 (2),1,1,0.139,0.431
ethanol degradation IV,HumanCyc,2,ALDH3A2;ACSS1,6 (6),0.031,0.399,0,,12 (13),1,1,0.139,0.431
RSK activation,Reactome,2,RPS6KA2;RPS6KA3,6 (6),0.031,0.399,0,,2 (2),1,1,0.139,0.431
MET activates PI3K/AKT signaling,Reactome,2,PIK3CA;HGF,6 (6),0.031,0.399,0,,3 (4),1,1,0.139,0.431
lysine degradation II (pipecolate pathway),HumanCyc,2,ALDH7A1;DHTKD1,6 (6),0.031,0.399,0,,18 (21),1,1,0.139,0.431
activation of camp-dependent protein kinase pka,BioCarta,2,CXCR4;EDNRA,31 (31),0.448,1,1,HMDB01201,5 (6),0.0695,0.374,0.139,0.432
MicroRNA (miRNA) biogenesis,Reactome,1,AGO4,12 (12),0.45,1,1,HMDB01201,5 (6),0.0695,0.374,0.14,0.432
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,1,CMPK2,23 (23),0.682,1,3,HMDB00288;HMDB00295;HMDB01546,57 (57),0.0462,0.365,0.14,0.432
Beta Ureidopropionase Deficiency,SMPDB,1,CMPK2,23 (23),0.682,1,3,HMDB00288;HMDB00295;HMDB01546,57 (57),0.0462,0.365,0.14,0.432
Pyrimidine Metabolism,SMPDB,1,CMPK2,23 (23),0.682,1,3,HMDB00288;HMDB00295;HMDB01546,57 (57),0.0462,0.365,0.14,0.432
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,1,CMPK2,23 (23),0.682,1,3,HMDB00288;HMDB00295;HMDB01546,57 (57),0.0462,0.365,0.14,0.432
Dihydropyrimidinase Deficiency,SMPDB,1,CMPK2,23 (23),0.682,1,3,HMDB00288;HMDB00295;HMDB01546,57 (57),0.0462,0.365,0.14,0.432
Signaling by FGFR2 in disease,Reactome,2,PIK3CA;FGFR2,27 (27),0.38,1,1,HMDB01201,6 (15),0.0829,0.406,0.14,0.432
Insulin receptor signalling cascade,Reactome,4,PIK3CA;INSR;IRS2;FGFR2,51 (51),0.234,0.967,1,HMDB01201,10 (12),0.134,0.545,0.14,0.432
GPCR signaling-G alpha s Epac and ERK,INOH,13,BRAF;PDGFA;RAPGEF3;WNT10A;TNFSF10;HGF;ADORA2A;CD80;BMP6;FGF11;IL10;RAP1B;IL18,272 (272),0.564,1,1,HMDB01201,4 (4),0.056,0.374,0.141,0.433
Thermogenesis,Wikipathways,8,MAPK11;MAPK13;MAPK12;PNPLA2;RPS6KA2;RPS6KA3;CREB3L2;PRKAG2,108 (108),0.154,0.865,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,16 (25),0.206,0.755,0.142,0.435
Aldosterone-regulated sodium reabsorption - Homo sapiens (human),KEGG,5,PIK3CA;INSR;PRKCA;SGK1;ATP1B3,37 (37),0.0321,0.41,0,,8 (8),1,1,0.142,0.436
Regulation of Actin Cytoskeleton,Wikipathways,13,BRAF;PDGFA;PDGFRA;ARHGEF6;ABI2;PIK3CA;PIK3C2B;PAK1;PIK3CG;FGF11;PPP1R12A;FGFR2;BCAR1,151 (151),0.0323,0.411,0,,4 (5),1,1,0.143,0.438
COPI-mediated anterograde transport,Reactome,4,ARF4;CD55;ARFGAP3;USO1,83 (83),0.578,1,1,HMDB01201,4 (4),0.056,0.374,0.143,0.438
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,Wikipathways,7,PAK1;PIK3CA;CD28;IL10;CARD11;CTLA4;GRAP2,63 (63),0.0324,0.411,0,,2 (2),1,1,0.143,0.438
PDGF Pathway,Wikipathways,1,PDGFA,10 (10),0.392,1,1,HMDB01043,6 (8),0.0829,0.406,0.144,0.439
Signaling by NTRK3 (TRKC),Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (8),0.096,0.441,0.096,0.441
Translocation of SLC2A4 (GLUT4) to the plasma membrane,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (7),0.096,0.441,0.096,0.441
TCR signaling,Wikipathways,0,,0 (0),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (9),0.096,0.441,0.096,0.441
tRNA processing in the nucleus,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (7),0.096,0.441,0.096,0.441
Energy dependent regulation of mTOR by LKB1-AMPK,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (7),0.096,0.441,0.096,0.441
Signaling by PDGF,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (8),0.096,0.441,0.096,0.441
Rap1 signalling,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (8),0.096,0.441,0.096,0.441
Signaling by FGFR4,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (9),0.096,0.441,0.096,0.441
Signaling by FGFR1,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (8),0.096,0.441,0.096,0.441
Signaling by FGFR2,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (15),0.096,0.441,0.096,0.441
Signaling by MET,Wikipathways,0,,0 (0),1,1,1,HMDB01201,7 (8),0.096,0.441,0.096,0.441
Cargo recognition for clathrin-mediated endocytosis,Wikipathways,0,,0 (0),1,1,1,HMDB00658#HMDB10370,7 (9),0.096,0.441,0.096,0.441
Signaling by EGFRvIII in Cancer,Reactome,1,PIK3CA,13 (13),0.477,1,1,HMDB01201,5 (9),0.0695,0.374,0.146,0.444
Constitutive Signaling by EGFRvIII,Reactome,1,PIK3CA,13 (13),0.477,1,1,HMDB01201,5 (9),0.0695,0.374,0.146,0.444
Tie2 Signaling,Reactome,1,PIK3CA,18 (18),0.592,1,1,HMDB01201,4 (4),0.056,0.374,0.146,0.444
Programmed Cell Death,Reactome,11,SATB1;CASP3;CFLAR;TNFSF10;BIRC2;AKT3;UNC5B;BMX;LY96;PPP3CC;DCC,121 (121),0.0332,0.411,0,,6 (10),1,1,0.146,0.444
Signaling by FGFR in disease,Reactome,3,PIK3CA;STAT1;FGFR2,47 (47),0.401,1,1,HMDB01201,6 (20),0.0829,0.406,0.146,0.444
Apelin signaling pathway - Homo sapiens (human),KEGG,8,MEF2C;TGFBR1;PIK3CG;AKT3;PLCB4;GNG2;ITPR2;PRKAG2,137 (137),0.348,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (9),0.096,0.441,0.147,0.444
Inflammasomes,Reactome,3,TXNIP;CASP1;NLRP3,15 (15),0.0335,0.411,0,,2 (4),1,1,0.147,0.444
N-Glycan antennae elongation,Reactome,3,MGAT4A;ST6GAL1;ST8SIA6,15 (15),0.0335,0.411,0,,2 (5),1,1,0.147,0.444
p130Cas linkage to MAPK signaling for integrins,Reactome,3,BCAR1;RAP1B;APBB1IP,15 (15),0.0335,0.411,0,,6 (8),1,1,0.147,0.444
Leucine Stimulation on Insulin Signaling,SMPDB,3,INSR;IRS2;PIK3CG,15 (15),0.0335,0.411,0,,2 (2),1,1,0.147,0.444
eicosanoid metabolism,BioCarta,2,TBXAS1;PTGIS,23 (23),0.308,1,1,HMDB01043,8 (9),0.109,0.479,0.148,0.444
Thrombin signalling through proteinase activated receptors (PARs),Reactome,1,GNG2,32 (32),0.797,1,1,HMDB01201,3 (3),0.0423,0.338,0.148,0.445
Ephrin signaling,Reactome,1,PAK1,19 (19),0.612,1,1,HMDB01201,4 (4),0.056,0.374,0.15,0.45
Signalling to ERKs,Reactome,2,MAPK11;BRAF,29 (29),0.415,1,1,HMDB01201,6 (6),0.0829,0.406,0.15,0.451
PTK6 Regulates RHO GTPases_ RAS GTPase and MAP kinases,Reactome,1,BCAR1,14 (14),0.502,1,1,HMDB01201,5 (5),0.0695,0.374,0.152,0.455
Hydrolysis of LPC,Reactome,1,GPCPD1,11 (11),0.422,1,1,HMDB10384,6 (9),0.0829,0.406,0.152,0.455
eukaryotic protein translation,BioCarta,3,EIF1;EIF4A2;EIF5,16 (17),0.0398,0.456,0,,0 (0),1,1,0.0398,0.456
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits,Wikipathways,3,EPAS1;CXCR4;PIK3CG,16 (16),0.0398,0.456,0,,0 (0),1,1,0.0398,0.456
Synthesis of PE,Reactome,2,ETNK1;LPIN1,14 (14),0.146,0.833,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,19 (21),0.24,0.854,0.152,0.456
Glucose Homeostasis,Wikipathways,0,,1 (1),1,1,2,HMDB00158;HMDB00159,21 (21),0.0351,0.338,0.153,0.456
S1P1 pathway,PID,1,S1PR1,20 (20),0.631,1,1,HMDB01201,4 (5),0.056,0.374,0.153,0.456
Lysine catabolism,Reactome,2,SLC25A21;ALDH7A1,12 (12),0.113,0.747,1,HMDB01201,26 (32),0.314,1,0.153,0.456
GPCR signaling-G alpha s PKA and ERK,INOH,13,BRAF;PDGFA;WNT10A;ADORA2A;TNFSF10;HGF;RAPGEF3;CD80;BMP6;FGF11;IL10;RAP1B;IL18,285 (285),0.632,1,1,HMDB01201,4 (4),0.056,0.374,0.154,0.456
Retrograde transport at the Trans-Golgi-Network,Reactome,3,RAB6B;VAMP4;STX16,49 (49),0.428,1,1,HMDB01201,6 (6),0.0829,0.406,0.154,0.456
Phosphatidylinositol phosphate metabolism,EHMN,8,PLCD3;PIK3C2B;PIK3CA;ATP8B2;PLCB4;PIK3CG;IPMK;PLD2,93 (93),0.0821,0.668,1,HMDB00295,39 (49),0.432,1,0.154,0.456
Signaling events mediated by TCPTP,PID,5,STAT1;HGF;INSR;JAK1;PIK3CA,38 (38),0.0355,0.43,0,,1 (2),1,1,0.154,0.456
Lysosome Vesicle Biogenesis,Reactome,2,AP1S2;TXNDC5,35 (35),0.512,1,1,HMDB01201,5 (6),0.0695,0.374,0.154,0.457
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,2,GNG2;RAPGEF3,35 (35),0.512,1,1,HMDB01201,5 (7),0.0695,0.374,0.154,0.457
Downstream signaling of activated FGFR2,Reactome,2,PIK3CA;FGFR2,30 (30),0.432,1,1,HMDB01201,6 (8),0.0829,0.406,0.155,0.457
Tryptophan catabolism,Reactome,1,SLC3A2,14 (14),0.502,1,2,HMDB00158;HMDB00159,31 (34),0.0713,0.381,0.155,0.457
HDMs demethylate histones,Reactome,6,KDM4C;JMJD6;KDM6A;KDM5B;KDM2A;KDM5C,51 (51),0.0361,0.434,0,,5 (5),1,1,0.156,0.459
Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human),KEGG,6,MAPK11;CASP1;MAPK13;CASP3;MAPK12;PPP3CC,51 (51),0.0361,0.434,0,,9 (10),1,1,0.156,0.459
G-protein beta:gamma signalling,Reactome,6,AKT3;JAK1;PIK3CA;PIK3CG;IL5RA;GNG2,51 (51),0.0361,0.434,0,,4 (7),1,1,0.156,0.459
AGE-RAGE pathway,Wikipathways,7,CASP3;FOXO1;PRKCA;STAT1;PRKCZ;MMP2;INSR,66 (66),0.0403,0.46,0,,0 (0),1,1,0.0403,0.46
E-cadherin signaling in keratinocytes,PID,1,PIK3CA,21 (21),0.649,1,1,HMDB01201,4 (4),0.056,0.374,0.157,0.46
Intra-Golgi traffic,Reactome,2,RAB30;STX16,45 (45),0.65,1,1,HMDB01201,4 (4),0.056,0.374,0.157,0.46
corticosteroids and cardioprotection,BioCarta,2,PIK3CA;NR3C1,27 (27),0.38,1,1,HMDB01201,7 (8),0.096,0.441,0.157,0.46
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Reactome,1,PIK3CA,15 (15),0.526,1,1,HMDB01201,5 (9),0.0695,0.374,0.158,0.46
Signaling by EGFR in Cancer,Reactome,1,PIK3CA,15 (15),0.526,1,1,HMDB01201,5 (9),0.0695,0.374,0.158,0.46
Signaling by Ligand-Responsive EGFR Variants in Cancer,Reactome,1,PIK3CA,15 (15),0.526,1,1,HMDB01201,5 (9),0.0695,0.374,0.158,0.46
N-cadherin signaling events,PID,2,GJA1;PIK3CA,36 (36),0.528,1,1,HMDB01201,5 (5),0.0695,0.374,0.158,0.461
Lysosome - Homo sapiens (human),KEGG,11,HEXA;CTSW;LGMN;AP1S2;LAPTM4A;ENTPD4;CTSS;CLN3;ACP5;ATP6V0A1;CTSO,123 (123),0.0368,0.441,0,,4 (4),1,1,0.158,0.461
Signaling by WNT,Reactome,8,RYK;WNT10A;PRKCA;CAMK2A;TLE4;PDE6A;GNG2;ITPR2,276 (278),0.961,1,2,HMDB01201;HMDB01397,22 (25),0.0383,0.338,0.158,0.461
Estrogen signaling pathway - Homo sapiens (human),KEGG,8,NCOA1;PIK3CA;ATF4;AKT3;PLCB4;MMP2;CREB3L2;ITPR2,136 (137),0.341,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,8 (9),0.109,0.479,0.159,0.463
Acetylcholine regulates insulin secretion,Reactome,1,PRKCA,10 (10),0.392,1,1,HMDB01201,7 (9),0.096,0.441,0.161,0.468
Signaling by EGFR,Reactome,3,LRIG1;STAM;PIK3CA,43 (43),0.348,1,1,HMDB01201,8 (9),0.109,0.479,0.162,0.47
Cargo recognition for clathrin-mediated endocytosis,Reactome,6,REPS2;VAMP4;SYT8;STAM;FCHO2;STON2,99 (99),0.349,1,1,HMDB00658#HMDB10370,8 (10),0.109,0.479,0.162,0.471
mTORC1-mediated signalling,Reactome,1,RRAGD,23 (24),0.682,1,1,HMDB01201,4 (4),0.056,0.374,0.163,0.471
Adrenaline_noradrenaline inhibits insulin secretion,Reactome,1,GNG2,23 (23),0.682,1,1,HMDB01201,4 (4),0.056,0.374,0.163,0.471
Interleukin-1 processing,Reactome,2,CASP1;IL18,7 (7),0.042,0.472,0,,0 (0),1,1,0.042,0.472
NCAM signaling for neurite out-growth,Reactome,3,CACNA1H;CACNA1S;NCAN,59 (59),0.551,1,1,HMDB01201,5 (5),0.0695,0.374,0.163,0.472
Biochemical Pathways Part I,Wikipathways,0,,0 (0),1,1,10,HMDB01044;HMDB00288;HMDB00618#HMDB01548;HMDB00295;HMDB01546;HMDB00159;HMDB01397;HMDB00536;HMDB00158;HMDB01201,460 (467),0.103,0.473,0.103,0.473
ADP signalling through P2Y purinoceptor 1,Reactome,1,GNG2,24 (24),0.698,1,1,HMDB01201,4 (4),0.056,0.374,0.166,0.476
Circadian entrainment - Homo sapiens (human),KEGG,6,PRKCA;CAMK2A;CACNA1H;CAMK2D;PLCB4;GNG2,96 (96),0.323,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,9 (11),0.122,0.512,0.167,0.476
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,4,AKT3;PIK3CA;ATP1B3;MGAM,44 (44),0.164,0.867,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,19 (27),0.24,0.854,0.167,0.476
Synthesis of 12-eicosatetraenoic acid derivatives,Reactome,1,ALOX12,7 (7),0.294,1,1,HMDB01043,10 (12),0.134,0.545,0.167,0.476
Metabolism of Spingolipids in ER and Golgi apparatus,Wikipathways,1,B3GALNT1,7 (7),0.294,1,1,HMDB04951,10 (21),0.134,0.545,0.167,0.476
Ligand-dependent caspase activation,Reactome,3,LY96;CFLAR;TNFSF10,16 (16),0.0398,0.456,0,,1 (1),1,1,0.168,0.476
RIPK1-mediated regulated necrosis,Reactome,3,BIRC2;CFLAR;TNFSF10,16 (16),0.0398,0.456,0,,3 (6),1,1,0.168,0.476
Regulated Necrosis,Reactome,3,BIRC2;CFLAR;TNFSF10,16 (16),0.0398,0.456,0,,3 (6),1,1,0.168,0.476
Sema3A PAK dependent Axon repulsion,Reactome,3,PLXNA1;PAK1;NRP1,16 (16),0.0398,0.456,0,,3 (3),1,1,0.168,0.476
Synthesis of PIPs at the early endosome membrane,Reactome,3,PIKFYVE;FIG4;INPP4B,16 (16),0.0398,0.456,0,,10 (16),1,1,0.168,0.476
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Reactome,3,F11R;PRKCZ;TGFBR1,16 (16),0.0398,0.456,0,,3 (3),1,1,0.168,0.476
Energy dependent regulation of mTOR by LKB1-AMPK,Reactome,2,RRAGD;PRKAG2,29 (29),0.415,1,1,HMDB01201,7 (7),0.096,0.441,0.168,0.476
palmitate biosynthesis,HumanCyc,1,ACOT7,8 (9),0.329,1,1,HMDB00220,9 (10),0.122,0.512,0.169,0.476
chrebp regulation by carbohydrates and camp,BioCarta,3,CXCR4;EDNRA;PRKAG2,42 (42),0.334,1,1,HMDB01201,9 (12),0.122,0.512,0.171,0.476
Signalling to RAS,Reactome,1,MAPK11,18 (18),0.592,1,1,HMDB01201,5 (5),0.0695,0.374,0.173,0.476
tRNA charging,HumanCyc,0,,38 (38),1,1,2,HMDB00158;HMDB00159,23 (24),0.0416,0.338,0.174,0.476
Glycerolipid Metabolism,SMPDB,0,,13 (13),1,1,2,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,23 (24),0.0416,0.338,0.174,0.476
Familial lipoprotein lipase deficiency,SMPDB,0,,13 (13),1,1,2,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,23 (24),0.0416,0.338,0.174,0.476
Mitochondrial tRNA aminoacylation,Reactome,0,,21 (21),1,1,2,HMDB00158;HMDB00159,23 (66),0.0416,0.338,0.174,0.476
tRNA Aminoacylation,Reactome,0,,42 (42),1,1,2,HMDB00158;HMDB00159,23 (66),0.0416,0.338,0.174,0.476
D-glyceric acidura,SMPDB,0,,13 (13),1,1,2,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,23 (24),0.0416,0.338,0.174,0.476
Cytosolic tRNA aminoacylation,Reactome,0,,24 (24),1,1,2,HMDB00158;HMDB00159,23 (66),0.0416,0.338,0.174,0.476
Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,0,,66 (66),1,1,2,HMDB00158;HMDB00159,23 (52),0.0416,0.338,0.174,0.476
Glycerol Kinase Deficiency,SMPDB,0,,13 (13),1,1,2,HMDB00220;HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,23 (24),0.0416,0.338,0.174,0.476
Generation of second messenger molecules,Reactome,2,GRAP2;PAK1,41 (41),0.599,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,5 (6),0.0695,0.374,0.174,0.476
GTP hydrolysis and joining of the 60S ribosomal subunit,Reactome,2,EIF4A2;EIF5,124 (126),0.985,1,1,HMDB01201,3 (4),0.0423,0.338,0.174,0.476
Cation-coupled Chloride cotransporters,Reactome,2,SLC12A4;SLC12A2,7 (7),0.042,0.472,0,,3 (3),1,1,0.175,0.476
Vitamin B2 (riboflavin) metabolism,Reactome,2,ACP5;ENPP1,7 (7),0.042,0.472,0,,10 (10),1,1,0.175,0.476
DSCAM interactions,Reactome,2,PAK1;DCC,7 (7),0.042,0.472,0,,3 (3),1,1,0.175,0.476
oxidative ethanol degradation III,HumanCyc,2,ALDH3A2;ACSS1,7 (7),0.042,0.472,0,,14 (15),1,1,0.175,0.476
Interferon gamma signaling,Wikipathways,2,SP100;B2M,7 (7),0.042,0.472,0,,4 (4),1,1,0.175,0.476
Chylomicron assembly,Reactome,0,,10 (10),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
VLDL assembly,Reactome,0,,5 (5),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
S1P4 pathway,PID,0,,14 (14),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
LDL remodeling,Reactome,0,,4 (4),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
Rev-mediated nuclear export of HIV RNA,Reactome,0,,33 (33),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
rho-selective guanine exchange factor akap13 mediates stress fiber formation,BioCarta,0,,11 (11),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
Mitochondrial translation termination,Reactome,0,,88 (89),1,1,1,HMDB01201,3 (25),0.0423,0.338,0.176,0.476
NEP/NS2 Interacts with the Cellular Export Machinery,Reactome,0,,30 (30),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
Export of Viral Ribonucleoproteins from Nucleus,Reactome,0,,31 (31),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
S1P5 pathway,PID,0,,8 (8),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
HDL clearance,Reactome,0,,5 (5),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
Chylomicron clearance,Reactome,0,,5 (5),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
VLDL clearance,Reactome,0,,6 (6),1,1,1,HMDB00658#HMDB10370,3 (4),0.0423,0.338,0.176,0.476
calcium signaling by hbx of hepatitis b virus,BioCarta,0,,16 (16),1,1,1,HMDB01201,3 (6),0.0423,0.338,0.176,0.476
Eukaryotic Translation Elongation,Reactome,0,,105 (106),1,1,1,HMDB01201,3 (25),0.0423,0.338,0.176,0.476
Nonsense-Mediated Decay (NMD),Reactome,0,,117 (118),1,1,1,HMDB01201,3 (4),0.0423,0.338,0.176,0.476
mcalpain and friends in cell motility,BioCarta,0,,30 (30),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
sprouty regulation of tyrosine kinase signals,BioCarta,0,,20 (20),1,1,1,HMDB01201,3 (4),0.0423,0.338,0.176,0.476
Assembly of active LPL and LIPC lipase complexes,Reactome,0,,14 (14),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (6),0.0423,0.338,0.176,0.476
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Reactome,0,,117 (118),1,1,1,HMDB01201,3 (4),0.0423,0.338,0.176,0.476
Mitochondrial translation elongation,Reactome,0,,88 (89),1,1,1,HMDB01201,3 (26),0.0423,0.338,0.176,0.476
MFAP5-mediated ovarian cancer cell motility and invasiveness,Wikipathways,0,,13 (13),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (3),0.0423,0.338,0.176,0.476
Interactions of Rev with host cellular proteins,Reactome,0,,37 (37),1,1,1,HMDB01201,3 (3),0.0423,0.338,0.176,0.476
Peptide chain elongation,Reactome,0,,100 (101),1,1,1,HMDB01201,3 (25),0.0423,0.338,0.176,0.476
Thyroxine (Thyroid Hormone) Production,Wikipathways,0,,6 (6),1,1,1,HMDB00158,3 (4),0.0423,0.338,0.176,0.476
aspirin triggered resolvin E biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB01999,3 (5),0.0423,0.338,0.176,0.476
Cell-type Dependent Selectivity of CCK2R Signaling,Wikipathways,0,,13 (13),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,3 (7),0.0423,0.338,0.176,0.476
Signaling by FGFR1,Reactome,3,BRAF;PIK3CA;MKNK1,50 (50),0.441,1,1,HMDB01201,7 (8),0.096,0.441,0.176,0.476
IL-5 Signaling Pathway,Wikipathways,5,IL5RA;STAT1;JAK1;PIK3CG;BTK,40 (40),0.043,0.477,0,,0 (0),1,1,0.043,0.477
Signaling events mediated by PTP1B,PID,6,BLK;PIK3CA;LEPR;PRLR;INSR;BCAR1,53 (53),0.0425,0.475,0,,1 (3),1,1,0.177,0.477
Oligodendrocyte Specification and differentiation(including remyelination)_ leading to Myelin Components for CNS,Wikipathways,0,,0 (0),1,1,1,HMDB08048#HMDB08036#HMDB08038,8 (11),0.109,0.479,0.109,0.479
Plasmalogen biosynthesis,Wikipathways,0,,0 (0),1,1,1,HMDB00220,8 (12),0.109,0.479,0.109,0.479
Signaling by EGFR,Wikipathways,0,,0 (0),1,1,1,HMDB01201,8 (14),0.109,0.479,0.109,0.479
Costimulation by the CD28 family,Wikipathways,0,,0 (0),1,1,1,HMDB01201,8 (9),0.109,0.479,0.109,0.479
Effects of PIP2 hydrolysis,Wikipathways,0,,0 (0),1,1,1,HMDB01043,8 (13),0.109,0.479,0.109,0.479
Vasopressin regulates renal water homeostasis via Aquaporins,Wikipathways,0,,0 (0),1,1,1,HMDB01201,8 (8),0.109,0.479,0.109,0.479
COPI-dependent Golgi-to-ER retrograde traffic,Reactome,3,ARF4;ARFGAP3;KIF1B,82 (82),0.767,1,1,HMDB01201,4 (4),0.056,0.374,0.178,0.481
Sorafenib Metabolism Pathway,SMPDB,1,PDIA4,15 (15),0.526,1,1,HMDB00295,6 (7),0.0829,0.406,0.18,0.486
Signaling by the B Cell Receptor (BCR),Reactome,8,BLNK;CD79A;CD79B;CARD11;RASGRP3;BTK;PLCG2;ITPR2,127 (127),0.276,1,1,HMDB01201,12 (14),0.159,0.616,0.181,0.488
Host Interactions of HIV factors,Reactome,4,AP1S2;PACS1;CD28;B2M,89 (89),0.634,1,1,HMDB01201,5 (5),0.0695,0.374,0.182,0.489
Phosphonate and phosphinate metabolism - Homo sapiens (human),KEGG,1,PCYT1B,6 (6),0.258,1,1,HMDB00618#HMDB01548,13 (57),0.171,0.653,0.182,0.489
Anti-diabetic Drug Potassium Channel Inhibitors Pathway_ Pharmacodynamics,PharmGKB,4,PIK3CA;INSR;IRS2;PIK3CG,28 (28),0.0447,0.492,0,,2 (2),1,1,0.184,0.493
Toll Like Receptor 4 (TLR4) Cascade,Reactome,11,MAPK11;BIRC2;PELI1;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;BTK;PLCG2;LY96,127 (127),0.0448,0.492,0,,5 (15),1,1,0.184,0.493
activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,BioCarta,2,CXCR4;EDNRA,45 (45),0.65,1,1,HMDB01201,5 (6),0.0695,0.374,0.185,0.494
Regulation of TLR by endogenous ligand,Reactome,1,LY96,16 (16),0.549,1,1,HMDB00658#HMDB10370,6 (12),0.0829,0.406,0.186,0.494
cadmium induces dna synthesis and proliferation in macrophages,BioCarta,1,PRKCA,16 (16),0.549,1,1,HMDB01201,6 (9),0.0829,0.406,0.186,0.494
Nucleotide-like (purinergic) receptors,Reactome,1,ADORA2A,16 (16),0.549,1,1,HMDB00295,6 (7),0.0829,0.406,0.186,0.494
Morphine Metabolism Pathway,SMPDB,1,PDIA4,16 (16),0.549,1,1,HMDB00295,6 (6),0.0829,0.406,0.186,0.494
IRS-mediated signalling,Reactome,3,PIK3CA;IRS2;FGFR2,45 (45),0.375,1,1,HMDB01201,9 (11),0.122,0.512,0.186,0.494
Alpha4 beta1 integrin signaling events,PID,1,BCAR1,34 (34),0.816,1,1,HMDB01201,4 (4),0.056,0.374,0.187,0.494
Signaling by FGFR2,Reactome,4,BRAF;PIK3CA;FGFR2;MKNK1,73 (73),0.476,1,1,HMDB01201,7 (9),0.096,0.441,0.187,0.494
COPII-mediated vesicle transport,Reactome,3,SCFD1;STX17;USO1,69 (69),0.658,1,1,HMDB01201,5 (9),0.0695,0.374,0.187,0.494
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling,Reactome,9,PDGFA;PDGFRA;HGF;CD28;CD80;IRS2;FGFR2;INSR;PIK3CA,97 (97),0.0458,0.495,0,,6 (12),1,1,0.187,0.494
MyD88:Mal cascade initiated on plasma membrane,Reactome,9,MAPK11;PELI1;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;BTK;LY96,97 (97),0.0458,0.495,0,,5 (15),1,1,0.187,0.494
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,9,MAPK11;PELI1;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;BTK;LY96,97 (97),0.0458,0.495,0,,5 (15),1,1,0.187,0.494
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,9,MAPK11;PELI1;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;BTK;LY96,97 (97),0.0458,0.495,0,,5 (15),1,1,0.187,0.494
Toll Like Receptor 2 (TLR2) Cascade,Reactome,9,MAPK11;PELI1;IRAK3;MEF2C;ATF1;RPS6KA2;RPS6KA3;BTK;LY96,97 (97),0.0458,0.495,0,,5 (15),1,1,0.187,0.494
Interleukin-4 and Interleukin-13 signaling,Wikipathways,9,IL10;FOXO1;HGF;S1PR1;IRF4;STAT1;IL18;MMP2;COL1A2,97 (97),0.0458,0.495,0,,2 (2),1,1,0.187,0.494
Signaling events mediated by VEGFR1 and VEGFR2,PID,4,MAPK11;BRAF;PRKCA;PIK3CA,68 (68),0.422,1,1,HMDB01201,8 (8),0.109,0.479,0.188,0.495
Arachidonic acid metabolism,Wikipathways,0,,0 (0),1,1,3,HMDB10384;HMDB01043;HMDB08048#HMDB08036#HMDB08038,83 (107),0.113,0.495,0.113,0.495
Signaling by FGFR1 in disease,Reactome,2,PIK3CA;STAT1,38 (38),0.557,1,1,HMDB01201,6 (17),0.0829,0.406,0.188,0.496
Effects of PIP2 hydrolysis,Reactome,2,DGKH;ITPR2,27 (27),0.38,1,1,HMDB01043,9 (13),0.122,0.512,0.188,0.496
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,Reactome,3,TNFSF13B;TNFRSF13C;BIRC2,17 (17),0.0466,0.497,0,,0 (0),1,1,0.0466,0.497
SRF and miRs in Smooth Muscle Differentiation and Proliferation,Wikipathways,3,MEF2C;CAMK2D;CCND2,17 (17),0.0466,0.497,0,,0 (0),1,1,0.0466,0.497
Canonical and Non-Canonical TGF-B signaling,Wikipathways,3,BMPR1A;TGFBR1;LOX,17 (17),0.0466,0.497,0,,0 (0),1,1,0.0466,0.497
Syndecan-2-mediated signaling events,PID,5,MMP2;TNFRSF13B;CASP3;CASK;FGFR2,41 (41),0.0471,0.498,0,,0 (1),1,1,0.0471,0.498
Nucleotide-binding Oligomerization Domain (NOD) pathway,Wikipathways,5,CASP1;NLRP3;CARD6;IL18;PRDM1,41 (41),0.0471,0.498,0,,0 (0),1,1,0.0471,0.498
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,13,MAPK11;PAK1;MAPK13;CLDN7;TGFBR1;WNT10A;NRP2;PIK3CA;MPP5;AKT3;SPARC;MMP2;MAPK12,160 (160),0.0479,0.503,0,,0 (0),1,1,0.0479,0.503
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Reactome,1,GJA1,1 (1),0.0486,0.503,0,,0 (0),1,1,0.0486,0.503
dermatan sulfate biosynthesis,HumanCyc,1,CHPF,17 (17),0.571,1,1,HMDB00295,6 (8),0.0829,0.406,0.192,0.504
Amino acid transport across the plasma membrane,Reactome,1,SLC3A2,32 (32),0.797,1,2,HMDB00158;HMDB00159,28 (32),0.0595,0.374,0.192,0.504
SHC-mediated cascade:FGFR2,Reactome,1,FGFR2,23 (23),0.682,1,1,HMDB01201,5 (6),0.0695,0.374,0.192,0.504
Organelle biogenesis and maintenance,Reactome,14,MAPK11;BBS9;BBS10;CEP97;PRKAG2;TTC26;SDCCAG8;IFT22;IQCB1;EXOC2;MAPK12;ARF4;RAB11A;IFT81,240 (240),0.278,1,1,HMDB01201,13 (14),0.171,0.653,0.192,0.504
GPCR signaling-cholera toxin,INOH,10,PDGFA;WNT10A;ADORA2A;HGF;TNFSF10;CD80;BMP6;FGF11;IL10;IL18,270 (270),0.851,1,1,HMDB01201,4 (4),0.056,0.374,0.193,0.505
Cellular senescence - Homo sapiens (human),KEGG,13,MAPK11;MDM2;MAPK13;FOXO1;TGFBR1;RASSF5;PIK3CA;SQSTM1;PPP3CC;AKT3;MAPK12;ITPR2;CCND2,160 (160),0.0479,0.503,0,,4 (5),1,1,0.193,0.506
ErbB2/ErbB3 signaling events,PID,1,PIK3CA,40 (40),0.864,1,1,HMDB01201,4 (4),0.056,0.374,0.195,0.508
Synthesis of PG,Reactome,1,PLD2,9 (9),0.361,1,1,HMDB08048#HMDB08036#HMDB08038,10 (13),0.134,0.545,0.195,0.508
Signaling by FGFR2 fusions,Reactome,1,FGFR2,1 (1),0.0486,0.503,0,,2 (2),1,1,0.195,0.508
Signaling by FGFR2 amplification mutants,Reactome,1,FGFR2,1 (1),0.0486,0.503,0,,2 (6),1,1,0.195,0.508
ALKBH2 mediated reversal of alkylation damage,Reactome,1,ALKBH2,1 (1),0.0486,0.503,0,,7 (7),1,1,0.195,0.508
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Wikipathways,1,NLRP3,1 (1),0.0486,0.503,0,,4 (10),1,1,0.195,0.508
glutamine biosynthesis,HumanCyc,1,GLUL,1 (1),0.0486,0.503,0,,6 (7),1,1,0.195,0.508
The role of Nef in HIV-1 replication and disease pathogenesis,Reactome,4,AP1S2;PACS1;CD28;B2M,29 (29),0.0499,0.511,0,,0 (0),1,1,0.0499,0.511
PDGFR-beta pathway,Wikipathways,4,STAT1;PIK3CA;JAK1;PRKCA,29 (29),0.0499,0.511,0,,0 (0),1,1,0.0499,0.511
G alpha (z) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB01201,9 (10),0.122,0.512,0.122,0.512
Activation of NMDA receptors and postsynaptic events,Wikipathways,0,,0 (0),1,1,1,HMDB01201,9 (11),0.122,0.512,0.122,0.512
Collagen biosynthesis and modifying enzymes,Wikipathways,0,,0 (0),1,1,1,HMDB00295,9 (9),0.122,0.512,0.122,0.512
Integrin alphaIIb beta3 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB01201,9 (11),0.122,0.512,0.122,0.512
Macroautophagy,Wikipathways,0,,0 (0),1,1,1,HMDB01201,9 (11),0.122,0.512,0.122,0.512
Renal cell carcinoma - Homo sapiens (human),KEGG,7,BRAF;PAK1;HGF;AKT3;EPAS1;RAP1B;PIK3CA,69 (69),0.0494,0.51,0,,3 (3),1,1,0.198,0.514
FRS-mediated FGFR2 signaling,Reactome,1,FGFR2,25 (25),0.712,1,1,HMDB01201,5 (6),0.0695,0.374,0.198,0.514
Legionellosis - Homo sapiens (human),KEGG,6,CASP1;CASP3;CXCL3;CLK1;IL18;TLR5,55 (55),0.0495,0.51,0,,1 (2),1,1,0.198,0.514
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,1,HEXA,15 (15),0.526,1,1,HMDB11592#HMDB06750,7 (31),0.096,0.441,0.201,0.521
IL-2 Signaling Pathway,Wikipathways,5,STAT1;CISH;JAK1;CCND2;NMI,42 (42),0.0514,0.523,0,,0 (0),1,1,0.0514,0.523
Splicing factor NOVA regulated synaptic proteins,Wikipathways,5,MAP4;PLCB4;RAP1GAP;PRKCZ;CASK,42 (42),0.0514,0.523,0,,0 (0),1,1,0.0514,0.523
GPCR Dopamine D1like receptor,INOH,1,CACNA1S,50 (50),0.917,1,1,HMDB01201,4 (4),0.056,0.374,0.204,0.527
Ganglio Sphingolipid Metabolism,Wikipathways,1,FUT1,13 (13),0.477,1,1,HMDB11592#HMDB06750,8 (15),0.109,0.479,0.206,0.531
RIG-I-like receptor signaling pathway - Homo sapiens (human),KEGG,7,MAPK11;MAPK13;CYLD;CXCL10;DDX3X;TRIM25;MAPK12,70 (70),0.0527,0.531,0,,0 (0),1,1,0.0527,0.531
Prolactin,NetPath,7,CISH;JAK1;PAK1;PRLR;STAT1;RPS6KA2;TEC,70 (70),0.0527,0.531,0,,0 (0),1,1,0.0527,0.531
Beta5 beta6 beta7 and beta8 integrin cell surface interactions,PID,3,SDC1;TGFBR1;ITGB7,18 (18),0.054,0.531,0,,0 (2),1,1,0.054,0.531
CREB3 factors activate genes,Reactome,2,CREB3L2;CREBRF,8 (8),0.0543,0.531,0,,0 (0),1,1,0.0543,0.531
TRAIL  signaling,Reactome,2,CFLAR;TNFSF10,8 (8),0.0543,0.531,0,,0 (0),1,1,0.0543,0.531
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Reactome,2,ARHGEF6;LIMS1,8 (8),0.0543,0.531,0,,0 (0),1,1,0.0543,0.531
Nevirapine Metabolism Pathway,SMPDB,1,ALDH1A1,8 (8),0.329,1,1,HMDB00295,12 (13),0.159,0.616,0.207,0.532
Hepatocellular carcinoma - Homo sapiens (human),KEGG,9,PRKCA;BRAF;WNT10A;TGFBR1;HGF;AKT3;IGF1R;PLCG2;PIK3CA,168 (168),0.43,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,9 (14),0.122,0.512,0.207,0.533
Downstream signaling events of B Cell Receptor (BCR),Reactome,2,CARD11;RASGRP3,30 (30),0.432,1,1,HMDB01201,9 (10),0.122,0.512,0.207,0.534
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,Wikipathways,4,PIK3CA;FOXO1;RB1CC1;PIK3CG,30 (30),0.0555,0.535,0,,0 (0),1,1,0.0555,0.535
Ciliary landscape,Wikipathways,16,USH1C;DOCK5;BBS9;ARFGAP3;CEP97;CAMK2A;CNOT6L;TTC26;DDX5;IFT22;IQCB1;EXOC2;RMND5A;ARMC8;YPEL5;IFT81,213 (213),0.0555,0.535,0,,0 (0),1,1,0.0555,0.535
Salivary secretion - Homo sapiens (human),KEGG,6,ATP1B3;KCNN4;PRKCA;PLCB4;ITPR2;SLC12A2,90 (90),0.272,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,15 (17),0.195,0.719,0.209,0.536
Golgi Associated Vesicle Biogenesis,Reactome,2,AP1S2;TXNDC5,56 (56),0.763,1,1,HMDB01201,5 (5),0.0695,0.374,0.209,0.536
IL-6 signaling pathway,Wikipathways,5,NCOA1;STAT1;IRF1;JAK1;PRDM1,43 (43),0.056,0.537,0,,0 (0),1,1,0.056,0.537
Endoderm Differentiation,Wikipathways,7,LHX1;LAMC1;HHEX;BMPR1A;STAT1;TBX21;NR3C1,71 (71),0.0562,0.537,0,,0 (0),1,1,0.0562,0.537
Acyl chain remodelling of PE,Reactome,1,PLA2G12A,30 (30),0.776,1,1,HMDB08048#HMDB08036#HMDB08038,5 (13),0.0695,0.374,0.211,0.539
MET activates PTK2 signaling,Reactome,3,HGF;ITGA3;LAMC1,18 (18),0.054,0.531,0,,2 (2),1,1,0.212,0.539
Serotonin Neurotransmitter Release Cycle,Reactome,3,SYN3;UNC13B;STXBP1,18 (18),0.054,0.531,0,,1 (1),1,1,0.212,0.539
Propanoate metabolism,EHMN,3,EHHADH;ACSS1;ALDH7A1,18 (18),0.054,0.531,0,,29 (33),1,1,0.212,0.539
AOP CYP2E1 Activation Leading To Neurodegeneration,Wikipathways,2,ERN1;EIF2AK3,8 (8),0.0543,0.531,0,,11 (12),1,1,0.212,0.539
Riboflavin metabolism - Homo sapiens (human),KEGG,2,ACP5;ENPP1,8 (8),0.0543,0.531,0,,13 (20),1,1,0.212,0.539
ca-calmodulin-dependent protein kinase activation,BioCarta,2,CAMK2D;CAMK2A,8 (8),0.0543,0.531,0,,1 (1),1,1,0.212,0.539
ethanol degradation II,HumanCyc,2,ALDH3A2;ACSS1,8 (8),0.0543,0.531,0,,11 (12),1,1,0.212,0.539
Signal amplification,Reactome,1,GNG2,31 (31),0.787,1,1,HMDB01201,5 (5),0.0695,0.374,0.214,0.539
Alpha9 beta1 integrin signaling events,PID,2,BCAR1;ADAM8,25 (25),0.344,1,1,HMDB01201,12 (13),0.159,0.616,0.214,0.539
Protein ubiquitination,Reactome,1,RNF144A,80 (80),0.982,1,1,HMDB01201,4 (4),0.056,0.374,0.214,0.539
Signaling by FGFR3 point mutants in cancer,Reactome,1,PIK3CA,22 (22),0.666,1,1,HMDB01201,6 (16),0.0829,0.406,0.215,0.539
Signaling by FGFR3 in disease,Reactome,1,PIK3CA,22 (22),0.666,1,1,HMDB01201,6 (16),0.0829,0.406,0.215,0.539
Amine compound SLC transporters,Reactome,1,SLC44A1,30 (30),0.776,1,2,HMDB00158;HMDB00159,31 (35),0.0713,0.381,0.215,0.539
fmlp induced chemokine gene expression in hmc-1 cells,BioCarta,4,NCF2;PRKCA;PAK1;PPP3CC,30 (30),0.0555,0.535,0,,1 (3),1,1,0.216,0.539
FCERI mediated NF-kB activation,Reactome,1,CARD11,99 (99),0.993,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,4 (4),0.056,0.374,0.216,0.539
EPHB-mediated forward signaling,Reactome,2,PAK1;ARPC2,35 (35),0.512,1,1,HMDB01201,8 (9),0.109,0.479,0.217,0.539
Scavenging of heme from plasma,Reactome,0,,12 (12),1,1,1,HMDB00658#HMDB10370,4 (10),0.056,0.374,0.217,0.539
glycoaminoglycan-protein linkage region biosynthesis,HumanCyc,0,,7 (7),1,1,1,HMDB00295,4 (5),0.056,0.374,0.217,0.539
SLIT2:ROBO1 increases RHOA activity,Reactome,0,,4 (4),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
SHC1 events in ERBB4 signaling,Reactome,0,,14 (14),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
SHC1 events in EGFR signaling,Reactome,0,,8 (8),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
EPHA-mediated growth cone collapse,Reactome,0,,15 (15),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Scavenging by Class F Receptors,Reactome,0,,6 (6),1,1,1,HMDB00658#HMDB10370,4 (9),0.056,0.374,0.217,0.539
EPH-ephrin mediated repulsion of cells,Reactome,0,,8 (8),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Retrograde neurotrophin signalling,Reactome,0,,14 (14),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
regulation of spermatogenesis by crem,BioCarta,0,,10 (10),1,1,1,HMDB01201,4 (7),0.056,0.374,0.217,0.539
Activated NTRK2 signals through RAS,Reactome,0,,9 (9),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Activated NTRK2 signals through CDK5,Reactome,0,,6 (6),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Signaling by NTRK2 (TRKB),Reactome,0,,20 (20),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
N-glycan trimming and elongation in the cis-Golgi,Reactome,0,,5 (5),1,1,1,HMDB00295,4 (13),0.056,0.374,0.217,0.539
Adenylate cyclase inhibitory pathway,Reactome,0,,14 (14),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Arachidonate production from DAG,Reactome,0,,5 (5),1,1,1,HMDB01043,4 (8),0.056,0.374,0.217,0.539
Inhibition of adenylate cyclase pathway,Reactome,0,,14 (14),1,1,1,HMDB01201,4 (4),0.056,0.374,0.217,0.539
Composition of Lipid Particles,Wikipathways,0,,4 (4),1,1,1,HMDB00658#HMDB10370,4 (10),0.056,0.374,0.217,0.539
Glycerophospholipid biosynthesis,Wikipathways,0,,0 (0),1,1,2,HMDB10384;HMDB08048#HMDB08036#HMDB08038,44 (94),0.129,0.543,0.129,0.543
Signaling by NTRK1 (TRKA),Wikipathways,0,,0 (0),1,1,1,HMDB01201,10 (11),0.134,0.545,0.134,0.545
RAF-MAP kinase cascade,Wikipathways,0,,0 (0),1,1,1,HMDB01201,10 (17),0.134,0.545,0.134,0.545
HIV Life Cycle,Wikipathways,0,,0 (0),1,1,1,HMDB01201,10 (11),0.134,0.545,0.134,0.545
Response to elevated platelet cytosolic Ca2+,Wikipathways,0,,0 (0),1,1,1,HMDB01201,10 (11),0.134,0.545,0.134,0.545
Cytosolic sensors of pathogen-associated DNA,Wikipathways,0,,0 (0),1,1,1,HMDB01044,10 (14),0.134,0.545,0.134,0.545
Salmonella infection - Homo sapiens (human),KEGG,8,MAPK11;CASP1;MAPK13;CXCL3;TLR5;IL18;MAPK12;ARPC2,86 (86),0.057,0.544,0,,3 (4),1,1,0.22,0.546
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,3,PIK3CA;PRKCA;BTK,42 (42),0.334,1,1,HMDB01043,13 (13),0.171,0.653,0.221,0.547
Synthesis of 5-eicosatetraenoic acids,Reactome,1,PON3,9 (9),0.361,1,1,HMDB01043,12 (15),0.159,0.616,0.222,0.548
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,6,EMB;CP;SLC40A1;SLC39A4;SLC13A5;SLC44A1,86 (87),0.239,0.982,2,HMDB00158;HMDB00159,66 (78),0.243,0.863,0.223,0.552
Downstream signaling of activated FGFR3,Reactome,1,PIK3CA,25 (25),0.712,1,1,HMDB01201,6 (7),0.0829,0.406,0.226,0.557
Downstream TCR signaling,Reactome,2,CARD11;PIK3CA,51 (51),0.716,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,6 (8),0.0829,0.406,0.227,0.557
Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMPDB,0,,11 (11),1,1,2,HMDB00158;HMDB00159,28 (28),0.0595,0.374,0.227,0.557
Tyrosinemia Type 3 (TYRO3),SMPDB,0,,11 (11),1,1,2,HMDB00158;HMDB00159,28 (28),0.0595,0.374,0.227,0.557
Na+/Cl- dependent neurotransmitter transporters,Reactome,0,,19 (19),1,1,2,HMDB00158;HMDB00159,28 (31),0.0595,0.374,0.227,0.557
&gamma;-glutamyl cycle,HumanCyc,0,,12 (13),1,1,2,HMDB00158;HMDB00159,28 (29),0.0595,0.374,0.227,0.557
Phenylketonuria,SMPDB,0,,11 (11),1,1,2,HMDB00158;HMDB00159,28 (28),0.0595,0.374,0.227,0.557
Phenylalanine and Tyrosine Metabolism,SMPDB,0,,11 (11),1,1,2,HMDB00158;HMDB00159,28 (28),0.0595,0.374,0.227,0.557
Chagas disease (American trypanosomiasis) - Homo sapiens (human),KEGG,9,MAPK11;IL10;MAPK13;CFLAR;TGFBR1;PIK3CA;AKT3;PLCB4;MAPK12,102 (102),0.0596,0.563,0,,7 (7),1,1,0.228,0.557
trans-Golgi Network Vesicle Budding,Reactome,2,AP1S2;TXNDC5,72 (72),0.871,1,1,HMDB01201,5 (6),0.0695,0.374,0.23,0.563
Clathrin derived vesicle budding,Reactome,2,AP1S2;TXNDC5,72 (72),0.871,1,1,HMDB01201,5 (6),0.0695,0.374,0.23,0.563
Interleukin-3_ 5 and GM-CSF signaling,Reactome,5,IL5RA;BLNK;PIK3CA;JAK1;TEC,44 (44),0.0608,0.569,0,,2 (3),1,1,0.231,0.564
Factors involved in megakaryocyte development and platelet production,Reactome,7,MAFG;DOCK5;DOCK11;IRF1;IRF2;JMJD1C;KIF1B,131 (131),0.453,1,1,HMDB01201,10 (11),0.134,0.545,0.231,0.564
Downstream signaling of activated FGFR4,Reactome,1,PIK3CA,27 (27),0.74,1,1,HMDB01201,6 (7),0.0829,0.406,0.232,0.565
Lissencephaly gene (LIS1) in neuronal migration and development,PID,4,RELN;PAFAH1B3;NDEL1;CLIP1,31 (31),0.0614,0.569,0,,1 (1),1,1,0.233,0.565
Trafficking of AMPA receptors,Reactome,4,CAMK2D;PRKCA;CAMK2A;MDM2,31 (31),0.0614,0.569,0,,5 (6),1,1,0.233,0.565
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,4,CAMK2D;PRKCA;CAMK2A;MDM2,31 (31),0.0614,0.569,0,,7 (8),1,1,0.233,0.565
Serotonin Receptor 4-6-7 and NR3C Signaling,Wikipathways,3,BRAF;ATF1;NR3C1,19 (19),0.0619,0.569,0,,2 (2),1,1,0.234,0.567
Interleukin-12 family signaling,Reactome,3,JAK1;IL27;STAT1,19 (19),0.0619,0.569,0,,2 (2),1,1,0.234,0.567
Growth hormone receptor signaling,Reactome,3,STAT1;CISH;IRS2,19 (19),0.0619,0.569,0,,4 (4),1,1,0.234,0.567
FCERI mediated MAPK activation,Reactome,3,PLCG2;GRAP2;PAK1,109 (109),0.905,1,1,HMDB01201,5 (5),0.0695,0.374,0.237,0.573
Purine salvage,Reactome,0,,13 (13),1,1,2,HMDB01044;HMDB01397,29 (31),0.0633,0.374,0.238,0.576
heparan sulfate biosynthesis (late stages),HumanCyc,1,NDST1,22 (22),0.666,1,1,HMDB00295,7 (8),0.096,0.441,0.24,0.579
Quercetin and Nf-kB- AP-1 Induced Cell Apoptosis,Wikipathways,1,MAFG,15 (15),0.526,1,1,HMDB01043,9 (9),0.122,0.512,0.24,0.579
Response to elevated platelet cytosolic Ca2+,Reactome,7,PDGFA;SERPING1;PRKCA;CTSW;SPARC;HGF;STXBP3,134 (134),0.477,1,1,HMDB01201,10 (17),0.134,0.545,0.24,0.579
Biosynthesis of EPA-derived SPMs,Wikipathways,0,,0 (0),1,1,1,HMDB01999,11 (27),0.147,0.579,0.147,0.579
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,Wikipathways,0,,0 (0),1,1,1,HMDB01999,11 (27),0.147,0.579,0.147,0.579
DAG and IP3 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (12),0.147,0.579,0.147,0.579
Downstream signaling of activated FGFR1,Reactome,1,PIK3CA,31 (31),0.787,1,1,HMDB01201,6 (7),0.0829,0.406,0.243,0.586
Vitamin D Receptor Pathway,Wikipathways,14,IGFBP5;DNER;FOXO1;NINJ1;SATB1;IRF4;IRF5;BGLAP;CTLA4;ADAMTS5;CD200;STAM;BMP6;PRDM1,184 (184),0.0644,0.588,0,,0 (1),1,1,0.0644,0.588
miRNA regulation of prostate cancer signaling pathways,Wikipathways,5,AKT3;MDM2;PDGFA;FOXO1;PIK3CA,45 (45),0.0657,0.598,0,,1 (2),1,1,0.245,0.589
Glucagon signaling in metabolic regulation,Reactome,1,GNG2,33 (33),0.807,1,1,HMDB01201,6 (7),0.0829,0.406,0.248,0.594
Phenylalanine and tyrosine catabolism,Reactome,0,,13 (13),1,1,2,HMDB00158;HMDB00159,30 (31),0.0672,0.374,0.249,0.594
Valine Leucine Isoleucine degradation,INOH,4,ALDH1A1;ALDH3A2;EHHADH;ALDH7A1,32 (32),0.0676,0.599,0,,37 (40),1,1,0.25,0.594
Effects of Botulinum toxin,PID,2,UNC13B;STXBP1,9 (9),0.0676,0.599,0,,1 (2),1,1,0.25,0.594
AKT phosphorylates targets in the nucleus,Reactome,2,AKT3;FOXO1,9 (9),0.0676,0.599,0,,2 (2),1,1,0.25,0.594
reversal of insulin resistance by leptin,BioCarta,2,LEPR;PRKAG2,9 (9),0.0676,0.599,0,,2 (3),1,1,0.25,0.594
PI3K/AKT activation,Reactome,2,PIK3CA;IRS2,9 (9),0.0676,0.599,0,,3 (4),1,1,0.25,0.594
Interleukin-1 Induced Activation of NF-kappa-B,Wikipathways,2,SQSTM1;PRKCZ,9 (9),0.0676,0.599,0,,2 (2),1,1,0.25,0.594
Nuclear Envelope Breakdown,Reactome,2,PRKCA;LPIN1,51 (51),0.716,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (7),0.096,0.441,0.253,0.594
Eukaryotic Translation Initiation,Reactome,2,EIF4A2;EIF5,131 (133),0.989,1,1,HMDB01201,5 (6),0.0695,0.374,0.253,0.594
Cap-dependent Translation Initiation,Reactome,2,EIF4A2;EIF5,131 (133),0.989,1,1,HMDB01201,5 (6),0.0695,0.374,0.253,0.594
Gene Silencing by RNA,Reactome,1,AGO4,133 (134),0.999,1,1,HMDB01201,5 (8),0.0695,0.374,0.255,0.594
Mitochondrial translation initiation,Reactome,0,,88 (89),1,1,1,HMDB01201,5 (8),0.0695,0.374,0.255,0.594
FRS-mediated FGFR4 signaling,Reactome,0,,22 (22),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
SHC-mediated cascade:FGFR4,Reactome,0,,20 (20),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
Mitochondrial translation,Reactome,0,,94 (95),1,1,1,HMDB01201,5 (47),0.0695,0.374,0.255,0.594
FGFR3 ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB00295,5 (5),0.0695,0.374,0.255,0.594
Synthesis of PS,Reactome,0,,2 (2),1,1,1,HMDB08048#HMDB08036#HMDB08038,5 (6),0.0695,0.374,0.255,0.594
P2Y receptors,Reactome,0,,12 (12),1,1,1,HMDB00295,5 (6),0.0695,0.374,0.255,0.594
SHC-mediated cascade:FGFR3,Reactome,0,,18 (18),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
aspirin-triggered lipoxin biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB01043,5 (9),0.0695,0.374,0.255,0.594
how progesterone initiates the oocyte maturation,BioCarta,0,,23 (23),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
LDL clearance,Reactome,0,,19 (19),1,1,1,HMDB00658#HMDB10370,5 (9),0.0695,0.374,0.255,0.594
Plasma lipoprotein clearance,Reactome,0,,33 (33),1,1,1,HMDB00658#HMDB10370,5 (9),0.0695,0.374,0.255,0.594
Platelet sensitization by LDL,Reactome,0,,17 (17),1,1,1,HMDB00658#HMDB10370,5 (6),0.0695,0.374,0.255,0.594
FRS-mediated FGFR1 signaling,Reactome,0,,23 (23),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
Lactose synthesis,Reactome,0,,3 (3),1,1,1,HMDB00295,5 (6),0.0695,0.374,0.255,0.594
FGFR3c ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB00295,5 (5),0.0695,0.374,0.255,0.594
Ceramide signalling,Reactome,0,,3 (3),1,1,1,HMDB04951,5 (5),0.0695,0.374,0.255,0.594
Pre-NOTCH Processing in Golgi,Reactome,0,,12 (12),1,1,1,HMDB00295,5 (5),0.0695,0.374,0.255,0.594
FRS-mediated FGFR3 signaling,Reactome,0,,20 (20),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,0,,30 (30),1,1,1,HMDB00295,5 (8),0.0695,0.374,0.255,0.594
SHC-mediated cascade:FGFR1,Reactome,0,,21 (21),1,1,1,HMDB01201,5 (5),0.0695,0.374,0.255,0.594
Demo complete,Wikipathways,0,,6 (6),1,1,1,HMDB00658#HMDB10370,5 (5),0.0695,0.374,0.255,0.594
Insulin signaling pathway - Homo sapiens (human),KEGG,11,BRAF;FOXO1;RHOQ;PIK3CA;PYGL;AKT3;IRS2;PRKCZ;MKNK1;INSR;PRKAG2,137 (137),0.0697,0.613,0,,3 (4),1,1,0.255,0.595
Valproic acid pathway,Wikipathways,1,EHHADH,13 (13),0.477,1,1,HMDB00295,11 (11),0.147,0.579,0.256,0.596
D-<i>myo</i>-inositol-5-phosphate metabolism,HumanCyc,3,PLCG2;PLCD3;PLCB4,20 (20),0.0703,0.613,0,,6 (8),1,1,0.257,0.597
Regulation of TP53 Activity through Methylation,Reactome,3,MDM2;JMY;MDM4,20 (20),0.0703,0.613,0,,4 (4),1,1,0.257,0.597
Herpes simplex infection - Homo sapiens (human),KEGG,14,JAK1;CLOCK;PILRA;CD74;TAP1;EIF2AK3;OAS3;HMGN1;SP100;STAT1;RNASEL;CASP3;HCFC2;SRSF5,185 (185),0.0667,0.599,0,,0 (0),1,1,0.0667,0.599
Type II diabetes mellitus - Homo sapiens (human),KEGG,5,CACNA1E;PIK3CA;INSR;IRS2;PRKCZ,46 (46),0.071,0.618,0,,5 (6),1,1,0.259,0.599
GABA B receptor activation,Reactome,1,GNG2,39 (39),0.857,1,1,HMDB01201,6 (6),0.0829,0.406,0.259,0.599
Activation of GABAB receptors,Reactome,1,GNG2,39 (39),0.857,1,1,HMDB01201,6 (6),0.0829,0.406,0.259,0.599
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Reactome,0,,13 (13),1,1,2,HMDB01388;HMDB00673,31 (42),0.0713,0.381,0.259,0.599
Fatty Acid Biosynthesis,SMPDB,0,,2 (2),1,1,2,HMDB00220;HMDB00806,31 (31),0.0713,0.381,0.259,0.599
mTOR signalling,Reactome,2,RRAGD;PRKAG2,40 (41),0.585,1,1,HMDB01201,9 (9),0.122,0.512,0.259,0.599
Pancreatic cancer - Homo sapiens (human),KEGG,7,BRAF;JAK1;TGFBR1;PIK3CA;AKT3;ARHGEF6;STAT1,75 (75),0.0713,0.619,0,,2 (2),1,1,0.259,0.599
Cushing syndrome - Homo sapiens (human),KEGG,12,BRAF;WNT10A;KMT2A;CACNA1S;CAMK2A;CACNA1H;CAMK2D;ATF4;RAP1B;PLCB4;CREB3L2;ITPR2,154 (154),0.0718,0.623,0,,13 (14),1,1,0.261,0.6
Beta Oxidation of Very Long Chain Fatty Acids,SMPDB,1,ABCD2,10 (10),0.392,1,1,HMDB02003,14 (14),0.183,0.686,0.261,0.6
Adrenoleukodystrophy_ X-linked,SMPDB,1,ABCD2,10 (10),0.392,1,1,HMDB02003,14 (14),0.183,0.686,0.261,0.6
Carnitine-acylcarnitine translocase deficiency,SMPDB,1,ABCD2,10 (10),0.392,1,1,HMDB02003,14 (14),0.183,0.686,0.261,0.6
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,2,TBXAS1;PTGIS,16 (16),0.181,0.867,1,HMDB01043,36 (43),0.407,1,0.266,0.608
Sialuria or French Type Sialuria,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
Sialuria or French Type Sialuria,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
Amino Sugar Metabolism,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
Tay-Sachs Disease,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,2,HEXA;GFPT1,17 (17),0.199,0.916,1,HMDB00295,32 (32),0.371,1,0.266,0.608
Irinotecan Action Pathway,SMPDB,1,PDIA4,23 (23),0.682,1,1,HMDB00295,8 (12),0.109,0.479,0.268,0.61
Irinotecan Metabolism Pathway,SMPDB,1,PDIA4,23 (23),0.682,1,1,HMDB00295,8 (12),0.109,0.479,0.268,0.61
Hepatitis C - Homo sapiens (human),KEGG,12,BRAF;EIF2AK3;JAK1;CFLAR;PIK3CA;CXCL10;OAS3;AKT3;STAT1;CLDN7;RNASEL;CASP3,155 (155),0.0745,0.64,0,,1 (2),1,1,0.268,0.61
Myometrial Relaxation and Contraction Pathways,Wikipathways,12,IGFBP5;GJA1;PRKCA;CAMK2A;CAMK2D;ATF1;ATF4;GRK5;PRKCZ;PLCG2;GNG2;ITPR2,155 (155),0.0745,0.64,0,,4 (4),1,1,0.268,0.61
Glycerolipid metabolism - Homo sapiens (human),KEGG,6,ALDH3A2;LPIN1;PNPLA2;DGKH;ALDH7A1;AGPAT4,61 (61),0.0747,0.64,0,,12 (36),1,1,0.269,0.611
TYROBP Causal Network,Wikipathways,6,CD84;IL18;TGFBR1;NCF2;APBB1IP;CREB3L2,60 (60),0.0701,0.613,0,,0 (0),1,1,0.0701,0.613
<i>S</i>-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,0,,4 (4),1,1,2,HMDB00158;HMDB00159,32 (35),0.0753,0.403,0.27,0.614
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Reactome,7,ITGAL;PILRA;ITGB7;CD96;B2M;CD200;SLAMF7,218 (221),0.91,1,1,HMDB04951,6 (19),0.0829,0.406,0.27,0.614
Cocaine addiction - Homo sapiens (human),KEGG,2,CREB3L2;ATF4,49 (49),0.695,1,1,HMDB00158,8 (8),0.109,0.479,0.271,0.615
Mineral absorption - Homo sapiens (human),KEGG,4,SLC46A1;SLC40A1;SLC39A4;ATP1B3,51 (51),0.234,0.967,1,HMDB00159,27 (29),0.324,1,0.271,0.615
Regulation of actin dynamics for phagocytic cup formation,Reactome,4,ABI2;PAK1;ARPC2;BTK,141 (141),0.916,1,1,HMDB01201,6 (12),0.0829,0.406,0.272,0.615
Signaling by the B Cell Receptor (BCR),Wikipathways,0,,0 (0),1,1,1,HMDB01201,12 (15),0.159,0.616,0.159,0.616
Endothelin Pathways,Wikipathways,2,PRKCA;EDNRA,33 (33),0.481,1,1,HMDB01043,12 (12),0.159,0.616,0.273,0.618
Translocation of GLUT4 to the plasma membrane,Reactome,1,PRKAG2,32 (32),0.797,1,1,HMDB01201,7 (7),0.096,0.441,0.273,0.618
CLEC7A (Dectin-1) signaling,Reactome,2,PLCG2;ITPR2,40 (40),0.585,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,10 (12),0.134,0.545,0.279,0.629
Nicotine Activity on Dopaminergic Neurons,Wikipathways,1,GNG2,21 (21),0.649,1,1,HMDB00158,9 (9),0.122,0.512,0.28,0.631
CTLA4 inhibitory signaling,Reactome,3,AKT3;CD80;CTLA4,21 (21),0.0792,0.666,0,,4 (4),1,1,0.28,0.631
Negative regulation of MET activity,Reactome,3,HGF;STAM;LRIG1,21 (21),0.0792,0.666,0,,4 (4),1,1,0.28,0.631
Interleukin-1 family signaling,Reactome,7,CASP1;PELI1;IRAK3;SQSTM1;IL18BP;IL18;MAP3K3,77 (77),0.0796,0.668,0,,2 (8),1,1,0.281,0.633
CD40/CD40L signaling,PID,4,MAPK11;BIRC2;PIK3CA;PIK3CG,34 (34),0.0809,0.668,0,,1 (1),1,1,0.284,0.638
Signaling by high-kinase activity BRAF mutants,Reactome,4,BRAF;RAP1B;PEBP1;APBB1IP,34 (34),0.0809,0.668,0,,6 (11),1,1,0.284,0.638
Melatonin metabolism and effects,Wikipathways,4,PRKCA;CLOCK;FOXO1;CAMK2A,34 (34),0.0809,0.668,0,,13 (15),1,1,0.284,0.638
Hyaluronan uptake and degradation,Reactome,2,HEXA;LYVE1,10 (10),0.0818,0.668,0,,5 (6),1,1,0.287,0.638
IRE1alpha activates chaperones,Reactome,2,ERN1;SERP1,10 (10),0.0818,0.668,0,,4 (4),1,1,0.287,0.638
Signal attenuation,Reactome,2,INSR;IRS2,10 (10),0.0818,0.668,0,,1 (1),1,1,0.287,0.638
Netrin mediated repulsion signals,Reactome,2,UNC5B;DCC,10 (10),0.0818,0.668,0,,2 (2),1,1,0.287,0.638
Phototransduction - Homo sapiens (human),KEGG,1,PDE6A,28 (28),0.752,1,1,HMDB01397,8 (8),0.109,0.479,0.287,0.638
Notch-mediated HES/HEY network,PID,5,BGLAP;CAMK2D;NCOR1;NCOA1;MAML2,48 (48),0.082,0.668,0,,3 (3),1,1,0.287,0.638
Nicotine Pathway (Dopaminergic Neuron)_ Pharmacodynamics,PharmGKB,5,STX7;VAMP4;GNG2;STX17;STX16,48 (48),0.082,0.668,0,,1 (1),1,1,0.287,0.638
Oocyte meiosis - Homo sapiens (human),KEGG,10,CPEB3;CAMK2A;PTTG1;CAMK2D;RPS6KA2;RPS6KA3;IGF1R;MAPK12;ITPR2;PPP3CC,125 (125),0.0827,0.672,0,,4 (4),1,1,0.289,0.638
COX reactions,Reactome,0,,1 (1),1,1,1,HMDB01043,6 (8),0.0829,0.406,0.289,0.638
Insulin effects increased synthesis of Xylulose-5-Phosphate,Reactome,0,,2 (2),1,1,1,HMDB00618#HMDB01548,6 (8),0.0829,0.406,0.289,0.638
Eukaryotic Translation Termination,Reactome,0,,103 (104),1,1,1,HMDB01201,6 (10),0.0829,0.406,0.289,0.638
guanosine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,12 (12),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.289,0.638
cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,BioCarta,0,,22 (22),1,1,1,HMDB01201,6 (7),0.0829,0.406,0.289,0.638
Influenza Life Cycle,Reactome,0,,53 (53),1,1,1,HMDB01201,6 (9),0.0829,0.406,0.289,0.638
Sema4D mediated inhibition of cell attachment and migration,Reactome,0,,8 (8),1,1,1,HMDB01201,6 (6),0.0829,0.406,0.289,0.638
Influenza Infection,Reactome,0,,63 (63),1,1,1,HMDB01201,6 (9),0.0829,0.406,0.289,0.638
Signaling by ROBO receptors,Wikipathways,0,,4 (4),1,1,1,HMDB01201,6 (8),0.0829,0.406,0.289,0.638
Signaling by ERBB4,Wikipathways,0,,5 (5),1,1,1,HMDB01201,6 (8),0.0829,0.406,0.289,0.638
regulation of ck1/cdk5 by type 1 glutamate receptors,BioCarta,0,,24 (24),1,1,1,HMDB01201,6 (7),0.0829,0.406,0.289,0.638
Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,1,GNG2,40 (40),0.864,1,1,HMDB01201,7 (7),0.096,0.441,0.289,0.638
Angiogenesis overview,Wikipathways,6,MAPK11;PAK1;PRKCA;BMX;MMP2;NRP1,61 (61),0.0747,0.64,0,,0 (0),1,1,0.0747,0.64
Hypoacetylaspartia,SMPDB,0,,14 (14),1,1,2,HMDB00536;HMDB01201,34 (34),0.0837,0.409,0.291,0.641
Aspartate Metabolism,SMPDB,0,,14 (14),1,1,2,HMDB00536;HMDB01201,34 (34),0.0837,0.409,0.291,0.641
Canavan Disease,SMPDB,0,,14 (14),1,1,2,HMDB00536;HMDB01201,34 (34),0.0837,0.409,0.291,0.641
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,5,SLC12A4;SLC26A11;SLC9A9;SLC3A2;SLC12A2,105 (105),0.582,1,2,HMDB00158;HMDB00159,47 (56),0.144,0.579,0.292,0.641
TLR p38,INOH,6,MAPK11;PSMB9;MAPK13;PSMA3;LY96;MAPK12,63 (63),0.0845,0.682,0,,1 (1),1,1,0.293,0.643
MECP2 and Associated Rett Syndrome,Wikipathways,6,FUT8;TAP1;NCOR1;SGK1;CAMK2A;MEF2C,63 (63),0.0845,0.682,0,,7 (8),1,1,0.293,0.643
Leptin signaling pathway,Wikipathways,7,CISH;FOXO1;NCOA1;LEPR;STAT1;PLCG2;JAK1,76 (76),0.0754,0.643,0,,0 (0),1,1,0.0754,0.643
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human),KEGG,11,MAPK11;SKIL;MAPK13;JAK1;WNT10A;PIK3CA;AKT3;BMPR1A;FGFR2;IGF1R;MAPK12,139 (139),0.0755,0.643,0,,0 (0),1,1,0.0755,0.643
Direct p53 effectors,PID,11,MDM2;CASP1;TAP1;IRF5;JMY;DDX5;MMP2;RCHY1;NDRG1;HGF;PRDM1,142 (143),0.0849,0.685,0,,1 (1),1,1,0.294,0.645
Energy Metabolism,Wikipathways,5,MEF2C;NCOA1;FOXO1;PPP3CC;PRKAG2,47 (47),0.0764,0.648,0,,0 (1),1,1,0.0764,0.648
Triglyceride biosynthesis,Reactome,1,LPIN1,14 (14),0.502,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,13 (18),0.171,0.653,0.297,0.65
ABC-family proteins mediated transport,Wikipathways,0,,0 (0),1,1,1,HMDB08048#HMDB08036#HMDB08038,13 (22),0.171,0.653,0.171,0.653
Arachidonic acid metabolism - Homo sapiens (human),KEGG,4,PTGIS;PLA2G12A;TBXAS1;ALOX12,63 (63),0.366,1,2,HMDB01043;HMDB08048#HMDB08036#HMDB08038,65 (75),0.238,0.85,0.3,0.656
N-Glycan biosynthesis - Homo sapiens (human),KEGG,5,DPM3;ST6GAL1;FUT8;MAN1B1;MGAT4A,49 (49),0.0879,0.697,0,,9 (36),1,1,0.302,0.658
Malaria - Homo sapiens (human),KEGG,5,SDC1;IL10;ITGAL;HGF;IL18,49 (49),0.0879,0.697,0,,3 (5),1,1,0.302,0.658
Platelet Aggregation Inhibitor Pathway_ Pharmacodynamics,PharmGKB,5,PLCG2;COL3A1;TBXAS1;COL1A1;COL1A2,49 (49),0.0879,0.697,0,,2 (5),1,1,0.302,0.658
PDGFR-alpha signaling pathway,PID,3,PDGFRA;PIK3CA;JAK1,22 (22),0.0885,0.697,0,,2 (2),1,1,0.303,0.66
Nanoparticle triggered autophagic cell death,Wikipathways,3,INSR;SH3GLB1;ATG7,22 (22),0.0885,0.697,0,,1 (1),1,1,0.303,0.66
PI3K-AKT-mTOR - VitD3 Signalling,Wikipathways,3,PIK3CA;IL10;CD80,22 (22),0.0885,0.697,0,,7 (8),1,1,0.303,0.66
FCERI mediated Ca+2 mobilization,Reactome,5,PLCG2;GRAP2;ITPR2;TEC;BTK,108 (108),0.607,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,11 (12),0.147,0.579,0.305,0.663
Cortisol synthesis and secretion - Homo sapiens (human),KEGG,6,CACNA1S;CACNA1H;ATF4;PLCB4;CREB3L2;ITPR2,64 (64),0.0896,0.698,0,,13 (13),1,1,0.306,0.664
GABA receptor activation,Reactome,1,GNG2,55 (55),0.936,1,1,HMDB01201,7 (7),0.096,0.441,0.306,0.665
Neovascularisation processes,Wikipathways,3,CXCR4;FLT4;TGFBR1,21 (21),0.0792,0.666,0,,0 (0),1,1,0.0792,0.666
ion channels and their functional role in vascular endothelium,BioCarta,2,CXCR4;EDNRA,47 (47),0.673,1,1,HMDB01201,10 (11),0.134,0.545,0.308,0.668
SNARE interactions in vesicular transport - Homo sapiens (human),KEGG,4,STX7;VAMP4;STX16;STX17,34 (34),0.0809,0.668,0,,0 (0),1,1,0.0809,0.668
Signaling of Hepatocyte Growth Factor Receptor,Wikipathways,4,PIK3CA;RAP1B;PAK1;HGF,34 (34),0.0809,0.668,0,,0 (0),1,1,0.0809,0.668
ifn alpha signaling pathway,BioCarta,2,JAK1;STAT1,10 (10),0.0818,0.668,0,,0 (1),1,1,0.0818,0.668
IL-13 signaling,INOH,2,JAK1;IRS2,10 (10),0.0818,0.668,0,,0 (0),1,1,0.0818,0.668
Type III interferon signaling,Wikipathways,2,STAT1;JAK1,10 (10),0.0818,0.668,0,,0 (0),1,1,0.0818,0.668
Ibuprofen Metabolism Pathway,SMPDB,1,PDIA4,23 (23),0.682,1,1,HMDB00295,10 (11),0.134,0.545,0.311,0.672
Platelet degranulation ,Reactome,5,SERPING1;CTSW;HGF;PDGFA;SPARC,129 (129),0.757,1,1,HMDB01201,9 (15),0.122,0.512,0.312,0.672
Class I MHC mediated antigen processing & presentation,Reactome,16,FBXL20;RNF34;ATG7;RCHY1;MRC1;TAP1;HERC4;BTK;NCF2;TRIM39;CTSS;B2M;MKRN1;KLHL25;LY96;ASB13,323 (324),0.504,1,1,HMDB01201,14 (24),0.183,0.686,0.312,0.672
heparan sulfate biosynthesis,HumanCyc,1,NDST1,29 (29),0.764,1,1,HMDB00295,9 (10),0.122,0.512,0.314,0.672
TNFR2 non-canonical NF-kB pathway,Reactome,5,TNFRSF17;TNFSF13B;TNFRSF13C;TNFRSF13B;BIRC2,50 (50),0.094,0.698,0,,2 (3),1,1,0.316,0.672
RHO GTPases Activate Formins,Reactome,2,CLIP1;NDEL1,123 (123),0.984,1,1,HMDB01201,7 (7),0.096,0.441,0.317,0.672
histamine degradation,HumanCyc,1,HNMT,2 (2),0.0948,0.698,0,,12 (13),1,1,0.318,0.672
lipoate salvage,HumanCyc,1,LIPT1,2 (2),0.0948,0.698,0,,4 (6),1,1,0.318,0.672
NAD phosphorylation and dephosphorylation,HumanCyc,1,NADK,2 (2),0.0948,0.698,0,,6 (7),1,1,0.318,0.672
choline degradation,HumanCyc,1,ALDH7A1,2 (2),0.0948,0.698,0,,6 (7),1,1,0.318,0.672
Sterols are 12-hydroxylated by CYP8B1,Reactome,1,PTGIS,2 (2),0.0948,0.698,0,,6 (10),1,1,0.318,0.672
Stimulation of the cell death response by PAK-2p34,Reactome,1,CASP3,2 (2),0.0948,0.698,0,,2 (2),1,1,0.318,0.672
Biosynthesis of DPAn-6 SPMs,Reactome,1,ALOX12,2 (2),0.0948,0.698,0,,3 (6),1,1,0.318,0.672
D-<i>myo</i>-inositol (3_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,IPMK,2 (2),0.0948,0.698,0,,8 (9),1,1,0.318,0.672
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA,HumanCyc,1,DHTKD1,2 (2),0.0948,0.698,0,,11 (12),1,1,0.318,0.672
phytol degradation,HumanCyc,1,ALDH3A2,2 (2),0.0948,0.698,0,,11 (14),1,1,0.318,0.672
Prednisolone Action Pathway,SMPDB,1,NR3C1,2 (2),0.0948,0.698,0,,1 (1),1,1,0.318,0.672
Prednisolone Metabolism Pathway,SMPDB,1,NR3C1,2 (2),0.0948,0.698,0,,1 (1),1,1,0.318,0.672
Biosynthesis of DPAn-3-derived maresins,Reactome,1,ALOX12,2 (2),0.0948,0.698,0,,6 (12),1,1,0.318,0.672
Renin secretion - Homo sapiens (human),KEGG,6,CACNA1S;PPP3CC;PDE1A;PLCB4;EDNRA;ITPR2,65 (65),0.0949,0.698,0,,16 (21),1,1,0.318,0.672
Target Of Rapamycin (TOR) Signaling,Wikipathways,4,RRAGD;PRKCA;PRKAG2;PRR5,36 (36),0.0954,0.698,0,,1 (1),1,1,0.319,0.672
Signaling by RAS mutants,Reactome,4,BRAF;RAP1B;PEBP1;APBB1IP,36 (36),0.0954,0.698,0,,6 (8),1,1,0.319,0.672
Fibrin Complement Receptor 3 Signaling Pathway,Wikipathways,4,CXCL3;LY96;CXCL10;RASSF5,36 (36),0.0954,0.698,0,,1 (2),1,1,0.319,0.672
EPH-Ephrin signaling,Reactome,2,PAK1;ARPC2,74 (74),0.881,1,1,HMDB01201,8 (9),0.109,0.479,0.321,0.672
Signaling by PTK6,Wikipathways,0,,2 (2),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Cholesterol metabolism - Homo sapiens (human),KEGG,0,,50 (50),1,1,1,HMDB00658#HMDB10370,7 (10),0.096,0.441,0.321,0.672
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,SMPDB,0,,10 (10),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
phosphatidylcholine biosynthesis pathway,BioCarta,0,,3 (3),1,1,1,HMDB08048#HMDB08036#HMDB08038,7 (8),0.096,0.441,0.321,0.672
tRNA processing in the nucleus,Reactome,0,,57 (57),1,1,1,HMDB01201,7 (10),0.096,0.441,0.321,0.672
guanine and guanosine salvage,HumanCyc,0,,2 (2),1,1,1,HMDB01397,7 (7),0.096,0.441,0.321,0.672
RHO GTPases Activate Formins,Wikipathways,0,,1 (1),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Adenylate cyclase activating pathway,Reactome,0,,10 (10),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Corticotropin Activation of Cortisol Production,SMPDB,0,,7 (7),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
L-dopachrome biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00158,7 (8),0.096,0.441,0.321,0.672
Vasopressin Regulation of Water Homeostasis,SMPDB,0,,7 (7),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Scavenging by Class B Receptors,Reactome,0,,6 (6),1,1,1,HMDB00658#HMDB10370,7 (15),0.096,0.441,0.321,0.672
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,SMPDB,0,,10 (10),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Dopamine Activation of Neurological Reward System,SMPDB,0,,6 (6),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
HIF1A and PPARG regulation of glycolysis,Wikipathways,0,,8 (8),1,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,7 (10),0.096,0.441,0.321,0.672
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,SMPDB,0,,6 (6),1,1,1,HMDB01201,7 (7),0.096,0.441,0.321,0.672
Ion channel transport,Reactome,13,ATP11B;ATP1B3;CAMK2D;SGK1;CAMK2A;ATP6V1E1;ATP11A;ATP8B2;ATP6V0A1;ATP2C1;ANO10;MCOLN2;ATP9A,179 (179),0.0962,0.698,0,,17 (24),1,1,0.321,0.672
Vitamin A Deficiency,SMPDB,3,ALDH1A1;PDIA4;RDH12,37 (37),0.267,1,1,HMDB08048#HMDB08036#HMDB08038,31 (31),0.362,1,0.322,0.672
Retinol Metabolism,SMPDB,3,ALDH1A1;PDIA4;RDH12,37 (37),0.267,1,1,HMDB08048#HMDB08036#HMDB08038,31 (31),0.362,1,0.322,0.672
Transcriptional regulation by RUNX2,Wikipathways,2,BGLAP;COL1A1,11 (11),0.0969,0.698,0,,7 (8),1,1,0.323,0.672
Hh mutants that don_t undergo autocatalytic processing are degraded by ERAD,Reactome,2,SEL1L;SYVN1,11 (11),0.0969,0.698,0,,4 (4),1,1,0.323,0.672
Signaling by Leptin,Reactome,2,LEPR;IRS2,11 (11),0.0969,0.698,0,,2 (3),1,1,0.323,0.672
Synthesis of PIPs at the late endosome membrane,Reactome,2,PIKFYVE;FIG4,11 (11),0.0969,0.698,0,,9 (12),1,1,0.323,0.672
Hh mutants abrogate ligand secretion,Reactome,2,SEL1L;SYVN1,11 (11),0.0969,0.698,0,,4 (4),1,1,0.323,0.672
Interleukin-6 signaling,Reactome,2,JAK1;STAT1,11 (11),0.0969,0.698,0,,2 (2),1,1,0.323,0.672
NAD metabolism_ sirtuins and aging,Wikipathways,2,FOXO1;NAMPT,11 (11),0.0969,0.698,0,,3 (4),1,1,0.323,0.672
serotonin degradation,HumanCyc,1,ALDH3A2,14 (15),0.502,1,1,HMDB00295,15 (20),0.195,0.719,0.325,0.675
Folate metabolism,INOH,1,PTS,31 (31),0.787,1,2,HMDB01201;HMDB01397,43 (46),0.125,0.524,0.326,0.675
Histidine metabolism - Homo sapiens (human),KEGG,3,ALDH3A2;HNMT;ALDH7A1,23 (23),0.0983,0.698,0,,32 (47),1,1,0.326,0.675
Canonical NF-kappaB pathway,PID,3,BIRC2;PRKCA;CYLD,23 (23),0.0983,0.698,0,,1 (1),1,1,0.326,0.675
Negative regulators of DDX58/IFIH1 signaling,Reactome,3,TRIM25;NLRC5;TAX1BP1,23 (23),0.0983,0.698,0,,2 (2),1,1,0.326,0.675
Regulation of TNFR1 signaling,Reactome,3,BIRC2;CYLD;TAX1BP1,23 (23),0.0983,0.698,0,,2 (2),1,1,0.326,0.675
Nephrin family interactions,Reactome,3,PIK3CA;CASK;CD2AP,23 (23),0.0983,0.698,0,,2 (2),1,1,0.326,0.675
stearate biosynthesis,HumanCyc,1,ACOT7,13 (13),0.477,1,1,HMDB00220,16 (17),0.206,0.755,0.327,0.675
G alpha (z) signalling events,Reactome,2,PRKCA;GNG2,47 (47),0.673,1,1,HMDB01201,11 (12),0.147,0.579,0.327,0.676
Cellular responses to external stimuli,Reactome,18,RRAGD;MDM2;MDM4;ATG7;WDR45;MAPK11;AGO4;CAMK2A;NCF2;CAMK2D;EPAS1;RPS6KA2;RPS6KA3;HMGA2;NR3C1;RB1CC1;PRKAG2;MAP1LC3B,413 (414),0.717,1,2,HMDB01201;HMDB01397,46 (57),0.139,0.563,0.33,0.68
Integrated Breast Cancer Pathway,Wikipathways,6,CASP3;MYCBP2;DHTKD1;BMPR1A;RASGRP3;FOXO1,66 (66),0.1,0.703,0,,9 (20),1,1,0.331,0.683
Class I MHC mediated antigen processing & presentation,Wikipathways,0,,0 (0),1,1,1,HMDB01201,14 (24),0.183,0.686,0.183,0.686
Alanine Aspartate Asparagine metabolism,INOH,0,,25 (25),1,1,2,HMDB00536;HMDB01201,38 (45),0.101,0.465,0.333,0.686
Lamivudine Metabolism Pathway,SMPDB,1,CMPK1,18 (18),0.592,1,1,HMDB00295,13 (13),0.171,0.653,0.333,0.686
Signaling by Rho GTPases,Reactome,23,RHOQ;ARHGAP6;ARHGAP32;ARHGAP24;NDEL1;RHOBTB1;RHPN2;FGD4;KDM4C;ARHGAP31;SRGAP1;PPP1R12A;ARHGAP12;BTK;PAK1;ARHGEF12;NCF2;ARHGEF11;CLIP1;ABI2;ARHGEF6;TIAM2;ARPC2,430 (435),0.346,1,1,HMDB01201,24 (27),0.293,1,0.334,0.686
PTEN Regulation,Reactome,4,MKRN1;RRAGD;AGO4;AKT3,96 (96),0.692,1,1,HMDB01201,11 (11),0.147,0.579,0.334,0.686
Wnt Signaling,Wikipathways,9,WNT10A;PRKCA;CAMK2A;CAMK2D;RYK;PLCB4;PPP3CC;CCND2;GPC4,114 (114),0.102,0.714,0,,1 (1),1,1,0.336,0.69
Inactivation_ recovery and regulation of the phototransduction cascade,Reactome,2,PDE6A;PRKCA,34 (34),0.497,1,1,HMDB01201,16 (18),0.206,0.755,0.336,0.69
TNF signaling,Reactome,4,SMPD3;BIRC2;CYLD;TAX1BP1,37 (37),0.103,0.714,0,,3 (3),1,1,0.337,0.691
purine nucleotides degradation,HumanCyc,1,XDH,12 (12),0.45,1,1,HMDB01397,18 (19),0.229,0.82,0.337,0.691
Regulation of PTEN gene transcription,Reactome,1,RRAGD,62 (62),0.955,1,1,HMDB01201,8 (8),0.109,0.479,0.339,0.695
Nitric oxide stimulates guanylate cyclase,Reactome,1,PDE1A,25 (25),0.712,1,1,HMDB01397,11 (11),0.147,0.579,0.341,0.697
Measles - Homo sapiens (human),KEGG,10,JAK1;TNFSF10;CD28;PIK3CA;EIF2AK3;OAS3;AKT3;STAT1;RCHY1;CCND2,131 (132),0.105,0.723,0,,1 (1),1,1,0.341,0.697
Sialic acid metabolism,Reactome,2,ST6GAL1;ST8SIA6,33 (33),0.481,1,1,HMDB00295,17 (27),0.218,0.788,0.341,0.697
Circadian Clock,Reactome,4,NR1D1;NCOR1;NAMPT;CLOCK,35 (35),0.088,0.697,0,,0 (2),1,1,0.088,0.697
O-linked glycosylation of mucins,Reactome,1,ST6GAL1,67 (67),0.965,1,1,HMDB00295,8 (8),0.109,0.479,0.342,0.698
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,8,BRAF;MDM2;PRKCA;CAMK2A;CAMK2D;RPS6KA2;RPS6KA3;GNG2,152 (153),0.46,1,1,HMDB01201,18 (19),0.229,0.82,0.342,0.698
JAK STAT MolecularVariation 2,INOH,5,IL5RA;JAK1;PRLR;STAT1;LEPR,50 (50),0.094,0.698,0,,0 (0),1,1,0.094,0.698
Intestinal infectious diseases,Reactome,1,PDZD3,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
Nef mediated downregulation of CD28 cell surface expression,Reactome,1,CD28,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
Regulation of TP53 Expression,Reactome,1,PRDM1,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
The IPAF inflammasome,Reactome,1,CASP1,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
SDK interactions,Reactome,1,SDK2,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
Transport of connexons to the plasma membrane,Reactome,1,GJA1,2 (2),0.0948,0.698,0,,0 (0),1,1,0.0948,0.698
Regulation of necroptotic cell death,Reactome,2,CFLAR;TNFSF10,11 (11),0.0969,0.698,0,,0 (1),1,1,0.0969,0.698
Dimerization of procaspase-8,Reactome,2,CFLAR;TNFSF10,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
Regulation by c-FLIP,Reactome,2,CFLAR;TNFSF10,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
Signaling mediated by p38-gamma and p38-delta,PID,2,MAPK13;MAPK12,11 (12),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
CASP8 activity is inhibited,Reactome,2,CFLAR;TNFSF10,11 (11),0.0969,0.698,0,,0 (1),1,1,0.0969,0.698
regulation of eif2,BioCarta,2,EIF2AK3;EIF5,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
cxcr4 signaling pathway,BioCarta,2,PIK3CA;CXCR4,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
il22 soluble receptor signaling pathway,BioCarta,2,JAK1;STAT1,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
insulin signaling pathway,BioCarta,2,PIK3CA;INSR,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
POU5F1 (OCT4)_ SOX2_ NANOG repress genes related to differentiation,Reactome,2,POU6F1;HHEX,11 (11),0.0969,0.698,0,,0 (0),1,1,0.0969,0.698
NRF2-ARE regulation,Wikipathways,3,PIK3CA;INSR;PRKCA,23 (23),0.0983,0.698,0,,0 (0),1,1,0.0983,0.698
RANKL,NetPath,3,ATP6V1E1;CYLD;SQSTM1,23 (23),0.0983,0.698,0,,0 (0),1,1,0.0983,0.698
caspase cascade in apoptosis,BioCarta,3,BIRC2;CASP1;CASP3,23 (23),0.0983,0.698,0,,0 (0),1,1,0.0983,0.698
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,3,MAPK11;MAPK13;MAPK12,23 (23),0.0983,0.698,0,,0 (0),1,1,0.0983,0.698
IL11,NetPath,3,STAT1;PRKCA;JAK1,23 (23),0.0983,0.698,0,,0 (1),1,1,0.0983,0.698
Wnt signaling pathway - Homo sapiens (human),KEGG,11,WNT10A;TBL1XR1;WISP1;PRKCA;CAMK2A;CAMK2D;RYK;PLCB4;PPP3CC;CCND2;GPC4,148 (149),0.106,0.73,0,,1 (1),1,1,0.343,0.699
TP53 Regulates Metabolic Genes,Reactome,5,GLS;RRAGD;PRKAG2;AGO4;AKT3,86 (86),0.407,1,1,HMDB01201,21 (25),0.262,0.923,0.345,0.702
Amino acid and oligopeptide SLC transporters,Reactome,1,SLC3A2,52 (52),0.925,1,2,HMDB00158;HMDB00159,41 (50),0.115,0.504,0.345,0.702
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Reactome,1,PTS,10 (10),0.392,1,1,HMDB00159,22 (27),0.273,0.957,0.346,0.703
Omega-3 fatty acid metabolism,EHMN,1,EHHADH,16 (16),0.549,1,1,HMDB01388,15 (16),0.195,0.719,0.346,0.703
Nicotinate metabolism,Reactome,3,NADK;PTGIS;NAMPT,24 (25),0.108,0.739,0,,39 (52),1,1,0.349,0.703
ER-Phagosome pathway,Reactome,3,TAP1;LY96;BTK,24 (24),0.108,0.739,0,,5 (11),1,1,0.349,0.703
Glutamate Neurotransmitter Release Cycle,Reactome,3,GLS;UNC13B;STXBP1,24 (24),0.108,0.739,0,,7 (8),1,1,0.349,0.703
Physiological and Pathological Hypertrophy of the Heart,Wikipathways,3,MAPK11;CAMK2D;MYEF2,24 (24),0.108,0.739,0,,2 (2),1,1,0.349,0.703
Olfactory transduction - Homo sapiens (human),KEGG,3,PDE1A;CAMK2D;CAMK2A,444 (447),1,1,1,HMDB01397,8 (8),0.109,0.479,0.351,0.703
Arachidonate Epoxygenase - Epoxide Hydrolase,Wikipathways,0,,7 (7),1,1,1,HMDB01043,8 (9),0.109,0.479,0.351,0.703
thyroid hormone metabolism II (via conjugation and/or degradation),HumanCyc,0,,7 (7),1,1,1,HMDB00295,8 (22),0.109,0.479,0.351,0.703
pyrimidine ribonucleosides salvage I,HumanCyc,0,,4 (4),1,1,1,HMDB00288,8 (9),0.109,0.479,0.351,0.703
Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMPDB,0,,8 (8),1,1,1,HMDB01201,8 (8),0.109,0.479,0.351,0.703
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Reactome,0,,9 (9),1,1,1,HMDB01043,8 (11),0.109,0.479,0.351,0.703
dolichol and dolichyl phosphate biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB01546,8 (10),0.109,0.479,0.351,0.703
5-Phosphoribose 1-diphosphate biosynthesis,Reactome,0,,3 (3),1,1,1,HMDB00618#HMDB01548,8 (8),0.109,0.479,0.351,0.703
Artemether Metabolism Pathway,SMPDB,0,,4 (4),1,1,1,HMDB00295,8 (9),0.109,0.479,0.351,0.703
Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin ,SMPDB,0,,8 (8),1,1,1,HMDB01201,8 (8),0.109,0.479,0.351,0.703
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin ,SMPDB,0,,8 (8),1,1,1,HMDB01201,8 (8),0.109,0.479,0.351,0.703
Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,0,,8 (8),1,1,1,HMDB01201,8 (8),0.109,0.479,0.351,0.703
Histone Modifications,Wikipathways,6,KMT2E;EZH1;KMT2A;KMT2C;SETD7;SETBP1,66 (66),0.1,0.703,0,,0 (0),1,1,0.1,0.703
MAP2K and MAPK activation,Reactome,4,BRAF;RAP1B;PEBP1;APBB1IP,38 (38),0.111,0.747,0,,6 (8),1,1,0.355,0.709
Ovarian tumor domain proteases,Reactome,4,TRIM25;VCPIP1;RNF128;TNIP1,38 (38),0.111,0.747,0,,3 (5),1,1,0.355,0.709
Signaling by moderate kinase activity BRAF mutants,Reactome,4,BRAF;RAP1B;PEBP1;APBB1IP,38 (38),0.111,0.747,0,,6 (8),1,1,0.355,0.709
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,4,BRAF;RAP1B;PEBP1;APBB1IP,38 (38),0.111,0.747,0,,6 (9),1,1,0.355,0.709
Etoposide Action Pathway,SMPDB,1,PDIA4,19 (19),0.612,1,1,HMDB00295,14 (14),0.183,0.686,0.357,0.711
Etoposide Metabolism Pathway,SMPDB,1,PDIA4,19 (19),0.612,1,1,HMDB00295,14 (14),0.183,0.686,0.357,0.711
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,2,ENPP2;ENPP1,31 (31),0.448,1,1,HMDB01546,20 (21),0.251,0.889,0.359,0.711
pyrimidine deoxyribonucleotide phosphorylation,HumanCyc,2,CMPK2;CMPK1,12 (12),0.113,0.747,0,,8 (8),1,1,0.359,0.711
Hyaluronan metabolism,Reactome,2,HEXA;LYVE1,12 (12),0.113,0.747,0,,5 (6),1,1,0.359,0.711
Stabilization of p53,Reactome,2,MDM2;MDM4,12 (12),0.113,0.747,0,,2 (2),1,1,0.359,0.711
Eicosanoids,Reactome,2,PTGIS;TBXAS1,12 (12),0.113,0.747,0,,9 (13),1,1,0.359,0.711
Ethanol oxidation,Reactome,2,ALDH1A1;ACSS1,12 (12),0.113,0.747,0,,14 (15),1,1,0.359,0.711
Nicotinamide salvaging,Reactome,2,PTGIS;NAMPT,12 (12),0.113,0.747,0,,30 (38),1,1,0.359,0.711
Oxidation of Branched Chain Fatty Acids,SMPDB,2,PHYH;ABCD2,12 (12),0.113,0.747,0,,25 (25),1,1,0.359,0.711
Activation of anterior HOX genes in hindbrain development during early embryogenesis,Wikipathways,2,HOXB3;HOXB4,12 (12),0.113,0.747,0,,1 (1),1,1,0.359,0.711
Notch signaling pathway,PID,5,APH1B;MAML2;NCOR1;RAB11A;DNER,53 (54),0.113,0.751,0,,1 (1),1,1,0.36,0.714
IL23-mediated signaling events,PID,4,PIK3CA;ITGA3;STAT1;IL18,37 (37),0.103,0.714,0,,0 (1),1,1,0.103,0.714
JAK STAT MolecularVariation 1,INOH,8,IL10;JAK1;TNFSF10;IL5RA;LEPR;PRLR;STAT1;IL18,98 (98),0.103,0.716,0,,0 (3),1,1,0.103,0.716
Binding and Uptake of Ligands by Scavenger Receptors,Wikipathways,0,,0 (0),1,1,1,HMDB00658#HMDB10370,15 (35),0.195,0.719,0.195,0.719
Abacavir transport and metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00295,15 (24),0.195,0.719,0.195,0.719
O-linked glycosylation,Wikipathways,0,,0 (0),1,1,1,HMDB00295,15 (18),0.195,0.719,0.195,0.719
ABC transporters - Homo sapiens (human),KEGG,4,ABCD2;TAP1;ABCA6;ABCA5,44 (44),0.164,0.867,1,HMDB00159,85 (129),0.713,1,0.368,0.727
HIV Infection,Reactome,8,CXCR4;AP1S2;PACS1;CD28;GTF2A1;CHMP5;B2M;TAF7,195 (197),0.737,1,1,HMDB01201,12 (13),0.159,0.616,0.368,0.728
Vitamin digestion and absorption - Homo sapiens (human),KEGG,2,SLC46A1;SLC23A1,24 (24),0.326,1,1,HMDB00658#HMDB10370,31 (39),0.362,1,0.37,0.732
TRAIL signaling pathway,PID,3,PIK3CA;CFLAR;TNFSF10,25 (25),0.119,0.779,0,,1 (1),1,1,0.372,0.734
regulation of eif-4e and p70s6 kinase,BioCarta,3,MKNK1;PRKCA;PIK3CA,25 (25),0.119,0.779,0,,2 (2),1,1,0.372,0.734
stathmin and breast cancer resistance to antimicrotubule agents,BioCarta,3,CAMK2D;MAPK13;CAMK2A,25 (25),0.119,0.779,0,,2 (2),1,1,0.372,0.734
tumor suppressor arf inhibits ribosomal biogenesis,BioCarta,3,MDM2;PIK3CA;POLR1A,24 (24),0.108,0.739,0,,0 (0),1,1,0.108,0.739
IL1 and megakaryocytes in obesity,Wikipathways,3,PIK3CA;NLRP3;IL18,24 (24),0.108,0.739,0,,0 (0),1,1,0.108,0.739
Acetylcholine Synthesis,Wikipathways,0,,7 (7),1,1,1,HMDB08048#HMDB08036#HMDB08038,9 (9),0.122,0.512,0.378,0.741
HDL assembly,Reactome,0,,8 (8),1,1,1,HMDB00658#HMDB10370,9 (10),0.122,0.512,0.378,0.741
Pentose Phosphate Metabolism,Wikipathways,0,,7 (7),1,1,1,HMDB00618#HMDB01548,9 (9),0.122,0.512,0.378,0.741
&gamma;-linolenate biosynthesis,HumanCyc,0,,14 (14),1,1,1,HMDB00673,9 (9),0.122,0.512,0.378,0.741
Plasmalogen biosynthesis,Reactome,0,,2 (2),1,1,1,HMDB00220,9 (12),0.122,0.512,0.378,0.741
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,0,,8 (8),1,1,1,HMDB01201,9 (9),0.122,0.512,0.378,0.741
nicotine degradation III,HumanCyc,0,,10 (10),1,1,1,HMDB00295,9 (23),0.122,0.512,0.378,0.741
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,8,CISH;MIR15B;PIK3CA;PIK3CG;CAMK2D;MYEF2;FGFR2;IGF1R,102 (102),0.122,0.792,0,,3 (3),1,1,0.38,0.743
Apoptotic cleavage of cellular proteins,Reactome,4,SATB1;CASP3;BMX;BIRC2,38 (38),0.111,0.747,0,,0 (0),1,1,0.111,0.747
miR-targeted genes in lymphocytes - TarBase,Wikipathways,30,RAB23;DOCK5;GEMIN7;IFRD1;ATP6V0A1;MAPK12;SLC12A2;SLC12A4;MIR15B;HACD3;DHX40;RAB30;ABHD10;BACH1;KCNN4;LAMC1;FNDC3A;UNC93B1;FAR1;SERP1;STX7;CLOCK;SRPRB;GFPT1;PDCD4;DDX5;ARF4;MSI2;NRP1;AMIGO2,489 (489),0.111,0.747,0,,0 (0),1,1,0.111,0.747
Surfactant metabolism,Reactome,1,ADORA2A,26 (26),0.726,1,1,HMDB08048#HMDB08036#HMDB08038,13 (14),0.171,0.653,0.383,0.75
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Wikipathways,0,,0 (0),1,1,1,HMDB01201,16 (22),0.206,0.755,0.206,0.755
Alcoholism - Homo sapiens (human),KEGG,5,BRAF;GNG2;CREB3L2;ATF4;ADORA2A,180 (180),0.941,1,1,HMDB00158,10 (10),0.134,0.545,0.388,0.757
HIV Life Cycle,Reactome,4,CXCR4;GTF2A1;CHMP5;TAF7,154 (156),0.945,1,1,HMDB01201,10 (11),0.134,0.545,0.389,0.757
Pathogenic Escherichia coli infection - Homo sapiens (human),KEGG,5,PRKCA;LY96;TLR5;TUBB2B;ARPC2,55 (55),0.127,0.798,0,,1 (1),1,1,0.39,0.757
IL-1 signaling pathway,Wikipathways,5,PELI1;SQSTM1;IRAK3;PRKCZ;MAP3K3,55 (55),0.127,0.798,0,,1 (1),1,1,0.39,0.757
Copper homeostasis,Wikipathways,5,CASP3;PIK3CA;XAF1;FOXO1;MDM2,55 (55),0.127,0.798,0,,1 (2),1,1,0.39,0.757
Microglia Pathogen Phagocytosis Pathway,Wikipathways,4,PLCG2;NCF2;PIK3CA;PIK3CG,40 (40),0.128,0.798,0,,2 (2),1,1,0.39,0.757
Valproic Acid Metabolism Pathway,SMPDB,1,EHHADH,11 (11),0.422,1,1,HMDB00295,25 (31),0.304,1,0.391,0.757
il-10 anti-inflammatory signaling pathway,BioCarta,2,IL10;JAK1,13 (13),0.129,0.798,0,,4 (4),1,1,0.393,0.757
effects of calcineurin in keratinocyte differentiation,BioCarta,2,PRKCA;PPP3CC,13 (13),0.129,0.798,0,,2 (3),1,1,0.393,0.757
trka receptor signaling pathway,BioCarta,2,PIK3CA;PRKCA,13 (13),0.129,0.798,0,,1 (1),1,1,0.393,0.757
Lysine Degradation,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
Hyperlysinemia I_ Familial,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
2-aminoadipic 2-oxoadipic aciduria,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
Pyridoxine dependency with seizures,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
Saccharopinuria/Hyperlysinemia II,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
sarcosine oncometabolite pathway ,SMPDB,2,ALDH7A1;SLC44A1,13 (13),0.129,0.798,0,,26 (26),1,1,0.393,0.757
Glutaric Aciduria Type I,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
Hyperlysinemia II or Saccharopinuria,SMPDB,2,ALDH7A1;DHTKD1,13 (13),0.129,0.798,0,,27 (27),1,1,0.393,0.757
AMPK signaling pathway - Homo sapiens (human),KEGG,9,FOXO1;PIK3CA;AKT3;LEPR;IRS2;IGF1R;INSR;CREB3L2;PRKAG2,120 (120),0.129,0.798,0,,20 (23),1,1,0.394,0.757
MyD88 cascade initiated on plasma membrane,Reactome,7,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3;TLR5,87 (87),0.13,0.798,0,,4 (9),1,1,0.394,0.757
Toll Like Receptor 10 (TLR10) Cascade,Reactome,7,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3;TLR5,87 (87),0.13,0.798,0,,4 (9),1,1,0.394,0.757
Toll Like Receptor 5 (TLR5) Cascade,Reactome,7,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3;TLR5,87 (87),0.13,0.798,0,,4 (9),1,1,0.394,0.757
signaling pathway from g-protein families,BioCarta,3,PRKCA;PPP3CC;RPS6KA3,26 (26),0.13,0.798,0,,3 (3),1,1,0.395,0.757
Insulin receptor recycling,Reactome,3,ATP6V1E1;INSR;ATP6V0A1,26 (26),0.13,0.798,0,,1 (2),1,1,0.395,0.757
Metal ion SLC transporters,Reactome,3,CP;SLC40A1;SLC39A4,26 (26),0.13,0.798,0,,5 (7),1,1,0.395,0.757
links between pyk2 and map kinases,BioCarta,3,PRKCA;BCAR1;PAK1,26 (26),0.13,0.798,0,,2 (2),1,1,0.395,0.757
Basigin interactions,Reactome,3,SLC3A2;ITGA3;ATP1B3,26 (27),0.13,0.798,0,,1 (1),1,1,0.395,0.757
Late Phase of HIV Life Cycle,Reactome,3,GTF2A1;CHMP5;TAF7,141 (143),0.97,1,1,HMDB01201,10 (10),0.134,0.545,0.396,0.758
Morphine Action Pathway,SMPDB,2,PDIA4;ATP1B3,44 (44),0.637,1,1,HMDB00295,16 (16),0.206,0.755,0.398,0.762
Bile acid biosynthesis,EHMN,4,ALDH3A2;EHHADH;ACOT7;ALDH7A1,53 (53),0.256,1,1,HMDB00658#HMDB10370,50 (55),0.517,1,0.4,0.765
Arachidonic acid metabolism,EHMN,2,PLA2G12A;ALOX12,99 (101),0.957,1,2,HMDB01043;HMDB08048#HMDB08036#HMDB08038,46 (53),0.139,0.563,0.402,0.767
Plasma lipoprotein assembly,Reactome,0,,19 (19),1,1,1,HMDB00658#HMDB10370,10 (11),0.134,0.545,0.404,0.767
Codeine Metabolism Pathway,SMPDB,0,,4 (4),1,1,1,HMDB00295,10 (12),0.134,0.545,0.404,0.767
FMO oxidises nucleophiles,Reactome,0,,3 (3),1,1,1,HMDB00925,10 (13),0.134,0.545,0.404,0.767
Miscellaneous substrates,Reactome,0,,12 (14),1,1,1,HMDB01043,10 (15),0.134,0.545,0.404,0.767
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Reactome,0,,2 (2),1,1,1,HMDB01999,10 (27),0.134,0.545,0.404,0.767
Biosynthesis of E-series 18(S)-resolvins,Reactome,0,,5 (5),1,1,1,HMDB01999,10 (19),0.134,0.545,0.404,0.767
melatonin degradation I,HumanCyc,0,,12 (12),1,1,1,HMDB00295,10 (13),0.134,0.545,0.404,0.767
purine deoxyribonucleosides salvage,HumanCyc,0,,13 (13),1,1,1,HMDB01044,10 (11),0.134,0.545,0.404,0.767
Celecoxib Metabolism Pathway,SMPDB,0,,8 (8),1,1,1,HMDB00295,10 (11),0.134,0.545,0.404,0.767
Pathogenic Escherichia coli infection,Wikipathways,5,PRKCA;LY96;TLR5;ARPC2;TUBB2B,56 (56),0.135,0.811,0,,1 (1),1,1,0.405,0.768
Androgen Receptor Network in Prostate Cancer,Wikipathways,6,PAK1;PIK3CA;NDRG1;ATF1;RAP1B;HGF,72 (72),0.136,0.811,0,,12 (12),1,1,0.408,0.771
Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha,Reactome,1,EPAS1,3 (3),0.139,0.811,0,,4 (4),1,1,0.413,0.771
PERK regulates gene expression,Reactome,1,EIF2AK3,3 (3),0.139,0.811,0,,2 (2),1,1,0.413,0.771
glutamate dependent acid resistance,HumanCyc,1,GLUL,3 (3),0.139,0.811,0,,3 (4),1,1,0.413,0.771
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis V (from Ins(1_3_4)P3),HumanCyc,1,IPMK,3 (3),0.139,0.811,0,,7 (8),1,1,0.413,0.771
RHO GTPases regulate CFTR trafficking,Reactome,1,RHOQ,3 (3),0.139,0.811,0,,1 (1),1,1,0.413,0.771
Signaling by FGFR2 IIIa TM,Reactome,1,FGFR2,3 (3),0.139,0.811,0,,1 (1),1,1,0.413,0.771
Lipoic acid metabolism - Homo sapiens (human),KEGG,1,LIPT1,3 (3),0.139,0.811,0,,1 (6),1,1,0.413,0.771
taurine biosynthesis,HumanCyc,1,CSAD,3 (3),0.139,0.811,0,,10 (11),1,1,0.413,0.771
PTK6 Down-Regulation,Reactome,1,SRMS,3 (3),0.139,0.811,0,,4 (4),1,1,0.413,0.771
D-<i>myo</i>-inositol (1_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,IPMK,3 (3),0.139,0.811,0,,8 (9),1,1,0.413,0.771
lipoate biosynthesis and incorporation,HumanCyc,1,LIPT1,3 (3),0.139,0.811,0,,7 (8),1,1,0.413,0.771
MET activates STAT3,Reactome,1,HGF,3 (3),0.139,0.811,0,,2 (2),1,1,0.413,0.771
acetate conversion to acetyl-CoA,HumanCyc,1,ACSS1,3 (3),0.139,0.811,0,,6 (6),1,1,0.413,0.771
glutamine degradation/glutamate biosynthesis,HumanCyc,1,GLS,3 (3),0.139,0.811,0,,4 (4),1,1,0.413,0.771
Hydrolysis of LPE,Reactome,1,GPCPD1,3 (3),0.139,0.811,0,,4 (7),1,1,0.413,0.771
tetrahydrobiopterin <i>de novo</i> biosynthesis,HumanCyc,1,PTS,3 (3),0.139,0.811,0,,9 (11),1,1,0.413,0.771
fatty acid &beta;-oxidation (unsaturated_ odd number),HumanCyc,1,EHHADH,3 (3),0.139,0.811,0,,8 (10),1,1,0.413,0.771
c-src mediated regulation of Cx43 function and closure of gap junctions,Reactome,1,GJA1,3 (3),0.139,0.811,0,,2 (2),1,1,0.413,0.771
Regulation of gap junction activity,Reactome,1,GJA1,3 (3),0.139,0.811,0,,2 (2),1,1,0.413,0.771
Hedgehog _off_ state,Wikipathways,1,PTCH1,3 (3),0.139,0.811,0,,6 (6),1,1,0.413,0.771
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis,HumanCyc,3,PLCG2;PLCD3;PLCB4,27 (27),0.141,0.818,0,,7 (13),1,1,0.418,0.779
VEGFR2 mediated vascular permeability,Reactome,3,AKT3;PAK1;PRR5,27 (27),0.141,0.818,0,,17 (17),1,1,0.418,0.779
C-type lectin receptors (CLRs),Reactome,3,PLCG2;PAK1;ITPR2,83 (83),0.775,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,14 (18),0.183,0.686,0.419,0.78
IL-4 Signaling Pathway,Wikipathways,5,MAPK11;STAT1;PIK3CA;JAK1;IRS2,54 (54),0.12,0.781,0,,0 (0),1,1,0.12,0.781
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,4,CACNA1H;SNTB1;ATP1B3;PDIA4,82 (82),0.568,1,1,HMDB00295,20 (21),0.251,0.889,0.421,0.783
Signaling by NOTCH1,Reactome,6,DNER;TBL1XR1;APH1B;NCOR1;TLE4;MAML2,73 (74),0.143,0.826,0,,3 (3),1,1,0.421,0.783
Cell-Cell communication,Reactome,9,F11R;PIK3CA;MPP5;ARHGEF6;SDK2;CLDN7;CD2AP;LIMS1;CASK,123 (124),0.144,0.83,0,,3 (3),1,1,0.423,0.786
Phenylalanine metabolism - Homo sapiens (human),KEGG,0,,17 (17),1,1,2,HMDB00158;HMDB00159,47 (72),0.144,0.579,0.423,0.786
PI Metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB08048#HMDB08036#HMDB08038,17 (29),0.218,0.788,0.218,0.788
Sialic acid metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00295,17 (27),0.218,0.788,0.218,0.788
Hair Follicle Development- Induction (Part 1 of 3),Wikipathways,4,BMPR1A;FGFR2;WNT10A;PTCH1,42 (42),0.145,0.833,0,,2 (2),1,1,0.426,0.789
Spry regulation of FGF signaling,Reactome,2,BRAF;MKNK1,14 (14),0.146,0.833,0,,3 (3),1,1,0.427,0.789
Bile salt and organic anion SLC transporters,Reactome,2,EMB;SLC13A5,14 (14),0.146,0.833,0,,14 (17),1,1,0.427,0.789
Regulation of IFNG signaling,Reactome,2,JAK1;STAT1,14 (14),0.146,0.833,0,,2 (3),1,1,0.427,0.789
Ras signaling in the CD4+ TCR pathway,PID,2,BRAF;PRKCA,14 (14),0.146,0.833,0,,1 (1),1,1,0.427,0.789
Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,2,INPP1;INPP4B,14 (14),0.146,0.833,0,,17 (18),1,1,0.427,0.789
Biosynthesis of EPA-derived SPMs,Reactome,0,,6 (6),1,1,1,HMDB01999,11 (27),0.147,0.579,0.428,0.79
Tramadol Metabolism Pathway,SMPDB,0,,7 (7),1,1,1,HMDB00295,11 (12),0.147,0.579,0.428,0.79
PTEN Regulation,Wikipathways,0,,1 (1),1,1,1,HMDB01201,11 (11),0.147,0.579,0.428,0.79
Disorders of the Krebs cycle,Wikipathways,0,,1 (1),1,1,1,HMDB01201,11 (14),0.147,0.579,0.428,0.79
Integrated Lung Cancer Pathway,Wikipathways,4,MDM2;PAK1;CASP3;BRAF,40 (40),0.128,0.798,0,,0 (0),1,1,0.128,0.798
BMAL1:CLOCK_NPAS2 activates circadian gene expression,Reactome,2,NAMPT;CLOCK,13 (13),0.129,0.798,0,,0 (1),1,1,0.129,0.798
multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation,BioCarta,2,IGF1R;PIK3CA,13 (13),0.129,0.798,0,,0 (0),1,1,0.129,0.798
Endosomal/Vacuolar pathway,Reactome,2,CTSS;B2M,13 (13),0.129,0.798,0,,0 (3),1,1,0.129,0.798
b cell survival pathway,BioCarta,2,PIK3CA;CASP3,13 (13),0.129,0.798,0,,0 (0),1,1,0.129,0.798
Other interleukin signaling,Reactome,3,JAK1;CASP3;SDC1,26 (26),0.13,0.798,0,,0 (2),1,1,0.13,0.798
Alpha6Beta4Integrin,NetPath,6,PAK1;PRKCA;LAMC1;PIK3CG;IRS2;PIK3CA,71 (71),0.13,0.798,0,,0 (0),1,1,0.13,0.798
Iron uptake and transport,Reactome,5,ATP6V1E1;SLC46A1;CP;SLC40A1;ATP6V0A1,58 (58),0.15,0.848,0,,17 (21),1,1,0.434,0.8
Signaling by BRAF and RAF fusions,Reactome,5,BRAF;RAP1B;PEBP1;APBB1IP;ATG7,58 (58),0.15,0.848,0,,6 (8),1,1,0.434,0.8
Tyrosine metabolism,EHMN,2,ALDH3A2;EHHADH,108 (110),0.97,1,3,HMDB00158;HMDB00295;HMDB00159,96 (105),0.155,0.613,0.436,0.803
Acetaminophen Metabolism Pathway,SMPDB,1,PDIA4,30 (31),0.776,1,1,HMDB00295,15 (16),0.195,0.719,0.437,0.803
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
Homocarnosinosis,SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
Succinic semialdehyde dehydrogenase deficiency,SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
Glutamate Metabolism,SMPDB,2,GLUL;GFPT1,23 (23),0.308,1,1,HMDB01397,47 (49),0.495,1,0.44,0.805
Apoptosis Modulation and Signaling,Wikipathways,7,BLK;CASP1;CASP3;CFLAR;TNFSF10;BIRC2;PTPN13,91 (91),0.153,0.859,0,,1 (1),1,1,0.44,0.805
Fatty acid degradation - Homo sapiens (human),KEGG,3,ALDH3A2;EHHADH;ALDH7A1,44 (44),0.361,1,1,HMDB00220,38 (50),0.424,1,0.441,0.805
p53 signaling pathway - Homo sapiens (human),KEGG,6,MDM2;MDM4;CASP3;ZMAT3;RCHY1;CCND2,72 (72),0.136,0.811,0,,0 (0),1,1,0.136,0.811
SUMOylation of transcription cofactors,Reactome,1,DDX17,3 (3),0.139,0.811,0,,0 (0),1,1,0.139,0.811
AlphaE beta7 integrin cell surface interactions,PID,1,ITGB7,3 (3),0.139,0.811,0,,0 (0),1,1,0.139,0.811
The AIM2 inflammasome,Reactome,1,CASP1,3 (3),0.139,0.811,0,,0 (1),1,1,0.139,0.811
Uric Acid-Lowering Drugs Pathway_ Pharmacodynamics,PharmGKB,1,XDH,3 (3),0.139,0.811,0,,0 (3),1,1,0.139,0.811
Transport of connexins along the secretory pathway,Reactome,1,GJA1,3 (3),0.139,0.811,0,,0 (0),1,1,0.139,0.811
Oligomerization of connexins into connexons,Reactome,1,GJA1,3 (3),0.139,0.811,0,,0 (0),1,1,0.139,0.811
Gap junction assembly,Reactome,1,GJA1,3 (3),0.139,0.811,0,,0 (0),1,1,0.139,0.811
Di-unsaturated fatty acid beta-oxidation,EHMN,1,EHHADH,23 (23),0.682,1,1,HMDB00673,18 (19),0.229,0.82,0.446,0.815
Interleukin receptor SHC signaling,Reactome,3,IL5RA;PIK3CA;JAK1,27 (27),0.141,0.818,0,,0 (1),1,1,0.141,0.818
alk in cardiac myocytes,BioCarta,3,MEF2C;BMPR1A;TGFBR1,27 (27),0.141,0.818,0,,0 (0),1,1,0.141,0.818
Follicle Stimulating Hormone (FSH) signaling pathway,Wikipathways,3,PRKCA;FOXO1;SGK1,27 (27),0.141,0.818,0,,0 (0),1,1,0.141,0.818
Photodynamic therapy-induced unfolded protein response,Wikipathways,3,ERN1;EIF2AK3;ATF4,27 (27),0.141,0.818,0,,0 (0),1,1,0.141,0.818
Triglyceride metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00658#HMDB10370,18 (30),0.229,0.82,0.229,0.82
Thiamine metabolic pathways,Wikipathways,0,,8 (8),1,1,1,HMDB00618#HMDB01548,12 (21),0.159,0.616,0.451,0.822
tyrosine degradation,HumanCyc,0,,5 (5),1,1,1,HMDB00158,12 (13),0.159,0.616,0.451,0.822
Fatty acids,Reactome,0,,15 (17),1,1,1,HMDB01043,12 (14),0.159,0.616,0.451,0.822
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes),HumanCyc,0,,4 (4),1,1,1,HMDB00295,12 (15),0.159,0.616,0.451,0.822
Phosphate bond hydrolysis by NUDT proteins,Reactome,0,,7 (7),1,1,1,HMDB00618#HMDB01548,12 (24),0.159,0.616,0.451,0.822
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,9,IGFBP5;GOLM1;WFS1;LAMC1;CP;MIA3;PNPLA2;MGAT4A;MMP2,126 (127),0.159,0.867,0,,3 (8),1,1,0.452,0.822
Post-translational protein phosphorylation,Reactome,8,IGFBP5;GOLM1;WFS1;LAMC1;CP;MIA3;MGAT4A;PNPLA2,109 (110),0.16,0.867,0,,2 (7),1,1,0.453,0.823
Interleukin-4 and 13 signaling,Reactome,2,JAK1;STAT1,15 (15),0.163,0.867,0,,2 (2),1,1,0.459,0.83
GRB2:SOS provides linkage to MAPK signaling for Integrins ,Reactome,2,RAP1B;APBB1IP,15 (15),0.163,0.867,0,,4 (6),1,1,0.459,0.83
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Reactome,2,NCOA1;PTGIS,15 (15),0.163,0.867,0,,14 (18),1,1,0.459,0.83
Phytochemical activity on NRF2 transcriptional activation,Wikipathways,2,PRKCA;PIK3CA,15 (15),0.163,0.867,0,,2 (3),1,1,0.459,0.83
Activation of BAD and translocation to mitochondria ,Reactome,2,AKT3;PPP3CC,15 (15),0.163,0.867,0,,4 (4),1,1,0.459,0.83
CREB phosphorylation through the activation of CaMKII,Reactome,2,CAMK2D;CAMK2A,15 (15),0.163,0.867,0,,5 (5),1,1,0.459,0.83
Interleukin-1 family signaling,Wikipathways,2,IL18;PTPN13,15 (15),0.163,0.867,0,,2 (4),1,1,0.459,0.83
Phase 0 - rapid depolarisation,Reactome,4,FGF11;CAMK2D;CACNA1S;CAMK2A,44 (44),0.164,0.867,0,,2 (2),1,1,0.46,0.83
Peroxisomal lipid metabolism,Reactome,3,PHYH;ALDH3A2;EHHADH,29 (29),0.165,0.867,0,,38 (60),1,1,0.462,0.83
Insulin-mediated glucose transport,PID,3,RHOQ;INSR;PRKCZ,29 (29),0.165,0.867,0,,3 (3),1,1,0.462,0.83
p38 MAPK signaling pathway,PID,3,MAPK11;CCM2;MAP3K3,29 (29),0.165,0.867,0,,1 (1),1,1,0.462,0.83
nfkb activation by nontypeable hemophilus influenzae,BioCarta,3,MAPK11;NR3C1;TGFBR1,29 (29),0.165,0.867,0,,1 (1),1,1,0.462,0.83
CDO in myogenesis,Reactome,3,MEF2C;MAPK11;MAPK12,29 (29),0.165,0.867,0,,3 (3),1,1,0.462,0.83
Myogenesis,Reactome,3,MEF2C;MAPK11;MAPK12,29 (29),0.165,0.867,0,,3 (3),1,1,0.462,0.83
Regulation of TP53 Activity,Reactome,11,MAPK11;MDM2;MDM4;RNF34;SGK1;AKT3;JMY;PRKAG2;PRR5;TAF7;PRDM1,162 (162),0.165,0.867,0,,11 (13),1,1,0.462,0.83
Small cell lung cancer - Homo sapiens (human),KEGG,7,CASP3;BIRC2;PIK3CA;LAMC1;AKT3;MAX;ITGA3,93 (93),0.166,0.867,0,,3 (3),1,1,0.463,0.832
Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human),KEGG,2,FUT8;CHST1,14 (14),0.146,0.833,0,,0 (0),1,1,0.146,0.833
Aquaporin-mediated transport,Reactome,1,GNG2,49 (49),0.913,1,1,HMDB01201,14 (14),0.183,0.686,0.466,0.837
Selenocysteine synthesis,Reactome,1,SECISBP2,103 (104),0.994,1,1,HMDB01201,13 (20),0.171,0.653,0.471,0.844
Glucuronidation,Wikipathways,0,,26 (26),1,1,1,HMDB00295,13 (14),0.171,0.653,0.473,0.844
Heme degradation,Reactome,0,,8 (8),1,1,1,HMDB00295,13 (14),0.171,0.653,0.473,0.844
Melanin biosynthesis,Reactome,0,,5 (5),1,1,1,HMDB00158,13 (23),0.171,0.653,0.473,0.844
Thiamine metabolism - Homo sapiens (human),KEGG,0,,15 (16),1,1,1,HMDB00158,13 (31),0.171,0.653,0.473,0.844
catecholamine biosynthesis,HumanCyc,0,,4 (4),1,1,1,HMDB00158,13 (16),0.171,0.653,0.473,0.844
Mycophenolic Acid Metabolism Pathway,SMPDB,0,,16 (16),1,1,1,HMDB00295,13 (16),0.171,0.653,0.473,0.844
Thyroid hormone synthesis,SMPDB,0,,9 (9),1,1,1,HMDB00158,13 (13),0.171,0.653,0.473,0.844
(S)-reticuline biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00158,13 (16),0.171,0.653,0.473,0.844
Metabolism of water-soluble vitamins and cofactors,Reactome,8,NADK;PTGIS;SLC23A1;ALDH1L2;ENPP1;SLC46A1;ACP5;NAMPT,111 (114),0.172,0.867,0,,94 (122),1,1,0.474,0.845
Notch,NetPath,5,APH1B;FHL1;NCOR1;CIR1;MAML2,58 (59),0.15,0.848,0,,0 (0),1,1,0.15,0.848
Viral myocarditis - Homo sapiens (human),KEGG,5,CD55;CASP3;ITGAL;CD28;CD80,58 (59),0.15,0.848,0,,0 (0),1,1,0.15,0.848
RhoA signaling pathway,PID,4,PLD2;PPP1R12A;MAPK12;PRKCZ,45 (45),0.173,0.867,0,,1 (1),1,1,0.477,0.85
Oncogenic MAPK signaling,Reactome,5,BRAF;RAP1B;PEBP1;APBB1IP;ATG7,61 (61),0.174,0.867,0,,6 (11),1,1,0.478,0.851
Circadian rhythm - Homo sapiens (human),KEGG,3,NR1D1;PRKAG2;CLOCK,30 (31),0.177,0.867,0,,2 (2),1,1,0.483,0.852
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,3,ENPP1;NADK;NAMPT,30 (30),0.177,0.867,0,,29 (55),1,1,0.483,0.852
Parkinson disease - Homo sapiens (human),KEGG,3,CASP3;LRRK2;ADORA2A,142 (142),0.971,1,1,HMDB00158,14 (15),0.183,0.686,0.485,0.852
Human T-cell leukemia virus 1 infection - Homo sapiens (human),KEGG,14,AKT3;TNFRSF13C;ITGAL;JAK1;TGFBR1;PIK3CA;B2M;PPP3CC;PTTG1;ATF4;MAP3K3;CREB3L2;NRP1;CCND2,219 (219),0.179,0.867,0,,5 (5),1,1,0.487,0.852
Warburg Effect,SMPDB,0,,45 (45),1,1,2,HMDB00618#HMDB01548;HMDB01201,54 (58),0.18,0.684,0.488,0.852
O-linked glycosylation,Reactome,3,ST6GAL1;ADAMTS5;SPON1,116 (116),0.925,1,1,HMDB00295,15 (18),0.195,0.719,0.489,0.852
Thermogenesis - Homo sapiens (human),KEGG,9,MAPK11;MAPK13;NDUFAF2;CREB3L2;PNPLA2;RPS6KA2;RPS6KA3;MAPK12;PRKAG2,229 (229),0.788,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,18 (25),0.229,0.82,0.489,0.852
mRNA capping,HumanCyc,1,CMTR1,4 (4),0.181,0.867,0,,6 (7),1,1,0.49,0.852
Adenosine P1 receptors,Reactome,1,ADORA2A,4 (4),0.181,0.867,0,,1 (1),1,1,0.49,0.852
TGFBR1 KD Mutants in Cancer,Reactome,1,TGFBR1,4 (4),0.181,0.867,0,,2 (2),1,1,0.49,0.852
Loss of Function of TGFBR1 in Cancer,Reactome,1,TGFBR1,4 (4),0.181,0.867,0,,2 (2),1,1,0.49,0.852
NAD salvage,HumanCyc,1,NAMPT,4 (4),0.181,0.867,0,,6 (7),1,1,0.49,0.852
Cam-PDE 1 activation,Reactome,1,PDE1A,4 (4),0.181,0.867,0,,4 (4),1,1,0.49,0.852
tryptophan degradation X (mammalian_ via tryptamine),HumanCyc,1,ALDH3A2,4 (4),0.181,0.867,0,,14 (15),1,1,0.49,0.852
ionomycin and phorbal ester signaling pathway,BioCarta,1,PRKCA,4 (4),0.181,0.867,0,,1 (2),1,1,0.49,0.852
Biosynthesis of DPAn-3 SPMs,Reactome,1,ALOX12,4 (4),0.181,0.867,0,,7 (27),1,1,0.49,0.852
Biosynthesis of DPA-derived SPMs,Reactome,1,ALOX12,4 (4),0.181,0.867,0,,8 (31),1,1,0.49,0.852
Synthesis of IPs in the nucleus,Reactome,1,IPMK,4 (4),0.181,0.867,0,,10 (14),1,1,0.49,0.852
phenylethylamine degradation I,HumanCyc,1,ALDH3A2,4 (4),0.181,0.867,0,,9 (10),1,1,0.49,0.852
Astrocytic Glutamate-Glutamine Uptake And Metabolism,Reactome,1,GLUL,4 (4),0.181,0.867,0,,6 (6),1,1,0.49,0.852
Neurotransmitter uptake and metabolism In glial cells,Reactome,1,GLUL,4 (4),0.181,0.867,0,,6 (6),1,1,0.49,0.852
Theophylline Pathway_ Pharmacokinetics,PharmGKB,1,XDH,4 (4),0.181,0.867,0,,2 (2),1,1,0.49,0.852
Fosphenytoin (Antiarrhythmic) Metabolism Pathway,SMPDB,1,SNTB1,4 (4),0.181,0.867,0,,2 (2),1,1,0.49,0.852
Interleukin-7 signaling,Wikipathways,1,CISH,4 (4),0.181,0.867,0,,2 (2),1,1,0.49,0.852
Caffeine and Theobromine metabolism,Wikipathways,1,XDH,4 (4),0.181,0.867,0,,11 (11),1,1,0.49,0.852
Wax biosynthesis,Reactome,1,FAR1,4 (4),0.181,0.867,0,,8 (12),1,1,0.49,0.852
Vitamin B6-dependent and responsive disorders,Wikipathways,1,ALDH7A1,4 (4),0.181,0.867,0,,12 (18),1,1,0.49,0.852
Defective CFTR causes cystic fibrosis,Reactome,2,SEL1L;DERL3,16 (16),0.181,0.867,0,,5 (6),1,1,0.49,0.852
Circadian rhythm pathway,PID,2,NR1D1;CLOCK,16 (16),0.181,0.867,0,,3 (3),1,1,0.49,0.852
control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk),BioCarta,2,MEF2C;PIK3CA,16 (16),0.181,0.867,0,,1 (1),1,1,0.49,0.852
CRMPs in Sema3A signaling,Reactome,2,PLXNA1;NRP1,16 (16),0.181,0.867,0,,2 (2),1,1,0.49,0.852
NRIF signals cell death from the nucleus,Reactome,2,APH1B;SQSTM1,16 (16),0.181,0.867,0,,2 (2),1,1,0.49,0.852
Phytanic acid peroxisomal oxidation,EHMN,2,PHYH;EHHADH,16 (16),0.181,0.867,0,,20 (22),1,1,0.49,0.852
NAD+ metabolism,Wikipathways,2,NADK;NAMPT,16 (16),0.181,0.867,0,,14 (14),1,1,0.49,0.852
Glycogen breakdown (glycogenolysis),Reactome,2,PGM2L1;PYGL,16 (16),0.181,0.867,0,,10 (12),1,1,0.49,0.852
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,0,,6 (6),1,1,1,HMDB01043,14 (16),0.183,0.686,0.494,0.854
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Reactome,0,,8 (8),1,1,1,HMDB01043,14 (15),0.183,0.686,0.494,0.854
Abacavir metabolism,Reactome,0,,5 (5),1,1,1,HMDB00295,14 (23),0.183,0.686,0.494,0.854
nicotine degradation IV,HumanCyc,0,,17 (17),1,1,1,HMDB00295,14 (28),0.183,0.686,0.494,0.854
Phenylalanine degradation,INOH,0,,13 (13),1,1,1,HMDB00159,14 (14),0.183,0.686,0.494,0.854
Tamoxifen Action Pathway,SMPDB,0,,10 (10),1,1,1,HMDB00295,14 (20),0.183,0.686,0.494,0.854
Tamoxifen Metabolism Pathway,SMPDB,0,,10 (10),1,1,1,HMDB00295,14 (20),0.183,0.686,0.494,0.854
Galactose metabolism,INOH,0,,13 (13),1,1,1,HMDB00295,14 (15),0.183,0.686,0.494,0.854
Signaling by TGF-beta family members,Reactome,7,F11R;SKIL;ZFYVE16;TGFBR1;NCOR1;BMPR1A;PRKCZ,96 (96),0.185,0.882,0,,7 (7),1,1,0.497,0.859
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,3,RASSF6;PAK1;RASSF2,28 (29),0.153,0.859,0,,0 (0),1,1,0.153,0.859
Reelin signaling pathway,PID,3,RELN;PIK3CA;ITGA3,28 (28),0.153,0.859,0,,0 (0),1,1,0.153,0.859
Transcriptional regulation of pluripotent stem cells,Reactome,3,HHEX;FOXP1;POU6F1,28 (28),0.153,0.859,0,,0 (0),1,1,0.153,0.859
Kit receptor signaling pathway,Wikipathways,5,PRKCA;STAT1;RPS6KA3;TEC;BTK,59 (59),0.158,0.867,0,,0 (0),1,1,0.158,0.867
Hepatitis B - Homo sapiens (human),KEGG,10,JAK1;TGFBR1;PIK3CA;AKT3;STAT1;DDX3X;CASP3;ATF4;CREB3L2;PRKCA,144 (144),0.163,0.867,0,,0 (0),1,1,0.163,0.867
pten dependent cell cycle arrest and apoptosis,BioCarta,2,PIK3CA;BCAR1,15 (15),0.163,0.867,0,,0 (0),1,1,0.163,0.867
Integrated Cancer Pathway,Wikipathways,2,ATF1;BACH1,15 (15),0.163,0.867,0,,0 (0),1,1,0.163,0.867
Interleukin-11 Signaling Pathway,Wikipathways,4,BGLAP;STAT1;ATF1;JAK1,44 (44),0.164,0.867,0,,0 (0),1,1,0.164,0.867
TNFs bind their physiological receptors,Reactome,3,TNFRSF17;TNFSF13B;TNFRSF13B,29 (29),0.165,0.867,0,,0 (1),1,1,0.165,0.867
ATF-2 transcription factor network,PID,5,MAPK11;MMP2;PRKCA;PDGFRA;COL24A1,60 (60),0.166,0.867,0,,0 (3),1,1,0.166,0.867
DNA Damage Response (only ATM dependent),Wikipathways,8,MDM2;WNT10A;PIK3C2B;PIK3CA;PIK3CG;AKT3;INSR;CCND2,110 (110),0.166,0.867,0,,0 (0),1,1,0.166,0.867
TNFalpha,NetPath,15,PAK1;TXNIP;CFLAR;BIRC2;PRKCA;TAX1BP1;DDX3X;PPP1R12A;STAT1;PRKCZ;MAP3K3;SMPD3;FOXO1;POLR1A;CASP3,234 (234),0.166,0.867,0,,0 (1),1,1,0.166,0.867
Notch Signaling Pathway,Wikipathways,5,APH1B;MAML2;NCOR1;CIR1;FHL1,61 (61),0.174,0.867,0,,0 (0),1,1,0.174,0.867
IL2 signaling events mediated by STAT5,PID,3,PIK3CA;JAK1;CCND2,30 (30),0.177,0.867,0,,0 (0),1,1,0.177,0.867
Tight junction interactions,Reactome,3,F11R;MPP5;CLDN7,30 (31),0.177,0.867,0,,0 (0),1,1,0.177,0.867
Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,3,HGF;TGFBR1;TSPAN8,30 (30),0.177,0.867,0,,0 (0),1,1,0.177,0.867
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,Wikipathways,3,IGFBP5;IGF1R;PIK3CG,30 (30),0.177,0.867,0,,0 (0),1,1,0.177,0.867
Notch,INOH,6,PSMB9;APH1B;SKIL;TLE4;PSMA3;MAML2,78 (79),0.178,0.867,0,,0 (0),1,1,0.178,0.867
Regulation of gene expression by Hypoxia-inducible Factor,Reactome,1,EPAS1,4 (4),0.181,0.867,0,,0 (0),1,1,0.181,0.867
TGFBR2 Kinase Domain Mutants in Cancer,Reactome,1,TGFBR1,4 (4),0.181,0.867,0,,0 (0),1,1,0.181,0.867
Loss of Function of TGFBR2 in Cancer,Reactome,1,TGFBR1,4 (4),0.181,0.867,0,,0 (0),1,1,0.181,0.867
chromatin remodeling by hswi/snf atp-dependent complexes,BioCarta,2,NR3C1;GTF2A1,16 (16),0.181,0.867,0,,0 (0),1,1,0.181,0.867
IGF-Ncore,Signalink,2,MDM2;SGK1,16 (16),0.181,0.867,0,,0 (0),1,1,0.181,0.867
Cell-extracellular matrix interactions,Reactome,2,LIMS1;ARHGEF6,16 (16),0.181,0.867,0,,0 (0),1,1,0.181,0.867
Interactome of polycomb repressive complex 2 (PRC2),Wikipathways,2,EZH1;STK38,16 (16),0.181,0.867,0,,0 (0),1,1,0.181,0.867
Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human),KEGG,10,ERN1;CASP3;PIK3CA;EIF2AK3;AKT3;LEPR;ATF4;IRS2;INSR;PRKAG2,149 (149),0.188,0.896,0,,1 (2),1,1,0.503,0.868
Omega-6 fatty acid metabolism,EHMN,1,EHHADH,28 (28),0.752,1,1,HMDB01043,20 (23),0.251,0.889,0.504,0.869
beta-Alanine metabolism - Homo sapiens (human),KEGG,3,ALDH3A2;EHHADH;ALDH7A1,31 (31),0.189,0.896,0,,29 (32),1,1,0.504,0.869
Regulation of Microtubule Cytoskeleton,Wikipathways,4,PRKCA;CLIP1;PAK1;PIK3CA,46 (46),0.183,0.874,0,,0 (0),1,1,0.183,0.874
Codeine Action Pathway,SMPDB,1,ATP1B3,32 (32),0.797,1,1,HMDB00295,19 (21),0.24,0.854,0.508,0.875
Deubiquitination,Reactome,18,MDM2;MDM4;CYLD;RNF128;TGFBR1;USP16;BIRC2;ATXN7;PSMB9;TNIP1;PSMA3;USP3;NLRP3;OGT;TRIM25;STAM;VCPIP1;ATXN3,296 (296),0.193,0.907,0,,3 (6),1,1,0.511,0.878
NOTCH1 Intracellular Domain Regulates Transcription,Reactome,4,MAML2;NCOR1;TLE4;TBL1XR1,47 (47),0.193,0.907,0,,2 (2),1,1,0.511,0.878
Abacavir transport and metabolism,Reactome,0,,10 (10),1,1,1,HMDB00295,15 (24),0.195,0.719,0.513,0.881
4-hydroxybenzoate biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00158,15 (17),0.195,0.719,0.513,0.881
Thyroxine biosynthesis,Reactome,0,,10 (10),1,1,1,HMDB00158,15 (17),0.195,0.719,0.513,0.881
Factors involved in megakaryocyte development and platelet production,Wikipathways,0,,18 (18),1,1,1,HMDB01201,15 (16),0.195,0.719,0.513,0.881
One carbon metabolism and related pathways,Wikipathways,3,PCYT1B;CSAD;ETNK1,52 (52),0.466,1,1,HMDB08048#HMDB08036#HMDB08038,38 (42),0.424,1,0.518,0.887
ABC transporter disorders,Reactome,2,SEL1L;DERL3,17 (17),0.199,0.916,0,,6 (7),1,1,0.52,0.887
Disorders of transmembrane transporters,Reactome,2,SEL1L;DERL3,17 (17),0.199,0.916,0,,6 (7),1,1,0.52,0.887
Metabolism of folate and pterines,Reactome,2,SLC46A1;ALDH1L2,17 (17),0.199,0.916,0,,19 (25),1,1,0.52,0.887
Acetylcholine Neurotransmitter Release Cycle,Reactome,2,UNC13B;STXBP1,17 (17),0.199,0.916,0,,6 (7),1,1,0.52,0.887
Regulation of RUNX1 Expression and Activity,Reactome,2,AGO4;CCND2,17 (18),0.199,0.916,0,,4 (4),1,1,0.52,0.887
Unblocking of NMDA receptor_ glutamate binding and activation,Reactome,2,CAMK2D;CAMK2A,17 (17),0.199,0.916,0,,5 (5),1,1,0.52,0.887
Phagosome - Homo sapiens (human),KEGG,10,PIKFYVE;STX7;MRC1;TAP1;CTSS;RAB5B;NCF2;ATP6V1E1;TUBB2B;ATP6V0A1,151 (152),0.199,0.916,0,,1 (1),1,1,0.52,0.888
Detoxification of Reactive Oxygen Species,Reactome,1,NCF2,36 (36),0.834,1,1,HMDB01397,19 (24),0.24,0.854,0.522,0.89
Mitotic Prophase,Reactome,3,PRKCA;USO1;LPIN1,143 (144),0.972,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,16 (16),0.206,0.755,0.523,0.89
Glucuronidation,Reactome,1,ABHD10,25 (25),0.712,1,1,HMDB00295,23 (31),0.283,0.989,0.525,0.89
Oncogene Induced Senescence,Reactome,3,MDM2;MDM4;AGO4,32 (32),0.202,0.918,0,,2 (2),1,1,0.525,0.89
Alpha-synuclein signaling,PID,3,BLK;PLD2;GRK5,32 (32),0.202,0.918,0,,3 (3),1,1,0.525,0.89
ROS_ RNS production in phagocytes,Reactome,3,NCF2;ATP6V1E1;ATP6V0A1,32 (32),0.202,0.918,0,,16 (21),1,1,0.525,0.89
Endosomal Sorting Complex Required For Transport (ESCRT),Reactome,3,STAM;VPS36;CHMP5,32 (32),0.202,0.918,0,,4 (4),1,1,0.525,0.89
miRNA regulation of p53 pathway in prostate cancer,Wikipathways,3,ZMAT3;CASP3;MDM2,32 (32),0.202,0.918,0,,1 (2),1,1,0.525,0.89
White fat cell differentiation,Wikipathways,3,FOXO1;NR3C1;IRF4,32 (32),0.202,0.918,0,,1 (2),1,1,0.525,0.89
Ceramide signaling pathway,PID,4,SMPD3;PAWR;PDGFA;PRKCZ,48 (48),0.203,0.92,0,,2 (2),1,1,0.527,0.893
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,1,ALOX12,19 (21),0.612,1,1,HMDB01999,28 (140),0.333,1,0.528,0.895
Aurora A signaling,PID,3,MDM2;PAK1;NDEL1,31 (31),0.189,0.896,0,,0 (0),1,1,0.189,0.896
Ovarian Infertility Genes,Wikipathways,3,PRLR;NCOR1;CCND2,31 (31),0.189,0.896,0,,0 (0),1,1,0.189,0.896
Vitamin A (retinol) metabolism,EHMN,1,ATP8B2,26 (26),0.726,1,1,HMDB00295,23 (28),0.283,0.989,0.531,0.898
Synthesis of Dolichyl-phosphate,Reactome,0,,6 (6),1,1,1,HMDB01546,16 (18),0.206,0.755,0.532,0.899
Surfactant metabolism,Wikipathways,0,,6 (6),1,1,1,HMDB08048#HMDB08036#HMDB08038,16 (17),0.206,0.755,0.532,0.899
pyrimidine deoxyribonucleotides biosynthesis from CTP,HumanCyc,0,,16 (16),1,1,1,HMDB01546,16 (17),0.206,0.755,0.532,0.899
Interleukin-17 signaling,Reactome,5,MEF2C;MAPK11;ATF1;RPS6KA2;RPS6KA3,65 (65),0.208,0.928,0,,4 (6),1,1,0.534,0.901
MAP kinase activation,Reactome,5,MEF2C;MAPK11;ATF1;RPS6KA2;RPS6KA3,65 (65),0.208,0.928,0,,4 (6),1,1,0.534,0.901
Phase I - Functionalization of compounds,Reactome,5,ALDH1A1;NCOA1;PTGIS;TBXAS1;ACSS1,107 (109),0.599,1,3,HMDB00925;HMDB00658#HMDB10370;HMDB01043,146 (193),0.348,1,0.535,0.902
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,2,SLC25A27;NDUFAF2,123 (123),0.984,1,1,HMDB01201,17 (23),0.218,0.788,0.545,0.906
Trk receptor signaling mediated by the MAPK pathway,PID,3,MEF2C;BRAF;RAP1B,33 (33),0.215,0.928,0,,1 (1),1,1,0.545,0.906
BDNF-TrkB Signaling,Wikipathways,3,MKNK1;PIK3CG;BRAF,33 (33),0.215,0.928,0,,2 (2),1,1,0.545,0.906
Prion disease pathway,Wikipathways,3,MEF2C;CASP3;IRF4,33 (33),0.215,0.928,0,,1 (2),1,1,0.545,0.906
27-Hydroxylase Deficiency,SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Congenital Bile Acid Synthesis Defect Type II,SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Familial Hypercholanemia (FHCA),SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Bile Acid Biosynthesis,SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Cerebrotendinous Xanthomatosis (CTX),SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Zellweger Syndrome,SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Congenital Bile Acid Synthesis Defect Type III,SMPDB,0,,17 (17),1,1,2,HMDB00220;HMDB00658#HMDB10370,61 (62),0.216,0.786,0.547,0.906
Tryptophan degradation,INOH,5,ALDH1A1;MDM2;ALDH3A2;ALDH7A1;EHHADH,66 (69),0.216,0.928,0,,54 (62),1,1,0.548,0.906
Beta-agonist/Beta-blocker Pathway_ Pharmacodynamics,PharmGKB,5,CACNA1S;PRKCA;GNG2;PLCB4;PRKCZ,66 (66),0.216,0.928,0,,8 (11),1,1,0.548,0.906
Synthesis of PIPs at the Golgi membrane,Reactome,2,PIKFYVE;FIG4,18 (18),0.217,0.928,0,,10 (15),1,1,0.548,0.906
Signaling by cytosolic FGFR1 fusion mutants,Reactome,2,PIK3CA;STAT1,18 (18),0.217,0.928,0,,3 (8),1,1,0.548,0.906
Norepinephrine Neurotransmitter Release Cycle,Reactome,2,UNC13B;STXBP1,18 (18),0.217,0.928,0,,8 (8),1,1,0.548,0.906
Polycystic Kidney Disease Pathway,Wikipathways,2,BRAF;KCNN4,18 (18),0.217,0.928,0,,8 (8),1,1,0.548,0.906
Regulation of signaling by CBL,Reactome,2,BLNK;PIK3CA,18 (18),0.217,0.928,0,,2 (2),1,1,0.548,0.906
Transcriptional Regulation by TP53,Reactome,17,RRAGD;MDM2;CASP1;RNF34;MDM4;SGK1;MAPK11;AKT3;PRR5;JMY;CNOT6L;AGO4;GLS;PRDM1;NDRG1;PRKAG2;TAF7,371 (374),0.634,1,1,HMDB01201,29 (37),0.343,1,0.549,0.906
Catecholamine biosynthesis,Reactome,0,,4 (4),1,1,1,HMDB00158,17 (18),0.218,0.788,0.55,0.906
Leukotriene metabolism,EHMN,4,ALDH3A2;EHHADH;ACOT7;ALDH7A1,103 (105),0.743,1,1,HMDB01043,24 (27),0.293,1,0.55,0.906
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,7,MAPK11;BIRC2;MEF2C;ATF1;RPS6KA2;RPS6KA3;LY96,101 (101),0.219,0.928,0,,5 (10),1,1,0.552,0.906
MyD88-independent TLR4 cascade ,Reactome,7,MAPK11;BIRC2;MEF2C;ATF1;RPS6KA2;RPS6KA3;LY96,101 (101),0.219,0.928,0,,5 (10),1,1,0.552,0.906
protein citrullination,HumanCyc,1,PADI4,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
Keratan sulfate degradation,Reactome,1,HEXA,5 (5),0.22,0.928,0,,3 (9),1,1,0.554,0.906
IRF3 mediated activation of type 1 IFN,Reactome,1,ZBP1,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
Caffeine metabolism - Homo sapiens (human),KEGG,1,XDH,5 (5),0.22,0.928,0,,18 (22),1,1,0.554,0.906
Activation of caspases through apoptosome-mediated cleavage,Reactome,1,CASP3,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
Cytochrome c-mediated apoptotic response,Reactome,1,CASP3,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
Sodium-coupled sulphate_ di- and tri-carboxylate transporters,Reactome,1,SLC13A5,5 (5),0.22,0.928,0,,4 (4),1,1,0.554,0.906
Estrogen biosynthesis,Reactome,1,HSD17B11,5 (5),0.22,0.928,0,,9 (10),1,1,0.554,0.906
Reelin signalling pathway,Reactome,1,RELN,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
NGF-independant TRKA activation,Reactome,1,ADORA2A,5 (5),0.22,0.928,0,,1 (1),1,1,0.554,0.906
Fructose catabolism,Reactome,1,ALDH1A1,5 (5),0.22,0.928,0,,10 (16),1,1,0.554,0.906
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,1,GFPT1,5 (5),0.22,0.928,0,,8 (11),1,1,0.554,0.906
Carnitine Synthesis,SMPDB,1,SETD7,5 (5),0.22,0.928,0,,19 (20),1,1,0.554,0.906
Taurine and Hypotaurine Metabolism,SMPDB,1,CSAD,5 (5),0.22,0.928,0,,12 (12),1,1,0.554,0.906
retinoate biosynthesis II,HumanCyc,1,XDH,5 (5),0.22,0.928,0,,5 (6),1,1,0.554,0.906
Riboflavin Metabolism,SMPDB,1,ENPP1,5 (5),0.22,0.928,0,,19 (19),1,1,0.554,0.906
D-Glutamine and D-glutamate metabolism - Homo sapiens (human),KEGG,1,GLS,5 (5),0.22,0.928,0,,8 (12),1,1,0.554,0.906
Threonine catabolism,Reactome,1,GCAT,5 (5),0.22,0.928,0,,12 (15),1,1,0.554,0.906
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer,Wikipathways,1,JAK1,5 (5),0.22,0.928,0,,4 (4),1,1,0.554,0.906
Hedgehog _on_ state,Wikipathways,1,PTCH1,5 (5),0.22,0.928,0,,2 (2),1,1,0.554,0.906
tRNA splicing,HumanCyc,1,TRPT1,5 (5),0.22,0.928,0,,8 (11),1,1,0.554,0.906
Gastric ulcer formation,Wikipathways,1,FAAH,5 (5),0.22,0.928,0,,2 (3),1,1,0.554,0.906
Aminosugars metabolism,INOH,1,GFPT1,20 (20),0.631,1,1,HMDB00295,30 (32),0.353,1,0.557,0.911
Prostaglandin formation from arachidonate,EHMN,2,PTGIS;ALOX12,34 (34),0.497,1,1,HMDB01043,41 (48),0.449,1,0.558,0.911
role of nicotinic acetylcholine receptors in the regulation of apoptosis,BioCarta,2,PIK3CA;CHRNB1,17 (17),0.199,0.916,0,,0 (0),1,1,0.199,0.916
IL-9 Signaling Pathway,Wikipathways,2,JAK1;STAT1,17 (17),0.199,0.916,0,,0 (0),1,1,0.199,0.916
Lung fibrosis,Wikipathways,5,ATP11A;MMP2;SKIL;PDGFA;HGF,64 (64),0.199,0.916,0,,0 (1),1,1,0.199,0.916
Signaling by TGF-beta Receptor Complex,Reactome,5,F11R;SKIL;NCOR1;TGFBR1;PRKCZ,67 (67),0.225,0.941,0,,7 (7),1,1,0.561,0.916
rho cell motility signaling pathway,BioCarta,3,NCF2;ARHGAP6;ARFGAP3,32 (34),0.202,0.918,0,,0 (0),1,1,0.202,0.918
Constitutive Androstane Receptor Pathway,Wikipathways,3,NCOA1;EHHADH;FOXO1,32 (32),0.202,0.918,0,,0 (1),1,1,0.202,0.918
IL5,NetPath,4,IL5RA;STAT1;JAK1;PIK3CG,48 (48),0.203,0.92,0,,0 (0),1,1,0.203,0.92
Exercise-induced Circadian Regulation,Wikipathways,4,CLOCK;ERC2;HERPUD1;NR1D2,48 (48),0.203,0.92,0,,0 (0),1,1,0.203,0.92
Negative regulation of FGFR2 signaling,Reactome,3,BRAF;FGFR2;MKNK1,34 (34),0.227,0.947,0,,4 (5),1,1,0.564,0.921
Pyruvate metabolism,INOH,3,ALDH1A1;ALDH3A2;ALDH7A1,34 (34),0.227,0.947,0,,31 (31),1,1,0.564,0.921
M Phase,Reactome,8,LPIN1;CLIP1;PRKCA;USO1;NIPBL;PTTG1;SDCCAG8;NDEL1,339 (340),0.994,1,1,HMDB07100#HMDB07098#HMDB07099#HMDB07161#HMDB07160#HMDB07218,18 (18),0.229,0.82,0.565,0.921
Tyrosine hydroxylase deficiency,SMPDB,0,,4 (4),1,1,1,HMDB00158,18 (18),0.229,0.82,0.567,0.922
superpathway of melatonin degradation,HumanCyc,0,,13 (13),1,1,1,HMDB00295,18 (24),0.229,0.82,0.567,0.922
Catecholamine Biosynthesis,SMPDB,0,,4 (4),1,1,1,HMDB00158,18 (18),0.229,0.82,0.567,0.922
Aromatic L-Aminoacid Decarboxylase Deficiency,SMPDB,0,,4 (4),1,1,1,HMDB00158,18 (18),0.229,0.82,0.567,0.922
MicroRNAs in cancer - Homo sapiens (human),KEGG,18,MDM2;PDGFA;MIR7-1;PDGFRA;MIR15B;PIK3CA;TNXB;MDM4;FOXP1;ST14;PLCG2;PDCD4;IRS2;GLS;CASP3;HMGA2;PRKCA;CCND2,299 (299),0.205,0.925,0,,0 (0),1,1,0.205,0.925
DroToll-like,INOH,5,APH1B;PSMA3;CASP1;CASP3;PSMB9,65 (65),0.208,0.928,0,,0 (1),1,1,0.208,0.928
Inflammatory bowel disease (IBD) - Homo sapiens (human),KEGG,5,TBX21;IL10;TLR5;STAT1;IL18,65 (65),0.208,0.928,0,,0 (0),1,1,0.208,0.928
Mitophagy - animal - Homo sapiens (human),KEGG,5,EIF2AK3;ATF4;NBR1;SQSTM1;TAX1BP1,65 (65),0.208,0.928,0,,0 (0),1,1,0.208,0.928
Hippo signaling pathway - Homo sapiens (human),KEGG,10,WNT10A;TGFBR1;RASSF6;BIRC2;DLG2;BMP6;BMPR1A;MPP5;PRKCZ;CCND2,153 (154),0.21,0.928,0,,0 (0),1,1,0.21,0.928
Alpha 6 Beta 4 signaling pathway,Wikipathways,3,PRKCA;LAMC1;IRS2,33 (33),0.215,0.928,0,,0 (0),1,1,0.215,0.928
IL-1 p38,INOH,5,MAPK11;PSMA3;PSMB9;MAPK13;MAPK12,66 (66),0.216,0.928,0,,0 (0),1,1,0.216,0.928
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,Wikipathways,2,BRAF;RAB5B,18 (18),0.217,0.928,0,,0 (0),1,1,0.217,0.928
oxidative stress induced gene expression via nrf2,BioCarta,2,MAFG;PRKCA,18 (18),0.217,0.928,0,,0 (0),1,1,0.217,0.928
internal ribosome entry pathway,BioCarta,2,CASP1;CASP3,18 (18),0.217,0.928,0,,0 (0),1,1,0.217,0.928
Pathway_PA165959425,PharmGKB,2,BRAF;FLT4,18 (18),0.217,0.928,0,,0 (1),1,1,0.217,0.928
JAK-STAT-Ncore,Signalink,2,CISH;STAM,18 (18),0.217,0.928,0,,0 (0),1,1,0.217,0.928
RUNX3 Regulates Immune Response and Cell Migration,Reactome,1,ITGAL,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Class IB PI3K non-lipid kinase events,PID,1,PIK3CG,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
SMAC binds to IAPs ,Reactome,1,CASP3,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
SMAC-mediated dissociation of IAP:caspase complexes ,Reactome,1,CASP3,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
SMAC-mediated apoptotic response,Reactome,1,CASP3,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Interleukin-9 signaling,Reactome,1,JAK1,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Binding and entry of HIV virion,Reactome,1,CXCR4,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
The fatty acid cycling model,Reactome,1,SLC25A27,5 (5),0.22,0.928,0,,0 (3),1,1,0.22,0.928
hiv-1 defeats host-mediated resistance by cem15,BioCarta,1,CXCR4,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Cross-presentation of soluble exogenous antigens (endosomes),Reactome,1,MRC1,5 (5),0.22,0.928,0,,0 (1),1,1,0.22,0.928
phospholipase c signaling pathway,BioCarta,1,PIK3CA,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Sperm:Oocyte Membrane Binding,Reactome,1,IZUMO1,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
TFAP2 (AP-2) family regulates transcription of cell cycle factors,Reactome,1,KDM5B,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
MET interacts with TNS proteins,Reactome,1,HGF,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
MET activates PTPN11,Reactome,1,HGF,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Transcriptional regulation of pluripotent stem cells,Wikipathways,1,EPAS1,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Interleukin-37 signaling,Reactome,1,IL18BP,5 (5),0.22,0.928,0,,0 (0),1,1,0.22,0.928
Wnt Canonical,INOH,8,PSMB9;WNT10A;SDC3;SDC1;SDC4;TLE4;PSMA3;GPC4,119 (119),0.221,0.929,0,,0 (0),1,1,0.221,0.929
Wnt Mammals,INOH,8,PSMB9;WNT10A;SDC3;SDC1;SDC4;TLE4;PSMA3;GPC4,119 (119),0.221,0.929,0,,0 (0),1,1,0.221,0.929
Nonalcoholic fatty liver disease,Wikipathways,10,ERN1;CASP3;PIK3CA;EIF2AK3;AKT3;LEPR;ATF4;IRS2;INSR;PRKAG2,155 (155),0.221,0.929,0,,0 (4),1,1,0.221,0.929
AMP-activated Protein Kinase (AMPK) Signaling,Wikipathways,5,LEPR;PIK3CA;INSR;PRKAG2;PIK3CG,68 (68),0.234,0.967,0,,7 (7),1,1,0.574,0.933
Regulation of Androgen receptor activity,PID,4,NCOA1;NR3C1;FOXO1;MDM2,51 (51),0.234,0.967,0,,3 (3),1,1,0.574,0.933
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,2,VNN3;ENPP1,19 (19),0.235,0.967,0,,20 (28),1,1,0.575,0.933
nitric oxide signaling pathway,BioCarta,2,PRKCA;PPP3CC,19 (19),0.235,0.967,0,,4 (5),1,1,0.575,0.933
RHO GTPases Activate ROCKs,Reactome,2,PAK1;PPP1R12A,19 (19),0.235,0.967,0,,5 (5),1,1,0.575,0.933
Translation Factors,Wikipathways,4,EIF1;EIF2AK3;EIF4A2;EIF5,50 (50),0.224,0.937,0,,0 (0),1,1,0.224,0.937
Colorectal cancer - Homo sapiens (human),KEGG,6,BRAF;CASP3;TGFBR1;PIK3CA;AKT3;DCC,86 (86),0.239,0.982,0,,1 (1),1,1,0.581,0.941
Alanine and aspartate metabolism,Wikipathways,0,,12 (12),1,1,1,HMDB00536,19 (20),0.24,0.854,0.583,0.941
UMP biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB00288,19 (20),0.24,0.854,0.583,0.941
TP53 Regulates Metabolic Genes,Wikipathways,0,,9 (9),1,1,1,HMDB01201,19 (25),0.24,0.854,0.583,0.941
RET signaling,Reactome,3,PRKCA;IRS2;RAP1GAP,35 (35),0.241,0.983,0,,2 (2),1,1,0.583,0.941
Amyotrophic lateral sclerosis (ALS),Wikipathways,3,CASP1;CASP3;PPP3CC,35 (35),0.241,0.983,0,,10 (11),1,1,0.583,0.941
Amino acid synthesis and interconversion (transamination),Reactome,3,GLUL;GLS;NAT8L,35 (35),0.241,0.983,0,,41 (46),1,1,0.583,0.941
BMP signaling Dro,INOH,3,BMPR1A;BMP6;MAML2,34 (34),0.227,0.947,0,,0 (0),1,1,0.227,0.947
Apoptotic execution phase,Reactome,4,SATB1;CASP3;BMX;BIRC2,52 (52),0.245,0.997,0,,2 (3),1,1,0.59,0.949
Ion homeostasis,Reactome,4,CAMK2D;ATP1B3;ITPR2;CAMK2A,52 (52),0.245,0.997,0,,9 (10),1,1,0.59,0.949
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,4,NCOA1;PRKCA;NCOR1;EHHADH,52 (52),0.245,0.997,0,,1 (9),1,1,0.59,0.949
Autoimmune thyroid disease - Homo sapiens (human),KEGG,4,IL10;CD28;CD80;CTLA4,52 (53),0.245,0.997,0,,3 (4),1,1,0.59,0.949
Degradation of the extracellular matrix,Reactome,7,CASP3;ADAM8;LAMC1;CTSS;CAPN5;ADAMTS5;MMP2,105 (105),0.248,1,0,,5 (8),1,1,0.594,0.956
Metabolism of cofactors,Reactome,1,PTS,19 (19),0.612,1,1,HMDB00159,36 (47),0.407,1,0.595,0.957
Detoxification of Reactive Oxygen Species,Wikipathways,0,,0 (0),1,1,1,HMDB01397,22 (26),0.273,0.957,0.273,0.957
Xenobiotics metabolism,EHMN,0,,51 (53),1,1,1,HMDB00295,20 (93),0.251,0.889,0.598,0.96
Nicotine Metabolism Pathway,SMPDB,0,,9 (9),1,1,1,HMDB00295,20 (21),0.251,0.889,0.598,0.96
AP-1 transcription factor network,PID,5,MAFG;IL10;NR3C1;COL1A2;GJA1,70 (70),0.253,1,0,,1 (5),1,1,0.6,0.961
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,2,INPP1;IPMK,20 (20),0.253,1,0,,10 (11),1,1,0.601,0.961
Hedgehog ligand biogenesis,Reactome,2,SEL1L;SYVN1,20 (20),0.253,1,0,,7 (7),1,1,0.601,0.961
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human),KEGG,2,CHPF;CHST3,20 (20),0.253,1,0,,3 (12),1,1,0.601,0.961
Nanomaterial induced apoptosis,Wikipathways,2,CASP3;CFLAR,20 (20),0.253,1,0,,1 (1),1,1,0.601,0.961
Phenytoin Pathway_ Pharmacokinetics,PharmGKB,2,PTGIS;TBXAS1,20 (20),0.253,1,0,,1 (1),1,1,0.601,0.961
RHO GTPase Effectors,Reactome,11,PAK1;KDM4C;RHPN2;ABI2;CLIP1;BTK;NDEL1;NCF2;PPP1R12A;RHOQ;ARPC2,300 (301),0.868,1,1,HMDB01201,24 (27),0.293,1,0.603,0.961
GABAergic synapse - Homo sapiens (human),KEGG,6,GLUL;HAP1;PRKCA;CACNA1S;GLS;GNG2,88 (88),0.255,1,0,,9 (9),1,1,0.604,0.961
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,6,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3,88 (88),0.255,1,0,,5 (11),1,1,0.604,0.961
Cell junction organization,Reactome,6,F11R;ARHGEF6;MPP5;LIMS1;SDK2;CLDN7,88 (89),0.255,1,0,,1 (1),1,1,0.604,0.961
Glypican 3 network,PID,1,PTCH1,6 (6),0.258,1,0,,1 (1),1,1,0.608,0.961
Synthesis of Lipoxins (LX),Reactome,1,ALOX12,6 (6),0.258,1,0,,12 (18),1,1,0.608,0.961
Negative feedback regulation of MAPK pathway,Reactome,1,BRAF,6 (6),0.258,1,0,,2 (2),1,1,0.608,0.961
urate biosynthesis/inosine 5_-phosphate degradation,HumanCyc,1,XDH,6 (6),0.258,1,0,,10 (11),1,1,0.608,0.961
PTK6 promotes HIF1A stabilization,Reactome,1,LRRK2,6 (6),0.258,1,0,,2 (2),1,1,0.608,0.961
Proton-coupled monocarboxylate transport,Reactome,1,EMB,6 (6),0.258,1,0,,3 (5),1,1,0.608,0.961
Activation of TRKA receptors,Reactome,1,ADORA2A,6 (6),0.258,1,0,,3 (3),1,1,0.608,0.961
estradiol biosynthesis I,HumanCyc,1,HSD17B11,6 (6),0.258,1,0,,12 (13),1,1,0.608,0.961
Galactose catabolism,Reactome,1,PGM2L1,6 (6),0.258,1,0,,8 (10),1,1,0.608,0.961
MET Receptor Activation,Reactome,1,HGF,6 (6),0.258,1,0,,3 (3),1,1,0.608,0.961
SMAD2/3 MH2 Domain Mutants in Cancer,Reactome,1,TGFBR1,6 (6),0.258,1,0,,2 (2),1,1,0.608,0.961
Loss of Function of SMAD2/3 in Cancer,Reactome,1,TGFBR1,6 (6),0.258,1,0,,2 (2),1,1,0.608,0.961
Pantothenate and CoA Biosynthesis,SMPDB,1,ENPP1,6 (6),0.258,1,0,,21 (21),1,1,0.608,0.961
Signaling by NOTCH4,Wikipathways,1,FLT4,6 (6),0.258,1,0,,3 (3),1,1,0.608,0.961
Pyrimidine biosynthesis,Reactome,0,,3 (3),1,1,1,HMDB00288,21 (22),0.262,0.923,0.613,0.967
Linoleic acid (LA) metabolism,Reactome,0,,8 (8),1,1,1,HMDB00673,21 (24),0.262,0.923,0.613,0.967
gluconeogenesis,HumanCyc,0,,25 (26),1,1,1,HMDB01201,21 (26),0.262,0.923,0.613,0.967
IL3,NetPath,4,PRKCA;FOXO1;ATF1;TEC,51 (51),0.234,0.967,0,,0 (0),1,1,0.234,0.967
akt signaling pathway,BioCarta,2,PIK3CA;FOXO1,19 (19),0.235,0.967,0,,0 (0),1,1,0.235,0.967
Other semaphorin interactions,Reactome,2,PLXNA1;PLXNC1,19 (19),0.235,0.967,0,,0 (0),1,1,0.235,0.967
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Reactome,4,APH1B;MAML2;NCOR1;TBL1XR1,54 (54),0.267,1,0,,3 (3),1,1,0.619,0.973
Constitutive Signaling by NOTCH1 PEST Domain Mutants,Reactome,4,APH1B;MAML2;NCOR1;TBL1XR1,54 (54),0.267,1,0,,3 (3),1,1,0.619,0.973
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Reactome,4,APH1B;MAML2;NCOR1;TBL1XR1,54 (54),0.267,1,0,,3 (3),1,1,0.619,0.973
Signaling by NOTCH1 in Cancer,Reactome,4,APH1B;MAML2;NCOR1;TBL1XR1,54 (54),0.267,1,0,,3 (3),1,1,0.619,0.973
Cardiac Hypertrophic Response,Wikipathways,4,CAMK2D;PRKCA;TGFBR1;FGFR2,54 (54),0.267,1,0,,4 (5),1,1,0.619,0.973
Signaling by NOTCH1 PEST Domain Mutants in Cancer,Reactome,4,APH1B;MAML2;NCOR1;TBL1XR1,54 (54),0.267,1,0,,3 (3),1,1,0.619,0.973
RHO GTPases Activate WASPs and WAVEs,Reactome,3,ABI2;ARPC2;BTK,37 (37),0.267,1,0,,4 (5),1,1,0.62,0.973
Allograft rejection - Homo sapiens (human),KEGG,3,IL10;CD28;CD80,37 (38),0.267,1,0,,1 (1),1,1,0.62,0.973
NCAM1 interactions,Reactome,3,CACNA1H;CACNA1S;NCAN,37 (37),0.267,1,0,,1 (1),1,1,0.62,0.973
phosphoinositides and their downstream targets,BioCarta,2,PRKCZ;BTK,21 (21),0.272,1,0,,1 (1),1,1,0.626,0.977
p53-Dependent G1/S DNA damage checkpoint,Reactome,2,MDM2;MDM4,21 (21),0.272,1,0,,2 (2),1,1,0.626,0.977
Arginine biosynthesis - Homo sapiens (human),KEGG,2,GLUL;GLS,21 (21),0.272,1,0,,18 (23),1,1,0.626,0.977
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Reactome,2,SKIL;NCOR1,21 (21),0.272,1,0,,4 (4),1,1,0.626,0.977
RHO GTPases activate PAKs,Reactome,2,PAK1;PPP1R12A,21 (21),0.272,1,0,,6 (6),1,1,0.626,0.977
p53-Dependent G1 DNA Damage Response,Reactome,2,MDM2;MDM4,21 (21),0.272,1,0,,2 (2),1,1,0.626,0.977
BMP Signalling Pathway,HumanCyc,2,BMPR1A;ZFYVE16,21 (21),0.272,1,0,,2 (2),1,1,0.626,0.977
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,6,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3,90 (90),0.272,1,0,,5 (11),1,1,0.626,0.977
MyD88 dependent cascade initiated on endosome,Reactome,6,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3,90 (90),0.272,1,0,,5 (11),1,1,0.626,0.977
TCA cycle,HumanCyc,0,,19 (19),1,1,1,HMDB01201,22 (23),0.273,0.957,0.627,0.977
Pentose phosphate pathway - Homo sapiens (human),KEGG,0,,30 (30),1,1,1,HMDB00618#HMDB01548,22 (35),0.273,0.957,0.627,0.977
Fructose Mannose metabolism,INOH,1,GFPT1,30 (30),0.776,1,1,HMDB01201,30 (33),0.353,1,0.628,0.979
HIF-2-alpha transcription factor network,PID,3,EPAS1;ADORA2A;POU6F1,35 (35),0.241,0.983,0,,0 (2),1,1,0.241,0.983
Photodynamic therapy-induced NF-kB survival signaling,Wikipathways,3,BIRC2;CFLAR;MMP2,35 (35),0.241,0.983,0,,0 (0),1,1,0.241,0.983
JAK-STAT-Core,Signalink,7,IL10;JAK1;IL5RA;LEPR;PRLR;STAT1;IL27,104 (104),0.241,0.985,0,,0 (0),1,1,0.241,0.985
Arginine Proline metabolism,INOH,4,ALDH1A1;GLUL;ALDH3A2;ALDH7A1,55 (55),0.277,1,0,,59 (68),1,1,0.633,0.986
Metabolism of nitric oxide,Wikipathways,0,,0 (0),1,1,1,HMDB00220,23 (26),0.283,0.989,0.283,0.989
Interleukin-2 family signaling,Reactome,3,IL5RA;PIK3CA;JAK1,38 (38),0.28,1,0,,2 (3),1,1,0.637,0.99
Signaling events mediated by HDAC Class II,PID,3,MEF2C;GNG2;NR3C1,38 (38),0.28,1,0,,1 (1),1,1,0.637,0.99
Interleukin-10 signaling,Wikipathways,3,CXCL10;CD80;IL18,38 (38),0.28,1,0,,2 (2),1,1,0.637,0.99
Primary Focal Segmental Glomerulosclerosis FSGS,Wikipathways,5,IRF6;ITGA3;LIMS1;CD80;CD2AP,73 (73),0.281,1,0,,1 (4),1,1,0.637,0.99
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,0,,22 (23),1,1,1,HMDB01043,23 (28),0.283,0.989,0.64,0.994
Pyrimidine salvage,Reactome,0,,11 (11),1,1,1,HMDB00288,23 (23),0.283,0.989,0.64,0.994
Metabolic reprogramming in colon cancer,Wikipathways,1,GLS,42 (42),0.877,1,1,HMDB00618#HMDB01548,27 (35),0.324,1,0.641,0.994
Nicotine Action Pathway,SMPDB,1,ATP1B3,36 (36),0.834,1,1,HMDB00295,29 (30),0.343,1,0.644,0.998
Cellular roles of Anthrax toxin,PID,2,CASP1;IL18,22 (22),0.29,1,0,,4 (4),1,1,0.649,0.999
Type II diabetes mellitus,Wikipathways,2,INSR;PRKCZ,22 (22),0.29,1,0,,4 (4),1,1,0.649,0.999
Interleukin-6 family signaling,Reactome,2,STAT1;JAK1,22 (22),0.29,1,0,,2 (3),1,1,0.649,0.999
TCA Cycle (aka Krebs or citric acid cycle),Wikipathways,0,,17 (17),1,1,1,HMDB01201,24 (24),0.293,1,0.653,0.999
alpha-linolenic acid (ALA) metabolism,Reactome,0,,13 (13),1,1,1,HMDB01388,24 (32),0.293,1,0.653,0.999
MAPK6/MAPK4 signaling,Reactome,3,MMP2;PAK1;FOXO1,39 (39),0.294,1,0,,5 (5),1,1,0.654,0.999
Pyruvate metabolism - Homo sapiens (human),KEGG,3,ALDH3A2;ACSS1;ALDH7A1,39 (39),0.294,1,0,,25 (31),1,1,0.654,0.999
Fructose metabolism,Reactome,1,ALDH1A1,7 (7),0.294,1,0,,15 (21),1,1,0.654,0.999
Signaling by TGF-beta Receptor Complex in Cancer,Reactome,1,TGFBR1,7 (7),0.294,1,0,,2 (2),1,1,0.654,0.999
CS/DS degradation,Reactome,1,HEXA,7 (7),0.294,1,0,,4 (16),1,1,0.654,0.999
Apoptotic factor-mediated response,Reactome,1,CASP3,7 (7),0.294,1,0,,2 (2),1,1,0.654,0.999
chondroitin sulfate degradation (metazoa),HumanCyc,1,HEXA,7 (7),0.294,1,0,,66 (134),1,1,0.654,0.999
inositol pyrophosphates biosynthesis,HumanCyc,1,IPMK,7 (7),0.294,1,0,,6 (10),1,1,0.654,0.999
TYSND1 cleaves peroxisomal proteins,Reactome,1,PHYH,7 (7),0.294,1,0,,1 (1),1,1,0.654,0.999
dopamine degradation,HumanCyc,1,ALDH3A2,7 (8),0.294,1,0,,16 (17),1,1,0.654,0.999
phosphatidylcholine biosynthesis,HumanCyc,1,PCYT1B,7 (7),0.294,1,0,,10 (12),1,1,0.654,0.999
dermatan sulfate degradation (metazoa),HumanCyc,1,HEXA,7 (7),0.294,1,0,,66 (135),1,1,0.654,0.999
Ifosfamide Pathway_ Pharmacokinetics,PharmGKB,1,ALDH1A1,7 (7),0.294,1,0,,1 (1),1,1,0.654,0.999
Reversal of alkylation damage by DNA dioxygenases,Reactome,1,ALKBH2,7 (7),0.294,1,0,,9 (9),1,1,0.654,0.999
Ethanol Degradation,SMPDB,1,ACSS1,7 (7),0.294,1,0,,17 (18),1,1,0.654,0.999
Caffeine Metabolism,SMPDB,1,XDH,7 (7),0.294,1,0,,24 (24),1,1,0.654,0.999
phosphatidylethanolamine biosynthesis II,HumanCyc,1,ETNK1,7 (7),0.294,1,0,,9 (12),1,1,0.654,0.999
superpathway of choline degradation to L-serine,HumanCyc,1,ALDH7A1,7 (7),0.294,1,0,,14 (16),1,1,0.654,0.999
RNA polymerase II transcribes snRNA genes,Wikipathways,1,RNU11,7 (7),0.294,1,0,,5 (6),1,1,0.654,0.999
Taste transduction - Homo sapiens (human),KEGG,2,PDE1A;KCNK5,83 (83),0.917,1,1,HMDB01397,27 (33),0.324,1,0.657,1
ECM proteoglycans,Reactome,4,LAMC1;TNXB;SPARC;NCAN,57 (57),0.3,1,0,,2 (3),1,1,0.661,1
Transcriptional regulation by RUNX2,Reactome,5,BGLAP;AKT3;STAT1;NR3C1;COL1A1,75 (75),0.3,1,0,,8 (10),1,1,0.661,1
G alpha (s) signalling events,Reactome,5,PDE1A;GNG2;RTP4;GRK5;ADORA2A,580 (583),1,1,1,HMDB01201,25 (33),0.304,1,0.666,1
Metabolism of nitric oxide,Reactome,0,,16 (16),1,1,1,HMDB00220,25 (26),0.304,1,0.666,1
eNOS activation,Reactome,0,,11 (11),1,1,1,HMDB00220,25 (26),0.304,1,0.666,1
eNOS activation and regulation,Reactome,0,,16 (16),1,1,1,HMDB00220,25 (26),0.304,1,0.666,1
Toll Like Receptor 9 (TLR9) Cascade,Reactome,6,MAPK11;PELI1;MEF2C;ATF1;RPS6KA2;RPS6KA3,94 (94),0.306,1,0,,5 (11),1,1,0.668,1
Tryptophan metabolism - Homo sapiens (human),KEGG,3,ALDH3A2;EHHADH;ALDH7A1,40 (40),0.307,1,0,,53 (81),1,1,0.67,1
The oncogenic action of 2-hydroxyglutarate,SMPDB,1,KDM2A,27 (27),0.74,1,1,HMDB01201,37 (40),0.416,1,0.67,1
Estrogen signaling pathway,Wikipathways,2,BRAF;PIK3CA,23 (23),0.308,1,0,,2 (2),1,1,0.671,1
PI-3K cascade:FGFR2,Reactome,2,PIK3CA;FGFR2,23 (23),0.308,1,0,,4 (6),1,1,0.671,1
Laminin interactions,Reactome,2,LAMC1;ITGA3,23 (23),0.308,1,0,,1 (1),1,1,0.671,1
Signaling events mediated by the Hedgehog family,PID,2,PIK3CA;PTCH1,23 (23),0.308,1,0,,2 (2),1,1,0.671,1
Proximal tubule bicarbonate reclamation - Homo sapiens (human),KEGG,2,GLS;ATP1B3,23 (23),0.308,1,0,,16 (17),1,1,0.671,1
G1/S DNA Damage Checkpoints,Reactome,2,MDM2;MDM4,23 (23),0.308,1,0,,2 (2),1,1,0.671,1
Butanoate metabolism,EHMN,2,EHHADH;ALDH7A1,23 (23),0.308,1,0,,33 (36),1,1,0.671,1
BBSome-mediated cargo-targeting to cilium,Reactome,2,BBS9;BBS10,23 (23),0.308,1,0,,1 (1),1,1,0.671,1
TCA cycle,EHMN,1,SLC13A5,30 (30),0.776,1,1,HMDB01201,35 (36),0.398,1,0.672,1
Chronic myeloid leukemia - Homo sapiens (human),KEGG,5,AKT3;BRAF;PIK3CA;TGFBR1;MDM2,76 (76),0.309,1,0,,1 (1),1,1,0.672,1
tRNA processing,Reactome,2,METTL1;ADAT3,103 (103),0.963,1,1,HMDB01201,27 (51),0.324,1,0.675,1
Pentose phosphate pathway (hexose monophosphate shunt),Reactome,0,,15 (15),1,1,1,HMDB00618#HMDB01548,26 (31),0.314,1,0.677,1
Saturated fatty acids beta-oxidation,EHMN,1,EHHADH,25 (25),0.712,1,1,HMDB00220,41 (43),0.449,1,0.684,1
PI3K Cascade,Reactome,3,PIK3CA;IRS2;FGFR2,41 (41),0.321,1,0,,7 (9),1,1,0.686,1
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,0,,14 (14),1,1,1,HMDB00618#HMDB01548,27 (29),0.324,1,0.689,1
Pentose Phosphate Pathway,SMPDB,0,,14 (14),1,1,1,HMDB00618#HMDB01548,27 (29),0.324,1,0.689,1
Ribose-5-phosphate isomerase deficiency,SMPDB,0,,14 (14),1,1,1,HMDB00618#HMDB01548,27 (29),0.324,1,0.689,1
Transaldolase deficiency,SMPDB,0,,14 (14),1,1,1,HMDB00618#HMDB01548,27 (29),0.324,1,0.689,1
The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMPDB,1,KDM2A,29 (29),0.764,1,1,HMDB01201,38 (41),0.424,1,0.689,1
Infectious disease,Reactome,10,CXCR4;AP1S2;PACS1;CD28;GTF2A1;PDZD3;CHMP5;B2M;STAM;TAF7,251 (253),0.783,1,1,HMDB01201,37 (55),0.416,1,0.691,1
RUNX2 regulates osteoblast differentiation,Reactome,2,BGLAP;COL1A1,24 (24),0.326,1,0,,5 (6),1,1,0.692,1
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,2,NCOA1;PTGIS,24 (24),0.326,1,0,,45 (51),1,1,0.692,1
RUNX2 regulates genes involved in cell migration,Reactome,1,AKT3,8 (8),0.329,1,0,,2 (2),1,1,0.694,1
XBP1(S) activates chaperone genes,Reactome,1,SERP1,8 (8),0.329,1,0,,4 (4),1,1,0.694,1
AMPK inhibits chREBP transcriptional activation activity,Reactome,1,PRKAG2,8 (8),0.329,1,0,,3 (3),1,1,0.694,1
Histidine catabolism,Reactome,1,HNMT,8 (8),0.329,1,0,,22 (23),1,1,0.694,1
Vitamin C (ascorbate) metabolism,Reactome,1,SLC23A1,8 (8),0.329,1,0,,9 (12),1,1,0.694,1
a4b7 Integrin signaling,PID,1,ITGB7,8 (8),0.329,1,0,,1 (1),1,1,0.694,1
HuR (ELAVL1) binds and stabilizes mRNA,Reactome,1,PRKCA,8 (8),0.329,1,0,,2 (2),1,1,0.694,1
visceral fat deposits and the metabolic syndrome,BioCarta,1,NR3C1,8 (8),0.329,1,0,,2 (3),1,1,0.694,1
Cross-presentation of particulate exogenous antigens (phagosomes),Reactome,1,NCF2,8 (8),0.329,1,0,,4 (5),1,1,0.694,1
Synthesis of UDP-N-acetyl-glucosamine,Reactome,1,GFPT1,8 (8),0.329,1,0,,17 (21),1,1,0.694,1
cbl mediated ligand-induced downregulation of egf receptors pathway,BioCarta,1,PRKCA,8 (8),0.329,1,0,,1 (2),1,1,0.694,1
Caffeine Pathway_ Pharmacokinetics,PharmGKB,1,XDH,8 (8),0.329,1,0,,2 (2),1,1,0.694,1
DNA Damage Reversal,Reactome,1,ALKBH2,8 (8),0.329,1,0,,10 (10),1,1,0.694,1
Betaine Metabolism,SMPDB,1,ALDH7A1,8 (8),0.329,1,0,,21 (22),1,1,0.694,1
Ifosfamide Action Pathway,SMPDB,1,ALDH1A1,8 (8),0.329,1,0,,15 (22),1,1,0.694,1
Ifosfamide Metabolism Pathway,SMPDB,1,ALDH1A1,8 (8),0.329,1,0,,15 (22),1,1,0.694,1
Effects of Nitric Oxide,Wikipathways,1,XDH,8 (8),0.329,1,0,,7 (7),1,1,0.694,1
MAPK6-MAPK4 signaling,Wikipathways,1,MMP2,8 (8),0.329,1,0,,5 (5),1,1,0.694,1
Hypothetical Craniofacial Development Pathway,Wikipathways,1,IRF6,8 (8),0.329,1,0,,2 (2),1,1,0.694,1
GABA shunt,HumanCyc,1,GLUL,8 (8),0.329,1,0,,12 (13),1,1,0.694,1
The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMPDB,1,KDM2A,30 (30),0.776,1,1,HMDB01201,38 (41),0.424,1,0.695,1
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Reactome,6,BLNK;CD79A;CD79B;BTK;PLCG2;ITPR2,97 (97),0.332,1,0,,6 (8),1,1,0.698,1
Toll Like Receptor 3 (TLR3) Cascade,Reactome,6,MAPK11;BIRC2;MEF2C;ATF1;RPS6KA2;RPS6KA3,97 (97),0.332,1,0,,4 (10),1,1,0.698,1
Interleukin-1 signaling,Reactome,4,PELI1;IRAK3;SQSTM1;MAP3K3,60 (60),0.333,1,0,,2 (8),1,1,0.699,1
Lysine metabolism,EHMN,4,SLC25A21;KMT2C;ALDH7A1;SETD7,60 (60),0.333,1,0,,39 (53),1,1,0.699,1
Steroids metabolism,INOH,0,,16 (16),1,1,1,HMDB00658#HMDB10370,28 (31),0.333,1,0.7,1
Citric acid cycle (TCA cycle),Reactome,0,,22 (22),1,1,1,HMDB01201,28 (30),0.333,1,0.7,1
Pentose phosphate cycle,INOH,0,,24 (24),1,1,1,HMDB00618#HMDB01548,28 (31),0.333,1,0.7,1
Dopamine metabolism,Wikipathways,0,,13 (13),1,1,1,HMDB00158,28 (32),0.333,1,0.7,1
The oncogenic action of Succinate,SMPDB,1,KDM2A,31 (31),0.787,1,1,HMDB01201,38 (41),0.424,1,0.7,1
The oncogenic action of Fumarate,SMPDB,1,KDM2A,31 (31),0.787,1,1,HMDB01201,39 (42),0.432,1,0.707,1
Pentose phosphate pathway,EHMN,0,,29 (29),1,1,1,HMDB00618#HMDB01548,29 (37),0.343,1,0.71,1
Gluconeogenesis,Reactome,0,,34 (35),1,1,1,HMDB01201,29 (34),0.343,1,0.71,1
Fructose and mannose metabolism,EHMN,0,,21 (21),1,1,1,HMDB01201,29 (34),0.343,1,0.71,1
Coregulation of Androgen receptor activity,PID,4,SVIL;KDM4C;PAWR;RPS6KA3,61 (61),0.344,1,0,,2 (2),1,1,0.711,1
Regulation of PTEN stability and activity,Reactome,2,AKT3;MKRN1,25 (25),0.344,1,0,,5 (5),1,1,0.712,1
IKK complex recruitment mediated by RIP1,Reactome,2,BIRC2;LY96,25 (25),0.344,1,0,,1 (1),1,1,0.712,1
Deadenylation of mRNA,Reactome,2,EIF4A2;CNOT6L,25 (25),0.344,1,0,,2 (4),1,1,0.712,1
Intrinsic Pathway for Apoptosis,Reactome,3,AKT3;CASP3;PPP3CC,43 (43),0.348,1,0,,4 (4),1,1,0.715,1
Type I diabetes mellitus - Homo sapiens (human),KEGG,3,CPE;CD28;CD80,43 (43),0.348,1,0,,3 (3),1,1,0.715,1
Regulation of nuclear beta catenin signaling and target gene transcription,PID,5,MDFIC;TLE4;CCND2;TBL1XR1;MMP2,80 (80),0.348,1,0,,2 (2),1,1,0.715,1
Aromatase deficiency,SMPDB,0,,12 (12),1,1,1,HMDB00295,30 (32),0.353,1,0.72,1
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,0,,12 (12),1,1,1,HMDB00295,30 (32),0.353,1,0.72,1
Androgen and Estrogen Metabolism,SMPDB,0,,12 (12),1,1,1,HMDB00295,30 (32),0.353,1,0.72,1
superpathway of tryptophan utilization,HumanCyc,2,ALDH3A2;DHTKD1,43 (45),0.625,1,1,HMDB00295,57 (70),0.564,1,0.72,1
Ethanol metabolism resulting in production of ROS by CYP2E1,Wikipathways,1,MAFG,9 (9),0.361,1,0,,13 (16),1,1,0.729,1
tryptophan degradation,HumanCyc,1,DHTKD1,9 (9),0.361,1,0,,19 (22),1,1,0.729,1
Methylation Pathways,Wikipathways,1,HNMT,9 (9),0.361,1,0,,5 (5),1,1,0.729,1
p75NTR recruits signalling complexes,Reactome,1,SQSTM1,9 (9),0.361,1,0,,2 (2),1,1,0.729,1
Hyperphenylalaninemia due to dhpr-deficiency,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Sodium/Proton exchangers,Reactome,1,SLC9A9,9 (9),0.361,1,0,,1 (2),1,1,0.729,1
adenosine nucleotides degradation,HumanCyc,1,XDH,9 (9),0.361,1,0,,12 (13),1,1,0.729,1
RHO GTPases Activate Rhotekin and Rhophilins,Reactome,1,RHPN2,9 (9),0.361,1,0,,1 (1),1,1,0.729,1
MAPK1 (ERK2) activation,Reactome,1,JAK1,9 (9),0.361,1,0,,2 (2),1,1,0.729,1
CHL1 interactions,Reactome,1,NRP1,9 (9),0.361,1,0,,1 (1),1,1,0.729,1
ROBO receptors bind AKAP5,Reactome,1,PRKCA,9 (9),0.361,1,0,,2 (2),1,1,0.729,1
signal dependent regulation of myogenesis by corepressor mitr,BioCarta,1,MEF2C,9 (9),0.361,1,0,,1 (1),1,1,0.729,1
Multifunctional anion exchangers,Reactome,1,SLC26A11,9 (9),0.361,1,0,,8 (10),1,1,0.729,1
Glucocorticoid Pathway (Peripheral Tissue)_ Pharmacodynamics,PharmGKB,1,NR3C1,9 (9),0.361,1,0,,4 (5),1,1,0.729,1
Sepiapterin reductase deficiency,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Segawa syndrome,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,1,ALDH1A1,9 (9),0.361,1,0,,11 (12),1,1,0.729,1
glycogenolysis,HumanCyc,1,PYGL,9 (9),0.361,1,0,,6 (7),1,1,0.729,1
Pterine Biosynthesis,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
TRIF-mediated programmed cell death,Reactome,1,LY96,9 (9),0.361,1,0,,1 (1),1,1,0.729,1
Cyclophosphamide Action Pathway,SMPDB,1,ALDH1A1,9 (9),0.361,1,0,,15 (23),1,1,0.729,1
Dopa-responsive dystonia,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),SMPDB,1,PTS,9 (9),0.361,1,0,,20 (20),1,1,0.729,1
Ca2+ activated K+ channels,Reactome,1,KCNN4,9 (9),0.361,1,0,,1 (1),1,1,0.729,1
Cyclophosphamide Metabolism Pathway,SMPDB,1,ALDH1A1,9 (9),0.361,1,0,,15 (23),1,1,0.729,1
retinoate biosynthesis I,HumanCyc,1,ALDH1A1,9 (9),0.361,1,0,,5 (6),1,1,0.729,1
Caloric restriction and aging,Wikipathways,1,NAMPT,9 (9),0.361,1,0,,3 (3),1,1,0.729,1
Signaling by NOTCH3,Reactome,3,APH1B;MAML2;STAT1,44 (44),0.361,1,0,,3 (3),1,1,0.729,1
Vasopressin-regulated water reabsorption - Homo sapiens (human),KEGG,3,CREB3L2;RAB5B;RAB11A,44 (44),0.361,1,0,,2 (2),1,1,0.729,1
Pyruvate dehydrogenase deficiency (E2),SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
Citric Acid Cycle,SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,0,,47 (48),1,1,1,HMDB01201,31 (36),0.362,1,0.73,1
Pyruvate dehydrogenase deficiency (E3),SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
2-ketoglutarate dehydrogenase complex deficiency,SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
Mitochondrial complex II deficiency,SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
Fumarase deficiency,SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
Congenital lactic acidosis,SMPDB,0,,21 (21),1,1,1,HMDB01201,31 (33),0.362,1,0.73,1
Interleukin-7 signaling,Reactome,2,HGF;JAK1,26 (26),0.362,1,0,,2 (2),1,1,0.73,1
Glypican 1 network,PID,2,BLK;TGFBR1,26 (26),0.362,1,0,,2 (2),1,1,0.73,1
Calmodulin induced events,Reactome,2,PDE1A;PRKCA,26 (26),0.362,1,0,,8 (9),1,1,0.73,1
CaM pathway,Reactome,2,PDE1A;PRKCA,26 (26),0.362,1,0,,8 (9),1,1,0.73,1
Nuclear signaling by ERBB4,Reactome,2,APH1B;NCOR1,26 (26),0.362,1,0,,1 (2),1,1,0.73,1
Regulation of IFNA signaling,Reactome,2,STAT1;JAK1,26 (26),0.362,1,0,,2 (9),1,1,0.73,1
Signaling by BMP,Reactome,2,BMPR1A;ZFYVE16,26 (26),0.362,1,0,,2 (2),1,1,0.73,1
Synaptic vesicle cycle - Homo sapiens (human),KEGG,4,UNC13B;ATP6V0A1;STXBP1;ATP6V1E1,63 (63),0.366,1,0,,10 (12),1,1,0.734,1
Cell-cell junction organization,Reactome,4,F11R;MPP5;SDK2;CLDN7,63 (64),0.366,1,0,,1 (1),1,1,0.734,1
Endometrial cancer,Wikipathways,4,AKT3;BRAF;PIK3CA;FGFR2,63 (63),0.366,1,0,,1 (4),1,1,0.734,1
Regulation of retinoblastoma protein,PID,4,MEF2C;BGLAP;MAPK11;CCND2,64 (64),0.378,1,0,,1 (2),1,1,0.745,1
Porphyrin metabolism,EHMN,1,SLC46A1,34 (34),0.816,1,1,HMDB00295,43 (48),0.465,1,0.747,1
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,2,ALDH3A2;ALDH7A1,27 (27),0.38,1,0,,22 (48),1,1,0.748,1
Collecting duct acid secretion - Homo sapiens (human),KEGG,2,ATP6V1E1;ATP6V0A1,27 (27),0.38,1,0,,7 (8),1,1,0.748,1
Endogenous sterols,Reactome,2,NCOA1;PTGIS,27 (27),0.38,1,0,,32 (43),1,1,0.748,1
Fatty Acid Elongation In Mitochondria,SMPDB,0,,7 (7),1,1,1,HMDB00220,33 (34),0.38,1,0.748,1
Glycogenosis_ Type IC,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Fructose-1_6-diphosphatase deficiency,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Metabolism of porphyrins,Reactome,0,,19 (19),1,1,1,HMDB00295,33 (37),0.38,1,0.748,1
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,0,,7 (7),1,1,1,HMDB00220,33 (34),0.38,1,0.748,1
Gluconeogenesis,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Glycogenosis_ Type IA. Von gierke disease,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Triosephosphate isomerase,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Glycogenosis_ Type IB,SMPDB,0,,22 (22),1,1,1,HMDB01201,33 (34),0.38,1,0.748,1
Biological oxidations,Reactome,6,TBXAS1;NCOA1;PTGIS;ABHD10;ACSS1;ALDH1A1,226 (231),0.966,1,4,HMDB00658#HMDB10370;HMDB00925;HMDB00295;HMDB01043,224 (321),0.4,1,0.754,1
Tryptophan metabolism,Wikipathways,3,ALDH1A1;MDM2;ALDH3A2,46 (46),0.388,1,0,,23 (27),1,1,0.755,1
Hedgehog signaling pathway - Homo sapiens (human),KEGG,3,SPOP;CCND2;PTCH1,46 (47),0.388,1,0,,1 (1),1,1,0.755,1
Shigellosis - Homo sapiens (human),KEGG,4,MAPK11;MAPK13;MAPK12;ARPC2,65 (65),0.389,1,0,,1 (2),1,1,0.756,1
FGFR2b ligand binding and activation,Reactome,1,FGFR2,10 (10),0.392,1,0,,3 (4),1,1,0.759,1
Digestion of dietary carbohydrate,Reactome,1,MGAM,10 (10),0.392,1,0,,13 (18),1,1,0.759,1
Crosslinking of collagen fibrils,Reactome,1,LOX,10 (10),0.392,1,0,,6 (6),1,1,0.759,1
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,1,HNMT,10 (10),0.392,1,0,,30 (32),1,1,0.759,1
putrescine degradation III,HumanCyc,1,ALDH3A2,10 (10),0.392,1,0,,14 (15),1,1,0.759,1
Gamma-carboxylation of protein precursors,Reactome,1,BGLAP,10 (10),0.392,1,0,,3 (8),1,1,0.759,1
Zinc influx into cells by the SLC39 gene family,Reactome,1,SLC39A4,10 (10),0.392,1,0,,1 (1),1,1,0.759,1
overview of telomerase protein component gene htert transcriptional regulation,BioCarta,1,MAX,10 (10),0.392,1,0,,1 (1),1,1,0.759,1
Activation of the AP-1 family of transcription factors,Reactome,1,MAPK11,10 (10),0.392,1,0,,2 (2),1,1,0.759,1
Insulin processing,Reactome,1,CPE,10 (10),0.392,1,0,,3 (3),1,1,0.759,1
PI3K events in ERBB4 signaling,Reactome,1,PIK3CA,10 (10),0.392,1,0,,3 (4),1,1,0.759,1
Gemcitabine Pathway_ Pharmacodynamics,PharmGKB,1,CMPK1,10 (10),0.392,1,0,,1 (1),1,1,0.759,1
Interleukin-12 signaling,Reactome,1,JAK1,10 (10),0.392,1,0,,2 (2),1,1,0.759,1
MAPK3 (ERK1) activation,Reactome,1,JAK1,10 (10),0.392,1,0,,2 (2),1,1,0.759,1
Trans-sulfuration pathway,Wikipathways,1,CSAD,10 (10),0.392,1,0,,13 (14),1,1,0.759,1
Leptin and adiponectin,Wikipathways,1,LEPR,10 (10),0.392,1,0,,2 (3),1,1,0.759,1
Cellular responses to stress,Reactome,12,MAPK11;MDM2;MDM4;CAMK2A;NCF2;CAMK2D;EPAS1;RPS6KA2;RPS6KA3;HMGA2;NR3C1;AGO4,344 (345),0.913,1,1,HMDB01397,39 (48),0.432,1,0.762,1
Regulation of RUNX2 expression and activity,Reactome,2,STAT1;NR3C1,28 (28),0.397,1,0,,3 (4),1,1,0.764,1
Citrate cycle,INOH,0,,32 (32),1,1,1,HMDB01201,35 (35),0.398,1,0.765,1
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,3,ENPP2;NADK;ENPP1,47 (47),0.401,1,0,,32 (36),1,1,0.768,1
Glycolysis and Gluconeogenesis,EHMN,2,ACSS1;ALDH7A1,66 (67),0.837,1,1,HMDB01201,45 (52),0.48,1,0.768,1
Galactosemia,SMPDB,0,,13 (13),1,1,1,HMDB00295,36 (36),0.407,1,0.773,1
Pyrimidine catabolism,Reactome,0,,12 (12),1,1,1,HMDB00288,36 (39),0.407,1,0.773,1
Amine-derived hormones,Reactome,0,,18 (18),1,1,1,HMDB00158,36 (38),0.407,1,0.773,1
Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human),KEGG,0,,11 (11),1,1,1,HMDB00158,36 (90),0.407,1,0.773,1
Galactose Metabolism,SMPDB,0,,13 (13),1,1,1,HMDB00295,36 (36),0.407,1,0.773,1
Glucose metabolism,Reactome,1,PGM2L1,90 (91),0.989,1,1,HMDB01201,37 (44),0.416,1,0.776,1
Integrin cell surface interactions,Reactome,4,F11R;ITGA3;ITGAL;ITGB7,67 (67),0.411,1,0,,1 (1),1,1,0.776,1
Generic Transcription Pathway,Reactome,37,BLK;NCOR1;KMT2C;KDM5B;AKT3;KRBA1;NDRG1;AGO4;CNOT6L;RRAGD;SGK1;MAX;GLS;EPC1;PRR5;MAPK11;CASP1;RNF34;KMT2A;MDM4;CTLA4;MAML2;NR3C1;PRKAG2;TAF7;KMT2E;MDM2;SKIL;ITGAL;NR1D1;JMY;STAT1;NR1D2;BGLAP;COL1A1;CCND2;PRDM1,1099 (1107),0.995,1,1,HMDB01201,37 (49),0.416,1,0.779,1
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,3,ALDH3A2;EHHADH;ALDH7A1,48 (48),0.414,1,0,,33 (42),1,1,0.78,1
Negative regulation of FGFR3 signaling,Reactome,2,BRAF;MKNK1,29 (29),0.415,1,0,,4 (4),1,1,0.78,1
Cyclin E associated events during G1/S transition ,Reactome,2,AKT3;MAX,29 (29),0.415,1,0,,4 (4),1,1,0.78,1
fc epsilon receptor i signaling in mast cells,BioCarta,2,PIK3CA;BTK,29 (29),0.415,1,0,,1 (1),1,1,0.78,1
Diuretics Pathway_ Pharmacodynamics,PharmGKB,2,STK39;SGK1,29 (29),0.415,1,0,,3 (3),1,1,0.78,1
TP53 Regulates Transcription of Cell Death Genes,Wikipathways,2,CASP1;NDRG1,29 (29),0.415,1,0,,7 (10),1,1,0.78,1
Nucleotide GPCRs,Wikipathways,1,ADORA2A,11 (11),0.422,1,0,,2 (2),1,1,0.786,1
Cimetidine Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Famotidine Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Dermatan sulfate biosynthesis,Reactome,1,NCAN,11 (11),0.422,1,0,,2 (2),1,1,0.786,1
CLEC7A (Dectin-1) induces NFAT activation,Reactome,1,ITPR2,11 (11),0.422,1,0,,6 (6),1,1,0.786,1
Taurine and hypotaurine metabolism - Homo sapiens (human),KEGG,1,CSAD,11 (11),0.422,1,0,,18 (22),1,1,0.786,1
Gamma-carboxylation_ transport_ and amino-terminal cleavage of proteins,Reactome,1,BGLAP,11 (11),0.422,1,0,,3 (8),1,1,0.786,1
Beta-oxidation of very long chain fatty acids,Reactome,1,EHHADH,11 (11),0.422,1,0,,15 (26),1,1,0.786,1
regulators of bone mineralization,BioCarta,1,ENPP1,11 (11),0.422,1,0,,3 (4),1,1,0.786,1
pertussis toxin-insensitive ccr5 signaling in macrophage,BioCarta,1,CXCR4,11 (11),0.422,1,0,,1 (2),1,1,0.786,1
RHO GTPases activate IQGAPs,Reactome,1,CLIP1,11 (11),0.422,1,0,,2 (2),1,1,0.786,1
Lactose Degradation,SMPDB,1,ATP1B3,11 (11),0.422,1,0,,9 (9),1,1,0.786,1
GAB1 signalosome,Reactome,1,PIK3CA,11 (11),0.422,1,0,,5 (6),1,1,0.786,1
Regulated proteolysis of p75NTR,Reactome,1,APH1B,11 (11),0.422,1,0,,1 (1),1,1,0.786,1
folate transformations,HumanCyc,1,ALDH1L2,11 (11),0.422,1,0,,19 (21),1,1,0.786,1
Pantoprazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,13 (14),1,1,0.786,1
Rabeprazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,13 (14),1,1,0.786,1
Esomeprazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,11 (13),1,1,0.786,1
Omeprazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,13 (14),1,1,0.786,1
Lansoprazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Gastric Acid Production,SMPDB,1,SSTR4,11 (11),0.422,1,0,,11 (12),1,1,0.786,1
Nizatidine Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Ranitidine Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
TRAF6-mediated induction of TAK1 complex within TLR4 complex,Reactome,1,LY96,11 (11),0.422,1,0,,3 (3),1,1,0.786,1
Betazole Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Roxatidine acetate Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,11 (12),1,1,0.786,1
Metiamide Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,11 (13),1,1,0.786,1
Pirenzepine Action Pathway,SMPDB,1,SSTR4,11 (11),0.422,1,0,,12 (13),1,1,0.786,1
Lactose Intolerance,SMPDB,1,ATP1B3,11 (11),0.422,1,0,,9 (9),1,1,0.786,1
3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,1,EHHADH,11 (11),0.422,1,0,,9 (10),1,1,0.786,1
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation,Wikipathways,1,FOXO1,11 (11),0.422,1,0,,1 (1),1,1,0.786,1
HDAC6 interactions,Wikipathways,1,PRKCZ,11 (11),0.422,1,0,,4 (6),1,1,0.786,1
Sterol Regulatory Element-Binding Proteins (SREBP) signalling,Wikipathways,4,PIK3CA;ACSS1;PRKAG2;LPIN1,68 (68),0.422,1,0,,3 (5),1,1,0.786,1
Protein-protein interactions at synapses,Reactome,5,PPFIBP1;DLG2;STXBP1;CASK;PPFIBP2,88 (88),0.426,1,0,,2 (2),1,1,0.789,1
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,1,PDP2,54 (54),0.932,1,1,HMDB01201,42 (44),0.457,1,0.789,1
Valine_ leucine and isoleucine degradation,EHMN,3,SLC3A2;EHHADH;ALDH7A1,49 (49),0.428,1,0,,53 (62),1,1,0.791,1
RNA Polymerase II Transcription,Reactome,43,BLK;NCOR1;KMT2C;GTF2A1;AKT3;KRBA1;ELL2;NDRG1;AGO4;CNOT6L;RRAGD;SGK1;MAX;GLS;EPC1;PRR5;EAF2;CASP1;RNF34;RNU11;KMT2A;MLLT3;MDM4;KDM5B;SRSF5;CTLA4;MAML2;NR3C1;PRKAG2;TAF7;KMT2E;MDM2;SKIL;ITGAL;NR1D1;JMY;STAT1;MAPK11;NR1D2;BGLAP;COL1A1;CCND2;PRDM1,1228 (1236),0.994,1,1,HMDB01201,39 (52),0.432,1,0.793,1
Transcriptional Regulation by MECP2,Wikipathways,2,MEF2C;SGK1,30 (30),0.432,1,0,,3 (3),1,1,0.794,1
Beta2 integrin cell surface interactions,PID,2,F11R;ITGAL,30 (30),0.432,1,0,,1 (6),1,1,0.794,1
Retinoic acid receptors-mediated signaling,PID,2,NCOA1;PRKCA,30 (30),0.432,1,0,,2 (2),1,1,0.794,1
Activation of BH3-only proteins,Reactome,2,AKT3;PPP3CC,30 (30),0.432,1,0,,4 (4),1,1,0.794,1
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,2,GLUL;ACSS1,30 (30),0.432,1,0,,44 (62),1,1,0.794,1
role of mef2d in t-cell apoptosis,BioCarta,2,PRKCA;PPP3CC,30 (30),0.432,1,0,,1 (1),1,1,0.794,1
Pre-NOTCH Transcription and Translation,Reactome,2,MAML2;AGO4,30 (30),0.432,1,0,,2 (2),1,1,0.794,1
Porphyria Variegata (PV),SMPDB,0,,15 (15),1,1,1,HMDB00295,39 (39),0.432,1,0.795,1
Acute Intermittent Porphyria,SMPDB,0,,15 (15),1,1,1,HMDB00295,39 (39),0.432,1,0.795,1
Porphyrin Metabolism,SMPDB,0,,15 (15),1,1,1,HMDB00295,39 (39),0.432,1,0.795,1
Hereditary Coproporphyria (HCP),SMPDB,0,,15 (15),1,1,1,HMDB00295,39 (39),0.432,1,0.795,1
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,SMPDB,0,,15 (15),1,1,1,HMDB00295,39 (39),0.432,1,0.795,1
Negative regulation of FGFR4 signaling,Reactome,2,BRAF;MKNK1,31 (31),0.448,1,0,,4 (4),1,1,0.808,1
Transferrin endocytosis and recycling,Reactome,2,ATP6V1E1;ATP6V0A1,31 (31),0.448,1,0,,6 (8),1,1,0.808,1
PD-1 signaling,Reactome,2,PDCD1LG2;CD274,31 (31),0.448,1,0,,3 (3),1,1,0.808,1
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,BioCarta,2,PIK3CA;BCAR1,31 (31),0.448,1,0,,1 (1),1,1,0.808,1
FGFR1 mutant receptor activation,Reactome,2,PIK3CA;STAT1,31 (31),0.448,1,0,,4 (15),1,1,0.808,1
Activated NOTCH1 Transmits Signal to the Nucleus,Reactome,2,APH1B;DNER,31 (32),0.448,1,0,,1 (1),1,1,0.808,1
Steroid biosynthesis - Homo sapiens (human),KEGG,0,,19 (19),1,1,1,HMDB00658#HMDB10370,41 (50),0.449,1,0.808,1
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Reactome,1,TRIM25,12 (12),0.45,1,0,,1 (1),1,1,0.809,1
Degradation of cysteine and homocysteine,Reactome,1,CSAD,12 (12),0.45,1,0,,34 (39),1,1,0.809,1
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Reactome,1,PELI1,12 (12),0.45,1,0,,2 (2),1,1,0.809,1
phospholipase c-epsilon pathway,BioCarta,1,RAPGEF3,12 (12),0.45,1,0,,4 (6),1,1,0.809,1
Signaling by NOTCH4,Reactome,1,APH1B,12 (12),0.45,1,0,,1 (1),1,1,0.809,1
TP53 Regulates Transcription of Caspase Activators and Caspases,Reactome,1,CASP1,12 (12),0.45,1,0,,2 (2),1,1,0.809,1
Interleukin-2 signaling,Reactome,1,JAK1,12 (12),0.45,1,0,,2 (2),1,1,0.809,1
Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction),PharmGKB,1,CACNA1E,12 (12),0.45,1,0,,2 (3),1,1,0.809,1
Trehalose Degradation,SMPDB,1,ATP1B3,12 (12),0.45,1,0,,10 (10),1,1,0.809,1
Ammonia Recycling,SMPDB,1,GLUL,12 (12),0.45,1,0,,29 (29),1,1,0.809,1
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,1,EHHADH,12 (12),0.45,1,0,,9 (10),1,1,0.809,1
Trihydroxycoprostanoyl-CoA beta-oxidation,EHMN,1,EHHADH,12 (12),0.45,1,0,,9 (10),1,1,0.809,1
Iron metabolism in placenta,Wikipathways,1,SLC40A1,12 (12),0.45,1,0,,2 (2),1,1,0.809,1
IRAK1 recruits IKK complex,Reactome,1,PELI1,12 (12),0.45,1,0,,2 (2),1,1,0.809,1
Josephin domain DUBs,Reactome,1,ATXN3,12 (12),0.45,1,0,,1 (1),1,1,0.809,1
Cardiac conduction,Reactome,7,ATP1B3;KCNK5;CACNA1S;CAMK2A;FGF11;CAMK2D;ITPR2,131 (131),0.453,1,0,,9 (10),1,1,0.812,1
Transcriptional regulation by RUNX3,Reactome,3,MAML2;ITGAL;MDM2,51 (52),0.453,1,0,,7 (7),1,1,0.812,1
Synaptic Vesicle Pathway,Wikipathways,3,SYN3;UNC13B;STXBP1,51 (51),0.453,1,0,,6 (7),1,1,0.812,1
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Fatty acid Metabolism,SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Carnitine palmitoyl transferase deficiency (I),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Glutaminolysis and Cancer,SMPDB,0,,37 (37),1,1,1,HMDB01201,42 (44),0.457,1,0.815,1
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Carnitine palmitoyl transferase deficiency (II),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Glutaric Aciduria Type I,SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Ethylmalonic Encephalopathy,SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Trifunctional protein deficiency,SMPDB,0,,14 (14),1,1,1,HMDB00220,42 (43),0.457,1,0.815,1
Cytochrome P450 - arranged by substrate type,Reactome,3,NCOA1;TBXAS1;PTGIS,66 (68),0.628,1,1,HMDB01043,91 (121),0.737,1,0.82,1
Tyrosine metabolism,INOH,0,,33 (33),1,1,1,HMDB00158,43 (44),0.465,1,0.821,1
Monoamine Transport,Wikipathways,2,UNC13B;ADORA2A,32 (32),0.465,1,0,,8 (14),1,1,0.821,1
RUNX2 regulates bone development,Reactome,2,BGLAP;COL1A1,32 (32),0.465,1,0,,5 (6),1,1,0.821,1
Propanoate metabolism - Homo sapiens (human),KEGG,2,EHHADH;ACSS1,32 (32),0.465,1,0,,40 (48),1,1,0.821,1
Glyoxylate metabolism and glycine degradation,Reactome,2,LIPT1;DHTKD1,32 (32),0.465,1,0,,33 (43),1,1,0.821,1
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human),KEGG,4,GJA1;ITGA3;CACNA1S;ITGB7,72 (72),0.466,1,0,,2 (2),1,1,0.822,1
Phosphodiesterases in neuronal function,Wikipathways,3,PDE1A;PDE6A;ADORA2A,52 (52),0.466,1,0,,10 (11),1,1,0.822,1
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,9,SSTR4;F2RL1;ADORA2A;S1PR1;LEPR;PRLR;CHRNB1;EDNRA;NR3C1,277 (277),0.926,1,1,HMDB00295,49 (130),0.51,1,0.827,1
Regulation of TP53 Activity through Phosphorylation,Reactome,5,MAPK11;MDM2;MDM4;PRKAG2;TAF7,93 (93),0.474,1,0,,3 (3),1,1,0.828,1
PKMTs methylate histone lysines,Reactome,4,KMT2E;KMT2A;KMT2C;SETD7,73 (73),0.476,1,0,,2 (2),1,1,0.83,1
Folate Metabolism,SMPDB,1,SLC46A1,13 (13),0.477,1,0,,27 (28),1,1,0.83,1
FGFR2c ligand binding and activation,Reactome,1,FGFR2,13 (13),0.477,1,0,,3 (3),1,1,0.83,1
Regulation of RUNX3 expression and activity,Reactome,1,MDM2,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
L-kynurenine degradation,HumanCyc,1,DHTKD1,13 (13),0.477,1,0,,27 (30),1,1,0.83,1
NF-kB is activated and signals survival,Reactome,1,SQSTM1,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
noradrenaline and adrenaline degradation,HumanCyc,1,ALDH3A2,13 (13),0.477,1,0,,19 (20),1,1,0.83,1
Methotrexate Action Pathway,SMPDB,1,SLC46A1,13 (13),0.477,1,0,,28 (29),1,1,0.83,1
Import of palmitoyl-CoA into the mitochondrial matrix,Reactome,1,PRKAG2,13 (13),0.477,1,0,,13 (14),1,1,0.83,1
DNA-PK pathway in nonhomologous end joining,PID,1,DNTT,13 (13),0.477,1,0,,1 (1),1,1,0.83,1
TRAF3-dependent IRF activation pathway,Reactome,1,TRIM25,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
activation of pkc through g-protein coupled receptors,BioCarta,1,PRKCA,13 (13),0.477,1,0,,2 (3),1,1,0.83,1
Downregulation of ERBB2:ERBB3 signaling,Reactome,1,AKT3,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
Presynaptic depolarization and calcium channel opening,Reactome,1,CACNA1E,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
Taxane Pathway_ Pharmacokinetics,PharmGKB,1,MAP4,13 (13),0.477,1,0,,2 (2),1,1,0.83,1
Methotrexate Pathway_ Pharmacokinetics,PharmGKB,1,SLC46A1,13 (13),0.477,1,0,,1 (1),1,1,0.83,1
Folate malabsorption_ hereditary,SMPDB,1,SLC46A1,13 (13),0.477,1,0,,27 (28),1,1,0.83,1
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,1,SLC46A1,13 (13),0.477,1,0,,27 (28),1,1,0.83,1
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Reactome,1,LY96,13 (13),0.477,1,0,,3 (3),1,1,0.83,1
Gemcitabine Action Pathway,SMPDB,1,CMPK1,13 (13),0.477,1,0,,8 (8),1,1,0.83,1
Gemcitabine Metabolism Pathway,SMPDB,1,CMPK1,13 (13),0.477,1,0,,8 (8),1,1,0.83,1
D-<i>myo</i>-inositol (1_4_5)-trisphosphate degradation,HumanCyc,1,INPP1,13 (13),0.477,1,0,,6 (6),1,1,0.83,1
Transcriptional regulation by RUNX3,Wikipathways,1,ITGAL,13 (13),0.477,1,0,,7 (7),1,1,0.83,1
RHO GTPases Activate NADPH Oxidases,Reactome,1,NCF2,13 (13),0.477,1,0,,11 (12),1,1,0.83,1
Disulfiram Action Pathway,SMPDB,1,ACSS1,25 (25),0.712,1,1,HMDB00158,76 (77),0.671,1,0.831,1
Cardiac Progenitor Differentiation,Wikipathways,3,MEF2C;CXCR4;PDGFRA,53 (53),0.479,1,0,,1 (1),1,1,0.831,1
Mitochondrial biogenesis,Reactome,3,MAPK11;MAPK12;PRKAG2,53 (53),0.479,1,0,,7 (8),1,1,0.831,1
Gene expression (Transcription),Reactome,45,BLK;NCOR1;KMT2C;KDM5B;AGO4;AKT3;KRBA1;EAF2;ELL2;POLR1A;SRSF5;CNOT6L;RRAGD;NFIB;SGK1;NDRG1;MAX;GLS;EPC1;PRR5;KMT2E;CASP1;RNF34;RNU11;KMT2A;MLLT3;SKIL;GTF2A1;CTLA4;MAML2;NR3C1;PRKAG2;TAF7;MAPK11;MDM2;MDM4;ITGAL;NR1D1;JMY;STAT1;NR1D2;BGLAP;COL1A1;CCND2;PRDM1,1364 (1373),0.999,1,1,HMDB01201,45 (66),0.48,1,0.832,1
Steroid Biosynthesis,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Simvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (46),0.48,1,0.832,1
Mevalonic aciduria,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Desmosterolosis,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Hypercholesterolemia,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Primary hyperoxaluria II_ PH2,SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
Rosuvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (46),0.48,1,0.832,1
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
Hyper-IgD syndrome,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Cholesteryl ester storage disease,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Pyruvate kinase deficiency,SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
Leigh Syndrome,SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
Wolman disease,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Cerivastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (46),0.48,1,0.832,1
Pyruvate Metabolism,SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
CHILD Syndrome,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,0,,22 (22),1,1,1,HMDB01201,45 (46),0.48,1,0.832,1
Zoledronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (46),0.48,1,0.832,1
Ibandronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,45 (45),0.48,1,0.832,1
Serotonin HTR1 Group and FOS Pathway,Wikipathways,2,BRAF;PIK3CA,33 (33),0.481,1,0,,3 (3),1,1,0.833,1
Signaling by NOTCH2,Reactome,2,APH1B;MAML2,33 (33),0.481,1,0,,1 (1),1,1,0.833,1
Cargo concentration in the ER,Reactome,2,MIA3;CTAGE5,33 (33),0.481,1,0,,1 (5),1,1,0.833,1
Polythiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Methyclothiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Bumetanide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Spironolactone Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Eplerenone Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Triamterene Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Amiloride Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Ethacrynic Acid Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Quinethazone Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Bendroflumethiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Chlorthalidone Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Trichlormethiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Iminoglycinuria,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Lysinuric Protein Intolerance,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Blue diaper syndrome,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Lysinuric protein intolerance (LPI),SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Cystinuria,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Indapamide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Furosemide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Torsemide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Hartnup Disorder,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Glucose Transporter Defect (SGLT2),SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Kidney Function,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Glucose Transporter Defect (SGLT2),SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (8),1,1,0.833,1
Metolazone Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,8 (9),1,1,0.833,1
Hydrochlorothiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Cyclothiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Hydroflumethiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Chlorothiazide Action Pathway,SMPDB,2,SLC3A2;ATP1B3,33 (33),0.481,1,0,,9 (9),1,1,0.833,1
Negative regulation of FGFR1 signaling,Reactome,2,BRAF;MKNK1,33 (33),0.481,1,0,,4 (4),1,1,0.833,1
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),Wikipathways,2,PRLR;NR3C1,33 (33),0.481,1,0,,2 (3),1,1,0.833,1
Selenoamino acid metabolism,Reactome,2,SECISBP2;HNMT,129 (130),0.988,1,1,HMDB01201,46 (61),0.488,1,0.834,1
Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,4,CACNA1S;GJA1;ITGA3;ITGB7,74 (74),0.487,1,0,,2 (2),1,1,0.837,1
Risedronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Pravastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Atorvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Alendronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Fluvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Pamidronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Lovastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00220,46 (46),0.488,1,0.838,1
Synthesis of bile acids and bile salts,Reactome,2,NCOA1;PTGIS,34 (34),0.497,1,0,,52 (75),1,1,0.844,1
Prolactin receptor signaling,Reactome,1,PRLR,14 (14),0.502,1,0,,3 (3),1,1,0.848,1
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,1,PTGIS,14 (14),0.502,1,0,,14 (29),1,1,0.848,1
Gap junction trafficking and regulation,Reactome,1,GJA1,14 (14),0.502,1,0,,2 (2),1,1,0.848,1
stress induction of hsp regulation,BioCarta,1,CASP3,14 (14),0.502,1,0,,1 (1),1,1,0.848,1
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Reactome,1,NDRG1,14 (14),0.502,1,0,,4 (7),1,1,0.848,1
Golgi Cisternae Pericentriolar Stack Reorganization,Reactome,1,USO1,14 (14),0.502,1,0,,3 (3),1,1,0.848,1
Regulation of TP53 Activity through Association with Co-factors,Reactome,1,AKT3,14 (14),0.502,1,0,,2 (2),1,1,0.848,1
Warfarin Pathway_ Pharmacodynamics,PharmGKB,1,BGLAP,14 (14),0.502,1,0,,1 (1),1,1,0.848,1
Lysosphingolipid and LPA receptors,Reactome,1,S1PR1,14 (14),0.502,1,0,,3 (5),1,1,0.848,1
sumoylation by ranbp2 regulates transcriptional repression,BioCarta,1,MDM2,14 (14),0.502,1,0,,1 (1),1,1,0.848,1
Malonyl-coa decarboxylase deficiency,SMPDB,1,ACSS1,14 (14),0.502,1,0,,38 (38),1,1,0.848,1
Malonic Aciduria,SMPDB,1,ACSS1,14 (14),0.502,1,0,,38 (38),1,1,0.848,1
Propanoate Metabolism,SMPDB,1,ACSS1,14 (14),0.502,1,0,,38 (38),1,1,0.848,1
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,1,ACSS1,14 (14),0.502,1,0,,38 (38),1,1,0.848,1
ERK Pathway in Huntington_s Disease,Wikipathways,1,CASP3,14 (14),0.502,1,0,,1 (1),1,1,0.848,1
Antiarrhythmic Pathway_ Pharmacodynamics,PharmGKB,3,CACNA1H;GJA1;GJA5,55 (55),0.504,1,0,,20 (23),1,1,0.849,1
RANKL-RANK (Receptor activator of NFKB (ligand)) Signaling Pathway,Wikipathways,3,STAT1;SQSTM1;ACP5,55 (55),0.504,1,0,,1 (2),1,1,0.849,1
Ub-specific processing proteases,Reactome,11,MDM2;MDM4;CYLD;RNF128;TGFBR1;USP16;BIRC2;ATXN7;PSMB9;USP3;PSMA3,220 (220),0.505,1,0,,1 (1),1,1,0.85,1
The citric acid (TCA) cycle and respiratory electron transport,Reactome,3,SLC25A27;PDP2;NDUFAF2,173 (173),0.991,1,1,HMDB01201,49 (56),0.51,1,0.85,1
Smooth Muscle Contraction,Reactome,2,PAK1;ANXA6,35 (35),0.512,1,0,,4 (4),1,1,0.855,1
Transcriptional Regulation by E2F6,Reactome,2,EPC1;MAX,35 (35),0.512,1,0,,2 (2),1,1,0.855,1
DDX58/IFIH1-mediated induction of interferon-alpha/beta,Reactome,3,TRIM25;NLRC5;TAX1BP1,56 (56),0.516,1,0,,3 (6),1,1,0.857,1
Role of Calcineurin-dependent NFAT signaling in lymphocytes,PID,3,PRKCA;CASP3;PRKCZ,56 (56),0.516,1,0,,2 (2),1,1,0.857,1
Signaling events mediated by HDAC Class I,PID,3,NCOR1;WDR77;MAX,56 (56),0.516,1,0,,1 (1),1,1,0.857,1
Interleukin-20 family signaling,Reactome,1,JAK1,15 (15),0.526,1,0,,2 (2),1,1,0.864,1
InlB-mediated entry of Listeria monocytogenes into host cell,Reactome,1,STAM,15 (15),0.526,1,0,,2 (2),1,1,0.864,1
Regulation of innate immune responses to cytosolic DNA,Reactome,1,ZBP1,15 (15),0.526,1,0,,1 (1),1,1,0.864,1
Sumoylation by RanBP2 regulates transcriptional repression,PID,1,MDM2,15 (15),0.526,1,0,,1 (1),1,1,0.864,1
telomeres telomerase cellular aging and immortality,BioCarta,1,PRKCA,15 (15),0.526,1,0,,1 (3),1,1,0.864,1
repression of pain sensation by the transcriptional regulator dream,BioCarta,1,RPS6KA3,15 (15),0.526,1,0,,1 (1),1,1,0.864,1
Fatty Acid Omega Oxidation,Wikipathways,1,ALDH1A1,15 (15),0.526,1,0,,2 (4),1,1,0.864,1
estrogen responsive protein efp controls cell cycle and breast tumors growth,BioCarta,1,TRIM25,15 (15),0.526,1,0,,1 (1),1,1,0.864,1
WNT5A-dependent internalization of FZD4,Reactome,1,PRKCA,15 (15),0.526,1,0,,4 (5),1,1,0.864,1
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,IPMK,15 (15),0.526,1,0,,10 (11),1,1,0.864,1
Validated nuclear estrogen receptor beta network,PID,1,NCOA1,15 (15),0.526,1,0,,1 (1),1,1,0.864,1
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,IPMK,15 (15),0.526,1,0,,7 (8),1,1,0.864,1
Histidine Metabolism,SMPDB,1,HNMT,15 (15),0.526,1,0,,39 (40),1,1,0.864,1
Histidinemia,SMPDB,1,HNMT,15 (15),0.526,1,0,,39 (40),1,1,0.864,1
Mercaptopurine Metabolism Pathway,SMPDB,1,XDH,15 (15),0.526,1,0,,18 (24),1,1,0.864,1
Early Phase of HIV Life Cycle,Reactome,1,CXCR4,15 (15),0.526,1,0,,1 (2),1,1,0.864,1
Glycogen Synthesis and Degradation,Wikipathways,2,GBE1;PYGL,36 (36),0.528,1,0,,5 (6),1,1,0.865,1
Trk receptor signaling mediated by PI3K and PLC-gamma,PID,2,PIK3CA;CAMK2A,36 (36),0.528,1,0,,3 (3),1,1,0.865,1
HSF1-dependent transactivation,Reactome,2,CAMK2D;CAMK2A,36 (36),0.528,1,0,,4 (4),1,1,0.865,1
Metalloprotease DUBs,Reactome,2,STAM;NLRP3,36 (36),0.528,1,0,,1 (1),1,1,0.865,1
Caspase Cascade in Apoptosis,PID,3,SATB1;CASP3;TNFSF10,57 (57),0.528,1,0,,1 (2),1,1,0.865,1
Androgen and estrogen biosynthesis and metabolism,EHMN,0,,87 (89),1,1,1,HMDB00295,53 (62),0.538,1,0.871,1
Endometrial cancer - Homo sapiens (human),KEGG,3,AKT3;BRAF;PIK3CA,58 (58),0.54,1,0,,1 (1),1,1,0.873,1
Regulation of mRNA stability by proteins that bind AU-rich elements,Reactome,2,MAPK11;PRKCA,37 (37),0.542,1,0,,3 (3),1,1,0.874,1
Metabolism of amino acids and derivatives,Reactome,13,GLUL;SLC3A2;DHTKD1;SECISBP2;NAT8L;LIPT1;SLC25A21;GCAT;CSAD;ALDH7A1;SLC44A1;GLS;HNMT,339 (342),0.846,1,3,HMDB00158;HMDB01201;HMDB00159,227 (285),0.645,1,0.876,1
p75NTR signals via NF-kB,Reactome,1,SQSTM1,16 (16),0.549,1,0,,2 (2),1,1,0.878,1
KSRP (KHSRP) binds and destabilizes mRNA,Reactome,1,MAPK11,16 (16),0.549,1,0,,3 (3),1,1,0.878,1
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,1,PDP2,16 (16),0.549,1,0,,14 (14),1,1,0.878,1
Recycling of bile acids and salts,Reactome,1,NCOA1,16 (16),0.549,1,0,,20 (24),1,1,0.878,1
Regulation of KIT signaling,Reactome,1,PRKCA,16 (16),0.549,1,0,,2 (2),1,1,0.878,1
PI3K events in ERBB2 signaling,Reactome,1,PIK3CA,16 (16),0.549,1,0,,3 (4),1,1,0.878,1
Elevation of cytosolic Ca2+ levels,Reactome,1,ITPR2,16 (16),0.549,1,0,,5 (6),1,1,0.878,1
Osteoclast Signaling,Wikipathways,1,ACP5,16 (16),0.549,1,0,,2 (4),1,1,0.878,1
Nuclear Receptors,Wikipathways,2,NR3C1;NR1D2,38 (38),0.557,1,0,,1 (5),1,1,0.883,1
Hedgehog _on_ state,Reactome,2,SPOP;PTCH1,38 (39),0.557,1,0,,2 (2),1,1,0.883,1
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,2,SKIL;NCOR1,38 (38),0.557,1,0,,6 (6),1,1,0.883,1
Signaling by Hedgehog,Reactome,4,SEL1L;SYVN1;SPOP;PTCH1,81 (82),0.559,1,0,,11 (11),1,1,0.884,1
Alzheimers Disease,Wikipathways,7,ERN1;EIF2AK3;CASP3;CACNA1S;PPP3CC;PLCB4;ITPR2,145 (145),0.561,1,0,,7 (8),1,1,0.885,1
Acyl chain remodelling of PI,Reactome,1,PLA2G12A,17 (17),0.571,1,0,,4 (8),1,1,0.891,1
TRAF6 mediated IRF7 activation,Reactome,1,TRIM25,17 (17),0.571,1,0,,2 (2),1,1,0.891,1
Activated point mutants of FGFR2,Reactome,1,FGFR2,17 (17),0.571,1,0,,3 (10),1,1,0.891,1
Nitrogen metabolism - Homo sapiens (human),KEGG,1,GLUL,17 (17),0.571,1,0,,17 (19),1,1,0.891,1
Biosynthesis of DHA-derived SPMs,Reactome,1,ALOX12,17 (19),0.571,1,0,,17 (72),1,1,0.891,1
endocytotic role of ndk phosphins and dynamin,BioCarta,1,PPP3CC,17 (17),0.571,1,0,,3 (3),1,1,0.891,1
superpathway of steroid hormone biosynthesis,HumanCyc,1,HSD17B11,17 (17),0.571,1,0,,32 (35),1,1,0.891,1
Butanoate metabolism,INOH,1,EHHADH,17 (17),0.571,1,0,,20 (23),1,1,0.891,1
Trafficking of GluR2-containing AMPA receptors,Reactome,1,PRKCA,17 (17),0.571,1,0,,5 (6),1,1,0.891,1
FGFR2 mutant receptor activation,Reactome,1,FGFR2,17 (17),0.571,1,0,,3 (11),1,1,0.891,1
Zinc transporters,Reactome,1,SLC39A4,17 (17),0.571,1,0,,1 (1),1,1,0.891,1
Doxorubicin Metabolism Pathway,SMPDB,1,XDH,17 (17),0.571,1,0,,14 (14),1,1,0.891,1
Mitochondrial LC-Fatty Acid Beta-Oxidation,Wikipathways,1,EHHADH,17 (17),0.571,1,0,,2 (6),1,1,0.891,1
Simplified Depiction of MYD88 Distinct Input-Output Pathway,Wikipathways,1,TLR5,17 (17),0.571,1,0,,1 (1),1,1,0.891,1
4-hydroxytamoxifen_ Dexamethasone_ and Retinoic Acids Regulation of p27 Expression,Wikipathways,1,MKNK1,17 (17),0.571,1,0,,4 (13),1,1,0.891,1
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Reactome,2,TRIM25;RCHY1,39 (39),0.571,1,0,,8 (10),1,1,0.891,1
Acebutolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Oxprenolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Esmolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Verapamil Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Disopyramide Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,11 (11),1,1,0.893,1
Bopindolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (9),1,1,0.893,1
Timolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Carteolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Bevantolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Practolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Dobutamine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Isoprenaline Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Arbutamine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (10),1,1,0.893,1
Amiodarone Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Levobunolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Metipranolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Mexiletine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Quinidine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Betaxolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Atenolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Alprenolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (10),1,1,0.893,1
Muscle/Heart Contraction,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (9),1,1,0.893,1
Diltiazem Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Propranolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Pindolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Penbutolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Metoprolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Bisoprolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Bupranolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (9),1,1,0.893,1
Nebivolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Amlodipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Nitrendipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Nisoldipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Nimodipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Ibutilide Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Tocainide Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Flecainide Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Isradipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (9),1,1,0.893,1
Nifedipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Felodipine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,9 (10),1,1,0.893,1
Nadolol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Sotalol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Epinephrine Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,61 (61),0.574,1,0,,10 (10),1,1,0.893,1
Breast cancer - Homo sapiens (human),KEGG,7,BRAF;WNT10A;NCOA1;PIK3CA;AKT3;FLT4;IGF1R,147 (147),0.576,1,0,,3 (3),1,1,0.894,1
Tyrosine metabolism - Homo sapiens (human),KEGG,0,,36 (36),1,1,1,HMDB00158,59 (78),0.577,1,0.894,1
Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human),KEGG,4,ITGA3;CACNA1S;PRKAG2;ITGB7,83 (83),0.578,1,0,,4 (5),1,1,0.895,1
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,2,GCAT;ALDH7A1,40 (40),0.585,1,0,,39 (50),1,1,0.899,1
Negative regulation of MAPK pathway,Reactome,2,BRAF;PEBP1,40 (40),0.585,1,0,,5 (5),1,1,0.899,1
TLR JNK,INOH,3,PSMB9;LY96;PSMA3,62 (62),0.585,1,0,,1 (1),1,1,0.899,1
Carvedilol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,62 (62),0.585,1,0,,10 (10),1,1,0.899,1
Labetalol Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,62 (62),0.585,1,0,,10 (10),1,1,0.899,1
Gastric cancer - Homo sapiens (human),KEGG,7,BRAF;WNT10A;TGFBR1;HGF;AKT3;FGFR2;PIK3CA,149 (149),0.59,1,0,,3 (4),1,1,0.901,1
Phospholipase C-mediated cascade; FGFR2,Reactome,1,FGFR2,18 (18),0.592,1,0,,4 (5),1,1,0.902,1
PI-3K cascade:FGFR3,Reactome,1,PIK3CA,18 (18),0.592,1,0,,4 (5),1,1,0.902,1
Activation of NF-kappaB in B cells,Reactome,1,CARD11,18 (18),0.592,1,0,,4 (5),1,1,0.902,1
Doxorubicin Pathway (Cancer Cell)_ Pharmacodynamics,PharmGKB,1,XDH,18 (18),0.592,1,0,,1 (1),1,1,0.902,1
Lamivudine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,CMPK1,18 (18),0.592,1,0,,1 (1),1,1,0.902,1
Protein methylation,Reactome,1,VCPKMT,18 (18),0.592,1,0,,2 (2),1,1,0.902,1
Alzheimer disease - Homo sapiens (human),KEGG,8,ERN1;EIF2AK3;CASP3;APH1B;CACNA1S;PPP3CC;PLCB4;ITPR2,171 (171),0.594,1,0,,7 (7),1,1,0.903,1
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,3,CACNA1H;SNTB1;ATP1B3,63 (63),0.596,1,0,,17 (25),1,1,0.905,1
Graft-versus-host disease - Homo sapiens (human),KEGG,2,CD28;CD80,41 (41),0.599,1,0,,2 (2),1,1,0.906,1
RNA Polymerase II Pre-transcription Events,Reactome,4,EAF2;MLLT3;GTF2A1;TAF7,86 (88),0.606,1,0,,4 (4),1,1,0.91,1
miRNAs involvement in the immune response in sepsis,Wikipathways,3,IL10;IRF1;IRF5,64 (64),0.607,1,0,,1 (1),1,1,0.91,1
Validated nuclear estrogen receptor alpha network,PID,3,NCOA1;DDX17;NCOR1,64 (64),0.607,1,0,,1 (1),1,1,0.91,1
Muscle contraction,Reactome,9,PAK1;ATP1B3;KCNK5;CACNA1S;CAMK2A;FGF11;CAMK2D;ANXA6;ITPR2,195 (195),0.61,1,0,,9 (10),1,1,0.912,1
Acyl chain remodelling of PG,Reactome,1,PLA2G12A,19 (19),0.612,1,0,,3 (8),1,1,0.912,1
Mitochondrial Gene Expression,Wikipathways,1,MYEF2,19 (19),0.612,1,0,,3 (3),1,1,0.912,1
HSP90 chaperone cycle for steroid hormone receptors (SHR),Reactome,1,NR3C1,19 (19),0.612,1,0,,10 (11),1,1,0.912,1
CD209 (DC-SIGN) signaling,Reactome,1,PAK1,19 (19),0.612,1,0,,6 (7),1,1,0.912,1
Glycosaminoglycan degradation - Homo sapiens (human),KEGG,1,HEXA,19 (19),0.612,1,0,,5 (27),1,1,0.912,1
Phase 4 - resting membrane potential,Reactome,1,KCNK5,19 (19),0.612,1,0,,1 (1),1,1,0.912,1
RHO GTPases activate CIT,Reactome,1,PPP1R12A,19 (19),0.612,1,0,,3 (3),1,1,0.912,1
GABA synthesis_ release_ reuptake and degradation,Reactome,1,STXBP1,19 (19),0.612,1,0,,15 (16),1,1,0.912,1
Translesion Synthesis by POLH,Reactome,1,RCHY1,19 (19),0.612,1,0,,4 (5),1,1,0.912,1
Small Ligand GPCRs,Wikipathways,1,S1PR1,19 (19),0.612,1,0,,1 (3),1,1,0.912,1
Overview of nanoparticle effects,Wikipathways,1,AKT3,19 (19),0.612,1,0,,1 (2),1,1,0.912,1
Transcriptional regulation by RUNX1,Wikipathways,1,BLK,19 (19),0.612,1,0,,4 (5),1,1,0.912,1
Listeria monocytogenes entry into host cells,Reactome,1,STAM,19 (19),0.612,1,0,,4 (4),1,1,0.912,1
tRNA modification in the nucleus and cytosol,Reactome,2,METTL1;ADAT3,42 (42),0.612,1,0,,24 (47),1,1,0.912,1
actions of nitric oxide in the heart,BioCarta,2,PIK3CA;FLT4,42 (42),0.612,1,0,,8 (10),1,1,0.912,1
Tyrosinemia_ transient_ of the newborn,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Monoamine oxidase-a deficiency (MAO-A),SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Hawkinsinuria,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Dopamine beta-hydroxylase deficiency,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Tyrosine Metabolism,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Alkaptonuria,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Tyrosinemia Type I,SMPDB,0,,18 (18),1,1,1,HMDB00158,66 (67),0.619,1,0.916,1
Bile acid and bile salt metabolism,Reactome,2,NCOA1;PTGIS,43 (43),0.625,1,0,,53 (80),1,1,0.919,1
Vitamin A and Carotenoid Metabolism,Wikipathways,2,ALDH1A1;RDH12,43 (43),0.625,1,0,,21 (21),1,1,0.919,1
Vitamin E metabolism,EHMN,2,EHHADH;ACOT7,43 (43),0.625,1,0,,20 (21),1,1,0.919,1
Breast cancer pathway,Wikipathways,7,BRAF;WNT10A;NCOA1;PIK3CA;AKT3;FLT4;IGF1R,154 (154),0.625,1,0,,4 (4),1,1,0.919,1
Acute myeloid leukemia - Homo sapiens (human),KEGG,3,AKT3;BRAF;PIK3CA,66 (66),0.628,1,0,,1 (1),1,1,0.92,1
FGFR2 ligand binding and activation,Reactome,1,FGFR2,20 (20),0.631,1,0,,3 (4),1,1,0.921,1
PI-3K cascade:FGFR4,Reactome,1,PIK3CA,20 (20),0.631,1,0,,4 (5),1,1,0.921,1
One carbon pool by folate - Homo sapiens (human),KEGG,1,ALDH1L2,20 (20),0.631,1,0,,9 (9),1,1,0.921,1
Tranexamic Acid Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Phenprocoumon Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (5),1,1,0.921,1
G beta:gamma signalling through PLC beta,Reactome,1,GNG2,20 (20),0.631,1,0,,1 (3),1,1,0.921,1
Lepirudin Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Coagulation ,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Dicoumarol Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Aminocaproic Acid Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Urokinase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Reteplase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Streptokinase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Tenecteplase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Alteplase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Anistreplase Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Aprotinin Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Phenindione Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Signaling by Hippo,Reactome,1,CASP3,20 (20),0.631,1,0,,2 (2),1,1,0.921,1
Warfarin Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Dicumarol Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Bivalirudin Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (4),1,1,0.921,1
Argatroban Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,5 (5),1,1,0.921,1
Ximelagatran Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (5),1,1,0.921,1
Acenocoumarol Action Pathway,SMPDB,1,COL1A1,20 (20),0.631,1,0,,4 (5),1,1,0.921,1
3-phosphoinositide degradation,HumanCyc,1,INPP4B,20 (20),0.631,1,0,,2 (5),1,1,0.921,1
TP53 Regulates Transcription of Cell Death Genes,Reactome,2,CASP1;NDRG1,44 (44),0.637,1,0,,7 (10),1,1,0.924,1
PLK1 signaling events,PID,2,PAK1;PPP1R12A,44 (44),0.637,1,0,,1 (1),1,1,0.924,1
Tacrolimus/Cyclosporine Pathway_ Pharmacodynamics,PharmGKB,2,MAFG;PPP3CC,44 (44),0.637,1,0,,1 (2),1,1,0.924,1
DNA Damage Response,Wikipathways,3,MDM2;CASP3;CCND2,68 (68),0.648,1,0,,1 (2),1,1,0.929,1
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,3,ALDH3A2;ACSS1;ALDH7A1,68 (68),0.648,1,0,,23 (31),1,1,0.929,1
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Reactome,1,EPAS1,21 (21),0.649,1,0,,4 (4),1,1,0.929,1
Fondaparinux Action Pathway,SMPDB,1,COL1A1,21 (21),0.649,1,0,,4 (5),1,1,0.929,1
Enoxaparin Action Pathway,SMPDB,1,COL1A1,21 (21),0.649,1,0,,4 (4),1,1,0.929,1
Presynaptic function of Kainate receptors,Reactome,1,GNG2,21 (21),0.649,1,0,,2 (2),1,1,0.929,1
activated TAK1 mediates p38 MAPK activation,Reactome,1,MAPK11,21 (21),0.649,1,0,,2 (4),1,1,0.929,1
pkc-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,BioCarta,1,PRKCA,21 (23),0.649,1,0,,1 (3),1,1,0.929,1
Sphingosine 1-phosphate (S1P) pathway,PID,1,S1PR1,21 (21),0.649,1,0,,4 (5),1,1,0.929,1
Ardeparin Action Pathway,SMPDB,1,COL1A1,21 (21),0.649,1,0,,4 (4),1,1,0.929,1
Heparin Action Pathway,SMPDB,1,COL1A1,21 (21),0.649,1,0,,5 (5),1,1,0.929,1
Mono-unsaturated fatty acid beta-oxidation,EHMN,1,EHHADH,21 (21),0.649,1,0,,11 (12),1,1,0.929,1
PI-3K cascade:FGFR1,Reactome,1,PIK3CA,21 (21),0.649,1,0,,4 (5),1,1,0.929,1
Imatinib and Chronic Myeloid Leukemia,Wikipathways,1,PDGFRA,21 (21),0.649,1,0,,1 (1),1,1,0.929,1
Morphine addiction - Homo sapiens (human),KEGG,4,PDE1A;PRKCA;GNG2;GRK5,91 (91),0.651,1,0,,9 (12),1,1,0.93,1
TLR NFkB,INOH,3,PSMB9;LY96;PSMA3,69 (69),0.658,1,0,,1 (1),1,1,0.933,1
Downstream signaling in na&#xef;ve CD8+ T cells,PID,3,BRAF;PRKCA;B2M,69 (69),0.658,1,0,,2 (9),1,1,0.933,1
Human Complement System,Wikipathways,4,PRKCA;LAMC1;CD55;SERPING1,92 (92),0.659,1,0,,2 (5),1,1,0.934,1
RNA Polymerase II Promoter Escape,Reactome,2,GTF2A1;TAF7,46 (46),0.661,1,0,,5 (5),1,1,0.935,1
Vitamin D in inflammatory diseases,Wikipathways,1,NR3C1,22 (22),0.666,1,0,,1 (2),1,1,0.937,1
Complement Activation,Wikipathways,1,CD55,22 (22),0.666,1,0,,1 (1),1,1,0.937,1
Intrinsic Pathway of Fibrin Clot Formation,Reactome,1,SERPING1,22 (22),0.666,1,0,,2 (6),1,1,0.937,1
CDP-diacylglycerol biosynthesis,HumanCyc,1,AGPAT4,22 (22),0.666,1,0,,11 (19),1,1,0.937,1
NOTCH2 Activation and Transmission of Signal to the Nucleus,Reactome,1,APH1B,22 (22),0.666,1,0,,1 (1),1,1,0.937,1
Doxorubicin Pathway_ Pharmacokinetics,PharmGKB,1,XDH,22 (22),0.666,1,0,,1 (1),1,1,0.937,1
Tryptophan metabolism,EHMN,1,ALDH7A1,22 (22),0.666,1,0,,68 (78),1,1,0.937,1
NAD+ biosynthetic pathways,Wikipathways,1,NAMPT,22 (22),0.666,1,0,,13 (13),1,1,0.937,1
RNA Polymerase II HIV Promoter Escape,Reactome,2,GTF2A1;TAF7,47 (47),0.673,1,0,,5 (5),1,1,0.94,1
RNA Polymerase II Transcription Initiation,Reactome,2,GTF2A1;TAF7,47 (47),0.673,1,0,,5 (5),1,1,0.94,1
RNA Polymerase II Transcription Initiation And Promoter Clearance,Reactome,2,GTF2A1;TAF7,47 (47),0.673,1,0,,7 (7),1,1,0.94,1
Transcriptional regulation of white adipocyte differentiation,Reactome,2,NCOA1;NCOR1,47 (47),0.673,1,0,,4 (4),1,1,0.94,1
PCP/CE pathway,Reactome,2,PRKCA;RYK,47 (47),0.673,1,0,,6 (7),1,1,0.94,1
HIV Transcription Initiation,Reactome,2,GTF2A1;TAF7,47 (47),0.673,1,0,,5 (5),1,1,0.94,1
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,2,CAMK2D;CAMK2A,47 (47),0.673,1,0,,13 (16),1,1,0.94,1
Regulation of Hypoxia-inducible Factor (HIF) by oxygen,Reactome,1,EPAS1,23 (23),0.682,1,0,,4 (4),1,1,0.943,1
Cellular response to hypoxia,Reactome,1,EPAS1,23 (23),0.682,1,0,,4 (4),1,1,0.943,1
RA biosynthesis pathway,Reactome,1,ALDH1A1,23 (23),0.682,1,0,,15 (17),1,1,0.943,1
Mannose type O-glycan biosynthesis - Homo sapiens (human),KEGG,1,FUT4,23 (23),0.682,1,0,,2 (27),1,1,0.943,1
Signaling events mediated by PRL,PID,1,BCAR1,23 (23),0.682,1,0,,1 (1),1,1,0.943,1
RAF-independent MAPK1/3 activation,Reactome,1,JAK1,23 (23),0.682,1,0,,4 (4),1,1,0.943,1
intrinsic prothrombin activation pathway,BioCarta,1,SERPING1,23 (23),0.682,1,0,,1 (4),1,1,0.943,1
RIP-mediated NFkB activation via ZBP1,Reactome,1,ZBP1,23 (23),0.682,1,0,,2 (6),1,1,0.943,1
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Reactome,1,CNOT6L,23 (23),0.682,1,0,,2 (2),1,1,0.943,1
ccr3 signaling in eosinophils,BioCarta,1,PRKCA,23 (23),0.682,1,0,,1 (1),1,1,0.943,1
Acyl chain remodelling of PS,Reactome,1,PLA2G12A,23 (23),0.682,1,0,,4 (9),1,1,0.943,1
Post-chaperonin tubulin folding pathway,Reactome,1,TUBB2B,23 (23),0.682,1,0,,2 (2),1,1,0.943,1
Assembly of collagen fibrils and other multimeric structures,Reactome,2,CTSS;LOX,48 (48),0.684,1,0,,6 (6),1,1,0.944,1
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,2,HEXA;GFPT1,48 (48),0.684,1,0,,52 (108),1,1,0.944,1
Differentiation Pathway,Wikipathways,2,PDGFA;HGF,48 (48),0.684,1,0,,9 (13),1,1,0.944,1
HATs acetylate histones,Reactome,6,CLOCK;NCOA1;ATXN7;MSL1;OGT;EPC1,142 (142),0.693,1,0,,2 (2),1,1,0.947,1
Arginine and proline metabolism - Homo sapiens (human),KEGG,2,ALDH3A2;ALDH7A1,49 (50),0.695,1,0,,56 (78),1,1,0.948,1
DNA Damage Bypass,Reactome,2,TRIM25;RCHY1,49 (49),0.695,1,0,,8 (10),1,1,0.948,1
Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human),KEGG,1,NDST1,24 (24),0.698,1,0,,3 (7),1,1,0.949,1
proteasome complex,BioCarta,1,PSMA3,24 (24),0.698,1,0,,2 (2),1,1,0.949,1
DARPP-32 events,Reactome,1,PPP3CC,24 (25),0.698,1,0,,11 (12),1,1,0.949,1
Miscellaneous transport and binding events,Reactome,1,ADD3,24 (24),0.698,1,0,,8 (10),1,1,0.949,1
Neddylation,Reactome,10,FEM1C;PSMB9;FBXL20;CUL9;ASB13;CISH;EPAS1;NUB1;PSMA3;KLHL25,234 (235),0.706,1,0,,4 (4),1,1,0.952,1
RAF activation,Reactome,1,BRAF,25 (25),0.712,1,0,,5 (5),1,1,0.954,1
TRP channels,Reactome,1,MCOLN2,25 (25),0.712,1,0,,2 (2),1,1,0.954,1
WNT ligand biogenesis and trafficking,Reactome,1,WNT10A,25 (26),0.712,1,0,,2 (2),1,1,0.954,1
Uptake and actions of bacterial toxins,Reactome,1,PDZD3,25 (25),0.712,1,0,,9 (11),1,1,0.954,1
EGFR downregulation,Reactome,1,STAM,25 (25),0.712,1,0,,5 (6),1,1,0.954,1
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,1,GNG2,25 (25),0.712,1,0,,2 (2),1,1,0.954,1
Methionine Cysteine metabolism,INOH,1,CSAD,25 (25),0.712,1,0,,40 (45),1,1,0.954,1
NOTCH3 Activation and Transmission of Signal to the Nucleus,Reactome,1,APH1B,25 (25),0.712,1,0,,3 (3),1,1,0.954,1
Activation of G protein gated Potassium channels,Reactome,1,GNG2,25 (25),0.712,1,0,,2 (2),1,1,0.954,1
G protein gated Potassium channels,Reactome,1,GNG2,25 (25),0.712,1,0,,2 (2),1,1,0.954,1
Peptide GPCRs,Wikipathways,3,SSTR4;CXCR4;EDNRA,75 (75),0.713,1,0,,2 (2),1,1,0.954,1
Aminosugars metabolism,EHMN,2,SLC3A2;HEXA,51 (51),0.716,1,0,,37 (43),1,1,0.955,1
snRNP Assembly,Reactome,2,GEMIN7;WDR77,52 (52),0.726,1,0,,3 (4),1,1,0.959,1
Metabolism of non-coding RNA,Reactome,2,GEMIN7;WDR77,52 (52),0.726,1,0,,3 (4),1,1,0.959,1
TLR ECSIT MEKK1 JNK,INOH,1,LY96,26 (26),0.726,1,0,,1 (1),1,1,0.959,1
Fertilization,Reactome,1,IZUMO1,26 (26),0.726,1,0,,4 (7),1,1,0.959,1
TRAF6 mediated NF-kB activation,Reactome,1,TRIM25,26 (26),0.726,1,0,,2 (5),1,1,0.959,1
Folate biosynthesis - Homo sapiens (human),KEGG,1,PTS,26 (26),0.726,1,0,,27 (57),1,1,0.959,1
RXR and RAR heterodimerization with other nuclear receptor,PID,1,NCOA1,26 (26),0.726,1,0,,6 (6),1,1,0.959,1
Formation of tubulin folding intermediates by CCT/TriC,Reactome,1,TUBB2B,26 (26),0.726,1,0,,4 (4),1,1,0.959,1
Termination of O-glycan biosynthesis,Reactome,1,ST6GAL1,26 (26),0.726,1,0,,2 (2),1,1,0.959,1
Downregulation of TGF-beta receptor signaling,Reactome,1,TGFBR1,26 (26),0.726,1,0,,2 (2),1,1,0.959,1
Sulfur amino acid metabolism,Reactome,1,CSAD,26 (27),0.726,1,0,,53 (66),1,1,0.959,1
RNA polymerase II transcribes snRNA genes,Reactome,3,ELL2;RNU11;GTF2A1,77 (77),0.729,1,0,,2 (3),1,1,0.959,1
UCH proteinases,Reactome,4,OGT;PSMB9;PSMA3;TGFBR1,102 (102),0.736,1,0,,1 (2),1,1,0.962,1
Methionine and cysteine metabolism,EHMN,3,SLC3A2;SLC26A11;CP,78 (78),0.737,1,0,,62 (80),1,1,0.962,1
Translocation of ZAP-70 to Immunological synapse,Reactome,1,PTPN22,27 (27),0.74,1,0,,4 (4),1,1,0.963,1
ZBP1(DAI) mediated induction of type I IFNs,Reactome,1,ZBP1,27 (27),0.74,1,0,,2 (6),1,1,0.963,1
triacylglycerol biosynthesis,HumanCyc,1,AGPAT4,27 (27),0.74,1,0,,20 (43),1,1,0.963,1
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Non Ketotic Hyperglycinemia,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Glycine and Serine Metabolism,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Dimethylglycine Dehydrogenase Deficiency,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Hyperglycinemia_ non-ketotic,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Dimethylglycine Dehydrogenase Deficiency,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Sarcosinemia,SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,1,GCAT,27 (27),0.74,1,0,,55 (55),1,1,0.963,1
DNA Damage/Telomere Stress Induced Senescence,Reactome,1,HMGA2,28 (28),0.752,1,0,,4 (5),1,1,0.966,1
Platelet calcium homeostasis,Reactome,1,ITPR2,28 (28),0.752,1,0,,5 (7),1,1,0.966,1
Phase 2 - plateau phase,Reactome,1,CACNA1S,28 (28),0.752,1,0,,2 (2),1,1,0.966,1
Butanoate metabolism - Homo sapiens (human),KEGG,1,EHHADH,28 (28),0.752,1,0,,26 (42),1,1,0.966,1
Prefoldin mediated transfer of substrate  to CCT/TriC,Reactome,1,TUBB2B,28 (28),0.752,1,0,,1 (1),1,1,0.966,1
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,4,ALDH3A2;GLUL;GLS;ALDH7A1,105 (106),0.757,1,0,,91 (125),1,1,0.968,1
Benzocaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Anileridine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Dectin-2 family,Reactome,1,PLCG2,29 (29),0.764,1,0,,3 (4),1,1,0.97,1
Mepivacaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Cyclin A:Cdk2-associated events at S phase entry,Reactome,1,AKT3,29 (29),0.764,1,0,,4 (4),1,1,0.97,1
Buprenorphine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Alvimopan Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (10),1,1,0.97,1
Downregulation of ERBB2 signaling,Reactome,1,AKT3,29 (29),0.764,1,0,,4 (4),1,1,0.97,1
Methadyl Acetate Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (10),1,1,0.97,1
Dezocine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Levomethadyl Acetate Action Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Escitalopram Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Levallorphan Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Dimethylthiambutene Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Ethylmorphine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Pentazocine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Naltrexone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Naloxone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Dihydromorphine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Ketobemidone  Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Chloroprocaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Cocaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Dibucaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Levobupivacaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Bupivacaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Levorphanol Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Propoxyphene Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Tramadol Action Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Diphenoxylate Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Oxycodone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Oxybuprocaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Prilocaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Procaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Proparacaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Ropivacaine Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Alfentanil Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Oxymorphone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Hydrocodone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Hydromorphone Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Sufentanil Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Remifentanil Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,11 (11),1,1,0.97,1
Fentanyl Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Carfentanil Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
3-Methylthiofentanyl Action Pathway,SMPDB,1,ATP1B3,29 (29),0.764,1,0,,10 (11),1,1,0.97,1
Phosphorylation of CD3 and TCR zeta chains,Reactome,1,PTPN22,30 (30),0.776,1,0,,4 (4),1,1,0.973,1
Pyruvate metabolism,Reactome,1,PDP2,30 (30),0.776,1,0,,24 (25),1,1,0.973,1
Activation of kainate receptors upon glutamate binding,Reactome,1,GNG2,30 (30),0.776,1,0,,4 (4),1,1,0.973,1
Deactivation of the beta-catenin transactivating complex,Reactome,1,TLE4,30 (30),0.776,1,0,,2 (2),1,1,0.973,1
Asthma - Homo sapiens (human),KEGG,1,IL10,30 (31),0.776,1,0,,5 (5),1,1,0.973,1
Regulation of TP53 Activity through Acetylation,Reactome,1,AKT3,30 (30),0.776,1,0,,7 (9),1,1,0.973,1
Desipramine Action Pathway,SMPDB,1,ATP1B3,30 (30),0.776,1,0,,15 (16),1,1,0.973,1
Nalbuphine Action Pathway,SMPDB,1,ATP1B3,30 (30),0.776,1,0,,11 (11),1,1,0.973,1
Dopaminergic Neurogenesis,Wikipathways,1,ALDH1A1,30 (30),0.776,1,0,,1 (1),1,1,0.973,1
Bile secretion - Homo sapiens (human),KEGG,1,ATP1B3,71 (71),0.971,1,1,HMDB00658#HMDB10370,112 (162),0.809,1,0.975,1
Galactose metabolism - Homo sapiens (human),KEGG,1,MGAM,31 (31),0.787,1,0,,32 (46),1,1,0.975,1
Activation of Matrix Metalloproteinases,Reactome,1,MMP2,31 (31),0.787,1,0,,1 (2),1,1,0.975,1
Inwardly rectifying K+ channels,Reactome,1,GNG2,31 (31),0.787,1,0,,3 (3),1,1,0.975,1
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,1,ATP1B3,31 (31),0.787,1,0,,18 (26),1,1,0.975,1
Ethanol effects on histone modifications,Wikipathways,1,ALDH1A1,31 (31),0.787,1,0,,16 (21),1,1,0.975,1
Complement and Coagulation Cascades,Wikipathways,2,CD55;SERPING1,59 (59),0.788,1,0,,1 (2),1,1,0.976,1
Phase II - Conjugation of compounds,Reactome,1,ABHD10,112 (115),0.996,1,1,HMDB00295,107 (148),0.794,1,0.976,1
Dengue-2 Interactions with Complement and Coagulation Cascades,Wikipathways,2,CD55;SERPING1,60 (60),0.796,1,0,,1 (2),1,1,0.978,1
Termination of translesion DNA synthesis,Reactome,1,TRIM25,32 (32),0.797,1,0,,2 (3),1,1,0.978,1
TGF-beta receptor signaling activates SMADs,Reactome,1,TGFBR1,32 (32),0.797,1,0,,4 (4),1,1,0.978,1
Autophagy - other - Homo sapiens (human),KEGG,1,ATG7,32 (32),0.797,1,0,,3 (3),1,1,0.978,1
Metformin Pathway_ Pharmacodynamic,PharmGKB,1,PRKAG2,32 (32),0.797,1,0,,1 (1),1,1,0.978,1
Heroin Action Pathway,SMPDB,1,ATP1B3,32 (32),0.797,1,0,,13 (14),1,1,0.978,1
Metabolism of steroid hormones,Reactome,1,HSD17B11,33 (33),0.807,1,0,,30 (36),1,1,0.98,1
Imipramine Action Pathway,SMPDB,1,ATP1B3,33 (33),0.807,1,0,,19 (20),1,1,0.98,1
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Reactome,1,TUBB2B,33 (33),0.807,1,0,,4 (4),1,1,0.98,1
Dilated cardiomyopathy (DCM) - Homo sapiens (human),KEGG,3,CACNA1S;ITGA3;ITGB7,89 (90),0.814,1,0,,4 (4),1,1,0.981,1
miRNA Regulation of DNA Damage Response,Wikipathways,3,MDM2;CASP3;CCND2,89 (89),0.814,1,0,,1 (2),1,1,0.981,1
Cellular Senescence,Reactome,7,MAPK11;MDM2;MDM4;RPS6KA2;RPS6KA3;HMGA2;AGO4,188 (189),0.814,1,0,,9 (11),1,1,0.981,1
Type 2 papillary renal cell carcinoma,Wikipathways,1,EPAS1,34 (34),0.816,1,0,,3 (3),1,1,0.982,1
Fatty Acid Beta Oxidation,Wikipathways,1,PNPLA2,34 (34),0.816,1,0,,29 (34),1,1,0.982,1
Fluoxetine Action Pathway,SMPDB,1,ATP1B3,34 (34),0.816,1,0,,15 (16),1,1,0.982,1
RNA Polymerase II Transcription Elongation,Reactome,2,EAF2;MLLT3,63 (65),0.818,1,0,,4 (4),1,1,0.982,1
Basal cell carcinoma - Homo sapiens (human),KEGG,2,WNT10A;PTCH1,63 (63),0.818,1,0,,1 (1),1,1,0.982,1
Peroxisomal protein import,Reactome,2,PHYH;EHHADH,64 (64),0.824,1,0,,1 (1),1,1,0.984,1
Proteasome Degradation,Wikipathways,2,PSMB9;PSMA3,64 (64),0.824,1,0,,1 (1),1,1,0.984,1
Collagen degradation,Reactome,1,MMP2,35 (35),0.825,1,0,,3 (5),1,1,0.984,1
Histidine metabolism,EHMN,1,ALDH7A1,35 (35),0.825,1,0,,42 (45),1,1,0.984,1
Prion diseases - Homo sapiens (human),KEGG,1,LAMC1,35 (35),0.825,1,0,,3 (3),1,1,0.984,1
toll-like receptor pathway,BioCarta,1,LY96,35 (35),0.825,1,0,,1 (1),1,1,0.984,1
Nuclear Receptors in Lipid Metabolism and Toxicity,Wikipathways,1,ABCD2,35 (35),0.825,1,0,,6 (12),1,1,0.984,1
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Reactome,3,KMT2E;KMT2A;KMT2C,92 (94),0.831,1,0,,2 (2),1,1,0.985,1
Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,2,PAK1;PIK3CG,65 (65),0.831,1,0,,8 (8),1,1,0.985,1
Busulfan Pathway_ Pharmacodynamics,PharmGKB,1,BIRC2,36 (36),0.834,1,0,,1 (1),1,1,0.985,1
Citalopram Action Pathway,SMPDB,1,ATP1B3,36 (36),0.834,1,0,,23 (27),1,1,0.985,1
Methadone Action Pathway,SMPDB,1,ATP1B3,36 (36),0.834,1,0,,16 (17),1,1,0.985,1
Ribosomal scanning and start codon recognition,Reactome,2,EIF4A2;EIF5,66 (68),0.837,1,0,,4 (5),1,1,0.986,1
Folate Metabolism,Wikipathways,2,INSR;SLC46A1,66 (66),0.837,1,0,,56 (66),1,1,0.986,1
Tight junction - Homo sapiens (human),KEGG,6,F11R;PRKCZ;DLG2;MPP5;CLDN7;PRKAG2,170 (170),0.84,1,0,,1 (1),1,1,0.986,1
HDACs deacetylate histones,Reactome,3,NCOR1;ARID4A;TBL1XR1,94 (94),0.841,1,0,,2 (3),1,1,0.987,1
Zinc homeostasis,Wikipathways,1,SLC39A4,37 (37),0.842,1,0,,1 (1),1,1,0.987,1
Wnt Signaling in Kidney Disease,Wikipathways,1,WNT10A,37 (37),0.842,1,0,,1 (1),1,1,0.987,1
Retinol metabolism - Homo sapiens (human),KEGG,2,ALDH1A1;RDH12,67 (67),0.843,1,0,,18 (24),1,1,0.987,1
Transcriptional regulation by RUNX1,Reactome,7,BLK;KMT2E;CCND2;KMT2A;KMT2C;CTLA4;AGO4,196 (198),0.845,1,0,,6 (9),1,1,0.987,1
RHO GTPases activate PKNs,Reactome,3,KDM4C;PAK1;PPP1R12A,95 (96),0.847,1,0,,14 (15),1,1,0.988,1
Mitochondrial Fatty Acid Beta-Oxidation,Reactome,1,ACOT7,38 (39),0.85,1,0,,53 (66),1,1,0.988,1
Degradation of beta-catenin by the destruction complex,Reactome,1,TLE4,39 (39),0.857,1,0,,2 (2),1,1,0.989,1
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,1,BGLAP,39 (40),0.857,1,0,,20 (33),1,1,0.989,1
Formation of Fibrin Clot (Clotting Cascade),Reactome,1,SERPING1,39 (39),0.857,1,0,,2 (7),1,1,0.989,1
Oxidative Stress Induced Senescence,Reactome,4,MAPK11;MDM2;MDM4;AGO4,125 (126),0.863,1,0,,7 (8),1,1,0.99,1
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Reactome,1,KDM5B,40 (40),0.864,1,0,,1 (1),1,1,0.99,1
CD22 mediated BCR regulation,Reactome,2,CD79A;CD79B,71 (71),0.866,1,0,,2 (2),1,1,0.991,1
SUMOylation,Reactome,4,SP100;DDX17;SATB1;MDM2,126 (126),0.867,1,0,,3 (3),1,1,0.991,1
RNA Polymerase III Abortive And Retractive Initiation,Reactome,1,NFIB,41 (42),0.871,1,0,,4 (5),1,1,0.991,1
Regulation of mitotic cell cycle,Reactome,1,PTTG1,41 (41),0.871,1,0,,4 (4),1,1,0.991,1
Glycine Serine metabolism,INOH,1,GCAT,41 (41),0.871,1,0,,51 (68),1,1,0.991,1
APC/C-mediated degradation of cell cycle proteins,Reactome,1,PTTG1,41 (41),0.871,1,0,,4 (4),1,1,0.991,1
RNA Polymerase III Transcription,Reactome,1,NFIB,41 (42),0.871,1,0,,4 (5),1,1,0.991,1
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,1,CP,42 (42),0.877,1,0,,52 (141),1,1,0.992,1
Stimuli-sensing channels,Reactome,3,ANO10;SGK1;MCOLN2,102 (102),0.879,1,0,,10 (13),1,1,0.992,1
Hedgehog _off_ state,Reactome,1,PTCH1,43 (44),0.883,1,0,,6 (6),1,1,0.993,1
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Reactome,1,GNG2,43 (43),0.883,1,0,,3 (3),1,1,0.993,1
Steroid hormones,Reactome,1,HSD17B11,43 (43),0.883,1,0,,33 (40),1,1,0.993,1
Transcription of the HIV genome,Reactome,2,GTF2A1;TAF7,75 (77),0.885,1,0,,7 (7),1,1,0.993,1
Mitotic G1-G1/S phases,Reactome,3,AKT3;MAX;CCND2,104 (104),0.887,1,0,,4 (4),1,1,0.993,1
FOXA1 transcription factor network,PID,1,NFIB,44 (44),0.889,1,0,,3 (4),1,1,0.994,1
Cyclin D associated events in G1,Reactome,1,CCND2,44 (44),0.889,1,0,,4 (4),1,1,0.994,1
G1 Phase,Reactome,1,CCND2,44 (44),0.889,1,0,,4 (4),1,1,0.994,1
Prader-Willi and Angelman Syndrome,Wikipathways,1,PRKCZ,44 (44),0.889,1,0,,2 (3),1,1,0.994,1
G1/S Transition,Reactome,2,AKT3;MAX,76 (76),0.89,1,0,,4 (4),1,1,0.994,1
Signaling by Retinoic Acid,Reactome,1,ALDH1A1,45 (45),0.894,1,0,,26 (29),1,1,0.994,1
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,9,FBXL20;RNF34;ATG7;ASB13;HERC4;TRIM39;MKRN1;KLHL25;RCHY1,263 (264),0.898,1,0,,4 (4),1,1,0.995,1
Glycine_ serine_ alanine and threonine metabolism,EHMN,2,SLC3A2;GCAT,78 (78),0.898,1,0,,72 (88),1,1,0.995,1
Cardiac muscle contraction - Homo sapiens (human),KEGG,2,CACNA1S;ATP1B3,78 (78),0.898,1,0,,3 (4),1,1,0.995,1
ATM Signaling Network in Development and Disease,Wikipathways,1,HMGN1,46 (46),0.899,1,0,,1 (1),1,1,0.995,1
Complement and coagulation cascades - Homo sapiens (human),KEGG,2,CD55;SERPING1,79 (79),0.902,1,0,,1 (2),1,1,0.995,1
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,2,XDH;CMPK1,79 (79),0.902,1,0,,12 (52),1,1,0.995,1
Trans-sulfuration pathway,Wikipathways,1,CSAD,47 (47),0.904,1,0,,26 (28),1,1,0.995,1
RNA Polymerase I Transcription Initiation,Reactome,1,POLR1A,48 (48),0.909,1,0,,2 (2),1,1,0.996,1
Huntington disease - Homo sapiens (human),KEGG,6,CASP3;DNAH6;HAP1;PLCB4;DNALI1;CREB3L2,193 (193),0.912,1,0,,3 (3),1,1,0.996,1
Estrogen-dependent gene expression,Reactome,4,NCOA1;GTF2A1;AGO4;DDX5,140 (142),0.914,1,0,,5 (7),1,1,0.996,1
Peptide ligand-binding receptors,Reactome,6,SSTR4;F2RL1;CXCL3;CXCL10;CXCR4;EDNRA,194 (194),0.915,1,0,,3 (5),1,1,0.996,1
Cytosolic sensors of pathogen-associated DNA ,Reactome,1,ZBP1,51 (51),0.921,1,0,,5 (13),1,1,0.997,1
TP53 Regulates Transcription of Cell Cycle Genes,Reactome,1,CNOT6L,51 (51),0.921,1,0,,2 (2),1,1,0.997,1
Vitamin B12 Metabolism,Wikipathways,1,INSR,51 (51),0.921,1,0,,51 (60),1,1,0.997,1
C-MYB transcription factor network,PID,2,NCOR1;COL1A2,85 (85),0.923,1,0,,2 (2),1,1,0.997,1
Peptide hormone metabolism,Reactome,1,CPE,53 (53),0.929,1,0,,10 (17),1,1,0.997,1
Regulation of PLK1 Activity at G2/M Transition,Reactome,2,PPP1R12A;SDCCAG8,87 (87),0.929,1,0,,5 (5),1,1,0.997,1
ESR-mediated signaling,Reactome,4,NCOA1;GTF2A1;AGO4;DDX5,148 (150),0.933,1,0,,7 (9),1,1,0.998,1
Complex I biogenesis,Reactome,1,NDUFAF2,55 (55),0.936,1,0,,2 (2),1,1,0.998,1
Formation of TC-NER Pre-Incision Complex,Reactome,1,HMGN1,57 (57),0.942,1,0,,1 (1),1,1,0.998,1
mRNA 3_-end processing,Reactome,1,SRSF5,58 (58),0.945,1,0,,1 (1),1,1,0.998,1
Metabolism of steroids,Reactome,3,NCOA1;HSD17B11;PTGIS,127 (127),0.95,1,0,,106 (144),1,1,0.999,1
Chaperonin-mediated protein folding,Reactome,2,GNG2;TUBB2B,97 (97),0.953,1,0,,4 (6),1,1,0.999,1
Separation of Sister Chromatids,Reactome,3,PTTG1;CLIP1;NDEL1,129 (129),0.953,1,0,,2 (2),1,1,0.999,1
Cellular response to heat stress,Reactome,2,CAMK2D;CAMK2A,99 (99),0.957,1,0,,8 (9),1,1,0.999,1
Systemic lupus erythematosus - Homo sapiens (human),KEGG,3,IL10;CD28;CD80,132 (133),0.958,1,0,,2 (3),1,1,0.999,1
Potassium Channels,Reactome,2,GNG2;KCNN4,100 (100),0.959,1,0,,4 (4),1,1,0.999,1
Signaling by Nuclear Receptors,Reactome,5,ALDH1A1;NCOA1;GTF2A1;AGO4;DDX5,193 (195),0.961,1,0,,31 (36),1,1,0.999,1
Translation initiation complex formation,Reactome,1,EIF4A2,66 (68),0.963,1,0,,1 (2),1,1,0.999,1
Protein folding,Reactome,2,GNG2;TUBB2B,103 (103),0.963,1,0,,4 (6),1,1,0.999,1
Activation of the mRNA upon binding of the cap-binding complex and eIFs_ and subsequent binding to 43S,Reactome,1,EIF4A2,67 (69),0.965,1,0,,1 (2),1,1,0.999,1
Cleavage of Growing Transcript in the Termination Region ,Reactome,1,SRSF5,67 (67),0.965,1,0,,1 (1),1,1,0.999,1
RNA Polymerase II Transcription Termination,Reactome,1,SRSF5,67 (67),0.965,1,0,,1 (1),1,1,0.999,1
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Reactome,1,KDM4C,68 (69),0.966,1,0,,10 (11),1,1,0.999,1
Gap-filling DNA repair synthesis and ligation in TC-NER,Reactome,1,HMGN1,68 (68),0.966,1,0,,1 (2),1,1,0.999,1
PPAR signaling pathway,Wikipathways,1,EHHADH,68 (68),0.966,1,0,,1 (7),1,1,0.999,1
Loss of Nlp from mitotic centrosomes,Reactome,1,SDCCAG8,69 (69),0.968,1,0,,2 (2),1,1,0.999,1
Loss of proteins required for interphase microtubule organization from the centrosome,Reactome,1,SDCCAG8,69 (69),0.968,1,0,,2 (2),1,1,0.999,1
Dual incision in TC-NER,Reactome,1,HMGN1,69 (69),0.968,1,0,,3 (3),1,1,0.999,1
Mitotic Anaphase,Reactome,3,PTTG1;CLIP1;NDEL1,140 (140),0.969,1,0,,4 (4),1,1,1,1
Glycolysis,Reactome,1,PGM2L1,70 (71),0.97,1,0,,26 (32),1,1,1,1
Mitotic Metaphase and Anaphase,Reactome,3,PTTG1;CLIP1;NDEL1,141 (141),0.97,1,0,,4 (4),1,1,1,1
Resolution of Sister Chromatid Cohesion,Reactome,2,CLIP1;NDEL1,109 (109),0.972,1,0,,6 (6),1,1,1,1
AURKA Activation by TPX2,Reactome,1,SDCCAG8,72 (72),0.973,1,0,,2 (2),1,1,1,1
Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,1,SRSF5,73 (73),0.974,1,0,,3 (4),1,1,1,1
Senescence-Associated Secretory Phenotype (SASP),Reactome,2,RPS6KA2;RPS6KA3,111 (112),0.974,1,0,,4 (4),1,1,1,1
RMTs methylate histone arginines,Reactome,1,WDR77,74 (74),0.975,1,0,,4 (4),1,1,1,1
PPAR signaling pathway - Homo sapiens (human),KEGG,1,EHHADH,74 (74),0.975,1,0,,5 (5),1,1,1,1
Processing of Capped Intron-Containing Pre-mRNA,Reactome,6,PPIL4;SMNDC1;RBM22;DDX5;SYF2;SRSF5,240 (240),0.978,1,0,,3 (4),1,1,1,1
Centrosome maturation,Reactome,1,SDCCAG8,80 (80),0.982,1,0,,2 (2),1,1,1,1
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,1,HMGN1,81 (81),0.982,1,0,,5 (6),1,1,1,1
Transport of Mature Transcript to Cytoplasm,Reactome,1,SRSF5,82 (82),0.983,1,0,,3 (4),1,1,1,1
RUNX1 regulates transcription of genes involved in differentiation of HSCs,Reactome,1,KMT2A,86 (88),0.986,1,0,,4 (4),1,1,1,1
Regulation of Complement cascade,Reactome,2,CD55;SERPING1,129 (130),0.988,1,0,,2 (8),1,1,1,1
GPCRs_ Class A Rhodopsin-like,Wikipathways,6,SSTR4;F2RL1;ADORA2A;CXCR4;EDNRA;GPR65,261 (261),0.989,1,0,,6 (10),1,1,1,1
RNA Polymerase I Chain Elongation,Reactome,1,POLR1A,91 (92),0.989,1,0,,4 (5),1,1,1,1
Oxidative phosphorylation - Homo sapiens (human),KEGG,2,ATP6V1E1;ATP6V0A1,133 (133),0.99,1,0,,15 (16),1,1,1,1
B-WICH complex positively regulates rRNA expression,Reactome,1,POLR1A,93 (94),0.99,1,0,,2 (2),1,1,1,1
Role of LAT2/NTAL/LAB on calcium mobilization,Reactome,1,PIK3CA,93 (93),0.99,1,0,,3 (5),1,1,1,1
Formation of the beta-catenin:TCF transactivating complex,Reactome,1,TLE4,93 (94),0.99,1,0,,4 (4),1,1,1,1
G2/M Transition,Reactome,2,PPP1R12A;SDCCAG8,137 (137),0.992,1,0,,8 (8),1,1,1,1
Mitotic G2-G2/M phases,Reactome,2,PPP1R12A;SDCCAG8,139 (139),0.992,1,0,,8 (8),1,1,1,1
Complement cascade,Reactome,2,CD55;SERPING1,140 (141),0.993,1,0,,4 (15),1,1,1,1
Antimicrobial peptides,Reactome,1,PGLYRP2,100 (106),0.993,1,0,,13 (23),1,1,1,1
Respiratory electron transport,Reactome,1,NDUFAF2,100 (100),0.993,1,0,,12 (15),1,1,1,1
Reproduction,Reactome,1,IZUMO1,103 (104),0.994,1,0,,8 (12),1,1,1,1
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,1,SLC25A27,103 (103),0.994,1,0,,10 (12),1,1,1,1
Mitotic Prometaphase,Reactome,3,CLIP1;NDEL1;SDCCAG8,186 (186),0.995,1,0,,6 (6),1,1,1,1
NoRC negatively regulates rRNA expression,Reactome,1,POLR1A,107 (108),0.995,1,0,,6 (9),1,1,1,1
Positive epigenetic regulation of rRNA expression,Reactome,1,POLR1A,108 (109),0.995,1,0,,4 (5),1,1,1,1
Negative epigenetic regulation of rRNA expression,Reactome,1,POLR1A,110 (111),0.996,1,0,,8 (12),1,1,1,1
RNA Polymerase I Promoter Clearance,Reactome,1,POLR1A,111 (112),0.996,1,0,,3 (4),1,1,1,1
RNA Polymerase I Transcription,Reactome,1,POLR1A,113 (114),0.996,1,0,,6 (8),1,1,1,1
Nucleotide Excision Repair,Reactome,1,HMGN1,113 (113),0.996,1,0,,7 (8),1,1,1,1
L13a-mediated translational silencing of Ceruloplasmin expression,Reactome,1,EIF4A2,123 (125),0.998,1,0,,1 (1),1,1,1,1
Cell Cycle Checkpoints,Reactome,4,MDM2;MDM4;NDEL1;CLIP1,249 (250),0.998,1,0,,3 (3),1,1,1,1
TCF dependent signaling in response to WNT,Reactome,2,TLE4;RYK,188 (190),0.999,1,0,,9 (11),1,1,1,1
Epigenetic regulation of gene expression,Reactome,1,POLR1A,150 (151),0.999,1,0,,18 (24),1,1,1,1
DNA Repair,Reactome,4,ALKBH2;RCHY1;TRIM25;HMGN1,317 (320),1,1,0,,38 (48),1,1,1,1
KitReceptor,NetPath,5,MAPK12;PRKCA;STAT1;PIK3CA;TEC,70 (70),0.253,1,0,,0 (0),1,1,0.253,1
Hypertrophy Model,Wikipathways,2,IFRD1;IL18,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
Angiogenesis,Wikipathways,2,PIK3CA;FGFR2,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
tgf beta signaling pathway,BioCarta,2,SKIL;TGFBR1,20 (20),0.253,1,0,,0 (1),1,1,0.253,1
NOTCH3 Intracellular Domain Regulates Transcription,Reactome,2,MAML2;STAT1,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
Receptor-type tyrosine-protein phosphatases,Reactome,2,PPFIBP1;PPFIBP2,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
HH-Ncore,Signalink,2,RAB23;SPOP,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
TP53 Network,Wikipathways,2,MDM2;TNFSF10,20 (20),0.253,1,0,,0 (0),1,1,0.253,1
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Wikipathways,3,IL10;RAP1B;PDCD4,36 (36),0.254,1,0,,0 (0),1,1,0.254,1
hiv-1 nef: negative effector of fas and tnf,BioCarta,4,MDM2;CASP3;CFLAR;BIRC2,53 (53),0.256,1,0,,0 (0),1,1,0.256,1
TNFR1-mediated ceramide production,Reactome,1,SMPD3,6 (6),0.258,1,0,,0 (0),1,1,0.258,1
NADE modulates death signalling,Reactome,1,CASP3,6 (6),0.258,1,0,,0 (0),1,1,0.258,1
SMAD2/3 Phosphorylation Motif Mutants in Cancer,Reactome,1,TGFBR1,6 (6),0.258,1,0,,0 (0),1,1,0.258,1
IL-6 signaling,INOH,1,JAK1,6 (6),0.258,1,0,,0 (0),1,1,0.258,1
RUNX1 regulates transcription of genes involved in BCR signaling,Reactome,1,BLK,6 (7),0.258,1,0,,0 (0),1,1,0.258,1
AndrogenReceptor,NetPath,9,MDM2;CASP1;CASP3;NCOA1;KDM4C;RCHY1;NCOR1;DDX5;SVIL,143 (143),0.259,1,0,,0 (0),1,1,0.259,1
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,17,TNFRSF17;TNFSF13B;IL10;TNFRSF13B;TGFBR1;TNFSF10;CXCL3;CXCL10;CXCR4;TNFRSF13C;BMP6;IL5RA;BMPR1A;PRLR;IL18;IL27;LEPR,294 (294),0.263,1,0,,0 (0),1,1,0.263,1
TSLP,NetPath,2,JAK1;STAT1,21 (21),0.272,1,0,,0 (0),1,1,0.272,1
igf-1 signaling pathway,BioCarta,2,IGF1R;PIK3CA,21 (21),0.272,1,0,,0 (0),1,1,0.272,1
IFN alpha signaling,INOH,2,JAK1;STAT1,21 (21),0.272,1,0,,0 (0),1,1,0.272,1
TGF-beta Receptor Signaling,Wikipathways,4,STAT1;SKIL;JAK1;TGFBR1,55 (55),0.277,1,0,,0 (0),1,1,0.277,1
BMP2 signaling TGF-beta MV,INOH,4,BMPR1A;BMP6;TGFBR1;MAML2,56 (56),0.288,1,0,,0 (0),1,1,0.288,1
Other types of O-glycan biosynthesis - Homo sapiens (human),KEGG,2,ST6GAL1;OGT,22 (22),0.29,1,0,,0 (0),1,1,0.29,1
inhibition of cellular proliferation by gleevec,BioCarta,2,PIK3CA;STAT1,22 (22),0.29,1,0,,0 (0),1,1,0.29,1
Pink/Parkin Mediated Mitophagy,Reactome,2,SQSTM1;MAP1LC3B,22 (22),0.29,1,0,,0 (0),1,1,0.29,1
Validated targets of C-MYC transcriptional repression,PID,5,CFLAR;DNTT;NDRG1;COL1A2;MAX,74 (74),0.29,1,0,,0 (0),1,1,0.29,1
Fibroblast growth factor-1,NetPath,5,RPS6KA3;SLAMF7;RAB11A;SDC1;FGFR2,74 (74),0.29,1,0,,0 (0),1,1,0.29,1
tsp-1 induced apoptosis in microvascular endothelial cell,BioCarta,1,CASP3,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
rna polymerase iii transcription,BioCarta,1,NR3C1,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
GLI proteins bind promoters of Hh responsive genes to promote transcription,Reactome,1,PTCH1,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
NrCAM interactions,Reactome,1,NRP2,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
IL-2 signaling,INOH,1,JAK1,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
IL-3 signaling,INOH,1,JAK1,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
ATF4 activates genes,Wikipathways,1,HERPUD1,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
Post-transcriptional silencing by small RNAs,Reactome,1,AGO4,7 (7),0.294,1,0,,0 (1),1,1,0.294,1
POU5F1 (OCT4)_ SOX2_ NANOG repress genes related to differentiation,Wikipathways,1,HHEX,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
Hfe effect on hepcidin production,Wikipathways,1,BMP6,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),Wikipathways,1,CTLA4,7 (7),0.294,1,0,,0 (0),1,1,0.294,1
IL-17 signaling pathway - Homo sapiens (human),KEGG,6,MAPK11;MAPK13;CASP3;CXCL3;CXCL10;MAPK12,93 (93),0.297,1,0,,0 (0),1,1,0.297,1
EGF-Ncore,Signalink,4,PRKCA;MDM2;LRIG1;PEBP1,57 (57),0.3,1,0,,0 (0),1,1,0.3,1
G alpha (s) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB01201,25 (25),0.304,1,0.304,1
Bladder Cancer,Wikipathways,3,MMP2;BRAF;MDM2,40 (40),0.307,1,0,,0 (0),1,1,0.307,1
induction of apoptosis through dr3 and dr4/5 death receptors,BioCarta,2,CASP3;TNFSF10,23 (23),0.308,1,0,,0 (0),1,1,0.308,1
GPCRs_ Class B Secretin-like,Wikipathways,2,ADGRL2;ADGRL4,23 (23),0.308,1,0,,0 (0),1,1,0.308,1
Antigen processing and presentation - Homo sapiens (human),KEGG,5,CTSS;LGMN;TAP1;CD74;B2M,77 (77),0.319,1,0,,0 (0),1,1,0.319,1
BMP receptor signaling,PID,3,BMPR1A;ZFYVE16;BMP6,41 (41),0.321,1,0,,0 (0),1,1,0.321,1
Bladder cancer - Homo sapiens (human),KEGG,3,MDM2;BRAF;MMP2,41 (41),0.321,1,0,,0 (0),1,1,0.321,1
miRs in Muscle Cell Differentiation,Wikipathways,3,MEF2C;PRKCA;PRKCZ,41 (41),0.321,1,0,,0 (0),1,1,0.321,1
Common Pathways Underlying Drug Addiction,Wikipathways,3,PRKCA;RAP1B;CAMK2A,41 (41),0.321,1,0,,0 (0),1,1,0.321,1
Intraflagellar transport,Reactome,3,IFT22;TTC26;IFT81,41 (41),0.321,1,0,,0 (0),1,1,0.321,1
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,Reactome,1,AGO4,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,BioCarta,1,NCOA1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
Interleukin-15 signaling,Reactome,1,JAK1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
Phase I biotransformations_ non P450,Wikipathways,1,PON3,8 (8),0.329,1,0,,0 (4),1,1,0.329,1
stat3 signaling pathway,BioCarta,1,JAK1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
inhibition of matrix metalloproteinases,BioCarta,1,MMP2,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
west nile virus,BioCarta,1,CASP3,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
g-secretase mediated erbb4 signaling pathway,BioCarta,1,PRKCA,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
Regulation of commissural axon pathfinding by SLIT and ROBO,Reactome,1,DCC,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
cell to cell adhesion signaling,BioCarta,1,BCAR1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
Ligand-receptor interactions,Reactome,1,PTCH1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
Regulation of PTEN mRNA translation,Reactome,1,AGO4,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
VEGF binds to VEGFR leading to receptor dimerization,Reactome,1,FLT4,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
VEGF ligand-receptor interactions,Reactome,1,FLT4,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
IL-4 signaling,INOH,1,JAK1,8 (8),0.329,1,0,,0 (0),1,1,0.329,1
TGF-Core,Signalink,3,BMPR1A;BMP6;TGFBR1,42 (42),0.334,1,0,,0 (0),1,1,0.334,1
Phase I - Functionalization of compounds,Wikipathways,0,,0 (0),1,1,3,HMDB00925;HMDB00658#HMDB10370;HMDB01043,144 (195),0.34,1,0.34,1
IL-7 Signaling Pathway,Wikipathways,2,STAT1;JAK1,25 (25),0.344,1,0,,0 (0),1,1,0.344,1
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,Wikipathways,2,FBN2;TGFBR1,25 (25),0.344,1,0,,0 (0),1,1,0.344,1
Hedgehog Signaling Pathway,Wikipathways,3,SPOP;CCND2;PTCH1,43 (43),0.348,1,0,,0 (0),1,1,0.348,1
miR-targeted genes in squamous cell - TarBase,Wikipathways,9,GFPT1;LAMC1;SRPRB;FNDC3A;DHX40;PDCD4;ARF4;NRP1;SLC12A2,158 (158),0.36,1,0,,0 (0),1,1,0.36,1
FSH,NetPath,1,FOXO1,9 (9),0.361,1,0,,0 (3),1,1,0.361,1
sonic hedgehog receptor ptc1 regulates cell cycle,BioCarta,1,PTCH1,9 (9),0.361,1,0,,0 (0),1,1,0.361,1
A third proteolytic cleavage releases NICD,Reactome,1,APH1B,9 (9),0.361,1,0,,0 (0),1,1,0.361,1
Formation of annular gap junctions,Reactome,1,GJA1,9 (9),0.361,1,0,,0 (0),1,1,0.361,1
Small interfering RNA (siRNA) biogenesis,Reactome,1,AGO4,9 (9),0.361,1,0,,0 (2),1,1,0.361,1
Macrophage markers,Wikipathways,1,CD74,9 (9),0.361,1,0,,0 (0),1,1,0.361,1
Structural Pathway of Interleukin 1 (IL-1),Wikipathways,3,MAPK11;MKNK1;MAP3K3,44 (44),0.361,1,0,,0 (0),1,1,0.361,1
Maturity onset diabetes of the young - Homo sapiens (human),KEGG,2,BHLHA15;HHEX,26 (26),0.362,1,0,,0 (0),1,1,0.362,1
TNFR1-induced NFkappaB signaling pathway,Reactome,2,BIRC2;CYLD,26 (26),0.362,1,0,,0 (0),1,1,0.362,1
Cytosolic DNA-sensing pathway - Homo sapiens (human),KEGG,4,CASP1;CXCL10;IL18;ZBP1,63 (63),0.366,1,0,,0 (1),1,1,0.366,1
GPCRs_ Other,Wikipathways,6,ADGRL2;ADORA2A;GPR55;S1PR1;GPR132;EDNRA,101 (101),0.367,1,0,,0 (0),1,1,0.367,1
Metabolism of porphyrins,Wikipathways,0,,0 (0),1,1,1,HMDB00295,32 (37),0.371,1,0.371,1
Peroxisome - Homo sapiens (human),KEGG,5,PHYH;ABCD2;XDH;FAR1;EHHADH,83 (83),0.377,1,0,,0 (0),1,1,0.377,1
Canonical and Non-canonical Notch signaling,Wikipathways,2,MAML2;DNER,27 (27),0.38,1,0,,0 (0),1,1,0.38,1
IL12-mediated signaling events,PID,4,TBX21;STAT1;IL18;B2M,65 (65),0.389,1,0,,0 (1),1,1,0.389,1
Oncostatin M Signaling Pathway,Wikipathways,4,CASP3;PRKCA;JAK1;STAT1,65 (65),0.389,1,0,,0 (0),1,1,0.389,1
Removal of aminoterminal propeptides from gamma-carboxylated proteins,Reactome,1,BGLAP,10 (10),0.392,1,0,,0 (3),1,1,0.392,1
Gap junction degradation,Reactome,1,GJA1,10 (10),0.392,1,0,,0 (0),1,1,0.392,1
regulation of transcriptional activity by pml,BioCarta,1,SP100,10 (10),0.392,1,0,,0 (0),1,1,0.392,1
Cohesin Loading onto Chromatin,Reactome,1,NIPBL,10 (10),0.392,1,0,,0 (0),1,1,0.392,1
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),Reactome,1,CTLA4,10 (11),0.392,1,0,,0 (1),1,1,0.392,1
LIF signaling,INOH,1,JAK1,10 (10),0.392,1,0,,0 (0),1,1,0.392,1
Cytokines and Inflammatory Response,Wikipathways,2,PDGFA;IL10,28 (29),0.397,1,0,,0 (0),1,1,0.397,1
IL3-mediated signaling events,PID,2,CISH;PIK3CA,28 (28),0.397,1,0,,0 (0),1,1,0.397,1
NOTCH-Ncore,Signalink,2,MAML2;RAB11A,28 (28),0.397,1,0,,0 (0),1,1,0.397,1
influence of ras and rho proteins on g1 to s transition,BioCarta,2,PIK3CA;PAK1,28 (28),0.397,1,0,,0 (0),1,1,0.397,1
Glucose metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB01201,35 (43),0.398,1,0.398,1
HIF-1-alpha transcription factor network,PID,4,NCOA1;CP;CXCR4;NDRG1,66 (66),0.4,1,0,,0 (3),1,1,0.4,1
Validated transcriptional targets of deltaNp63 isoforms,PID,3,MDM2;ITGA3;RRAD,47 (48),0.401,1,0,,0 (0),1,1,0.401,1
Pathways in clear cell renal cell carcinoma,Wikipathways,5,KDM5C;RAPGEF5;PDGFRA;SSPN;SQSTM1,86 (86),0.407,1,0,,0 (1),1,1,0.407,1
Neutrophil degranulation,Reactome,25,ORMDL3;MGAM;RAP1B;ATP6V0A1;TXNDC5;ATP11B;ATG7;GSDMD;PRDX4;B2M;YPEL5;GMFG;CD55;RAB3D;PYGL;ATP11A;ITGAL;CREG1;ADAM8;MNDA;RAB5B;CTSS;SLPI;DDX3X;ARMC8,485 (490),0.408,1,0,,0 (4),1,1,0.408,1
TNF,INOH,4,PSMA3;PSMB9;CASP3;CFLAR,67 (67),0.411,1,0,,0 (0),1,1,0.411,1
Notch signaling pathway - Homo sapiens (human),KEGG,3,APH1B;MAML2;CIR1,48 (48),0.414,1,0,,0 (0),1,1,0.414,1
Alpha6 beta4 integrin-ligand interactions,PID,1,LAMC1,11 (11),0.422,1,0,,0 (0),1,1,0.422,1
Apoptotic cleavage of cell adhesion  proteins,Reactome,1,CASP3,11 (11),0.422,1,0,,0 (0),1,1,0.422,1
apoptotic dna-fragmentation and tissue homeostasis,BioCarta,1,CASP3,11 (11),0.422,1,0,,0 (0),1,1,0.422,1
granzyme a mediated apoptosis pathway,BioCarta,1,CASP3,11 (11),0.422,1,0,,0 (0),1,1,0.422,1
Nucleotide Excision Repair ,SMPDB,1,POLR1A,11 (11),0.422,1,0,,0 (0),1,1,0.422,1
NHR,Signalink,3,NR1D1;NR3C1;NR1D2,49 (49),0.428,1,0,,0 (0),1,1,0.428,1
Mitophagy,Reactome,2,SQSTM1;MAP1LC3B,30 (30),0.432,1,0,,0 (0),1,1,0.432,1
TGF-beta receptor signaling,PID,3,ZFYVE16;TGFBR1;CAMK2A,50 (50),0.441,1,0,,0 (0),1,1,0.441,1
Chemokine receptors bind chemokines,Reactome,3,CXCL3;CXCL10;CXCR4,50 (50),0.441,1,0,,0 (0),1,1,0.441,1
The citric acid (TCA) cycle and respiratory electron transport,Wikipathways,0,,0 (0),1,1,1,HMDB01201,40 (44),0.441,1,0.441,1
POU5F1 (OCT4)_ SOX2_ NANOG activate genes related to proliferation,Reactome,1,POU6F1,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
IL9,NetPath,1,JAK1,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Caspase-mediated cleavage of cytoskeletal proteins,Reactome,1,CASP3,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Butyrophilin (BTN) family interactions,Reactome,1,XDH,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
NOTCH2 intracellular domain regulates transcription,Reactome,1,MAML2,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Receptor Mediated Mitophagy,Reactome,1,MAP1LC3B,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Gap junction trafficking,Reactome,1,GJA1,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Bone Morphogenic Protein (BMP) Signalling and Regulation,Wikipathways,1,BMPR1A,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
RalA downstream regulated genes,Wikipathways,1,EXOC2,12 (12),0.45,1,0,,0 (0),1,1,0.45,1
Nuclear Receptor transcription pathway,Reactome,3,NR1D1;NR3C1;NR1D2,51 (51),0.453,1,0,,0 (0),1,1,0.453,1
Wnt Signaling Pathway,Wikipathways,3,GJA1;PRKCA;RYK,51 (51),0.453,1,0,,0 (0),1,1,0.453,1
TGF-beta Signaling Pathway,Wikipathways,7,SKIL;NEDD9;ZFYVE16;TGFBR1;MEF2C;BCAR1;COL1A2,132 (132),0.461,1,0,,0 (0),1,1,0.461,1
T-Cell antigen Receptor (TCR) Signaling Pathway,Wikipathways,5,CARD11;GRAP2;CD28;PAK1;IRF4,92 (92),0.464,1,0,,0 (0),1,1,0.464,1
Development and heterogeneity of the ILC family,Wikipathways,2,TBX21;IL18,32 (32),0.465,1,0,,0 (0),1,1,0.465,1
TGF_beta_Receptor,NetPath,9,SKIL;FOXO1;ZFYVE16;TGFBR1;NCOA1;PIK3CA;MEF2C;SPARC;BCAR1,173 (174),0.465,1,0,,0 (0),1,1,0.465,1
Adherens junction - Homo sapiens (human),KEGG,4,IGF1R;INSR;TGFBR1;FARP2,72 (72),0.466,1,0,,0 (0),1,1,0.466,1
Activation of DNA fragmentation factor,Reactome,1,CASP3,13 (13),0.477,1,0,,0 (1),1,1,0.477,1
Apoptosis induced DNA fragmentation,Reactome,1,CASP3,13 (13),0.477,1,0,,0 (1),1,1,0.477,1
Notch-HLH transcription pathway,Reactome,1,MAML2,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
NICD traffics to nucleus,Reactome,1,MAML2,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
p53 signaling pathway,BioCarta,1,MDM2,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
TNFR1-induced proapoptotic signaling,Reactome,1,CYLD,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
il 6 signaling pathway,BioCarta,1,JAK1,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
attenuation of gpcr signaling,BioCarta,1,PRKCA,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
Non-homologous end-joining - Homo sapiens (human),KEGG,1,DNTT,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
role of mitochondria in apoptotic signaling,BioCarta,1,BIRC2,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
TFs Regulate miRNAs related to cardiac hypertrophy,Wikipathways,1,MYEF2,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
Development of pulmonary dendritic cells and macrophage subsets,Wikipathways,1,IRF4,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
EDA Signalling in Hair Follicle Development,Wikipathways,1,PTCH1,13 (13),0.477,1,0,,0 (0),1,1,0.477,1
Selenoamino acid metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB01201,45 (59),0.48,1,0.48,1
Apoptosis - multiple species - Homo sapiens (human),KEGG,2,BIRC2;CASP3,33 (33),0.481,1,0,,0 (0),1,1,0.481,1
Pregnane X Receptor pathway,Wikipathways,2,NCOA1;FOXO1,33 (33),0.481,1,0,,0 (1),1,1,0.481,1
Bacterial invasion of epithelial cells - Homo sapiens (human),KEGG,4,PIK3CA;BCAR1;ARPC2;CD2AP,74 (74),0.487,1,0,,0 (0),1,1,0.487,1
IL1,NetPath,3,PELI1;IRAK3;SQSTM1,54 (54),0.491,1,0,,0 (1),1,1,0.491,1
Hematopoietic cell lineage - Homo sapiens (human),KEGG,5,IL5RA;ITGA3;CD55;MS4A1;DNTT,96 (97),0.502,1,0,,0 (0),1,1,0.502,1
RUNX3 regulates NOTCH signaling,Reactome,1,MAML2,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
Atypical NF-kappaB pathway,PID,1,PIK3CA,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
Mitotic Telophase/Cytokinesis,Reactome,1,NIPBL,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
akap95 role in mitosis and chromosome dynamics,BioCarta,1,DDX5,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
Repression of WNT target genes,Reactome,1,TLE4,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
apoptotic signaling in response to dna damage,BioCarta,1,CASP3,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
il 2 signaling pathway,BioCarta,1,JAK1,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
JNK signaling in the CD4+ TCR pathway,PID,1,GRAP2,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
Ifosfamide Pathway_ Pharmacodynamics,PharmGKB,1,ALDH1A1,14 (14),0.502,1,0,,0 (0),1,1,0.502,1
HIV-1 Nef: Negative effector of Fas and TNF-alpha,PID,2,CASP3;CFLAR,35 (35),0.512,1,0,,0 (0),1,1,0.512,1
Class I PI3K signaling events mediated by Akt,PID,2,AKT3;FOXO1,35 (35),0.512,1,0,,0 (0),1,1,0.512,1
Viral carcinogenesis - Homo sapiens (human),KEGG,10,MDM2;JAK1;PIK3CA;GTF2A1;SP100;ATF4;DDX3X;CASP3;CREB3L2;CCND2,201 (201),0.515,1,0,,0 (0),1,1,0.515,1
Hepatitis C and Hepatocellular Carcinoma,Wikipathways,3,CASP3;JAK1;TGFBR1,56 (56),0.516,1,0,,0 (0),1,1,0.516,1
Regulation of sister chromatid separation at the metaphase-anaphase transition,Wikipathways,1,PTTG1,15 (15),0.526,1,0,,0 (0),1,1,0.526,1
IL-6-type cytokine receptor ligand interactions,Reactome,1,JAK1,15 (15),0.526,1,0,,0 (1),1,1,0.526,1
il 4 signaling pathway,BioCarta,1,JAK1,15 (15),0.526,1,0,,0 (0),1,1,0.526,1
Elastic fibre formation,Reactome,2,FBN2;FBLN2,36 (36),0.528,1,0,,0 (0),1,1,0.528,1
CRH,NetPath,2,PLCG2;PRKCA,36 (36),0.528,1,0,,0 (0),1,1,0.528,1
Neurexins and neuroligins,Reactome,3,DLG2;STXBP1;CASK,57 (57),0.528,1,0,,0 (0),1,1,0.528,1
p73 transcription factor network,PID,4,MAPK11;MDM2;RCHY1;JAK1,79 (79),0.539,1,0,,0 (0),1,1,0.539,1
p53 pathway,PID,3,MDM2;MDM4;SETD7,58 (58),0.54,1,0,,0 (0),1,1,0.54,1
signal transduction through il1r,BioCarta,2,PEBP1;IRAK3,37 (37),0.542,1,0,,0 (2),1,1,0.542,1
Wnt Signaling Pathway and Pluripotency,Wikipathways,5,PRKCA;CCND2;LRRK2;WNT10A;PRKCZ,101 (101),0.547,1,0,,0 (1),1,1,0.547,1
Hedgehog Signaling Pathway,Wikipathways,1,PTCH1,16 (16),0.549,1,0,,0 (0),1,1,0.549,1
human cytomegalovirus and map kinase pathways,BioCarta,1,PIK3CA,16 (16),0.549,1,0,,0 (0),1,1,0.549,1
G13 Signaling Pathway,Wikipathways,2,PIK3CA;RHPN2,38 (38),0.557,1,0,,0 (0),1,1,0.557,1
Oncostatin_M,NetPath,2,STAT1;JAK1,38 (38),0.557,1,0,,0 (0),1,1,0.557,1
Liver steatosis AOP,Wikipathways,5,PNPLA2;NCOA1;EHHADH;FOXO1;PRKAG2,103 (103),0.565,1,0,,0 (0),1,1,0.565,1
Formation of Senescence-Associated Heterochromatin Foci (SAHF),Reactome,1,HMGA2,17 (17),0.571,1,0,,0 (1),1,1,0.571,1
y branching of actin filaments,BioCarta,1,ARPC2,17 (17),0.571,1,0,,0 (0),1,1,0.571,1
tnfr1 signaling pathway,BioCarta,1,CASP3,17 (17),0.571,1,0,,0 (0),1,1,0.571,1
Cyclophosphamide Pathway_ Pharmacodynamics,PharmGKB,1,ALDH1A1,17 (17),0.571,1,0,,0 (0),1,1,0.571,1
NOTCH1 regulation of human endothelial cell calcification,Wikipathways,1,GJA5,17 (17),0.571,1,0,,0 (0),1,1,0.571,1
Signaling events mediated by HDAC Class III,PID,2,ACSS1;FOXO1,39 (39),0.571,1,0,,0 (0),1,1,0.571,1
Nuclear Receptors Meta-Pathway,Wikipathways,15,DNER;NAV3;FOXO1;MAFG;FGD4;BIRC2;HGF;SQSTM1;ABHD2;NCOA1;IRS2;SLC39A4;NR3C1;EHHADH;AMIGO2,316 (316),0.574,1,0,,0 (0),1,1,0.574,1
Oxidative Damage,Wikipathways,2,MAPK13;CASP3,40 (40),0.585,1,0,,0 (0),1,1,0.585,1
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,Wikipathways,1,JAK1,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
Other glycan degradation - Homo sapiens (human),KEGG,1,HEXA,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
atm signaling pathway,BioCarta,1,MDM2,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
er associated degradation (erad) pathway,BioCarta,1,MAN1B1,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
regulation of cell cycle progression by plk3,BioCarta,1,CASP3,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
Genes targeted by miRNAs in adipocytes,Wikipathways,1,GJA1,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway,Wikipathways,1,COL2A1,18 (18),0.592,1,0,,0 (0),1,1,0.592,1
TGF-beta signaling pathway - Homo sapiens (human),KEGG,4,BMPR1A;BMP6;TGFBR1;ZFYVE16,85 (85),0.597,1,0,,0 (0),1,1,0.597,1
Gastrin,NetPath,2,PRKCA;BCAR1,41 (41),0.599,1,0,,0 (0),1,1,0.599,1
Eukaryotic Transcription Initiation,Wikipathways,2,POLR1A;TAF7,41 (41),0.599,1,0,,0 (0),1,1,0.599,1
Genotoxicity pathway,Wikipathways,3,TNFRSF17;MDM2;SEL1L,64 (64),0.607,1,0,,0 (0),1,1,0.607,1
prion pathway,BioCarta,1,LAMC1,19 (19),0.612,1,0,,0 (0),1,1,0.612,1
Apoptosis Modulation by HSP70,Wikipathways,1,CASP3,19 (19),0.612,1,0,,0 (0),1,1,0.612,1
HH-Core,Signalink,1,PTCH1,19 (19),0.612,1,0,,0 (0),1,1,0.612,1
Farnesoid X Receptor Pathway,Wikipathways,1,IRS2,19 (19),0.612,1,0,,0 (1),1,1,0.612,1
Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex,Wikipathways,1,ZFX,19 (19),0.612,1,0,,0 (0),1,1,0.612,1
G alpha (i) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB01201,65 (93),0.613,1,0.613,1
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB01201,66 (91),0.619,1,0.619,1
miR-targeted genes in leukocytes - TarBase,Wikipathways,7,MIR15B;KCNN4;ATP6V0A1;IFRD1;UNC93B1;DDX5;ARF4,154 (154),0.625,1,0,,0 (0),1,1,0.625,1
SUMOylation of transcription factors,Reactome,1,MDM2,20 (20),0.631,1,0,,0 (0),1,1,0.631,1
Olfactory bulb development and olfactory learning,Wikipathways,1,LRRK2,20 (20),0.631,1,0,,0 (0),1,1,0.631,1
BMP Signaling Pathway in Eyelid Development,Wikipathways,1,FGFR2,20 (20),0.631,1,0,,0 (0),1,1,0.631,1
Androgen receptor signaling pathway,Wikipathways,4,NCOA1;MDM2;NCOR1;FOXO1,89 (89),0.634,1,0,,0 (0),1,1,0.634,1
Spliceosome - Homo sapiens (human),KEGG,6,PRPF40B;SMNDC1;RBM22;DDX5;SYF2;SRSF5,134 (134),0.639,1,0,,0 (0),1,1,0.639,1
TICAM1_ RIP1-mediated IKK complex recruitment ,Reactome,1,BIRC2,21 (21),0.649,1,0,,0 (1),1,1,0.649,1
p38 signaling mediated by MAPKAP kinases,PID,1,MAPK11,21 (21),0.649,1,0,,0 (0),1,1,0.649,1
cell cycle: g2/m checkpoint,BioCarta,1,MDM2,21 (21),0.649,1,0,,0 (0),1,1,0.649,1
Regulation of Apoptosis by Parathyroid Hormone-related Protein,Wikipathways,1,PIK3CG,21 (21),0.649,1,0,,0 (0),1,1,0.649,1
TGF-Ncore,Signalink,2,SKIL;NR3C1,45 (45),0.65,1,0,,0 (0),1,1,0.65,1
Proteasome - Homo sapiens (human),KEGG,2,PSMB9;PSMA3,45 (45),0.65,1,0,,0 (0),1,1,0.65,1
Basal transcription factors - Homo sapiens (human),KEGG,2,GTF2A1;TAF7,45 (45),0.65,1,0,,0 (0),1,1,0.65,1
Human metabolism overview,Wikipathways,0,,0 (0),1,1,1,HMDB00618#HMDB01548,73 (113),0.656,1,0.656,1
Ubiquitin mediated proteolysis - Homo sapiens (human),KEGG,6,MDM2;BIRC2;RCHY1;HERC4;RHOBTB1;SYVN1,137 (137),0.66,1,0,,0 (0),1,1,0.66,1
BDNF,NetPath,2,IRS2;RPS6KA3,46 (46),0.661,1,0,,0 (0),1,1,0.661,1
hypoxia and p53 in the cardiovascular system,BioCarta,1,MDM2,22 (22),0.666,1,0,,0 (0),1,1,0.666,1
erk1/erk2 mapk signaling pathway,BioCarta,1,MKNK1,22 (22),0.666,1,0,,0 (1),1,1,0.666,1
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Reactome,2,GTF2A1;TAF7,47 (47),0.673,1,0,,0 (0),1,1,0.673,1
Heart Development,Wikipathways,2,MEF2C;BMPR1A,47 (47),0.673,1,0,,0 (0),1,1,0.673,1
Protein export - Homo sapiens (human),KEGG,1,SRPRB,23 (23),0.682,1,0,,0 (0),1,1,0.682,1
APC/C:Cdc20 mediated degradation of Securin,Reactome,1,PTTG1,23 (23),0.682,1,0,,0 (0),1,1,0.682,1
RNA Polymerase III Transcription Termination,Reactome,1,NFIB,23 (24),0.682,1,0,,0 (0),1,1,0.682,1
tnf/stress related signaling,BioCarta,1,ATF1,23 (23),0.682,1,0,,0 (0),1,1,0.682,1
cyclins and cell cycle regulation,BioCarta,1,CCND2,23 (23),0.682,1,0,,0 (0),1,1,0.682,1
EBV LMP1 signaling,Wikipathways,1,MAP3K3,23 (23),0.682,1,0,,0 (0),1,1,0.682,1
Hedgehog,INOH,3,PSMB9;PSMA3;PTCH1,72 (72),0.686,1,0,,0 (0),1,1,0.686,1
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,3,CASP1;TUBB2B;CASK,73 (73),0.695,1,0,,0 (0),1,1,0.695,1
IL-3 Signaling Pathway,Wikipathways,2,IL5RA;JAK1,49 (49),0.695,1,0,,0 (0),1,1,0.695,1
Hematopoietic Stem Cell Differentiation,Wikipathways,2,RIOK3;CXCR4,49 (49),0.695,1,0,,0 (0),1,1,0.695,1
Fas,INOH,1,CASP3,24 (24),0.698,1,0,,0 (0),1,1,0.698,1
C-MYC pathway,PID,1,MAX,25 (25),0.712,1,0,,0 (0),1,1,0.712,1
Hedgehog,NetPath,1,PTCH1,25 (25),0.712,1,0,,0 (0),1,1,0.712,1
Twelve loci associated with ADHD,Wikipathways,1,FOXP2,26 (26),0.726,1,0,,0 (0),1,1,0.726,1
ALK1 signaling events,PID,1,TGFBR1,26 (26),0.726,1,0,,0 (0),1,1,0.726,1
TSH,NetPath,1,IGF1R,26 (26),0.726,1,0,,0 (1),1,1,0.726,1
PPAR Alpha Pathway,Wikipathways,1,EHHADH,26 (26),0.726,1,0,,0 (1),1,1,0.726,1
Steatosis AOP,Wikipathways,1,INSR,26 (26),0.726,1,0,,0 (1),1,1,0.726,1
Apoptosis-related network due to altered Notch3 in ovarian cancer,Wikipathways,2,ERN1;SQSTM1,53 (53),0.736,1,0,,0 (0),1,1,0.736,1
FGFR2 alternative splicing,Reactome,1,FGFR2,27 (27),0.74,1,0,,0 (0),1,1,0.74,1
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Reactome,1,PTTG1,27 (27),0.74,1,0,,0 (0),1,1,0.74,1
Wnt signaling network,PID,1,RYK,28 (29),0.752,1,0,,0 (0),1,1,0.752,1
TWEAK,NetPath,1,BIRC2,28 (28),0.752,1,0,,0 (0),1,1,0.752,1
multi-step regulation of transcription by pitx2,BioCarta,1,CCND2,28 (28),0.752,1,0,,0 (1),1,1,0.752,1
Selective Serotonin Reuptake Inhibitor Pathway_ Pharmacodynamics,PharmGKB,1,PLCB4,28 (28),0.752,1,0,,0 (0),1,1,0.752,1
Validated transcriptional targets of TAp63 isoforms,PID,2,MDM2;ITGA3,55 (55),0.754,1,0,,0 (0),1,1,0.754,1
Staphylococcus aureus infection - Homo sapiens (human),KEGG,2,IL10;ITGAL,55 (56),0.754,1,0,,0 (12),1,1,0.754,1
Ebola Virus Pathway on Host,Wikipathways,5,IGF1R;PIK3CA;ITGA3;STAT1;PAK1,130 (130),0.763,1,0,,0 (0),1,1,0.763,1
Budding and maturation of HIV virion,Reactome,1,CHMP5,30 (30),0.776,1,0,,0 (0),1,1,0.776,1
RNA Polymerase I Promoter Escape,Reactome,1,POLR1A,30 (30),0.776,1,0,,0 (0),1,1,0.776,1
Phase II - Conjugation of compounds,Wikipathways,0,,0 (0),1,1,1,HMDB00295,104 (151),0.784,1,0.784,1
RNA Polymerase I Transcription Termination,Reactome,1,POLR1A,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
Molecules associated with elastic fibres,Reactome,1,FBLN2,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
RNA polymerase - Homo sapiens (human),KEGG,1,POLR1A,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,PTTG1,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
Matrix Metalloproteinases,Wikipathways,1,MMP2,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
IL17 signaling pathway,Wikipathways,1,JAK1,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
Toll-like Receptor Signaling,Wikipathways,1,TLR5,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
Tumor suppressor activity of SMARCB1,Wikipathways,1,PTCH1,31 (31),0.787,1,0,,0 (0),1,1,0.787,1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma,Wikipathways,3,RYK;CCND2;WNT10A,86 (86),0.795,1,0,,0 (0),1,1,0.795,1
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,PTTG1,32 (32),0.797,1,0,,0 (0),1,1,0.797,1
Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,1,PPP3CC,32 (32),0.797,1,0,,0 (0),1,1,0.797,1
Validated targets of C-MYC transcriptional activation,PID,3,CCND2;MAX;NDUFAF2,87 (87),0.801,1,0,,0 (0),1,1,0.801,1
integrin signaling pathway,BioCarta,1,BCAR1,33 (33),0.807,1,0,,0 (0),1,1,0.807,1
Oxidative Stress,Wikipathways,1,XDH,33 (33),0.807,1,0,,0 (1),1,1,0.807,1
IL-1 JNK,INOH,2,PSMB9;PSMA3,62 (62),0.811,1,0,,0 (0),1,1,0.811,1
ATM pathway,PID,1,MDM2,34 (34),0.816,1,0,,0 (0),1,1,0.816,1
Formation of RNA Pol II elongation complex ,Reactome,2,EAF2;MLLT3,63 (65),0.818,1,0,,0 (0),1,1,0.818,1
G1 to S cell cycle control,Wikipathways,2,MDM2;CCND2,64 (64),0.824,1,0,,0 (0),1,1,0.824,1
IL-1 NFkB,INOH,2,PSMB9;PSMA3,64 (64),0.824,1,0,,0 (0),1,1,0.824,1
SUMO E3 ligases SUMOylate target proteins,Reactome,4,SP100;DDX17;SATB1;MDM2,120 (120),0.841,1,0,,0 (0),1,1,0.841,1
ATR signaling pathway,PID,1,MDM2,37 (37),0.842,1,0,,0 (0),1,1,0.842,1
Thyroid cancer - Homo sapiens (human),KEGG,1,BRAF,37 (37),0.842,1,0,,0 (0),1,1,0.842,1
Regulation of Telomerase,PID,2,IRF1;MAX,68 (68),0.849,1,0,,0 (1),1,1,0.849,1
LncRNA involvement in canonical Wnt signaling and colorectal cancer,Wikipathways,3,RYK;CCND2;WNT10A,97 (97),0.856,1,0,,0 (0),1,1,0.856,1
Ghrelin,NetPath,1,PRKCA,39 (39),0.857,1,0,,0 (0),1,1,0.857,1
mRNA Splicing - Major Pathway,Reactome,6,PPIL4;SMNDC1;RBM22;DDX5;SYF2;SRSF5,178 (178),0.869,1,0,,0 (0),1,1,0.869,1
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway,Wikipathways,1,BIRC2,41 (41),0.871,1,0,,0 (0),1,1,0.871,1
Neural Crest Differentiation,Wikipathways,3,COL2A1;LHX1;FGFR2,101 (101),0.874,1,0,,0 (0),1,1,0.874,1
FOXM1 transcription factor network,PID,1,MMP2,42 (42),0.877,1,0,,0 (0),1,1,0.877,1
Kinesins,Reactome,1,KIF1B,43 (43),0.883,1,0,,0 (0),1,1,0.883,1
WNT-Core,Signalink,1,RYK,44 (44),0.889,1,0,,0 (0),1,1,0.889,1
mRNA Splicing,Reactome,6,PPIL4;SMNDC1;RBM22;DDX5;SYF2;SRSF5,186 (186),0.894,1,0,,0 (0),1,1,0.894,1
FOXA2 and FOXA3 transcription factor networks,PID,1,NR3C1,45 (45),0.894,1,0,,0 (4),1,1,0.894,1
RAGE,NetPath,1,PRKCZ,45 (45),0.894,1,0,,0 (0),1,1,0.894,1
Notch Signaling,Wikipathways,1,APH1B,45 (45),0.894,1,0,,0 (0),1,1,0.894,1
Presenilin action in Notch and Wnt signaling,PID,1,APH1B,46 (46),0.899,1,0,,0 (0),1,1,0.899,1
Aryl Hydrocarbon Receptor Pathway,Wikipathways,1,NCOA1,46 (46),0.899,1,0,,0 (1),1,1,0.899,1
RNA degradation - Homo sapiens (human),KEGG,2,BTG3;CNOT6L,79 (79),0.902,1,0,,0 (0),1,1,0.902,1
Cell Differentiation - Index,Wikipathways,1,MEF2C,48 (48),0.909,1,0,,0 (0),1,1,0.909,1
NRF2 pathway,Wikipathways,4,MAFG;HGF;SLC39A4;SQSTM1,142 (142),0.919,1,0,,0 (1),1,1,0.919,1
Cytoplasmic Ribosomal Proteins,Wikipathways,2,RPS6KA2;RPS6KA3,88 (88),0.932,1,0,,0 (0),1,1,0.932,1
Retinoblastoma Gene in Cancer,Wikipathways,2,MDM2;MAPK13,89 (89),0.935,1,0,,0 (0),1,1,0.935,1
Cell Cycle,Wikipathways,3,PTTG1;MDM2;CCND2,120 (120),0.935,1,0,,0 (0),1,1,0.935,1
Mesodermal Commitment Pathway,Wikipathways,4,BMPR1A;HMGA2;ATP8B2;KDM6A,153 (153),0.943,1,0,,0 (0),1,1,0.943,1
Cell cycle - Homo sapiens (human),KEGG,3,PTTG1;MDM2;CCND2,124 (124),0.944,1,0,,0 (0),1,1,0.944,1
Preimplantation Embryo,Wikipathways,1,IRF4,59 (59),0.947,1,0,,0 (0),1,1,0.947,1
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Reactome,2,CLIP1;NDEL1,96 (96),0.951,1,0,,0 (0),1,1,0.951,1
Amplification of signal from the kinetochores,Reactome,2,CLIP1;NDEL1,96 (96),0.951,1,0,,0 (0),1,1,0.951,1
Metapathway biotransformation Phase I and II,Wikipathways,5,HNMT;NDST1;CHST3;CHST1;NAT8L,186 (186),0.951,1,0,,0 (0),1,1,0.951,1
Cell Differentiation - Index expanded,Wikipathways,1,MEF2C,62 (62),0.955,1,0,,0 (0),1,1,0.955,1
miRNAs involved in DNA damage response,Wikipathways,1,MIR15B,62 (62),0.955,1,0,,0 (0),1,1,0.955,1
Wnt,NetPath,1,PRKCA,68 (69),0.966,1,0,,0 (0),1,1,0.966,1
SUMOylation of chromatin organization proteins,Reactome,1,SATB1,70 (70),0.97,1,0,,0 (0),1,1,0.97,1
Mitotic Spindle Checkpoint,Reactome,2,CLIP1;NDEL1,113 (113),0.976,1,0,,0 (0),1,1,0.976,1
SUMOylation of DNA damage response and repair proteins,Reactome,1,SP100,76 (76),0.978,1,0,,0 (0),1,1,0.978,1
Recruitment of NuMA to mitotic centrosomes,Reactome,1,SDCCAG8,79 (79),0.981,1,0,,0 (0),1,1,0.981,1
Recruitment of mitotic centrosome proteins and complexes,Reactome,1,SDCCAG8,80 (80),0.982,1,0,,0 (0),1,1,0.982,1
mRNA surveillance pathway - Homo sapiens (human),KEGG,1,MSI2,91 (91),0.989,1,0,,0 (0),1,1,0.989,1
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,1,REXO2,101 (105),0.994,1,0,,0 (0),1,1,0.994,1
SRP-dependent cotranslational protein targeting to membrane,Reactome,1,SRPRB,123 (124),0.998,1,0,,0 (1),1,1,0.998,1
Olfactory Signaling Pathway,Reactome,1,RTP4,435 (437),1,1,0,,0 (0),1,1,1,1